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PREFACE.
T his study was c a r r ie d  o u t during  th e  ten u re  o f  my appointm ent as R esident 
A ss is ta n t Pjsysician a t  R uch ill Fever H o sp ita l, Glasgow, which I  he ld  from the  
p e rio d  November 1940 u n t i l  May 1942. The main p a r t  o f  th e  work was perform ed 
during  th e  y ear 1941 and f in a l ly  concluded in  February 1942, a t  which tim e I  
rece iv ed  my rec ru itm en t n o tic e  c a l l in g  me to  His M ajesty*s Forces.
I  have always had an in c l in a t io n  towards b iochem istry  s in ce , w hile studying 
fo r  my B.Sc. degree, I  had worked fo r  two y ears  in  the  Physiology L ab o ra to rie s . 
Imm ediately a f t e r  my appointm ent to  R uchill H osp ita l I  became fa m ilia r  w ith 
some o f  th e  methods which had been suggested fo r  the  estim atio n  o f  the  
sulphonamide drugs in  the v a rio u s  b io lo g ic a l f lu id s .  I t  was my prim ary 
in te n tio n  to become f u l ly  conversant w ith  one o f  th ese  methods in  o rd e r to  
p roeecu te  a study o f  th e  abso rp tion  and ex cre tio n  o f th e  sulphonamide drugs, 
which had a t  th a t  time received  l i t t l e  a t te n tio n  in  th i s  country .
A ccordingly, I  made o b serv a tio n s  on th e  co n cen tra tion  o f  sulphanilam ide, 
su lphapyrid ine  and su lp h a th iazo le  in  th e  blood and u rin e  when th e se  drugs 
were adm inistered  to normal persons; in ten d in g  to use  th i s  knowledge as a b a s is  
fo r  fu r th e r  study in  one o r  o th e r  o f  the  acu te  in fe c tio n s  fo r  which they were 
being used in  th e  h o s p ita l .  During th i s  time I  had the  o p p o rtu n ity  o f  
observing a la rg e  number o f cases o f in fe c t io u s  d isea se , and I  became e sp e c ia lly  
in te re s te d  in  lo b a r  pneumonia, one o f the  d isea ses  in  which th e  sulphonamide 
drugs were A pparently having s t r ik in g  e f f e c ts .
R uch ill H osp ital has s e t  a s id e  two wards fo r  th e  recep tio n  o f  pneumonia in  
a d u lt  males and fem ales. A fte r a p re lim in ary  p e rio d , during which I  made m yself 
fa m ilia r  w ith  th e  c l in ic a l  and b a c te r io lo g ic a l exam inations which th i s  type of
case re q u ire s , I  f in a l ly  had th e  good fo rtu n e  to  be in  charge o f  both  pneumonia 
wards.
S ulphapyriaine  had f i r s t  been used in  th e  trea tm en t o f  lo b a r  pneumonia a t  
R u ch ill H osp ita l in  1938. Under th e  guidance o f  Dr. T. Anderson, Deputy 
S uperin tenden t, I  commenced a more thorough study o f  th e  u se  o f  t h i s  drug in  th e  
trea tm en t o f  p a t ie n ts  su ffe r in g  from lo b a r  pneumonia by in v e s t ig a t in g  i t s  
abso rp tion  and ex c re tio n . This a lso  demanded a knowledge o f  th e  p a tien t*  s f lu i d  
in ta k e  and u r in e  ou tp u t.
The typ ing  o f th e  sputum o f  a l l  p a t ie n ts  was c a r r ie d  o u t by th e  d i r e c t  
N eufeld capsule-sw elling  t e s t ,  p rev io u s ly  employed a t  R uch ill H o sp ita l; and i f  
th e  type o f  Jm fecting  pneumococcus could n o t be id e n t i f ie d  by th i s  method, then 
mouse in o c u la tio n  was perform ed. Blood c u ltu re s  were taken in  a l l  cases.
Towards the  end o f  the  study, I  decided to  t r y  th e  e f f e c t  o f  vaccine 
therapy  combined w ith chemotherapy, but u n fo r tu n a te ly  only 61 cases were t re a te d  
in  th i s  manner when the  work was in te r ru p te d . The to t a l  number o f  cases 
in v e s t ig a te d  was 370-
I  should l i k e  to  thank Dr. W.M. E l l i o t t ,  M edical Superin tendent o f  R uch ill 
H o sp ita l, fo r  h is  perm ission to ca rry  ou t th i s  in v e s t ig a t io n . I  am g re a tly  
indeb ted  to  Dr. T. Anderson fo r  h is  many h e lp fu l suggestions and c r i t ic is m , 
and fo r  the  encouragement he gave me throughout th e  whole o f  th i s  woric. My 
thanks a re  a lso  due to  th e  S is te r s  and nursing  s t a f f  o f  th e  pneumonia wards 
fo r  th e i r  co -operation  a t  a l l  tim es.
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INTRODUcTIOij1
Pneumonia i s  a d isease  which has been known to  man fo r  cen tu ries*  I t  i s  
a d isea se  which may be prim ary o r  secondary, and th e  c h a ra c te r  o f  th e  le s io n  
produced may be e i th e r  patchy o r  massive* Thus pa tchy  co n so lid a tio n s  a re  
ty p ic a l o f  bronchopneumonia, w hile m assive le s io n s  a re  c h a r a c te r i s t ic  of 
lo b a r  pneumonia. Under the  im petus o f  the  d iscovery  o f  b a c te r ia  and th e i r  
p o ss ib le  r e la t io n  to d isea se , in v e s t ig a tio n s  o f pneumonia, and p a r t i c u la r ly  o f  
lo b a r  pneumonia, were commenced over f i f t y  y ears  ago.
I t  was in  th e  y ear l 88l  th a t  S ternberg  f i r s t  is o la te d ,  c u ltu re d  and 
described  the  pneumococcus. While in  search  o f  th e  e t io lo g ic a l  agent o f 
ra b ie s ,  P a s teu r in o cu la ted  r a b b i ts  w ith  the  s a l iv a  o f  a c h ild  dead from th a t  
d isease  and produced what he c a lle d  a "sputum sep ticaem ia ."  S ternberg  
in je c te d  ra b b its  subcutaneously w ith s a liv a  from him self and o th e r  normal 
persons and produced an apparen tly  s im ila r  in fe c t io u s  p ro cess . The organism 
is o la te d  by th e se  workers i s  now known as the  pneuraococcus o r d ip lococcus 
pneumoniae.
When f i r s t  d iscovered , the  organism was n o t known to  be a sso c ia te d  w ith 
d isease  in  man. A search was being made fo r  th e  cau sa tiv e  agen t o f pneumonia 
and in  the y ear 1382 F ried lan d e r is o la te d  from e ig h t cases o f pneumonia an 
organism which he believed  to  be re sp o n sib le  f o r  a l l  cases o f pneumonia. 
Subsequently th i s  organism was found in  only occasio n a l cases o f pneumonia and 
i s  now known as F ried lan d e r1 s b a c i l lu s .  As a r e s u l t  o£ th e  in te n s iv e  
in v e s t ig a t io n s  o f  F rankel, i t  was e s ta b lish e d  in  1886 th a t  th e  pneumococcus is  
th e  u sual cause o f  lo b a r  pneumonia in  man. Although i t  i s  n o t th e  only  cau sa tiv e
fa c to r  o f lo b a r  pneumonia, i t  i s  c e r ta in ly  th e  most im portan t e t io lo g ic a l  agent. 
Thus C ec il, Baldwin and Larsen (1927) found pneumococci p re se n t in  over 95 p e r  
cen t, o f 2000 cases o f  lo b a r  pneumonia; w hile S u t i i f f  and F in land  (1933) 
is o la te d  pnaimococci from 98 p e r cen t, o f  th e i r  839 cases.
Pneumococcal lo b a r  pneumonia i s  s t i l l  a very  p re v a le n t d isea se  in  t h i s  
country and accounts fo r  many deaths annually* Since th e  in tro d u c tio n  o f  "P ron tost! 11 
in  1935 many chem otherapeutic agents o f  th e  sulphonamide c la s s  have been employed 
in  th e  trea tm en t o f pneumococcal lo b a r  pneumonia, and have done much to  reduce th e  
m o r ta li ty  r a te .  However, in  Scotland during  1940, d e sp ite  modem chemotherapy ,
873 d eath s were a t t r ib u te d  to  th i s  cause. The death  r a te  i s  s t i l l  high and th e re  
i s  adequate scope fo r  fu r th e r  in v e s t ig a tio n  o f  th i s  d isea se . A ccordingly, I  was 
prompted to  study pneumococcal lo b a r  pneumonia as i t  occurs in  a d u lts ,  making a 
sp e c ia l study o f the  absorp tion  and ex cre tio n  o f  su lphapyrid ine .
Before proceeding to the d e sc r ip tio n  o f th e  370 cases which comprise the  
p re se n t s e r ie s ,  I  in te n d  to survey some o f  the  f a c to r s  which p rev ious workers 
have shown to  be o f value in  the  p rognosis  o f pneumonia. These p ro g n o stic  f a c to rs  
w il l  l a t e r  form the  b a s is  o f  a n a ly s is  o f the  p re se n t s e r ie s .  The second ch ap te r
i
i s  devoted to  the  trea tm en t o f pneumococcal lo b a r  pneumonia. This has changed
considerab ly  in  th e  l a s t  f iv e  y ears . In  th e  p a s t  the  c h ie f  a id s  to the
symptomatic trea tm en t have been the  ad m in is tra tio n  o f  type s p e c if ic  a n t i -
pneumococcal serums, o r  o f  pneumococcus vacc ines. That serum i s  o f  value cannot j
be doubted, bu t such trea tm en t i s  la b o rio u s , expensive and h ard ly  j u s t i f i a b l e  in  j
a l l  cases fo r  which type s p e c if ic  anti-pneum ococcal serum i s  a v a ila b le . Of
vaccine therapy  s t i l l  l e s s  can be sa id  to commend i t .  Chemotherapy, however, provides 
an easy and r e la t iv e ly  inexpensive form o f  trea tm en t. A b r ie f  c la s s i f ic a t io n
o f  the  more im portan t sulphonamide drugs w ill  be given, and th e i r  absorp tion  and
ex cre tio n , and the  methods a v a ila b le  fo r  th e i r  estim ation  in  th e  blood an<|drine
w ill  be desc rib ed . The m e rits  o f th ese  drugs when used in  th e  tre a tm e it o f
pneumococcal lo b a r  pneumonia w ill  be d iscu ssed , as w ill the  value o f  combined
chemo therapy and vaccine therapy . I  s h a l l  then proceed to  d e sc rib e  in  d e ta i l  th e  
various methods, c l in ic a l ,  b a c te r io lo g ic a l, biochem ical and th e ra p e u tic , which 
were employed in  in v e s t ig a tin g  the  cases.
7.
With th i s  f i r s t  p a r t  o f  th e  study a s  a b a s is , I  s h a ll  n e x t tu rn  to  a 
c a re fu l a n a ly s is  o f  the  cases, e sp e c ia lly  in  re sp e c t o f  f a c to r s  o f  p ro g n o stic  
im portance. S pec ial emphasis w ill  be given to  th e  f a t a l  cases which w ill  be 
described  in  d e ta i l .  The r e s u l t s  o f th e  biochem ical study w ill  then be given. 
F i r s t ,  a comparison w ill  be made o f the  blood le v e ls  ob ta ined  when vario u s  
sulphonamides a re  adm in istered  in  varying dosage to normal in d iv id u a ls ; then a 
study w ill  be made o f  th e  ab so rp tio n  and ex cre tio n  o f  su lph ap y rid in e  when 
adm in istered  to  p a t ie n ts  su ffe r in g  from pneumonia. F in a lly , th e  im p lic a tio n s  
o f  th ese  r e s u l t s  in  th e  handling  o f  pneumonia cases w ill  be d iscu ssed .
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CHAPTER I .
The e f f e c t  o f  v a rio u s  f a c to r s  on p ro gnosis  in  pneumococcal lo b a r  pneumonia.
The f a c to r s  governing th e  outcome o f  any a cu te  in fe c t io n  a re  numerous and
b a s ic a l ly  w il l  depend on th e  v iru le n c e , p a th o g e n ic ity  and type o f  th e  in f e c t in g
organism , and on th e  r e s is ta n c e  o f  th e  h o s t. In  pneumonia th e  e x te n to f  th e
d is e a se  and th e  d u ra tio n  o f  i l l n e s s  p r io r  to  th e  i n s t i t u t i o n  o f  tre a tm e n t have
an im p o rtan t b earin g  on outcome, as have many o th e r  f a c to r s  which we a re  about 
«
to d isc u ss . The fa c to r s  o f known p ro g n o s tic  s ig n if ic a n c e  a re  adm irably 
d e sc rib ed  in  such e x c e lle n t tex tbooks as those  o f  Bullowa (1937) 811(1 Heffron 
( I 939) .  A b r ie f  d e sc r ip tio n  o f  th o se  f a c to r s  which were considered  during  th e  
study o f  th e  370 cases o f  lo b a r  pneumonia w i l l ,  however, be given.
1 . The s ig n if ic a n c e  o f  the  type o f  in f e c t in g  oneumococcus:
The e a r l i e s t  c la s s i f i c a t io n  o f  th e  pneumococcus can be tra c ed  to  th e  y ear 
1897 when Bezan^on and G riffpn , a s  a r e s u l t  o f  th e  d iscovery  th a t  a n t i -  
pneumococcal serum had a g g lu tin a tin g  p ro p e r t ie s ,  re p o rte d  th a t  th e re  e x is te d  
sev e ra l s t r a in s  o f  pneumococci which d if f e r e d  s e ro lo g ic a lly . T heir f in d in g s  
depended on th e  f a c t  th a t  se ra  p rep ared  from a c e r ta in  s t r a in  would a g g lu tin a te  
pneumococci i s o la te d  from some p a t ie n ts  s u ffe r in g  from lo b a r  pneumonia bu t n o t 
from o th e rs . They a lso  observed marked a g g lu tin a tio n  between th e  serum o f  
c e r ta in  p a t ie n ts  and th e  p a r t i c u la r  organism causing th e  in f e c t io n .  In  th e  y ear 
1399 E^yre and Washbourn observed d if fe re n c e s  between pneumococcus s t r a in s  in  
p ro te c tio n  t e s t s  in  anim als. I t  was n o t u n t i l  1910, however, th a t  an a ttem p t 
was made to  sep a ra te  th e  pn eumo coccus in to  th e  v a rio u s  types w ith  which we a re  
now fa m ilia r .  The f i r s t  work was done by H eufeld and Handel, who, by immunising
ho rses  and r a b b i ts ,  p repared  a serum which p ro te c te d  a g a in s t th e  m a jo rity  o f  
th e  p re v a le n t s t r a in s  o f  pneumococci, bu t n o t a l l  s t r a in s .  They reco rded  th e  
e x is ten c e  o f  a t  l e a s t  two d i s t i n c t  groups o f  th e  organism s, one o f  which they  
regarded  as a  " ty p ic a l group." They a lso  s ta te d  th a t  th e re  were perhaps /
perhaps sev e ra l o th e r  sep a ra te  groups as w e ll. In  1913 Dochez and G ille s p ie  
were ab le  by p ro te c tio n  and a g g lu tin a tio n  t e s t s  to  sub-d iv ide  pneumococci in to  
fo u r groups. As a l l  th e  s t r a in s  w ith in  each o f  th e  f i r s t  th re e  groups id e n t i f ie d  
by Dochex and G ille sp ie  have been found im m unologically id e n t ic a l ,  th ese  groups 
a re  now designated  Types I ,  I I  and I I I .  These workers a lso  recogn ised  o th e r  
types which d id  n o t belong to  Types I ,  I I  o r  I I I ,  and which d if f e r e d  
im m unologically from one ano ther. As none o f  th e se  types was encountered 
freq u e n tly  i t  seemed most convenient fo r  d e s c r ip t iv e  purposes to  p lace  then in  
a m iscellaneous group designated  as Group IV.
Type I  o f  Dochez and G ille sp ie  corresponded to  Neufeld and H andel's 
" ty p ic a l group", w hile Type I I  in c luded  Neufeld and H andel's "Franz" s t r a in .
Type I I I  co n s is ted  o f organisms o f  the  pneumococcus raucosus ty p es , w hile Group 
IV included  a l l  o th e r  pneumococci.
From 1915 onwards t i l l  192? various workers, in c lu d in g  Avery, S tillm an , 
Cooper, Mickulon and ELanc, d escribed  d i s t in c t  types o f pneumococci. Cooper, 
in  1927, u sing  pneumococci i s o la te d  by the v a rio u s  workers, seg regated  ten  
new types, and designated  them Types I V . . . .X I I I .  In  1932* however, n in e teen  
a d d itio n a l types were added to  th e  l i s t ,  making tw enty-nine types in  a l l ,  which 
were p rev io u sly  considered to g e th e r as Group IV o r  u n c la s s if ie d  s t r a in s .  Because 
o f  the  cross a g g lu tin a tio n  and c ross p ro te c tio n  between Types VI and XXVI and 
th e i r  re sp e c tiv e  serums, Cooper and her a s so c ia te s  re fe r re d  to them as Types 
Via and VIb, o r  simply as Type VI. S im ila rly , Types XV and XXX a re  regarded
as id e n t ic a l .  This c la s s i f ic a t io n  o f  pneumococci in to  th ir ty - tw o  se ro lo g ic a l 
types does n o t exhaust the p o s s ib i l i ty  o f th e re  being s t i l l  o th e r  ty p es, as 
indeed a t h i r t y - th i r d  type has re c e n tly  been recognised .
A general re la tio n s h ip  e x is t s  between the  p rognosis and th e  type o f 
in fe c t in g  pneumococcus. Thus some types a re  n e a r ly  always a sso c ia te d  w ith  h igher
case f a t a l i t y  r a te s  than o th e rs . The a b i l i ty  to  produce vary ing  amounts of /
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o f  s p e c if ic  cap su la r p o ly sacch arid e  during  growth in f lu e n c e s  th e  changes o f  
recovery . Type I  pneumococci produce r e la t iv e ly  l i t t l e  s p e c if ic  cap su la r 
po ly sacch arid e  in  t h e i r  growth, w hile s t r a in s  o f  Type I I  pneumococci produce 
la r g e r  amounts, and Type I I I  pneumococci s t i l l  more. As th e se  substances have
th e  a b i l i ty  s p e c if ic a l ly  to  in h ib i t  th e  ac tio n  o f  pneumococcal a n tib o d ie s , i t
i s  n o t su rp r is in g  th a t  the  f a t a l i t y  r a te s  p ro g ress iv e ly  in c re a se  from Type I  
to Type I I I  in fe c t io n s . Cruickshank (1933) r a th e r  s t r e s s e s  th i s  r e la t io n s h ip . 
As y e t ,  l i t t l e  i s  known regard ing  prognosis in  in fe c t io n s  due to  o th e r  types.
Table I ,  taken from Heffron (1939), i l l u s t r a t e s  th e  f a t a l i t y  r a te s  o f
the  d i f f e r e n t  types in  a la rg e  s e r ie s  o f  cases taken from American, B r i t i s h
and o th e r  workers.
Table I .
Pneumococcal Lobar Pneumonia: F a ta l i ty  r a te s  according to  the  Type o f








No. o f 
Cases.
F a ta l i  ty  
Rate %.
No. o f 
Cases.
F a ta l i ty  
Rate %.
No. o f  
Cases.
F a ta l i ty  
Rate %•
I 23L3 29.O 774 19*3 3088 2 6 .6
I I 1753 37*1 627 29.0 2380 35.0
I I I 1109 46.0 105 39.0 1214 45.4
Gp.IV 1764 23.2 505 1 4 .5 2269 21.3
The conclusions to be drawn are  th a t  Type I  pneumonia i s  a m oderately severe
i l l n e s s ,  w hile Type I I  pneumonia i s  u su a lly  a f a i r l y  severe d isea se . The
explanation  o f  th e  very high f a t a l i t y  r a te  in  Type I I I  in fe c t io n s  may p a r t ly  be
due to th e  f a c t  th a t  th i s  type o f  in fe c tio n  has a tendency to  a tta ck  o ld e r
in d iv id u a ls . The f a t a l i t y  r a te  o f  Type I I I  in fe c t io n s  in  young a d u lts  i s  much 
lower than in  e ld e r ly  p a t ie n ts .  In Group IV in fe c tio n s  the  f a t a l i t y  r a te  i s  
low er than in  the previous th re e  types. Of in d iv id u a l types o f th i s  group
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group Heffron (1939) re p o r ts  th a t  th e  f a t a l i t y  r a t e  o f  Type V in fe c t io n s  was 
32 .6  p e r  cen t, and i t  i s  in te r e s t in g  to  n o te  th a t  th i s  type i s  im m unologically 
r e la te d  to  Type I I .  In  Type VII th e  r a te  was 24.5 p e r  c e n t . ,  w hile  in  th e  
case o f  Type VIII i t  was 22.9 p e r  cen t. This l a t t e r  type i s  im m unologically 
r e la te d  to  Type I I I ,  though l e s s  severe ; but i t s  s e v e r ity , as in  case o f 
Type I I I ,  depends on th e  age o f  th e  p a t ie n t .
A ccordingly, i t  i s  considered an e s s e n tia l  f a c to r  to know th e  type o f  
pneumococcus causing the  in fe c t io n ,  t a t  by the  exam ination o f  th e  sputum o f  
a l l  p a t ie n ts  su ffe r in g  from lo b a r  pneumonia, as soon a f t e r  adm ission as p o ss ib le .
I t  i s  in te r e s t in g  to n o te , a t  th i s  s tag e , th a t  the  c l in ic a l  p ic tu re  v a r ie s  
considerab ly  w ith  th e  type o f in fe c t in g  pneumococcus (Lord, 193T)* Thus Type 
I  in fe c t io n s  a re  ty p ic a lly  sudden in  o n se t w ith a high tem perature and a re  
o f te n  a sso c ia ted  w ith delirium . Although Type I I  in fe c t io n s  a re  much more 
severe , the  to x ic  p a l lo r  and q u ie t re s ig n a tio n  o f  th e  p a t ie n t  c o n tra s t  favourably  
w ith  th e  high colour and r e s t le s s n e s s  o f Type I  in fe c t io n s .  Type I I I  in fe c tio n s  
o fte n  occur in  th e  aged and d e b i l i te d  and e sp e c ia lly  in  p a t ie n ts  who have a 
h is to ry  o f  prev ious ch est tro u b le . In  younger a d u lts , Type I I I  in fe c t io n s  
a re  l e s s  severe. Group IV in fe c tio n s  as a ru le  a re  m ild.
Numerous f a c to r s  appear to  in flu en c e  the  frequency w ith which th e  v a rio u s  
types occur. Thus geographic and gross c lim a tic  d if fe re n c e s  have a d e f in i te  
e f f e c t ,  as Types I  and I I  are  more freq u en tly  encountered in  Europe than 
elsew here, and are  most common in  tem perate zones. There a re , however, o th e r
fa c to r s  beside geographical and c lim a tic  v a r ia t io n s . Experience has shown th a t  
th e  inc idence  o f d i f f e r e n t  types v a r ie s  w ith in  one given p lace  in  d i f f e r e n t  
y e a rs . C ecil £ t  a l . ( I 927) noted v a r ia t io n s  in  th e  type inc idence  over a p e riod  
o f  f iv e  y ears  a t  B ellevue H o sp ita l, New York City (see  Table I I ) .
Table I I
Annual v a r ia t io n  in  the  in c id en ce  o f  pneuraococcus jy p e s .
Year No. o f  Cases. I I I I I I Group IV
1920-21 377 45 .2 15*9 14 .5 23.5
1921-22 534 33.7 18.1 15 .7 32.5
1922-23 319 21.0 20.6 1 7 .2 41.0
192>24 275 30-9 20.0 16.0 33.0
1924-25 408 35.7 20.0 7.9 36.2
Macgregor (1933) Glasgow in  a s e r ie s  o f  cases from 1930“ 32 no ted  much l e s s  
v a r ia tio n  than th i s  in  the  in c id en ce  o f  types. V aria tio n s  in  the  type in c idence  
in  th e  same y ear in  d i f f e r e n t  p la ce s  have a lso  been recorded.
Monthly v a r ia tio n  in  the  inc idence  o f types does a lso  occur. I t  i s  
g en era lly  recognised  th a t  most cases o f pneumonia occur in  w in te r and sp ring .
Data on type inc idence  have come la rg e ly  from the  ta b u la tio n  o f  such
cases. Although y early  d iffe re n c e s  in  type in c id en ce  a re  e a s i ly  dem onstrable, .
as i s  the  f a c t  th a t  in  the  w in te r and sp ring  months when pneumonia i s  most
p re v a le n t, the  types most commonly causing lo b a r  pneumonia a re  most freq u en tly
encountered; y e t  adequate re p o r ts  a re  la ck in g  th a t  dem onstrate the  type
in c id en ce  in  a la rg e  s e r ie s  o f cases occu rring  in  summer. S ra illie  (1933)
re p o rted  th a t  no one type was p re v a len t in  only one month o r season, but th a t
th e re  was a general d is t r ib u t io n  o f the  various types over the whole y ear. No
la rg e  s e r ie s  o f cases i s  a v a ila b le  showing the  in c id en ce  o f  the  va rio u s  types
by months throughout the  y ear. F in land  and S u t l i f f  (1934), however, have
shown th e  monthly inc idence  o f Types I ,  I I ,  I I I  and VIII over a p e rio d  o f
th re e  y ears . They noted  th a t  Types I  and I I I  showed a seasonal v a r ia t io n  and 
were more frequen t in  w in ter and sp ring ; while Type I I  although showing d igh t 
seasonal v a r ia tio n , tended to occur more uniform ly throughout the  y ear. Type 
VIII was common in  w in ter and sp rin g , and freq u en tly  absen t in  midsummer.
D espite  such v a r ia t io n s , under o rd in a ry  co n d itio n s  Types I  and I I  a re  n e a r ly
always th e  two commonest types found* However, during  th e  course o f  epidem ics, 
e i th e r  o f th e se  o r  some o th e r  s in g le  type may prove u n u sually  p re v a le n t.
2. The s ig n if ic a n c e  o f Bacteraem ia;
The p resence  o r absence o f  in v asion  o f th e  blood stream in  pneumococcal 
lo b a r  pneumonia i s  one o f th e  most im portan t p ro g n o stic  f a c to r s  we possess*
I t  i s  w ell known th a t  the  f a t a l i t y  r a te  o f  cases w ith  bacteraem ia i s  sev e ra l 
tim es h igher than th a t  o f cases w ith  s t e r i l e  blood c u ltu re s .
The fo llow ing  f ig u re s  re p re se n t a la rg e  s e r ie s  o f  cases in v e s t ig a te d  
by numerous American workers (H effron 1939)*
Ho. o f Cases. F a ta l i ty  Rate %. 
W ithout Bacteraem ia 2158 13*3
With Bacteraem ia 816 6l *8
Table I I I  from Heffron (1939) shows th e  inc idence  o f  bacteraem ia and 
the  f a t a l i t y  r a te s  among th e  various ty p es.
Table I I I
Pneumococcal Lobar Pneumonia: F a ta l i ty  r a te s  o f  in d iv id u a l types in  th e
absence and presence o f bacteraem ia.
TYPE
W ithout Bacteraem ia 
No. o f Cases. F a ta l i ty  Rate
With Bacteraem ia.
No. o f  Cases. F a ta l i ty  
Rate
I 457 15 .3 351 58.1
I I 364 13 .5 3L5 74.0
I I I 108 28.7 72 86.1
Gp. IV 33L 9.1 90 60.0  |
A ll Types 1260 14 .3 828 66.8
I t  i s  in te r e s t in g  to  n o te  th a t  in  cases w ith  bacteraem ia th e  h ig h est f a t a l i t y  
ra te s  occur in  Types I I I  and I I  and th e  low est in  Group IV and Type I .
We may summarise by saying th a t  in  pneumococcal lo b a r  pneumonia th e  
dem onstration o f  bacteraem ia must be considered  im portan t evidence th a t  a 
se r io u s  d e fic ien cy  e x is ts  in  th e  re s is ta n c e  o f  th e  h o s t to  th e  invad ing  organism s.
3 . The s ig n if ic a n c e  o f  th e  e x ten t o f Pulmonary  Involvement:
The ex ten t o f pneumonic co n so lid a tio n  i s  a v a lu ab le  p ro g n o stic  f a c to r ,  and 
th e  outlook i s  d e f in i te ly  p o o res t when th e  d isea se  extends from lo b e  to  lo b e .
Thus, as th e  number o f lo b es  involved  in c re a se s , th e  f a t a l i t y  r a t e  in c re a se s , 
being h ig h est in  the  presence  o f  th e  most ex tensive  le s io n s ,  even in  th e  
absence o f  bacteraem ia.
Cohn and Lewis, (1935), t r e a te d  1400 cases a t  th e  H osp ital o f  th e  
R o ck efe lle r I n s t i t u t e  fo r  Medical Research and o b ta ined  the  fo llow ing  f a t a l i t y  
r a te s  fo r  th e  number o f lo b es  invo lved  (see  Table IV ).
Table IV
Pneumococcal Lobar Pneumonia: F a ta l i ty  r a te s  according  to the  e x te n t o f  
pulmonary involvem ent:
No. o f  Lobes 
involved. No. o f  Cases.
F a ta l i ty  Rate 
%.





The f a t a l i t y  r a te  i s  a lso  h igher in  cases o f  double pneumonia, where th e re  i s  
involvement o f  both s id e s , than in  cases where th e re  i s  u n i l a t e r a l  involvem ent
o f  two lo b es . The question  o f whether involvem ent o f  th e  r ig h t  o r  l e f t  s ide
causes the  h ig h est f a t a l i t y  r a te  i s  apparen tly  d o u b tfu l. Chatard (1910), a t  
th e  Johns Hopkins H osp ita l, rep o rted  th a t  the f a t a l i t y  r a te  o f cases w ith  
involvement o f the  r ig h t  s ide  was h igher than w ith  involvem ent o f  th e  l e f t  side , 
w hile Vi tug snd Hizon (1928) rep o rted  th e  rev erse  (quoted H effron).
4. The s ig n if ic a n c e  o f  the  d u ra tio n  o f  the  i l l n e s s  a t  th e  
tim e o f adm ission to  h o s p ita l:
The d u ra tio n  o f  th e  i l l n e s s  a t  th e  tim e trea tm en t i s  in s t i t u t e d  has a 
marked e f f e c t  on the  recovery  r a te .  In  general the  e a r l i e r  trea tm en t i s  
commenced th e  b e t te r  a re  th e  chances o f recovery , and the  l e s s  trea tm en t i s  
req u ired . I t  i s  w ell known th a t  p a t ie n ts  respond more re a d ily  when 
chemotherapy i s  i n s t i tu t e d  p r io r  to  th e  fo u r th  day o f  i l l n e s s  than a f t e r  i t ,  
and th a t  th e  f a t a l i t y  r a te  r i s e s  sharp ly  in  p a t ie n ts  n o t re c e iv in g  trea tm en t 
u n t i l  a f t e r  the  fo u r th  day. Since o rd in a r i ly  the  blood stream i s  n o t 
invaded u n t i l  a f t e r  the  th i r d  day, i f  trea tm en t i s  in s t i t u t e d  p r io r  to  th i s  
time th e  occurrence o f a blood stream invasion  i s  made l e s s  lik e ly *
5. The s ig n if i cance of  Age;
Age i s  a very im portan t fa c to r  in  p ro g n o sis , the  f a t a l i t y  r a te  being 
high in  th e  very young and very o ld  p a t ie n ts  in  whom re s is ta n c e  i s  low, 
while in  p a t ie n ts  o f in te rm ed ia te  age, who have a h igher immunity, th e  
f a t a l i t y  r a te  i s  low er. The low f a t a l i t y  r a te  found in  the  l a t t e r  p a r t  
o f childhood continues in  a d u lt l i f e  up to  about the age o f  20 y ears .
A fter t h i s  the  p ropo rtion  o f  cases dying in c re a se s  w ith each decade o f  l i f e .  
The fa c to r  o f age may be o f d e f in i te  im portance in  p a t ie n ts  by th e  tim e they  
reach  th e i r  f o r t i e th  y ear, fo r the  p ropo rtion  o f cases w ith  bacteraem ia i s  
h igher in  the  o ld e r than in  the younger groups, as was shown by th e  r e s u l t s  
o f the  M assachusetts Pneumonia S e rie s  (H effron 1939)*
6. Tfre s ig n ific a n ce  o f  Sex:
L i t t l e  inform ation  has appeared in  l i t e r a t u r e  to  determ ine the  e f f e c t ,  
i f  any, o f  sex on p rognosis. A s e r ie s  o f cases s tu d ied  by Cohn and Lewis
(1935) a t  the  H ospital o f the  R ockefe ller I n s t i t u t e  fo r  M edical Research 
revealed  a f a t a l i t y  r a te  o f 18*9 p e r cen t, smong 1863 m ales and a r a te  o f
21.9 p e r cen t, smong 393 fem ales. The tru e  s ig n if ic a n c e  o f  sex in  r e la t io n
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r e l a t io n  to  p ro gnosis  i s  not known, f o r  th e  p ro p o r tio n  of a l l  cases  in
e i th e r  sex in  any community i s  unknown and th e  cases s tu d ied  r e f e r  only  to
h o s p i ta l is e d  c a se s . The f ig u re s  a re  weighted in  fav o u r of m ales, as more males
th an  fem ales w ith  pneumonia a re  h o s p i ta l is e d ,  and p o ss ib ly  th e  sm alle r number of
fem ales e n te r in g  h o s p i ta ls  do so because they  re p re se n t th e  more severe  cases
in  t h e i r  sex group. Such an occurrence may give an ap p aren tly  h ig h e r f a t a l i t y
r a te  among the  fem ales which a re  h o s p i ta l is e d .
7 . The s ig n if ic a n c e  of the  Temperature Range:
The tem perature range i s  o f l i t t l e  help  in  e s tim a tin g  p ro g n o sis . Gases
w ith  p e r s is te n t ly  low tem peratures due to  overwhelming in fe c tio n s  a re  very
s e r io u s , bu t cases w ith  very  high tem pera tu res, o r continued h igh  tem p era tu res ,
a re  not n e c e s sa r ily  se r io u s . Cole (1923) , in  a s e r ie s  of 763 cases a t  th e
H o sp ita l of th e  R o ck efe lle r I n s t i t u t e  fo r  M edical R esearch, showed th a t  th e
a t  d i f f e r e n t  le v e ls  
f a t a l i t y  r a te  o f cases  w ith  tem peratu res^d id  no t re v e a l any p a r t i c u la r
r e la t io n  to  the  degree o f p y rex ia  and the  ou tlook .
8 • ' The s ig n if ic a n c e  of th e  P u lse  R ate .
E arly  in  the i l l n e s s ,  the p u lse  r a te  g ives no sp e c ia l  in fo rm ation
concerning p ro g n o sis . Cole (1928) and o th e rs  have shown th a t  cases w ith  a
maximum p u lse  r a te  o f 120 p e r  minute o r under have a b e t t e r  p rognosis  than
those  in  which th e  r a te  exceeds t h i s  f ig u r e .  L ate  in  th e  d isea se  a  g rad u a lly
in c re a s in g  p u lse  r a te  i s  u su a lly  of se r io u s  consequence and in d ic a t iv e  of
com plications•
9 . The s ig n ific a n ce  o f th e  R esp ira tio n  R ate:
The r e s p ir a t io n  r a te  and the  c h a ra c te r  of th e  b rea th in g  are  more
im portant th an  th e  two p rev ious f a c to r s ,  and they  y ie ld  in fo rm ation  concerning
the  s e v e r ity  of th e  in fe c t io n  and the  probable outcome of th e  case . Cole (1928)
and o th e rs  showed th a t  low f a t a l i t y  r a te s  p re v a il  in  cases in  which th e  maximum
/
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maximum r e s p ir a t io n  r a te  i s  under 40 p e r minute* Cole fu r th e r  s tu d ie d  the  
c h a ra c te r  of th e  r e s p i r a t io n s ,  as w e ll as  th e  r a t e ,  and found t h i s  of g re a t 
p ro g n o s tic  s ig n if ic a n c e . Rapid shallow  b rea th in g  i s  of s e r io u s  consequence 
and in  extreme cases each b re a th  i s  a s tru g g le  in  which th e  accesso ry  m uscles 
o f r e s p ir a t io n  come in to  p lay .
IQ .The s ig n if ic a n c e  of L a b ia l Herpes:
The p ro g n o s tic  value of l a b i a l  herpes seems very  d o u b tfu l, bu t Lord 
(1925) no tes th a t  i t  has been regarded as a favou rab le  s ig n .
11. The s ig n if ic a n c e  of D elirium :
D elirium , when marked, i s  g en e ra lly  regarded  as a n  unfavourable  s ig n ; 
i t  occurs most fre q u e n tly  in  a lco h o lic  p a t ie n ts .
12. The s ig n if ic a n c e  of th e  presence of C om plications, 
and of A ssociated  D isease:
The chances of recovery  a re  adverse ly  in flu en ce  by th e  development 
o f c e r ta in  com plica tions. Among th e  commonest compli c a t ions a re  inc luded  
s t e r i l e  p le u ra l  e f fu s io n , empyema, m en in g itis , o t i t i s  m edia, a r t h r i t i s ,  
p e r ic a r d i t i s  and e n d o c a rd itis . The f i r s t  two tend  to  p ro long  convalescence 
w hile  m en in g itis  and e n d o c a rd itis , although r a th e r  uncommon, a re  in v a r ia b ly  
f a t a l .  I t  i s  in te r e s t in g  to  no te  th a t  such com plications a re  o f te n  a sso c ia te d  
w ith  a c e r ta in  type of organism. Thus H effron (1939) showed th a t  empyemata 
were commonly found in  the  presence o f a Type I  in fe c t io n .
Lobar pneumonia, occurring  during  th e  course of c e r ta in  ch ron ic  
d is e a s e s , has i t s  p rognosis unfavourably a l te r e d .  This i s  e s p e c ia l ly  tru e  
in  th e  case of ca rd io v ascu la r d isea se  and o f chron ic  n e p h r i t i s .  S im ila r ly  
th e  p rognosis i s  adverse ly  a ffe c te d  in  those su ffe r in g  from d ia b e te s , 
o b es ity  and alcoholism .
13 . The s ig n if ic a n c e  o f  th e  Leucocyte Count:
In  most in fe c t io n s  due to  pathogenic b a c te r ia ,  the  presence  o f  a leu co cy te  s i s  
i s  regarded as a b e n e f ic ia l  s ign . The degree and k ind  o f  le u c o c y tic  response 
w ill  depend upon whether th e  in fe c t io n  i s  acu te  o r  ch ron ic , and a lso  on th e  
cau sa tiv e  organism. In fe c tio n  w ith the  pneumococcus g en era lly  induces a w ell 
marked leu co cy te  response. The in c re a se  i s  in  the  n e u tro p h il polymorphonuclear 
le u co c y te s , w hile th e  lymphocytes and monocytes in  th e  c irc u la t in g  blood a re  
found to  be reduced* This i s  n o t always th e  case, and a leucopen ia  o r  dim inution 
o f w hite c e l l s  below 5>000 Pe r  cubic m.m. i s  o c ca s io n a lly  met w ith . T his i s  
due to  th e  e f f e c t  o f the  toxaemia on both the  c ir c u la t in g  leu co cy tes  and on 
th e  bone marrow before  the  body can respond to th e  in fe c t io n .
S tud ies  o f the  leu co cy te  counts o f  p a t i e i t s  su ffe r in g  from pneumococcal 
lo b a r  pneumonia have been recorded w ith  v a ria b le  r e s u l t s .  Thus in  a s e r ie s  o f  
463 typed cases Avery, Chickering, Cole and Dochez (1917) found th a t  th e  f a t a l i t y  
r a te  was in v e rse ly  p ro p o rtio n a l to  th e  degree o f  le u c o c y tic  response. T heir 
f ig u re s , taken from Heffron (1939)» a re  shown below ( see Table V).
Tab le  V
Pneumococcal Lobar Pneumonia: F a ta l i ty  Rates according to  th e  leu co cy te  count:
Leucocyte Count. No. o f  Cases. F a ta l i ty  Rate %.
under 10,000 29 65.5
10 -  20,000 143 23.7
20 -  30,000 177 18.0
39 -  40,000 76 14 .4
40 -  50,000 29 24.1
§ver ^0,000 9 11.0
M iddleton and Gibbon (1930) showed th a t  a w ell marked le u c o c y to s is  was 
u su a lly  a favourab le  s ign , but th a t  th i s  was n o t always the  case . These 
f in d in g s  were confirmed by Meyer (1 930  w^ ° found th a t  th e  d eath  r a te  in  
p a t ie n ts  su ffe r in g  from pneumococcal lo b a r  pneumonia was h ig h e s t where th e  
leu co cy te  response was poor, bu t y e t  deaths d id  occur even in  th e  presence o f  
a w ell marked lc u co c y to s is .
Although a favourab le  r e s u l t  may be expected in  the  presence  o f  a marked
le u c o c y tic  response, th i s  view i s  n o t held by a l l  workers. Bullowa (1927) found
no re la t io n s h ip  between the  degree o f le u c o c y to s is  and th e  outcome o f  th e  i l l n e s s .
An in te n s iv e  study o f th e  leu co cy te  count in  pneumonia was made by Fleming
in  1936. This worker p o in ted  ou t th a t  although a leu co cy te  count o f over
15»000 p e r cubic m.m. in  th e  f i r s t  th re e  days o f  i l l n e s s  was a good p ro g n o stic  
s ign , i t  was im possib le to p ro g n o s tic a te  from th a t  one sign s lone . He showed 
th a t  th e  degree o f le u co c y to s is  v a ried  w ith th e  type o f in fe c t in g  pneumococcus 
and w ith the  age o f  the  p a t ie n t .  A leu co cy te  count o f  more than 20,000 p e r 
cubic m.m. was th e  usual fin d in g  in  Type I  and Group IV In fe c tio n s , whereas 
in  Type I I  and Type I I I  in fe c tio n s  the  i n i t i a l  count was u s u a lly  le s s  than 
20,000 p e r cubic m.m. Fleming a lso  noted  th a t  counts were u su a lly  h igher in  
younger than in  o ld e r p a t ie n ts .  He suggested th a t  in  p ro g n o s tic a tin g  from 
th e  leu co cy te  count i t  was necessary  to  take in to  account th e  type o f  in fe c t in g  
pneumococcus and the  age o f th e  p a t ie n t ,  and a lso  to  re p e a t th e  counts a t  
d a ily  in te r v a ls .
CHAPTER I I .
The Chemotherapy o f Pneumococoal Lobar Pneumonia.
The trea tm en t o f pneumococcal lo b a r  pneumonia h as  a l te r e d  co n sid e rab ly  
s in ce  th e  beginn ing  of t h i s  cen tu ry  when trea tm en t was la rg e ly  sym ptom atic.
A new e ra  in  th e  trea tm en t o f pneumonia was in tro d u ced  by N eufeld and Handel 
in  th e  y e a r  1910 when s p e c if ic  anti-pneum ococcal serum was f i r s t  used . Many 
chem ical ag en ts  have s in ce  been employed, b u t u n t i l  re c e n tly  none has been 
found to  e x e r t s p e c if ic  th e ra p e u tic  p ro p e r t ie s .  The f a c t  th a t  c e r ta in  p re p a r­
a tio n s  of th e  qu in ine group have been shown to  e x e r t a  v a lu ab le  degree o f 
b a c te r ic id a l  o r b a c te r io s ta t i c  e f f e c t  on th e  pneumococcus, e i th e r  in  v i t r o  
o r  in  v iv o , was a f in d in g  of co n sid e rab le  im portance. Q uinine i t s e l f  was one 
o f th e  f i r s t  chem otherapeutic agen ts used in  th e  trea tm en t of lo b a r  pneumonia 
and German w orkers have re p o rte d  favou rab le  r e s u l t s  w ith  t h i s  d ru g . E thy l 
hydrocupre ine , now m arketed under th e  p ro p r ie ta ry  name of o p to ch in , h as been 
used w ith  vary ing  su ccess , as shown by Y/right e t  a l .  (1912) and Moore and 
Chesney (1917) . Toxic m a n ife s ta tio n s  a r e ,  however, n o t uncommonly met w ith  
fo llow ing  th e  use o f t h i s  d rug , as was shown by W right e t  a l .  ( I 9 I2 ) .
The most ou ts tan d in g  advance made in  the  chem otherapeutics of b a c te r ia l  
in fe c t io n s  was undoubtedly the  in tro d u c tio n  of ” Pronto  s i  1” in  th e  y e a r  1935 
f o r  th e  trea tm en t of haem olytic s tre p to c o c c a l in f e c t io n s .  S ince th en  many 
chem otherapeutic agen ts have been in troduced  and s e v e ra l o f th e se  have been 
proved to  be e f fe c t iv e  in  th e  trea tm en t of pneumococcal lo b a r  pneumonia. As 
th e  newer sulphonamides a re  d e r iv a t iv e s  o f th e  e a r l i e r  £-am ino-benzene- 
sulphonam ide, t h e i r  s t ru c tu re  i s  more r e a d i ly  understood when one i s  f a m il ia r  
w ith  th e  sim p ler compound; •
(1) C la s s if ic a t io n  o f  th e  Commoner Sulphonamides.
I t  was in  February 1935, th a t  Domagk pub lished  h is  r a th e r  s t a r t l i n g  
r e s u l t s  ( in  b a c te r ia l  in fe c tio n s )  vdth  the  hydroch loride  o f  4 sulphamido 2 : 4 
d i amino-a zo-benzol. This drug, a red  dye marketed as "P ro n to s il"  was 
adm in istered  o ra l ly  and was o f p ro p h y lac tic  value a g a in s t experim ental in fe c t io n s  
w ith haem olytic s tre p to c o c c i. In  France s im ila r  success was rep o rted  by 
L ev ad iti and Vaisraan (1935) using  the  compound ru b iazo l o r  4 - sulpham ido-2:4 diamo- 
6-carboxy-azo-benzene. As in  the  case o f  experim ental work, so in  th e  case o f 
c l in ic a l  r e s u l t s ,  the  e a r l i e s t  re p o r ts  were pub lished  by German and French workers. 
In  th e  y ear 1935, T refouel Mine, and J . ,  N i t t i  and Bo v e t suggested th a t  th e se  
complex substances were reduced in  th e  body w ith a s p l i t t i n g  o f f  a t  th e  azo 
lin k a g e  to  form p-am ino-benzene-sulphonam ide. In  th i s  country B u ttle , Grey and 
Stephenson (193&), iu  mouse p ro te c tio n  t e s t s ,  showed th a t  when given o ra l ly  
j>-amino-benzene sulphonamide i s  l e s s  to x ic  than "Pronto s i  I.” Colebrook, B u ttle
and O’Meara (193&) a lso  showed th a t  £-am ino-benzene-sulphonamide possessed  
b a c te r io s ta t ic  and b a c te r ic id a l a c t iv i ty  ag a in s t haem olytic s tre p to co c c i in  
c u ltu re  media and in  blood. These workers suggested  th a t  th e  a c tio n  o f 
"P ro n to s il"  was due to  the ac tio n  o f the  £-amino-benzene~sulphonamide, which i s  
formed by the  reduction  o f the  complex substance. I t  i s  th e re fo re  seen th a t  
£ - amino-benzene-sulphon&mide, the  amide o f su lp h a n ilic  ac id , and now g en era lly  
c a lle d  sulphanilam ide, i s  one o f  th e  sim plest y e t most e f fe c t iv e  o f  th e  
chem otherapeutic agen ts we p o ssess . I t  i s  indeed from th i s  simple substance 
th a t  many more sulphonamides can be constructed .
One o f th e  sim p lest and most convenient c la s s i f ic a t io n s  o f  th e  sulphonamide
drugs i s  to  regard  them as d e r iv a tiv e s  o f  sulphanilam idej hence we may 
ap p ro p ria te ly  commence by d e sc rib in g  th e  chemical n a tu re  o f  th i s  substance. At
th e  o u ts e t  i t  i s  w ell to  remember th a t  most o f the  sulphonamides have th re e  k inds 
o f  names, a chemical name d esc rib in g  accu ra te ly  the  c o n s ti tu tio n  o f  th e  /
th e  substance, a m edical d esig n a tio n  which i s  a shortened  form and a v a rio u s  
number o f tra d e  names. Whenever p o s s ib le  th e  chemical name o r  more o fte n  i t s  
shortened form i s  used.
pr-amino-benzene-sulphonamide, S u lphan il amide o r  P ro n to s il  Album.
sulphonamide drugs, and being the  amide o f s u lp h a n ilic  ac id , th e  d esig n a tio n  o f  
sulphanilam ide i s  both accu ra te  and b r ie f .  Of over fo r ty  tra d e  names in d ic a tin g  
p ro p r ie ta ry  brands o f th i s  compound those  most commonly employed in c lu d e  P ro n to s il  
Album and S trep to c id e . The formula o f  sulphanilam ide i s  rep resen ted  th u s :-
O ther sulphonamides may be regarded as d e r iv a tiv e s  o f ]D-amino-benzene 
sulphonamide and as f a l l in g  in to  two groups according to  whether s u b s t i tu t io n  
tax es  p lace  in  the  amino (NHg) o r  in  th e  amide (SO^Hg) group. The e a r l i e r  
sulphonamides belong to  the  f i r s t  c la s s  and they a re  s p l i t  up in  th e  body w ith 
th e  re le a s e  o f sulphanilam ide. The l a t e r  compounds such as su lphapyrid ine , 
su lp h a th iazo le  and su lphad iaz ine  f a l l  in to  the second category and th e se  more 
a c tiv e  compounds do n o t depend fo r  t h e i r  a c tio n  on th e  production o f  sulphanilam ide. 
The more im portan t members o f  the  f i r s t  group, in  which the amino (NH2) group i s  
rep laced , inc lude  P ro n to s il  Rubrum o r  Sulphonaraido-chrysoidin, P ro n to s il  Soluble, 
Rubiazol, P ro sep tasin e  and S o lu sep tasine .
Of the  drugs derived  from jd-amino-benzene sulphonamide in  which th e  amide 
(SO2NH2) ra d ic a l i s  rep laced , one o f  th e  e a r l i e s t  was Uleron. The in tro d u c tio n  o f 
more re c e n t compounds have, however, le d  to  i t s  d isu se . O ther compounds inc luded  in  
th i s  second group a re  su lphapyrid ine , su lp h a th iazo le  and su lphad iaz ine . As th ese  
drugs a re  a l l  a c tiv e  chem otherapeutic agents in  the  trea tm en t o f  pneumococcal lo b a r  
pneumonia, th e i r  chemical s tru c tu re  i s  considered below.
jo-amino-benzene-sulphonamide i s  th e  sim p lest and most w idely used  o f a l l
2(]^am ino-benzene-sulphonam ido)pyridine, S ulphapyrid ine o r  Dagenan (M & B 693)
This compound i s  derived  from sulphanilam ide by th e  s u b s t i tu t io n  fo r  one 
hydrogen atom in  th e  amide p o rtio n  o f the  m olecule o f  b asic  p y rid in e  group. I t  
p ossesses a much h igher degree o f a c t iv i ty  than su lphan ilam ide, thereby  extending
considerab ly  th e  f i e ld  o f chem otherapeutics.
HHR < 0  SO pNH O
The sodium s a l t  i s  so lub le  in  w ater and may consequently  be used  fo r  p a re n te ra l
ad m in is tra tio n . Being a s a l t  o f  a weak ac id  w ith  a s trong  base, i t  y ie ld s  a
h igh ly  a lk a l in e  so lu tio n , th e  pH exceeding 9»
2(B-amino-benzen e-sulphonamido) t h i a zol e , Sulp h a th iazo le  o r  
Thiazamide (M & B 670) .
This compound*like su lphapyrid ine , i s  an extrem ely powerful chem otherapeutic
S— CH
agent.   /
N— CH
As in  the case o f su lphapyrid ine , a so lub le  sodium s a l t  i s  a v a ila b le  fo r  
p a re n te ra l ad m in is tra tio n .
From S u lp h a th iazo le , o th e r compounds have been ob ta ined  by re p la c in g  one o f  
th e  hydrogen atoms in  the  th ia z o le  r in g . Thus 2 -su lp h a n ily l araino-4-methyl 
th ia z o le  (M & B 838) has been employed c l in ic a l ly ,  bu t has f a l le n  in to  d isu se  
because o f i t s  l i a b i l i t y  to  produce p e rip h e ra l neuropathy and o f  a g re a te r  
l i a b i l i t y  to  d ep o sit c ry s ta ls  in  the  u r in a ry  t r a c t  than su lp h a th iazo le . 
2(jfc-araino-benzene-sulphonainido) pyrLididine, o r  S ulphadiazine.
This compound i s  th e  pyrim idine agalo^ge o f su lphapyrid ine .
NH0 O  s o „ n h - J  S h
2 4 .
The c l in ic a l  d a ta  a v a ila b le  concerning th e  u se  o f  t h i s  drug a re  in s u f f ic ie n t  to  
p re d ic t  i t s  u lt im a te  p lace  in  chemotherapy, b i t  th e  r e s u l t s  o f  F in land  e t  a l . 
(1941) show th a t  i t  i s  an e f fe c t iv e  chem otherapeutic agent in  th e  trea tm en t o f 
pneumococcal and meningococcal in fe c t io n s .
( I I )  The Absorption and Excretion o f th e  Commoner Sulphonamides.
(a) Sulphanilam iae.
The in c re a s in g  use o f £ - amino-benzene-sulphonamide in  the  trea tm en t of 
s tre p to co c c a l in fe c t io n s  prompted M arshall, Emerson and C u tting  (1937) to  
p u b lish  t h e i r  r e s u l ts  concerning the absorp tion  and ex cre tio n  o f £-am ino- 
benzene-sulphonamide as e a r ly  as in  the  y ear 1937* The f i r s t  experim ents 
were perform ed on dogs. A fte r the  ad m in is tra tio n  of sulphanilam ide by mouth, 
subcutaneously o r  in trav en o u sly , i t  was found th a t  the  drug was absorbed and 
excreted  ra p id ly  and in  most cases could be almost com pletely accounted fo r  
by d i r e c t  de term inations in  the  u r in e . Thus, a f t e r  a s in g le  o ra l dose th e  
wofkers recovered as much as 93 Pe r  cen t, o f th e  drug from th e  u r in e  in  24 hours 
and 95 Pe r  cen t, in  48 hours. In  r a b b its  i t  was found th a t  th e  amount o f  
su lp h an il amide excreted  in  the  u r in e  was considerab ly  l e s s  than in  th e  case o f * 
dogs. I f  the  r a b b i t ’ s u r in e  was f i r s t  tre a te d  w ith hydroch lo ric  ac id  a g re a t 
in c re a se  in  th e  amount o f su lphan il amide was noted. This was due to th e  f a c t  
th a t  the  ra b b it  excreted  the  drug p a r t ly  in  the form o f a conjugated d e r iv a tiv e  
in  which th e  amino group i s  blocked. P e rr in  Long (1936) te s te d  th e  e f f e c t  
o f th e  conjugated su lp h an il amide on {J-haemolytic s tre p to co c c a l in fe c t io n s  in  
mice and found i t  to  be alm ost in a c t iv e , w hile B u ttle , Gray and Stephenson
(1936) s ta te d  th a t  the  a ce ty l d e r iv a tiv e  i s  much l e s s  a c tiv e  than i s
sulphanilam ide i t s e l f .
These p relim inary  remarks on the  ex cre tio n  o f th e  drug in  anim als help  to
c la r i f y  the  s i tu a t io n , as i t  occurs in  human su b je c ts , fo r  in  humans th e  drug 
behaves as in  the  ra b b it .  In  man, su lp h an il amide i s  ra p id ly  absorbed from the
/
th e  a lim entary  t r a c t .  A bsorption i s  alm ost e n t i r e ly  from th e  sm all in t e s t in e  
and n o t from th e  stomach. Following a s in g le  o ra l  dose, th e  maximum co n cen tra tio n  
in  the  blood i s  reached in  th re e  to  four hours, f a l l in g  to  zero in  24 to  48 hours. 
In  the  blood 20 to 40 p e r cen t, o f  the drug i s  p re se n t in  th e  in a c t iv e  a c e ty l 
o r  conjugated form. The drug i s  s e le c t iv e ly  absorbed, on to  th e  co rpuscles o f  th e  
blood fo r  th e  concen tra tion  here i s  50 p e r c en t, g re a te r  than th a t  in  the  plasm a, 
as was shown by Hansen (1939)•
Following abso rp tio n , th e  drug i s  re a d ily  d i f f u s ib le  and f in d s  i t s  way 
ra p id ly  in to  a l l  sec re tio n s  and t is s u e s  o f th e  body in  alm ost equal co n cen tra tio n . 
The co n cen tra tion  in  f a t  and bone, however, i s  l e s s  than elsew here.
M arshall and h is  a ss o c ia te s  (1937) showed th a t  a f te r  ab so rp tion  and 
d is t r ib u t io n  to  the  t is s u e s  su lp h an il amide i s  excreted  in  th e  u r in e  p a r t ly  as 
th e  f re e  base and p a r t ly  in  th e  in a c tiv e  a c e ty la te d  form. In  th e  u r in e  about 
50 per cen t, o f  th e  drug i s  in  the  in a c t iv e  conjugated form. This conjugated 
form i s  m ainly, i f  n o t e n t i r e ly ,  £-acetyl-am ino-benzene-sulphonam ide. The r a te  
o f ex cre tion  o f the  drug seems to follow  the  u r in e  flow and n o t the  con cen tra tio n  
in  the  plasma. This can be explained  by reab so rp tio n  from th e  kidney tu b u le s  
a f t e r  f i l t r a t i o n  through the g lom eruli. This dependence o f th e  r a te  o f 
e lim in a tio n  on the  u r in e  flow makes i t  p o ss ib le  to  wash ou t th e  drug by prom oting 
d iu re s is .  Thus M arshall and h is  a s so c ia te s  (1937) found th a t  re n a l impairment 
was p re sen t and normal e lim in a tio n  was la ck in g  in  a case which had co n siderab le  
q u a n ti t ie s  o f £ - amino-benzene-sulphonamide in  th e  blood 24 hours a f t e r  the
ad m in is tra tio n  o f the drug. In  such p a t ie n ts ,  sm aller doses o f  th e  drug w ill  
give r e la t iv e ly  high blood le v e ls  and severa l days a f t e r  d isco n tin u in g  therapy  
th e re  w ill  be considerab le  amounts o f su lp h an il amide in  th e  blood. M arshall
(1937) a lso  s tu d ied  p a tie n ts  who were rece iv in g  d iv ided  doses o f  su lp h an il amide 
over a p e rio d  o f severa l days. Blood con cen tra tio n s  reached high le v e ls  a f t e r  /
a f t e r  3 - 4  hours bu t i t  took about 24 hours to  reach  maximum le v e ls .  A fte r 
two to  th re e  days a s ta t e  o f  equ ilib rium  was reached between th e  amount o f  
drug in g e s ted  and th a t  ex cre ted . When th i s  s ta t e  was reached i t  was o ften  
p o ss ib le  to  account fo r  alm ost 100 per cen t, o f th e  drug in g e s te d  ty  th e  to t a l  
excre tio n  o f su lp h an il amide in  th e  f re e  and conjugated forms. I t  i s ,  however, 
p o ss ib le  th a t  under c e r ta in  co n d itio n s  a small amount may be ex cre ted  in  th e  
u r in e  in  some o th e r  form, o r  e lim ina ted  through some channel o th e r  than th e  
kidneys. S im ila r ly  a f t e r  the  c essa tio n  o f therapy i t  tak es  two to  th re e  days 
to  f re e  the  system from th e  drug.
M arshall1s r e s u l t s  may be summarised by s ta t in g  th a t  th e  co n cen tra tio n  o f  
th e  drug in  th e  blood w ill  depend on severa l fa c to rs .  These a r e : -  
( i )  The dose p e r u n i t  o f body weight
( i i )  The r a te  and com pleteness o f absorp tion  from the i n t e s t i n a l  t r a c t .
( i i i )  The d is t r ib u t io n  r a t io  o f the  drug in  th e  body ( i . e .  th e  r e la t iv e  
amount o f  a c tiv e  t is s u e s  to t is s u e s  l ik e  bone and f a t  which do n o t  absorb 
much o f  the  drug)
(iv ) The e ff ic ie n c y  o f the  k idneys in  ex cre tin g  the  drug.
(v) The amount o f  th e  drug th a t  i s  conjugated.
( b) Sulphapy r id in e .
Sulphapyridine i s  much l e s s  so lub le  in  w ater than i s  su lp h an il amide.
Long and Fein stone (193^) consider th a t  su lphapyrid ine  i s  absorbed l e s s  re a d ily
and more i r r e g u la r ly  than su lp h an il amide, and th a t  i t  i s  excre ted  more slow ly.
Baines and Wein (1939) s tu d ied  th e  absorp tion  and excretion  o f  su lphapyrid ine
in  healthy  a d u lts . They found th a t  a f t e r  s in g le  o ra l  doses o f  2 gms. and 1 gm.
th e  blood concen tra tion  reached a maximum in  5 -  7 hours. They no ted  th a t  20
p e r cen t, o f th e  drug had been e lim inated  by the  time the  maximum blood
concen tra tion  was reachedj up to 60 p e r cen t, was excreted  w ith in  t^ 4 hours
and up to  70 p e r cen t, was ob tained  by the  tim e the  drug was no lo n g e r p re se n t /
p re se n t in  th e  blood. In  th e  u r in e  about 50 Pe r c en t, o f th e  drug was 
ex cre ted  in  th e  f re e  form and 50 p e r  c en t, in  th e  conjugated o r  a c e ty la te d  
form, though th e  amount o f  conjugated drug v a ried  from 30-70 p e r cen t.
I t  should be noted th a t  Irith  su lphapyrid ine  a la r g e r  amount may be excreted  in
th e  conjugated form than in  the  case o f su lp h an il amide. Long and F einstone
(1938) suggested th a t  in  th e  blood 10-20 p e r cen t, o f  th e  drug was p re se n t in  
the  conjugated form. Long and B liss  (1939) have noted as much as 75 Pe r 
cen t, o f  th e  drug in  the  blood in  the  conjugated form, w hile Kinsman e t  a l .
(1939) re p o r t  33 Pe r cen t. There thus appears to be considerab le  in d iv id u a l
v a r ia tio n  in  th e  amount o f drug p re sen t in  the  in a c t iv e  conjugated form. Long
and B lis s  ( I 939) found th a t  a f t e r  a s in g le  o ra l dose o f su lphapyrid ine  39 to
79 p e r cen t, o f the  drug was excreted  in  th e  u r in e , w hile a f te r  m u ltip le  doses
51 to  64 p e r cen t, o f the  drug was so excre ted . I f  i t  i s  lo g ic a l  to assume
th a t  th e  bulk o f th e  absorbed drug i s  ex cre ted , then such f ig u re s  re p re se n t
the  amount o f drug which wss a c tu a lly  absorbed. In  o th e r  words, the  absorp tion
o f su lphapyrid ine  i s  l e s s  complete than th a t  o f su lp h an il amide. Cunningham
(1938) was ihe  f i r s t  to re p o r t  blood co n cen tra tion  during  d isea se . In  the
trea tm en t o f pneumococcal m en ing itis  he estim ated  th e  blood and ce reb ro sp in a l
f lu id  co n cen tra tio n s  snd found those o f the  sp inal f lu id  were approxim ately
h a lf  o f the  blood le v e ls .  FLippin e t  a l , (1939) 9 in  the  trea tm en t o f lo b a r
pneumonia noted the  marked v a ria tio n  in  the  a b i l i ty  to absorb the  drug among
in d iv id u a ls  rece iv in g  the  same dossge. Bullowa (4-940) confirmed th i s
u n p re d ic ta b i l i ty  o f the  blood concen tra tion  when su lphapyrid ine  was adm in istered
o r a l ly .  I t  seems th a t  th e  concen tra tion  o f th i s  drug in  th e  blood may be
exceedingly low in  s p i te  o f the  f a c t  th a t  la rg e  doses a re  adm in istered . The
absorp tion  o f  su lphapyrid ine i s  thus n o t so p ro p o rtio n a l to  the  dosage as 
i s  th e  case w ith su lp h an il amide.
The amount o f  a c e ty l d e r iv a tiv e  p re se n t in  th e  blood i s  n e g lig ib le  a t  f i r s t ,  
a lthough i f  su lphapyrid ine  a d m in is tra tio n  i s  continued th e  amount o f a c e ty l 
d e r iv a tiv e  in c re a se s  up to  24 hours* The lo n g e r th e  drug i s  ad m in istered , the  
g re a te r  i s  the  tendency fo r  th e  amount o f a ce ty l d e r iv a tiv e  p re se n t to  in c re a se . 
A fte r withdrawal th e  drug i s  e lim inated  a t  f i r s t  ra p id ly , and then more slow ly, 
so th a t  tra c e s  may be found in  the  u r in e  fo r  up to  f iv e  days. The f r e e  form i s  
e lim ina ted  more ra p id ly  than the  conjugated fonp.
( c) Sulphathia z o le .
P e rr in  Long (1940) noted th a t  th i s  drug i s  absorbed more re a d ily  from the  
a lim entary  t r a c t  than i s  su lphapyrid ine . L ike su lphapyrid ine  i t  i s  poorly  
absorbed by the  r e c ta l  mucosa. Spink and Hensen (1940) s ta te d  th a t  w hile 
su lp h a th iazo le  i s  absorbed l e s s  re a d ily  than su lp h an il amide, i t  i s  more re a d ily  
absorbed than i s  su lphapyrid ine . I t  i s  f a i r l y  uniform ly recognised  th a t  the  peak 
in  the  blood concen tra tion  i s  4 -  6 hours a f t e r  ad m in is tra tio n , hence th e  drug 
may be adm in istered  s ix -h o u rly . In  an a n a ly s is  o f severa l hundred cases, Spink 
and Hansen found the  average amount of conjugated drug in  th e  blood was 20 per  
c e n t . ,  th i s  form being regarded as in a c t iv e . This f ig u re  resem bles th a t  o f 
sulphan i l  Ami de and i s  much lower thsn  the amount o f  conjugated su lphapyrid ine  found 
in  the  blood. C a rro ll, Keppel end Lewis (1940) d id  no te  th a t  th e re  was v a r i a b i l i ty  
in  the  absorp tion  o f th i s  drug in  d if f e r e n t  in d iv id u a ls . Thus in  one case 
rece iv in g  6 gms. d a ily  the blood concen tra tion  was l e s s  than 1 mg. p e r 100 c . c . , 
whereas in  ano ther case rece iv in g  4 gms. d a ily  the  blood co n cen tra tion  reached 
6 mgms. p e r 100 c .c .
In  experim ental work in  anim als i t  was found th a t  i f  th e  blood co n cen tra tion  
was low then a la rg e  amount o f th e  drug was found in  the faece s , thus in d ic a tin g  
poor absorp tion  in  such cases. Hence i t  i s  d e f in i te ly  o f  value in  t r e a t in g  
p a t ie n ts  w ith sulphonamides to  know whether the  drug i s  absorbed re a d ily  o r  i f  
most o f i t  i s  excreted  in  the faeces. Following ab so rp tion , su lp h a th iazo le  i s
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i s  d i s t r ib u te d  in  th e  t i s s u e s  in  about th e  same r a t io  as  has been noted  fo r  
sulphanilam ide. S u lp h a th iazo le  i s  excreted  much more ra p id ly  than su lp h apyrid ine , 
i f  ren a l fu n c tio n  i s  norm al. Also, much l e s s  a ce ty l su lp h a th iazo le  i s  p re se n t in  
the  u r in e  than in  the case o f  su lphapyrid ine . A fte r a s in g le  dose, Long (1940) 
recovered 80 -  90 p e r cen t, o f the drug from th e  u r in e  w ith in  24 hours.
I I I .  Methods Employed in  t he E stim ation  o f the  Sulphonamides.
The estim ation  o f the  concen tra tion  o f the  sulphonamides in  the blood and 
o th e r f lu id s  i s  c a rr ie d  o u t w ith a view to  c o n tro llin g  the  dosage, so as to 
m aintain an optimum concen tra tion  o f the  drug in  th e  blood o r  ce reb ro sp in a l f lu id ;  
and to c o n tro llin g  the  e lim in a tio n  o f the  drug in  the u r in e . I  consider th a t  a 
knowledge o f the  absorp tion  and ex cre tion  o f su lphapyrid ine , used in  the  trea tm en t 
o f p a t ie n ts  su ffe rin g  from pneumococcal lo b a r  pneumonia, i s  most d e s ira b le  o r 
even e s s e n t ia l .  A ccordingly, the  v a rio u s  methods described  fo r  the  e s tim a tio n  o f 
sulphonamides a re  d iscussed  b r ie f ly ,  and the advantages o f  the  method to  be 
adopted a re  s ta te d .
(a) Method o f Fuller_(19^>72_»
This i s  the  f i r s t  method to be described  in  B r i t is h  jo u rn a ls . I t  depends on 
the  d ia z o t is a tio n  o f the  sulphonamide w ith sodium n i t r i t e ,  and then coupling w ith 
a lk a lin e  tl^rmol o r  0 -n ap h th o l, in  the  case o f u r in e , to  g ive a red  c o lo u ra tio n , 
which i s  compared w ith th a t  o f a so lu tio n  o f the  corresponding drug o f known s tre n g th
(b) Method of_M arshall^ Emerson and C utting (1957)«
In th i s  method the  plasma p ro te in s  are  p re c ip i ta te d  by means o f a lcoho l and the  
so lu tio n  i s  a c id if ie d  before d ia z o tisa tio n  o f the  sulphonamide w ith n i tro u s  acid  
and coupling w ith dimethyl-fl(-naphthylamine, to  produce a p u rp lish  red  dye which can
be estim ated  by c o lo rim e tric  comparison. The re a c tio n  depends on the  presence  o f
an amino group s u b s titu te d  in  the  benzene r in g  and i t  can be used fo r  any compound
to which the  sulphonamide i s  changed in  the  organism and in  which the  amino group
i s  in t a c t .  The colour re a c tio n  i s  veiy d e l ic a te ,  being d e te c ta b le  in  a so lu tio n  o f
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o f  th e  sulphonamide o f  one p a r t  in  twenty m illio n  p a r t s  o f  w ater. The 
co lo u ra tio n  ob ta ined  i s  compared a f t e r  ten  m inutes w ith  s tandard  so lu tio n s  
s im ila r ly  tre a te d .
( c) M arshellys_m odification_of_the_ aboye_method_{l932l#
With alcohol p r e c ip i ta t io n  o f  the  p ro te in s  M arshall found i t  was n o t 
p o s s ib le  to  estim ate  the  amount o f conjugated drug p re se n t. He used in s te a d , 
to luene  sulphonic acid  in  a co n cen tra tio n  which was s u ita b le ,  n o t on ly  fo r  
p ro te in  p re c ip i ta t io n ,  but a lso  fo r  d ia z o t is a tio n  and h y d ro ly s is  o f the  
conjugated compound on hea tin g . This method proved very s a t is fa c to ry ,  but the  
development o f  the  co lou ra tion  fo llow ing coupling w ith dimethyl-xA-nephthylamine 
was n o t sp e c ia lly  rap id  and the co lo u ra tio n  was n o t permanent.
( d) P roo§lj3_m ethod_(19j$^.
Proom combined th e  two p rev ious methods, i . e .  a v a r ia tio n  in v o lv in g  both 
F u lle r* s  and M arshall*s, Etoerson’ s and C u ttin g ’ s method. F u lle r  p r e c ip i ta te s
the  plasma p ro te in s  w ith  t r ic h lo r a c e t ic  ac id , d ia z o t is e s  by the  a d d itio n  o f
n i t r i t e
sodium^and Couples the diazo compound w ith thymol in  a lk a l in e  so lu tio n  to  give 
an orange dye. M arshall e t  a l . , on the  o th e r hand, p re c ip i ta te  the  p ro te in s  
w ith a lco h o l, a c id ify  the  f i l t r a t e  w ith hydroch loric  a c id , d ia z o t is e  and 
couple w ith dim etbyl-r^naphthylam ine in  acid  so lu tio n  to  give a p u rp lish  dye.
Proom combines th ese  methods in  th a t  he u ses  t r i c h lo r a c e t ic  ac id  to 
p r e c ip i ta te  th e  p ro te in s  as i t  i s  b e t te r  than a lcohol and avoids th e  n e c e s s ity  
o f a c id u la tin g  the  f i l t r a t e .  He d ia z o t is e s  w ith sodium n i t r i t e  and couples 
th e  d ia z o tise d  drug w ith dimetl^l-vls-naphtbylamine.
(e) B ratton and Marshall* s Method (1959)»
The d isadvantages o f dim e th y l-^ -n ap h th y l amine, the coupling reag en t
p rev io u s ly  used, were the  n e ce ss ity  o f a c a ta ly s t  fo r  th e  rap id  development of 
co lour in  weak so lu tio n s , and the need o f an excess o f the  reagen t and a lso  o f  
a c e r ta in  amount o f alcohol to  keep' th e  azo dye in  so lu tio n .
B ratton  and M arshall s ta te d  th a t  the  id e a l  coupling reag en t should e x h ib it  
r a p id i ty  o f coupling , s e n s i t iv i ty ,  p u r i ty ,  r e p ro d u c ib il i ty  and be u n a ffec ted  in  
r a p id i ty  o f  coupling by change o f pH from 1 to  2; and the  azo dye formed should 
be ac id  so lu b le  and n o t a f fe c te d  in  colour by pH changes from 1 to 2. The most 
s u ita b le  compound was found to be N -(l-naph thy l) e thy lene  diam ine d ih y d ro ch lo rid e .
The use  o f  t r i c h lo r a c e t ic  acid  fo r  th e  p re c ip i ta t io n  o f  th e  plasma p ro te in s  
was p re fe rre d  to  p -to lu en e  sulphonic acid  because o f i t s  co n stan t q u a li ty  and 
p u r ity  and as su p p lie s  a re  re a d ily  o b ta in ab le . D ia zo tisa tio n  was performed 
usin g  sodium n i t r i t e  and excess o f  the  sodium n i t r i t e  was destroyed  by the  
in tro d u c tio n  o f ammonium sulpham ate, a f t e r  whic h coupling was performed w ith 
W -(l-naphthyl) ethylene diamine d ihyd roch lo ride .
For the a c tu a l comparison o f co lours , various methods may be employed.
The most a ccu ra te  r e s u l t s  can be ob tained  u sin g  a p h o to -e le c tr ic  co lo rim ete r.
For o rd in ary  purposes, however, a Duboscq co lo rim eter g ives extrem ely s a t i s fa c to ry  
r e s u l t s .  The Lovibond Comparator, fo r  which sp ec ia l d is c s  a re  a v a ila b le  fo r  
the  estim ation  o f sulphonamides ty  various methods, may be employed when l e s s  
a ccu ra te  r e s u l t s  w ill s u f f ic e .
While th e  above method i s  in tended  p rim arily  fo r  sulphanilam ide, i t  can 
a lso  be used fo r  o th e r sulphonamide d e r iv a tiv e s  such as su lphapyrid ine  and 
su lp h a th iazo le . V&th th ese  drugs, i f  the  corresponding standard  so lu tio n  i s  
not a v a ila b le , then the r e s u l t  must be m u ltip lie d  by a co rre c tio n  fa c to r  
(Lankford 1940).
( f )  Micro and Bedside Methods^
Such methods a re  a v a ila b le  t u t  a re  l e s s  accu ra te  than th e  methods 
p rev io u s ly  described .
M arshall and C utting (193^) in troduced  a micro method u s in g  dimethyl-oly- 
naphthylam ine as coupling reag en t. Comparison was made in  a Rosenfeld photo­
e le c t r i c  co lo rim eter; while in  a s im ila r  method MacLachlan, Carey and B u tle r
(1938) p re fe rre d  an Evelyn p h o to -e le c tr ic  co lo rim eter.
R atish  and Bullowa (1939) adopted a bedside method fo r  th e  estim atio n  o f  
su lphapyrid ine . One cubic cen tim etre  o f  bLood i s  req u ired  and th e  drug i s  
ex tra c te d  w ith  e th e r  and £ -to lu en e  sulphonic a c id , a f t e r  which i t  i s  d ia z o tise d  
and coupled. The method i s  ra p id , but recovery  i s  n o t complete.
Schoeffel (1940) in troduced  a bedside method invo lv ing  th e  p r in c ip le s  o f  
B ratton and M arsh a ll 's  method. Only a drop o f  f lu id  i s  req u ired  and a f t e r  the  
development o f  the  co lo u ra tio n , the  f in a l  coloured so lu tio n  i s  absorbed on a 
s t r ip  o f  f i l t e r  paper and compared with standard  s t r ip s .  S h e fte l (1941) a lso  
in troduced  a m od ifica tion  o f  B ratton and M a rsh a ll 's  method in  which the  reag en ts  
a re  added to  th e  d ilu te d  blood in  the form o f t a b le t s ,  and the  co lour developed 
i s  compared w ith  th a t  o f a l u c i t e  wedge in  a sp ec ia l co lo rim ete r.
In  conclusion , i t  would appear th a t  the  method o f B ratton and M arshall i s  
the  most r e l ia b le  and gives extrem ely accu ra te  r e s u l t s ,  even in  the  absence o f  
a p h o to -e le c tr ic  co lo rim eter. Accordingly, th i s  method was adopted in  my study 
o f the  absorp tion  and ex cre tion  o f  the  sulphonamides. I t  i s  described  in  
d e ta i l  in  Chapter I I I .
IV. The to x ic i ty  o f the Sulphonamides.
In the  ea rly  days o f sulphonamide therapy  th e  fe a r  o f to x ic  re a c tio n s  
a tten d an t upon th e  ad m in is tra tio n  o f the  drugs had a g re a t deal to  do w ith th e  
h e s i ta n t  a t t i tu d e  o f many ph y sic ian s  towards th e i r  u se . Although th i s  f e a r  was 
b e n e f ic ia l in  p reven ting  in d isc r im in a te  use o f th e  drugs, i t  was a lso  re sp o n sib le  
fo r  th e i r  misuse in  p a t ie n ts  in  whom otherw ise  th e  drug might have had a l i f e -  
saving e f fe c t .  At p re sen t, in  h o sp ita l p a t ie n ts  a t  any r a te ,  p roper p recau tio n s  
a re  taken in  th e  case o f those  rece iv in g  the  drug, so th a t  to x ic  m an ife s ta tio n s  
a re  noted a t  th e i r  in c ep tio n , and measures can be taken to d im in ish  th e i r  s e v e r ity .
In  anim als i t  i s  g en era lly  acute to x ic  symptoms which have been described  and
th ese  c o n s is t la rg e ly  o f nervous m an ife s ta tio n s . In  th e  case o f  mice, 
sulphanilaaddeproduces p a ra ly s is  w ith in co o rd in a te  movements, w hile /
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w hile su lphapyrid ine  induces a s ta t e  o f  h y p e r -e x c i ta b il i ty  w ith  convulsions, 
as shown by Wien (1938) .  The e f f e c t s  o f  chronic to x ic i ty  have a lso  been described  
by numerous w orkers, in c lu d in g  Wien (1938)* Archfer and Discombe (1937)> Gross and 
Cooper (1939) y anc* Rimington and Hemmings (1938)*
In  humans, acu te  to x ic  symptoms a re  r a re ly  recorded and we meet w ith more 
chronic symptoms which a re  ra re ly  re fe ra b le  to th e  nervous system. The dangerous 
s ta t e s  in  humans a re  g en era lly  accompanied by changes in  the  blood c e l l s .  The 
to x ic  m an ife s ta tio n s  o f most o f th e  sulphonamide drugs a re  somewhat s im ila r  and
may be c la s s i f ie d  as m ild, moderate and sev ere :-
(a) Mild symptoms: These in c lu d e  general m ala ise , headache, d iz z in e ss ,
anorex ia , nausea, vomiting and sometimes s l ig h t  cyanosis. Such fe a tu re s  a re  
p o ss ib ly  c e reb ra l in  o r ig in  (M arshall 1939)*
(b) M oderately to x ic  symptoms: This s ta t e  i s  a p rogression  o f  the  fo rego ing ,
and i s  accompanied by cyanosis and a c id o s is . These l a t t e r  symptoms a re  considered
to  be d i r e c t  to x ic  e f fe c ts  o f  the  drugs.
(c) Severe to x ic  symptoms: These inc lu d e  skin m a n ife s ta tio n s , py rex ia , 
numbness and p a ra es th e s ia  o f the hands and f e e t ,  abdominal pain  and d ia rrh o ea , 
leucopen ia , ag ran u lo cy to sis , jau n d ice  due to  to x ic  h e p a t i t i s ,  acu te  haem olytic 
anaemia, and p e r s is te n t  sulphemoglobinaemia. The presence o f drug fev e r and 
ra sh es  and o f haem olytic anaemia probably rep re se n t ia io sy n cracy  to  th e  drug,
as suggested by M arshall (1939)> and such symptoms and signs a re  warning s ig n a ls  
o f impending danger. O ccasionally  c r is e s  follow  severe to x ic  e f f e c t s  and r e s u l t  
in  co llap se  o r  even in  death , as s ta te d  by Schmitker (1940). I t  should be no ted , 
however, th a t  most deaths a re  due to  severe haem olytic anaemia, ag ran u lo cy to sis  
o r to x ic  h e p a t i t i s .  I t  i s  a lso  in te re s t in g  to  n o te  th a t  th e re  i s  a re la tio n s h ip
in  the  occurrence o f  c e r ta in  to x ic  m an ife sta tio n s . Thus during th e  f i r s t  week of
th e rap y ,m ala ise , headache, nausea, vom iting, cyanosis and acute haem olytic anaemia 
a re  encountered. During the  second week one fin d s  drug rash es  and drug pyrex ia
/
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drug py rex ia  and a lso  to x ic  h e p a t i t i s  causing jau n d ice . In  the  th i r d  week th e re  
may be a chronic p ro g ress iv e  anaemia o r  ag ran u lo cy to s is . In  view off th e se  to x ic  
m a n ife s ta tio n s , the  drugs must be given w ith  co n sid erab le  caution  to  any p a t ie n t  
su ffe r in g  from anaemia, leucopen ia , jau n d ice  o r im paired ren a l fu n c tio n .
I  sh a ll  now review th e  to x ic  m a n ife s ta tio n s  as they a f f e c t  v a rio u s  s y s te m s .
Nervous m an ife s ta tio n s : Headache i s  a f a i r l y  common symptom, and may be an
im portant sign  o f the  development o f drug fe v e r, drug rashes o r  haem olytic anaemia. 
D izziness i s  a lso  a common to x ic  f a c to r ,  but i s  no t se r io u s . I t  i s  freq u e n tly  
noted in  ambulatory p a t ie n ts ,  and i s  o f l i t t l e  im portance, and by i t s e l f  does n o t 
w arrant the  cessa tio n  o f therapy. T in n itu s  and v e rtig o  a re  o ccas io n a lly  found.
A fe e lin g  o f  general m ala ise , anorex ia, nausea and vomiting a re  f a i r l y  common and 
a re  probably th e  r e s u l t  o f  a c e n tra l ac tio n  o f  th e  drug. Nausea and vom iting may 
be so severe as to  in te r f e r e  se r io u s ly  w ith th e  ad m in is tra tio n  o f the  drug. Nausec 
and vomiting tend to  be much more severe and more freq u en t w ith  su lphapyrid ine  than 
w ith the  o th e r sulphonamides. I t  i s  indeed only w ith su lphapyrid ine th a t  vom iting 
c o n s ti tu te s  a problem in  therapy . No s a t i s fa c to ry  explanation  as to the  cause o f 
nausea o r vom iting has y e t been forthcom ing, and various a ttem pts to  overcome 
these  re a c tio n s  have n o t proved successfu l in  a l l  cases. In  c e r ta in  in d iv id u a ls , 
sulphonamides produce a fe e lin g  o f depression  and somnolence may be marked, w hile 
o ccas io n a lly  e la t io n  i s  ev iden t. Mild confusion i s  o ften  seen but frank 
d is o r ie n ta tio n  i s  ra re . Toxic psychoses have developed during  therapy w ith  
sulphonamides and in  such cases abnormal m ental re a c tio n  occu rrin g  during  the  
course o f acu te  f e b r i le  in fe c tio n  must be d is tin g u ish ed  from re a c tio n  due to  
a c tu a l sulphonamide therapy. P e rip h e ra l n e u r i t i s  has occurred  e sp e c ia lly  w ith 
sulphonamides contain ing  methyl ra d ic a ls . The p a t ie n ts  complain o f pain  in  the  
arms and le g s  end th e re  i s  o ften  numbness and p a ra e s th e s ia . Such changes may occur 
between th e  10 th  and 20th day o f therapy o r a f t e r  the  drug has been d isco n tin u ed .
The mode o f  production o f n e u r i t i s  i s  unknown. I t  may re p re se n t an in d iv id u a l
/
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in d iv id u a l response to  the drug and i t  need n o t be r e la te d  to  la rg e  doses. Recovery 
has occurred but in  c e r ta in  cases no improvement has been no ted .
Cyanosis: This i s  a common to x ic  m a n ife s ta tio n , though i t  i s  n o t n e c e s sa r ily
se r io u s . I t  i s  n o t a sso c ia te d  w ith re s p ira to ry  d i s t r e s s  and i s  n o t n e c e s sa r ily  
accompanied by a change in  the  cond ition  o f th e  blood pigment. M arshall and 
Walzl (1937) s ta te d  th a t  i t  i s  due to the  form ation o f  a pigment in  the  body 
from condensation p roducts o f th e  drug i t s e l f ,  and i t  i s  considered th a t  i t  i s  net 
a symptom which should d e te r  fu r th e r  ad m in is tra tio n  o f th e  drug. Colebrook and 
Kenny (1936) and Discombe (1937) dem onstrated th e  presence o f sulphamoglobinaemia 
in  p a t ie n ts  rece iv in g  ’’P ro n to s il .  w Archer and Discombe (1937) suggested th a t  
i t  was due to  the  union o f i n t e s t in a l  hydrogen su lph ide  w ith haemoglobin; a 
re a c tio n  which was ca ta ly sed  by sulphanilam ide, and th a t  i t  was minimised by 
w ithholding a c tiv e  p u rg a tiv e s . Paton and Eaton (1937) recommended the  
exclusion  o f eggs from the d ie t  during sulphanilam ide therapy. Methaemoglobinaemie
may lik ew ise  be found, but i t  causes no tro u b le  as i t  i s  ra p id ly  converted in to  
haemoglobin on the  cessa tio n  o f therapy. Cyanosis p e r s is t in g  fo r  ten  days a f t e r  
the  cessa tio n  of therapy cannot be due to  methaemoglobinaemi^fcut must be due to 
sulphamoglobinaemia, as s ta te d  by Schn itker (1940). Cyanosis i s  as a ru le  le s s  
marked w ith su lphapyrid ine and su lp h ath iax o le  than w ith sulphanilam ide, and Long
(I 9 3 9 )  never n o ticed  in  the trea tm en t o f lo b a r pneumonia w ith  su lphapyrid ine  
th a t  i t  co n trib a ted  s ig n if ic a n tly  to the  cyanosis a lready  p re se n t, and indeed 
chemotherapy was afterw ards a ttended  by a decrease in  the  degree o f cyanosis.
A cidosis: Long and B liss  (1939) observed a c id o s is  during sulphanilam ide
therapy  and they advised the  ro u tin e  use o f sodium b icarbonate  during  su lp h an il ami d< 
therapy . M arshall, Emerson and C utting  (193$) explained  th i s  a c id o s is  and the  
a lk a l in i ty  o f  the  u r in e  which was p re se n t by dem onstrating th a t  70 -  80 p er 
cen t, o f th e  drug in  th e  g lom erular f i l t r a t e  i s  reabsorbed in  the  tu b u le s , and 
they suggested th a t  th i s  process in te r f e r e s  w ith  the  reab so rp tio n  o f  b icarbonate  
and base. Although th e re  i s  a r i s e  in  the u rin a ry  b icarbonate  and the  u r in e  pH, 
th e  a lv e o la r  carbon d io x id e , blood carbon d ioxide and blood pH only drop s l ig h t ly ,
/
s l ig h t ly ,  and no change in  v e n t i la t io n  i s  p re se n t. Sulphanilam ide th e re fo re  
p rov ides a prim ary a lk a l i  d e f i c i t  type o f  a c id o s is .
Drug fe v e r: Such py rex ia  o ften  reaches 102 to  103°F. and i t  g e n e ra lly  occurs
seven to  tw elve days a f t e r  th e  o n se t o f therapy . I t  o fte n  p recedes a drug ra sh , 
and i t  subsides ra p id ly  along w ith the fad ing  o f  the  ra sh , on the withdrawal o f  
th e  drug. This to x ic  m an ife s ta tio n  may be confused w ith recrudescence o f the 
o r ig in a l  in fe c t io n , though u su a lly  the  l a t t e r  occurs a f t e r  th e  drug I s  s t o p p e d ,  
as was shown by Colebrook and P urdie  (1937)- Lockwood, Coburn and S tokinger (193$) 
d if f e r e n t ia te d  th ree  types o f f e b r i le  response to sulphanilam ide. The common 
type i s  th a t  described  above in  which the  tem perature f a l l s  soon a f t e r  the drug 
i s  stopped. O ccasionally  high fev er and c h i l l s  occur w ithin  24 hours o f  commencing 
therapy in  p a t ie n ts  who have a low to le ran ce ; w hile in  the th ir d  group a re  p laced  
those p a t ie n ts  who have p rev io u s ly  shown to x ic  m a n ife s ta tio n s , and who now 
e x h ib it h y p e rsen s itiv en ess .
As in  cases w ith headache, py rex ia  c o n s t i tu te s  an im portan t warning sign 
in  the course o f  sulphonamide therapy.
Drug rashes: These may appear in  anything up to  5 P©r  cen t, o f a l l  cases
rece iv in g  sulphonamides. The commonest v a r ie t ie s  inc lude  erythem atous,
sc& rlatin ifo rm , m orb illifo rm , p u rp u ric , e x fo l ia t iv e  and u r t i c a r i a l  le s io n s .
A rash  may be tra n s ie n t  and m ild, o r prolonged and severe. They may appear
e a r ly  in  therapy o r n o t u n t i l  severa l days a f te r  therapy has ceased, A ra sh  i s
g en era lly  accompanied by py rex ia  and m ala ise , though th i s  i s  n o t always th e  case.
The ra sh  may be g en e ra lised , commencing on the  face and spreading  to the  trunk
and lim bs; o r  e lse  i t  may be sharp ly  lo c a l is e d  as on the  bu ttocks o r lo g s . I t
may o r may n o t cause i tc h in g . M orbilliform  rashes are  th e  commonest, and although
they do n o t fade com pletely on p re ssu re , they do cause more blanching o f the
skin than i s  the  case w ith a ty p ic a l measles e rup tion . A ra sh  g en era lly  rem ains 
fo r  a few days, during which time the  tem perature i s  e lev a ted , and then i t  fades /
fad es  le av in g  no sca rrin g . No o th e r  to x ic  m a n ife s ta tio n s  may be noted  
during the  p resence o f a ra sh  and th e re  i s  no a l te r a t io n  in  th e  red  c e l l  count. 
The rash  may in  some in s ta n c e s  be caused by p h o to s e n s it is a tio n  o f  th e  sk in , 
hence Hallam (1939) advocated th a t  p a t ie n ts  should be ou t o f  s tro n g  su n lig h t 
during sulphonamide therapy.
Blood d v sc ra s ia s : (a) A granulocytosis. This i s  one o f  th e  most se r io u s
com plications produced by sulphonamide drugs. I t  i s  p o ss ib le  th a t  th i s  condition  
may be f a i r l y  common, but i f  leu co cy te  counts a re  n o t perform ed minor degrees 
o f  the condition  w ill no t be recognised . I t  may be found in  cases which do 
n o t respond w ell to  th e  drug. Every p a t ie n t  re ce iv in g  a sulphonamide fo r  more 
than ten days should have a w hite c e l l  count perform ed, e sp e c ia lly  i f  th e re  i s  
a d e te r io ra tio n  o f the  p a tien t*  s general co n d itio n . Kracke (1938) noted th a t  
ag ran u lo cy to sis  was p a r t ic u la r ly  l i a b l e  to occur i f  therapy had been continued 
fo r  fou rteen  days o r lo n g er. Long e t  a l . (1940) found ag ran u lo cy to sis  was 
commoner w ith su lphapyrid ine than w ith sulphanilam ide. A granulocytosis need 
n o t be accompanied by anaemia.
(b) Haemolytic anaemia. Acute haem olytic snaemia 
u su a lly  occurs during the  f i r s t  few days o f trea tm en t. There i s  a sudden f a l l  
in  the  red  blood c e l l  count and in  the  haemoglobin, to g e th e r w ith d is tu rb e d  l i v e r  
fu n c tio n , a varying degree o f jau n d ice , a marked re’jd tu lo c y to s is  and le u c o c y to s is  
ana haem aturia.
A more chronic form o f  haem olytic anaemia may be seen in  cases receiv ing  
sulphonamides over long p e rio d s . In  such cases, -there i s  a slow and p ro g ress iv e  
drop in  th e  red  blood c e l l  count and the  haemoglobin. There i s  no damage from 
such anaemia.
Renal d istu rbance: Haematuria i s  o ften  encountered w ith su lphapyrid ine
and su lp h a th iazo le . These drugs may cause th e  d ep osition  o f concre tions o f  th e  
ace ty l d e r iv a tiv e s  in  the re n a l t r a c t ,  e sp e c ia lly  in  the  c o lle c tin g  tu b u le s  
w ith re s u lt in g  haem aturia. Anuria i s  much more se rio u s  but i s  fo r tu n a te ly  r a re .
I t  may be due to a t ru e  to x ic  in ju ry  o f  the  tu b u les  o f  th e  kidney o r  e ls e  to  
th e  deposition  o f th e  a c e ty l d e r iv a tiv e  o f  th e  drug in  the  tu h i le s ,  re n a l pe lves 
o r  u re te r s .
L iver d is tu rb an ce : The occurrence o f jau n d ice  w ith a decrease in  l i v e r
fu n c tio n  w ithout acu te  haem olytic anaemia has been noted  in  p a t ie n ts  re ce iv in g  
sulphonamide^, In  such cases the jau n d ice  i s  d e f in i te ly  regarded as being a to x ic  
re a c tio n  to  th e  drug. Cases o f subacute and o f f a t a l  acu te  l i v e r  a trophy have 
been rep o rted  b a t a re  exceedingly ra re .
The to x ic  m an ife s ta tio n s  o f sulphanilam ide, su lphapyrid ine  and su lp h a th iazo le  
found by Long and h is  a sso c ia te s  (1940), occu rrin g  in  the  trea tm en t o f  h o sp ita lis e d  
a d u lts  a t  th e  Johns Hopkins H o sp ita l, a re  summarised in  Table I and the  frequency 
o f  th e  commoner m an ife s ta tio n s  no ted .
Table I . 39.
The to x ic  m a n ife s ta tio n s  o f su lphan ilam ide, su lp h ap y rid in e  and 
su lp h a th iaz o le  • ( Long e t  a l .  1940 )•
Toxic
M a n ife s ta tio n s •
Sulphanilam ide 
(1000 cases)
S u lphapyrid ine 
(297 cases  )
S u lp h a th iazo le  
(271 case s  )
Nausea & F a ir ly  common. F requen t. Uncommon.
Vomiting.
D izz in ess. Common. Common. Uncommon.
Psychoses. 0 .6$  occurs e a r ly 0 .3$  occurs e a r ly . Not re p o r te d .
N e u r i t i s . Very r a r e . Not re p o rte d . Not re p o r te d .
C yanosis. Very common occurs Common, s l ig h t  in Uncommon.
e a r ly  and l a t e . degree.
A c id o sis . 1 .9$  occurs a t Not re p o rte d . Not re p o r te d .
any tim e.
Drug Fever. 10$ g e n e ra lly  p re sen t 4$ g e n e ra lly 5$ g e n e ra lly
5-9th  day. 5-9th  day. 5-9th  day .
Drug Rash. 1 .9$  may take  any 2$ may take  any 5$ g e n e ra lly
form . form. n o d u la r.
H e p a t i t is . 0 .6$  may occur Very r a r e . Not re p o r te d .
e a r ly  o r l a t e .
Leucopenia c 0 .3$  may occur 0 .6$  may occur 1 .6$  may occur
Agranu io cy t openi a. e a r ly  o r l a t e . e a r ly  o r l a t e . e a r ly  o r l a t e .
Acute 0 .1$  commonest 0 .3$  commonest Not re p o r te d .
A granu locy tosis• l7 -2 5 th  day. I7 -2 5 th  day.
M ild Haemolytic 3$ occurs R are. Not re p o r te d .
Anaemia. e a r ly  o r l a t e .
Acute Haemolytic 1 . 8$ occurs 0 .6$  occurrs Not re p o r te d .
Anaemia. I - 5 th  day. I - 5 th  day.
H aem aturia. Not re p o rte d . 8$ g e n e ra lly 2.5$  g e n e ra lly
p re sen t e a r ly . p re sen t e a r ly .
A nuria w ith Not re p o rte d . 0 .3$  g e n e ra lly 0 .7$  g e n e ra lly
Azotaeraia. p re sen t f i r s t p re se n t f i r s t
te n  days. te n  days.
Hyperleuco- P resen t in  acute P resen t in  acu te Not re p o r te d .
c y to s is . haem olytic anaemia. haem olytic anaemia. 1
In je c t io n  of Not re p o rte d . Not re p o rte d . 4$ may accompany
s c le ra  and ra sh  and fe v e r .
co n ju n ctiv a .
Purpura ' R are. R are. Not re p o rte d .
haem orrhagica•
O cular and R are. R are. Not re p o r te d .
A udito iy
D istu rbances.
Jaund ice . Accompanies acu te Accompanies acu te Not re p o r te d .
haem olytic anaemia haem olytic anaemia
o r h e p a t i t i s . o r h e p a t i t i s .
P a in fu l jo in t s . R eported. Not re p o rte d . Reported accompany­
in g  ra sh .
S to m a tit is . R are. Not re p o rte d . Not re p o r te d .
A lim entary B leeding r a r e , R are. Not re p o r te d .
d is tu rb a n ce .
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D iarrhoea uncommon.
(V) The r e la t iv e  m e rits  o f  th e  more im portan t sulphonamides in  th e  trea tm en t 
o f  pneumococcal lo b a r  pneumonia; th e  methods o f  a d m in is tra tio n ; and
th e  dosage req u ired .
Domagk's o r ig in a l  P ro n to s il  and sulphanilam ide i t s e l f  have n o t proved o f any 
g re a t value in  the  trea tm en t o f pneumococcal lo b a r  pneumonia. Many compounds 
a l l i e d  to  o r  derived  from sulphanilam ide have been examined and some o f th ese  
have been proved to  be d i s t in c t ly  more a c tiv e  a g a in s t th e  pneumococcus than 
sulphanilam ide i t s e l f .  Those drugs which a re  s u f f ic ie n t ly  a c tiv e  must a t  the  
same time be s u f f ic ie n t ly  no n -to x ic  to  j u s t i f y  c l in ic a l  t r i a l .  Sulphapyrid ine 
was f i r s t  used in  the  trea tm en t o f lo b a r  pneumonia in  1937* Experim ental and 
c l in ic a l  in v e s t ig a tio n s  showed the  new drug, su lp h apyrid ine , to be e f fe c t iv e  
a g a in s t a l l  types o f pneumococci. Sulphapyrid ine was found to have a n t i -  
pneumococcal p ro p e r tie s  possessed  by no o th e r  drug and i t  was accord ing ly  
u n iv e rs a lly  regarded as the  drug o f choice in  the  trea tm en t o f pneumococcal 
lo b a r  pneumonia.
Advances in  chemotherapy have been o ccu rring  during th e  p a s t  few y ea rs  a t  
an ever a c c e le ra tin g  pace and severa l more re c en t compounds a re  now a v a ila b le  fo r  
use  in  the treatm ent o f pneumococcal lo b a r  pneumonia. In  o rd er to  ev a lu a te  the  
com parative m erits  o f th e  newer agents i t  i s  necessary  to  compare th e i r  e f fe c ts  
w ith  those o f a proven form o f therapy . Hence th e  c l in ic a l  r e s u l t s  ob ta ined  in  
th e  trea tm en t o f pneumococcal lo b a r  pneumonia w ith su lp h a th iazo le  and 
su lphad iaz ine  must be compared w ith  those obtained  u sin g  su lphapyrid ine , which 
i s  a recognised and e f fe c t iv e  form o f therapy.
The follow ing d iscussion  summarises some o f th e  in v e s t ig a tio n s  which 
have been made upon th e  r e la t iv e  m e rits  o f the  sulphonamide group o f  drugs in  
th e  trea tm en t o f  lo b a r  pneumonia.
(a) Sulphanilam ide:
Lob&r pneumonia due to  the  pneumococcus does n o t respond c o n s is te n tly  to  
sulphanilam ide therapy . Kolmer e t  a l . (1939) showed th a t  in  experim ental 
pneumococcal in fe c t io n s  in  ra b b its  and mice sulphanilam ide possessed  a c t iv i ty  in  
Types I ,  I I  and I I I ,  and perhaps b e t te r  in  Types I I  and I I I  than in  Type I .  The 
u se  o f sulphanilam ide in  human in fe c t io n s  was l im ite d  la rg e ly  to  those types fo r  
which no ty p e -sp e c if ic  anti-pneum ococcal serum was a v a ila b le . Heintzelman e t  a l .
(1937) rep o rted  n in e teen  cases o f Type I I I  pneumonia in  which the  m o rta lity  was 
considerab ly  lower in  the  cases which were tre a te d  w ith sulphanilam ide compared 
w ith c o n tro lle d  cases. These workers suggested the  use o f sulphanilam ide in  
Type I I I  pneumonia u n t i l  s u f f ic ie n t  cases were accumulated to  j u s t i f y  a f in a l  
judgment as to  th e  e ff ic a cy  o f the  drug. The advent o f su lphapyrid ine  has 
supplanted e n t i r e ly  the  u se  o f sulphanilam ide in  the  trea tm en t o f pneumococcal 
lo b a r  pneumonia. Sulphanilam ide, however, s t i l l  rem ains the  drug o f  choice in  
th e  trea tm en t o f s trep to co cca l pneumonia.
( b) Sulp hapy r i  din e :
This drug was shown by Whitby ( I 938) c o n s is te n tly  to  p ro te c t mice ag a in s t 
l e th a l  doses o f pneumococci and to  be as e f fe c t iv e , dose fo r  dose, as 
sulphanilam ide i s  a g a in s t haem olytic s tre p to c o c c i. Thus su lphapyrid ine  p ro te c ted  
th e  mouse e f fe c t iv e ly  a g a in s t 10,000 l e th a l  doses o f Type I  pneumococci and i t  
a ffo rd ed  considerab le  p ro te c tio n  ag a in s t 10,000 l e th a l  doses o f  o th e r  types o f 
pneumococci. Whitby found th a t  p ro te c tio n  was most marked a g a in s t Types I ,  VII 
and V III, but a lso  e f fe c t iv e  a g a in s t Types I I ,  I I I  and V. Sulphapyrid ine was 
accord ing ly  found to  have anti-pneum ococcal p ro p e r tie s  possessed  by no o th e r  
drug, and i t  was n o t excessive ly  to x ic  in  experim ental in fe c t io n s  in  anim als.
This flew drug c e r ta in ly  seemed worthy o f c l in ic a l  t r i a l .
Evans and G aisford  (193^)> having a sc e rta in ed  th a t  su lphapyrid ine  could be 
given w ith s a fe ty  to  hea lth y  human beings and th a t  moderate doses were w ell 
to le ra te d  and produced no untoward symptoms, t r i e d  th e  e f f e c t  o f  t h i s  drug on a 
s e r ie s  o f p a t ie n ts  su ffe r in g  from lo b a r  pneumonia. In  a study o f one hundred 
cases th e  m o rta lity  r a te  was 8 p e r  c e n t .;  whereas th a t  o f a s im ila r  number o f 
cases used as a co n tro l and re c e iv in g  only symptomatic trea tm en t was 27 P©r  cen t. 
S ince th e  year 1938, workers a l l  over the world have rep o rted  success w ith 
su lphapyrid ine .
Thus, in  South A frica , Agranat e t  a l .  (1939) in  a s e r ie s  o f two hundred and 
e ig h ty  cases, in c lu d in g  both Europeans and n a t iv e s ,  rep o rted  good r e s u l t s ,  as 
d id  Anderson and Dowdeswell (1939) in  Kenya. American workers a lso  rep o rted  
favourab le  r e s u l t s .  Pepper e t  a l .  (1939) in  a t r i a l  study o f fo u r hundred typed 
cases o f  pneumococcal lo b a r  pneumonia rep o rted  a f a t a l i t y  r a te  o f 7 p e r cen t.
Although su lphapyrid ine i s  e f fe c t iv e  in  reducing the  m o rta lity  r a te  o f lo b a r  
pneumonia, i t s  e f f e c t  on the  course o f the  d isea se  must a lso  be s tu d ied . A ll 
workers have been im pressed by the  s t r ik in g  frequency w ith which the  in i t i a t i o n  
o f  drug trea tm en t was follow ed, w ithin  24 hours o r  l e s s ,  by a c r i t i c a l  drop in  
th e  p a tien t*  s tem perature and f a l l  in  the  p u lse  r a te .  This tem perature drop was 
n o t im m ediately accompanied by any s ig n if ic a n t  change in  the  lung s ig n s , but i t  
always re f le c te d  a marked c l in ic a l  improvement in  the toxaemia and general w e ll- 
being o f the  p a t ie n t .  R esolution of the  conso lidated  lung  occurred w ith in  a 
v a r ia b le  period  o f tim e. The c l in ic a l  improvement which accompanies th e  cessa tio n  
o f  fe v e r, p o in ts  r a th e r  to the p ro b a b il i ty  th a t  i t  i s  a consequence o f ra p id  
te rm ina tion  o f th e  in v asiv e  phase o f the  in fe c tio n .
Com plications c h a r a c te r is t ic  o f pneumococcal lo b a r  pneumonia may occur in
cases tr e a te d  w ith su lphapyrid ine . Thus delayed re so lu tio n , s t e r i l e  e ffu s io n s  and 
empyemata a re  a l l  f a i r l y  common; while m en in g itis , p e r i c a r d i t i s  and a r t h r i t i s  
a re  much le s s  common.
Dosage: I t  has a lread y  been noted  th a t  th e re  i s  g re a t in d iv id u a l
v a r ia tio n  in  th e  a b i l i ty  to  absoito su lphapyxld ine. Long (1939) s ta te d  th a t  a 
d e s ira b le  range o f blood con cen tra tio n  i s  from 4 - 6  mgm. p e r 100 c .c .  fo r  
m oderately i l l  p a t ie n ts  and 6 - 1 0  mgm. p er 100 c .c .  fo r  sev e ra ly  i l l  p a t ie n ts .  
Bullowa (1940) showed th a t  high le v e ls  were n o t e s s e n t ia l  fo r  cure and recovery 
could take p lace  re g a rd le ss  o f blood co n cen tra tio n . The d e s i r a b i l i ty  o f  a 
c e r ta in  blood le v e l  remains to  be proved. As a ru le ,  fo r  m oderately i l l  
p a t ie n ts  the  req u ired  blood concen tra tion  recommended by Long (1939) i s  a t ta in e d  
by the  o ra l  ad m in is tra tio n  o f 2 gm. followed by 1 gra. fo u r-h o u rly  u n t i l  the  
tem perature has been s e t t le d  fo r  3 -  5 days. The ta b le t s  may e i th e r  be swallowed 
o r  given crushed in  milk o r  w ater. I f  o ra l therapy i s  im p rac tic ab le , o r i f  
i t  i s  p a r t ic u la r ly  d e s ira b le  to a t ta in  a high blood co n cen tra tion  ra p id ly  in  
a severa ly  i l l  p a t ie n t ,  then a so lu tio n  of th e  sodium s a l t  may be given 
in trav en o u sly . Great care  must, o f course, be exerc ised  owing to  the 
a lk a l in i ty  o f such a so lu tio n . Kinsman e t  a l .  (1939) s tre s s e d  th e  im portance 
o f  the  need fo r  estim atin g  blood le v e ls  in  o rd e r to ensure th e  maximum 
recovery ra te .  These workers suggested th a t  i f  th e  blood le v e l  i s  below 6.0 mgm. 
p e r 100 c .c . ,  and the  p a t ie n t  i s  n o t responding w ell, then th e  sodium s a l t  
should be adm inistered  in trav en o u sly .
(c) Sulphathiazole :
The a c t iv i ty  o f  su lp h a th iazo le  in  experim ental in fe c t io n s  w ith
pneumococci was shown by Cooper, Gross and Lewis (1939) to  be o f  a low er o rd e r
than th a t  o f su lphapyrid ine , so i t  seemed u n lik e ly  th a t  su lp h a th iazo le  would
prove as e f fe c t iv e  as su lphapyrid ine in  the  trea tm en t o f pneumonia, though a
g re a te r  degree o f to le ran ce  might compensate fo r  th i s  l e s s e r  a c t iv i ty  and
j u s t i f y  an a l te rn a t iv e  th e ra p eu tic  agent. McKee e t  a l .  (1939) t however, found 
l i t t l e  d iffe ren c e  between su lp h a th iazo le  and su lphapyrid ine in  pneumococcal 
in fe c t io n s  in  mice. The f i r s t  re p o rt o f i t s  c l in ic a l  use in  pneumonia was in  j
in  th e  year 1940 by G se ll, who s tu d ied  s ix ty  cases o f acu te  lo b a r  pneumonia 
tre a te d  w ith su lp h a th iazo le . He noted th e  ra p id  decrease in  fe v e r , a marked 
change in  the  c l in ic a l  p ic tu re  in  from 1 2 - 4 8  hours, and th e  com parative 
absence o f vom iting. In  th i s  country th e  f i r s t  re p o rts  on th e  use o f 
su lp h a th iazo le  in  pneumonia were by G aisford and Whitelaw (1940). C ontrol 
cases were given su lphapyrid ine , the  trea tm en t being s im ila r  to  th a t  adopted by 
Evans and G aisford (1938)* The s e r ie s  was sm ell and inc luded  only 1'9 cases.
They noted th a t  the  f a l l  in  tem perature was n o t so marked as in  the  case o f 
su lphapyrid ine and th a t  th e re  was a corresponding la g  in  the  period  o f  acute 
i l l n e s s .  No deaths occurred in  the  ten cases tre a te d  w ith su lp h a th iazo le  o r  in  
th e  n ine  c o n tro ls  tre a te d  with su lphapyrid ine . The c h ie f  p o in t noted  ves the  
lack  o f vomiting in  the  cases re c e iv in g  su lp h a th iazo le . ELippin e t  a l .  (1941) 
recorded the  trea tm en t o f two hundred cases o f lo b a r  pneumonia, compared with 
two hundred cases tr e a te d  by su lphapyrid ine . The re sp e c tiv e  m o rta lity  r a te s  
were 11 p er cen t, fo r  su lp h a th iazo le  ana 15 p e r cen t, fo r  su lphapyrid ine , o r 
i f  a co rrec tio n  i s  made fo r  deaths w ithin  24 hours o f adm ission, th e  f ig u re s  
a re  7*8 p er cent, and 11.9 p e r cen t, re sp e c tiv e ly . T hirty -seven  o f  a l l  the 
cases received  serum therapy in  ad d itio n  to  chemotherapy. The c l in ic a l  response 
was s im ila r  in  both groups. Sulphapyrid ine, however, brought down th e  tem perature 
more ra p id ly  than d id  su lp h a th iazo le . The d u ra tio n  o f s tay  in  h o s p ita l  was 
s im ila r  in  both groups, and com plications showed th e  same inc idence . The 
advantage o f su lp h a th iazo le  was th e  l e s s e r  frequency and se v e r ity  o f  nausea 
and vom iting.
Dosage: A blood concen tra tion  o f 4 -  6 mgm. p e r 100 c .c .  i s  suggested as
adequate fo r  m oderately i l l  p a t ie n ts  and a le v e l  o f  6 -  10 mgm. p e r 100 c .c . fo r  
sev ere ly  i l l  p a t ie n ts .  In  o rd er to  evalua te  the  in flu en ce  o f  the  drug co n cen tra tio  
on the th e rap eu tic  response, F lip p in  a l . (1941) c o rre la te d  blood le v e ls  w ith  
th e  dura tion  o f py rex ia . Using th is  f a l l  in  tem perature as a b a s is  fo r
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fo r  measurement, no s t a t i s t i c a l  s ig n if ic a n c e  between the  response o f  p a t ie n ts  
having low and high blood co n cen tra tio n s  was found. On s im ila r  dosage blood 
le v e l s  w ith su lp h a th iazo le  were found to be low er than w ith su lp h apyrid ine , 
t h i s  being due to the  more rap id  ex cre tio n  o f su lp h a th iaz o le . To o b ta in  the  
necessa ry  blood co n cen tra tio n , th e  o ra l  a d m in is tra tio n  o f  an i n i t i a l  dose o f 
4 gms. followed by 1 gm. fo u r-hou rly  i s  recommended. The drug i s  adm in istered  
u n t i l  the  tem perature has been s e t t le d  fo r  3 “ 5 days and th e  p a t ie n t  shows 
s ig n s  o f c l in ic a l  improvement. When a rap id  e lev a tio n  o f blood co n cen tra tio n  
i s  d e s ired , as in  very acu te ly  i l l  p a t ie n ts ,  an i n i t i a l  in travenous in je c t io n  
o f th e  sodium s a l t  should be given in  s t e r i l e  d i s t i l l e d  w ater.
(d) Sulphadiazine:
This recen t sulphonamide has been used in  America w ith co n sid e rab le  success 
by Long (1941), F inland e t  a l , (1941) and F lip p in  e t  a l . (1941). A ll workers 
ob tained  a low er f a t a l i t y  r a te  w ith su lphad iaz ine  than w ith su lphapyrid ine  
o r  su lp h a th iazo le . The acute course o f th e  i l l n e s s  was considerab ly  
shortened and th e  m ajo rity  o f p a t ie n ts  were e s s e n t ia l ly  a f e b r i le  o r  recovered 
th i r ty - s ix  hours a f te r  re ce iv in g  the f i r s t  dose. Com plications occurred  but 
were few. The duration  o f s tay  in  h o sp ita l was very s im ila r  to  th a t  w ith 
su lphapyrid ine and su lp h a th iazo le . An advantage o f th i s  drug would appear 
to  be i t s  low to x ic i ty ,  as few to x ic  m an ife s ta tio n s  have been rep o rted  as y e t.
Dosage: Sulphadiazine i s  re a d ily  absorbed and consequently  high blood
le v e ls  a re  e a s i ly  a tta in e d . A s u ita b le  dose i s  th e  o ra l  ad m in is tra tio n  o f an 
i n i t i a l  dose o f  4 gms. o r  2 gms. followed by 1 gm. fo u r-h o u rly .
(VI) Chemotherapy combined w ith serum therapy  and vaccine therapy .
(a) Serum therapy^
The adoption o f  serum therapy in  th i s  country  has always lagged f a r  behind
th a t  in  America. In  th a t  country  serum trea tm en t and a l l  th e  d ia g n o stic
f a c i l i t i e s  which i t  demands have been o rg an ised , in  many c e n tre s  to  p e rfe c t io n ,
and have produced r e s u l t s  on a sca le  unapproached elsew here. Since th e  f i r s t
s c e p tic a l re cep tio n  o f su lphapyrid ine in  America, opinion has slowly veered towards
in c re as in g  emphasis on the  value o f chemotherapy and le s s  on th a t  o f  serum.
A lte rn a tio n  o f th e  two methods o f  trea tm en t has now ceased and p r a c t ic a l ly  a l l
p a t ie n ts  now rece iv e  some form o f  chemotherapy. Many workers, both in  th i s
country end in  America, heve ob tained  extrem ely good r e s u l t s  w ith serum therapy
combined w ith chemotherapy, and they are  perhaps ra th e r  r e lu c ta n t  to ab o lish
th i s  method o f therapy. In  R uch ill H o sp ita l, Anderson end C airns (1940) in
the  trea tm en t o f Type I I  in fe c t io n s  w ith combined serum and chemotherapy rep o rted
a f a t a l i t y  r a te  o f 5 p e r c e n t . , which was low er than th a t  ob ta ined  in  cases
tre a te d  w ith su lphapyrid ine alone. Recently Plummer e t  a l .  (1941) in  a s e r ie s
o f  607 cases obtained a f a t a l i t y  r a te  o f 11.1 p e r cen t, in  306 cases rece iv in g
chemotherapy alone, and a r a te  o f 14.6  per cen t, in  cases re c e iv in g  chemotherapy
and serum. I f  a co rrec tio n  i s  made to exclude 24 hour dea th s , the  re sp ec tiv e
f ig u re s  a re  9*3 Pe r cen t, and 9 .8  p e r cen t. The t r i v i a l  d iffe re n c e  between th ese
fig u re s  p e rs is te d  throughout c lo se r  analyses and th e re  was no g re a t d iffe re n c e
whether the cases were tre a te d  e a r ly  o r  l a t e ,  o r whether they had bacteraem ia o r
n o t, o r whether they belonged to the  lower o r  h igher age groups. Also, no
im portant d iffe ren c e  was noted in  the  frequency o f the vario u s  com plications.
These workers suggested th a t  serum therapy should be used only  in  the  case o f 
p a tie n ts  who cannot to le r a te  sulphonamide therapy o r  who do not respond adequately  
to  the  drug w ithin  24 -  43 hours o f ad m in is tra tio n .
I t  should be remembered th a t  th e  p roduction  o f concen tra ted  anti-pneum ococcal 
ra b b it  serum fo r  t r e a t in g  th e  many d i f f e r e n t  types o f pneumococcal in fe c t io n s  i s  
a la b o rio u s  and expensive  p ro cess  and in c re a s in g  r e s t r i c t io n  o f  in d ic a t io n s  fo r  
i t s  u se  may reduce demand to an uneconomical supply le v e l .  Thus i t  i s  th a t  we 
may w ell see th e  passing  o f anti-pneum ococcal serum in  favour o f chemotherapy 
alone. Only one o f my cases, a severe Type I I  in fe c tio n  w ith m en in g itis , 
received  serum therapy combined w ith chemotherapy.
(b) Vaccine^therapy^
Vaccines have been used in  various p a r t s  o f the  world in  the  trea tm en t o f 
pneumonia, in c lu d in g  America, A frica  and In d ia , as well as in  th i s  country.
Thus in  th e  year 1927 Wynn advocated the  use o f  vaccine therapy  in  pneumonia. 
U nfortunate ly , most re p o rts  r e la t in g  to th e  vaccine trea tm en t o f pneumonia a re  
o f  a c l in ic a l  n a tu re  and d e ta i le d  in form ation , so e s s e n tia l  to  e s ta b lish in g  
the  value, i f  any, o f th i s  procedure, i s  conspicuously lack in g . The ra t io n a le  
o f vaccine therapy i s  based on the  assumption th a t  th e  p a re n te ra l in je c t io n  o f 
d e v ita lis e d  organisms w ill  a c c e le ra te  the  immunity response. L ive organisms a re , 
however, a f a r  b e t te r  an tigen  than k i l le d  ones, and in  pneumonia la rg e  numbers 
o f  l iv e  organisms a re  in  the lung  and may gain access to  the  blood stream as w ell. 
In pneumonia the  curve o f in to x ic a tio n  r i s e s  ra p id ly  and remains a t  a high 
le v e l  fo r  severa l days. S p ec ific  a n tib o d ie s , however, appear about the  4 th  o r 
5th  day, the  curve r is in g  slowly, and then ra p id ly  reaching th e  curve o f in to x ic ­
a tio n  about the  7 th day, a t  which time a c r i s i s  w ill occur. A ccordingly, i t  
would be d e s ira b le  to aim a t  the  production o f a n tib o d ie s , w hile the  curve o f 
toxaemia i s  s t i l l  r i s in g .  Barsch (1931) dem onstrated the p resence  o f an tib o d ie s  
in  the p a t ie n t1 s serum th re e  days a f t e r  the ad m in is tra tio n  o f  pneumococcus 
vaccine. Such an tib o d ie s  were produced as a r e s u l t  o f the ad m in is tra tio n  o f 
vaccine, fo r  even i f  the  vaccine adm inistered d if fe re d  from th e  type o f 
in fe c tin g  pneumococcus, then the antibody response which developed was sp e c if ic
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s p e c if ic  fo r  the  type o f vaccine given. Thus th e  a d m in is tra tio n  o f a ty p e- 
s p e c if ic  vaccine to  a p a t ie n t  su ffe r in g  from pneumonia would r e s u l t  in  a 
g re a te r  p roduction  o f  antibody than in  a esse  no t re c e iv in g  vaccine. Barach 
did n o te , however, th a t  in  some p a t ie n ts  who recovered , no antibody was 
dem onstrable, w hile in  o th e rs  death  occurred  even when antibody was p re se n t. 
O bjections to  the use o f vaccines in  th e  trea tm en t o f acu te  in fe c tio n s  a re  the  
fe a r  o f producing a re a c tio n  and a phase o f lowered immunity. R eactions only 
occur in  p a t ie n ts  who a re  s e n s it is e d , and even la rg e  doses o f pneuraococcus 
vaccines can be given w ithout th e  r is k s  o f a n eg ative  phase. Vaccine therapy  
has th e  advantage o f being inexpensive, as vaccines a re  e a s i ly  prepared  and 
a re  a v a ila b le  fo r  a l l  types o f pneumococci. In  th ese  re sp e c ts  i t  compares 
favourably  w ith serum therapy  which i s  much more expensive, la b o rio u s  to 
adm in ister and i s  only a v a ila b le  fo r  c e r ta in  types o f pneumococci. Vaccine 
trea tm en t has no t gained much favour in  the  trea tm en t o f lo b a r  pneumonia e i th e r  
abroad o r  in  th i s  country. Wynn (1936) bas, however, used i t  fo r  many years  
and re p o r ts  favourable r e s u l t s ,  e sp e c ia lly  i f  the cases a re  tre a te d  by th e  
th ir d  day of i l ln e s s .  I t  i s  now w ell recognised th a t  one o f th e  sulphonamide 
drugs should never be denied the  p a t ie n t  su ffe rin g  from lo b a r  pneumonia.
The ac tio n  o f su lphapyrid ine i s  e s s e n tia l ly  b a c te r io s ta t ic .  I t  in te r f e r e s  
w ith the  growth o f th e  in fe c tin g  b a c te r ia , while th e  n a tu ra l  defence 
mechanism has to compete w ith th e i r  d e s tru c tio n . Although su lphapyrid ine i s  
extrem ely b e n e f ic ia l y e t i t  does n o t cure a l l  p a t ie n ts .  I t  i s  thus 
incumbent on the  physician  to  use  any a v a ila b le  means o f in c re a s in g  immunity 
in  ad d ition  to  adm in istering  a sulphonamide.
At p re sen t th e re  a re  few' re p o r ts  o f the use o f  combined chemotherapy and
vaccine therapy in  the  trea tm en t o f acute in f e c t io n s . Cokkinis and McELligott
(1938) suggested th a t  in  gonococcal in fe c tio n s  b e t te r  r e s u l t s  were ob ta ined  i f  /
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i f  the  trea tm en t was delayed fo r  a time to allow  an in c reased  immunity to  
develop as a r e s u l t  o f th e  in fe c t io n , o r  i f  th e  immunity was a r t i f i c i a l l y  
induced by a vaccine.
Accordingly, I  thought i t  would be in te r e s t in g  to  know i f  we could 
supplement th e  b e n e f ic ia l  ac tio n  o f su lphapyrid ine  by the  a d m in is tra tio n  o f  
pneumococcus vaccines to p a t ie n ts  su ffe rin g  from lo b a r  pneumonia. MacLean,
Rogers and Fleming (1939) in  th e  trea tm en t o f experim ental pneumococcal in fe c t io n s  
in  mice ■, ■' i no ted  th a t  vaccine combined with chemotherapy was extrem ely 
advantageous. There appears to  be no reason why vaccines should n o t a lso  be 
o f value to  humans su ffe rin g  from pneumonia, bu t as y e t th e re  a re  no r e s u l t s  
pub lished  in  th i s  country o f combined vaccine and chemotherapy in  the  
trea tm en t o f lo b a r  pneumonia.
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CHAPTER I I I .
The Methods employed in  the  Examin a tio n  o f  P a t ie n ts  s u ffe r in g
from Pneumococcal Lobar Pneumonia;
A fte r th e  admission o f p a t ie n ts  su ffe r in g  from lo b a r  pneumonia to  
R u ch ill H o sp ita l, a complete p h y sica l examination was made, a f t e r  which th e  
b a c te r io lo g ic a l d iagnosis  was e s ta b lish e d . The methods adopted in  the  typing  
o f  sputum and o f  blood c u ltu re s  a re  described , as a re  o th e r  la b o ra to ry  t e s t s  
which were perform ed. The method employed in  the  estim ation  o f  th e  
co n cen tra tion  o f  su lphapyrid ine in  the  blood and u r in e  i s  d escribed  in  d e ta i l .  
Measurement o f  th e  f lu id  in ta k e  and o f the  u r in e  ou tpu t had a lso  to  be 
undertaken . F in a lly , the p re p a ra tio n  o f the  pneumococcus vaccine , which was 
adm in istered  to a small number o f  cases combined w ith  chemotherapy i s  
described .
1 . C lin ic a l Examination.
(a) The in te rro g a tio n  o f the  p a t ie n t:
The com plaint o f the  p a t ie n t  was f i r s t  a sc e rta in ed  and in  most cases 
was found to be pain  in  the  ch est.
In  considering  the  h is to ry  o f the  p re sen t i l l n e s s ,  one in q u ired  
c a re fu lly  in to  the  mode o f  o n se t. Most freq u e n tly  the  on set was sudden with 
a  r ig o r ,  pain  in  the chest and cough, while l e s s  freq u en tly  th e  o n se t was 
in s id io u s  w ith  p re lim inary  re s p ira to ry  c a ta rrh . Less common symptoms were 
headache and vom iting.
As reg ard s  the  p a s t h is to ry , no te  was made o f  any p rev ious ch est 
d isea se , o r  any a sso c ia ted  d isea ses  such as card io v ascu la r o r  chronic ren a l 
d isease , o r  m etabolic  d is tu rb an ces  such as d ia b e te s  m e lli tu s .
Family h is to ry  was o f  im portance in  y ie ld in g  in fo rm ation  regard ing  th e  
presence o f  co n tac t w ith tu b e rc u lo s is . In  considering  personal h a b its , the  
question  o f alcoholism  was im portan t, in  th a t  de lirium  was more common and 
severe  among a lco h o lic s .
(b) General examination o f  th e  p a t ie n t .
The tem perature, p u lse  r a t e  and re s p ira t io n  r a te  were recorded  
by the  nurse  on adm ission.
Note was made o f  how th e  p a t ie n t  la y  in  bed and whether th e re  
was dyspnoea o r  n o t.
The s ta t e  o f  n u tr i t io n  o f  the  p a t ie n t  was then noted.
On exam ination o f th e  sk in , no te  was taken o f the  p resence  o f  
cyanosis o r jau n d ice  and a lso  o f the  presence o f  f a c ia l  herpes. The hands 
were examined fo r  the  presence o f  clubbing o f  th e  f in g e rs .
An examination o f th e  th ro a t  was made and sp ec ia l a t te n tio n  
was pa id  to  th e  tongue, no te  being made o f whether i t  was d e a n  and m oist, 
fu rred  and m oist, o r fu rred  and dry.
(c) Regional examination o f the  p a t ie n t .
The re s p ira to ry  system was f i r s t  examined. This comprised a complete 
exam ination o f th e  chest by the  usual methods o f  in sp e c tio n , p a lp a tio n , 
percussion  and a u sc u lta tio n . The i n i t i a l  exam ination in  p r a c t ic a l ly  a l l  
cases in d u d e d  an a n te r io r  ana a p o s te r io r  exam ination o f th e  c h es t, t u t  
th e re a f te r ,  i f  th e  p a t ie n t  was se r io u s ly  i l l ,  th e  ch est was n o t examined 
p o s te r io r ly  as the  a x i l la  provided easy access to  a l l  lo b es.
The card io v ascu lar system was a lso  c a re fu lly  examined. Note was 
made o f any abnorm ality in  o th e r systems.
2. B a c te r io lo g ic a l exam ination.
(a) Sputum.
The im portance o f o b ta in in g  a specimen o f  sputum as soon as p o ss ib le
cannot be minimised. The sputum was c o lle c te d  in to  wide mouthed g la ss  b o t t le s
w ith  screw-on caps. These b o t t le s  contained no a n t is e p t ic s ,  as typ ing
depends on the  presence o f l iv in g  organisms.
O ccasionally  in  female p a t ie n ts  o r  in  the  e a r lv  stamps n f
specimen o f  sputum could only be obtained  a f t e f  f t s gfm portan?e was i f r i s s e d .
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Lord ( I 925) and o th e rs  have s tre s se d  the  im portance o f  o b ta in in g  s u ita b le  
specimens o f sputum coughed up from the  deep a i r  passages. Such specimens way 
con tain  some blood and tend to  be th ic k  and s tick y  and they  a re  r e la t iv e ly  f r e e  
from s a liv a  and n a sa l s e c re tio n s . One cubic cen tim etre  o f  sputum was u su a lly  
s u f f ic ie n t ,  though a t  tim es sm aller amounts su ff ic e d  and in  a l l  cases i t  was 
ob tained  p r io r  to  the  in s t i tu t io n  o f trea tm en t.
Having ob ta ined  th e  necessary  specimen, n o te s  were made o f  th e  fo llow ing 
general c h a r a c te r is t ic s  o f  the  sputum -  co lour, odour, c h a rac te r , co n sis ten ce  
and amount.
Pneumococcus Typing.
The o ld e r method o f pneumococcus typing  by a g g lu tin a tin g  sera  has given 
way alm ost e n t i r e ly  to  the  more ra p id  method o f typ ing  by capsu lar sw elling .
In  1902 Neufeld f i r s t  described  th e  Neufeld re a c tio n  o r "Quellung" e f f e c t ,  
which i s  ch a rac te rised  by the  sw elling  o f the capsule o f  the  pneumococcus when 
placed  in  co n tac t w ith the  corresponding a n ti serum. I t  was n o t u n t i l  1932» 
however, th a t  the  rap id  method o f  typing  was employed ro u tin e ly  in  t h i s  country , 
being in troduced  by Armstrong, Logan and Smeall (1932). In  I933» th e  use  
horse  serum was superceeded by th a t  o f  ra b b it  serum, which owing to  i t s  g re a te r  
s p e c i f ic i ty  le d  to in c reased  accuracy in  type d iag n o sis . The ra p id ity  o f  th e  
method le d  to  i t s  general adoption.
( i )  The d i r e c t  method o f typ ing .
The a n ti se ra  used fo r  typing were supplied  by L ederle  L ab o ra to rie s  in  small
g la ss  b o t t le s ,  each con tain ing  h a lf  a cubic cen tim etre  o f a n ti  serum a lread y
tin te d  w ith a lk a l in e  methylene b lue. To f a c i l i t a t e  typ ing , s ix  composite b o t t le s
o f pooled serum were used. These s ix  b o t t le s  o f pooled serum were la b e l le d  
A, B, C, D, E, F. The in d iv id u a l types contained in  each o f  th e se  b o t t le s  
o f  pooled serum are  shown th u s :-
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Pooled Serum Types.
A. I ,  I I ,  VII.
B. I l l ,  IV, V, VI, V III.
C. IX, X II, XIV, XV, XVII, XXXIII.
d. x, x i ,  n n ,  xx, x x ii , xxiv.
e . r a ,  x v i n ,  x ix , xx i, x x v iii.
f. xnn, xxv, xxvii, xxix, xxn, xxxii.
Six  sn a il  f le c k s  o f  sputum were p laced  on two g la ss  s l id e s  by means o f  a 
platinum  loop . To each in  tu rn  a lo o p fu l o f pooled serum A to  F was added, 
thoroughly mixed w ith the  sputum, and a coverg lass ap p lied . A fte r a few m inutes 
th e  s l id e s  were examined under an o i l  immersion le n s . The Neufeld re a c tio n  was 
e a s ily  recognised . In  the  Neufeld re a c tio n  th e re  was a ty p ic a l "ground g la ss"  
appearance and a d e f in i te  o u tlin e j i t s  width being eq u iv a len t to  th e  d iam eter 
o f th e  pneumococcus, though i t  may be la rg e r  as in  the  case o f Type I I I  
pneumococcus. In  a l l  types the  sharpness o f o u tl in e  was o f more d ia g n o stic  
value than th e  degree o f sw elling . I t  must be remembered, however, th a t  a 
l i g h t  halo norm ally appears around the  organism due to  re f ra c t io n  from th e  
capsu les.
Each p rep a ra tio n  w ith the pooled serum (A to  F) was examined in  tu rn  
owing to  the  p o s s ib i l i ty  o f th e re  being more than one type o f  in fe c t in g  organism. 
When the  Neufeld re a c tio n  was ob tained  w ith th e  pooled serum fu r th e r  p re p a ra tio n s  
were made w ith monovaleat se ra  fo r  a l l  types contained in  the  p a r t i c u la r  pooled 
serum. The im portance o f examining a l l  th e  pooled serum re a c tio n s  and a l l  types 
was to  exclude the  p o s s ib i l i ty  o f doub lt in fe c t io n s . I f  a Neufeld re a c tio n  was 
n o t found a t  th e  i n i t i a l  exam ination, then the s l id e s  were re-exam ined a f t e r
standing  a t  room tem perature fo r  t h i r ty  m inutes.
( i i )  The in d i r e c t  o r  mouse method o f  typ ing .
Owing to  the  d i f f i c u l ty  in  o b ta in in g  su p p lie s  o f  m ice, i t  was n o t 
p o ss ib le  to  adopt both the  d ire c t  and in d ir e c t  methods o f  typ ing  in  a l l  cases.
In  50 o r  approxim ately one seventh o f a l l  the  cases s tu d ie d , th e  N eufeld 
re a c tio n  was n o t ob ta ined  by the  d i r e c t  method o f  typ ing . In  a l l  such cases 
the  in d i r e c t  method in v o lv in g  the  use  o f  mice was employed. The sputum was 
em ulsified  w ith two to  f iv e  cubic cen tim etres  o f H a rtley ’ s b ro th ; th e  amount 
depending on th e  q u an tity  o f  sputum supp lied . One cubic cen tim etre  o f  th i s  
emulsion was in je c te d  in to  the  p e r ito n e a l cav ity  o f a w hite mouse. Twenty- 
four hours l a t e r ,  the  typ ing  o f pneuraococci which were p rev io u s ly  scarce  
became p o s s ib le , owing to the  rap id  m u ltip l ic a tio n  o f  pneumococci in  th e  
p e r ito n e a l c av ity . In  c e r ta in  cases i f  i t  was thought necessary  to  know the  
r e s u l t  o f  typ ing  e a r l i e r ,  a p e r ito n e a l puncture was performed a f t e r  fo u r hours 
and sev e ra l drops o f  p e r ito n e a l exudate ob ta ined . These drops were te s te d  
f i r s t l y  w ith  th e  pooled serum, and then w ith monovalent se ra . By th i s  
means one could u su a lly  a sc e r ta in  th e  type o f  in fe c t in g  pneumococcus, though 
o ccas io n a lly  th e  organisms were n o t p re sen t in  s u f f ic ie n t  numbers to  show the  
Neufeld re a c tio n . In  a l l  cases th e  mouse was k i l l e d  24 hours a f t e r  in o cu la tio n  
i f  i t  had n o t a lready  died, and samples o f the  h e a r t blood and p e r ito n e a l f lu id  
ob tained  fo r  c u ltu re . Loopsful o f the  p e r ito n e a l f lu id  were p laced  on two 
g la ss  s l id e s , and typing  performed exac tly  as described  fo r  the  d i r e c t  method. 
The c u ltu re s  in  H artley1 s b ro th  were examined a f t e r  24 hours fo r  the  presence o f  
a Neufeld re a c tio n . I f  th e re  s t i l l  remained doubt as to the  causal organism, 
then a b ro th  c u ltu re  was streaked  on to a blood agar p la te  and incubated  fo r  
24 hours. I f  pneumocccci were p re sen t then f l a t  smooth green co lo n ies  w ith  the  
edge d is t in c t ly  ra ise d  were obtained and such were subm itted to th e  b i le  
s o lu b i l i ty  t e s t .  I f  the pneumococcus was n o t th e  cause o f the  pneumonia, then 
th e  blood agar p la te  o ften  gave an in d ic a tio n  o f  th e  organism p re se n t.
P la te s  I  end I I  show p re p a ra tio n s  o f p e r ito n e a l f lu id  co n ta in in g  Type
I I  pneumococci in  th e  presence o f  Type I  end I I  en tiserum , th e  N eufeld 
reac tio n  being seen in  P la te  I I .
( i i i )  Typing o f cases from which sputum was n o t re a d ily  o b ta in ed .
I f  no sputum i s  a v a ila b le  th e  type o f in fe c tio n  may be determ ined by th e
examination o f  m a te ria l ob tained  on a pharyngeal o r la ry n g ea l swab; o r  by 
the  examination o f lung  ju ic e  ob tained  by means o f a lung  punctu re . This 
method was employed in  severa l o f my cases in  o rd e r to determ ine th e  type o f  
th e  in fe c t in g  pneumococcus when th e re  was marked lo b a r  con so lid a tio n  though 
no spiitum was o b ta in ab le . A long fin e -b o red  need le  was employed, and 
under p rocaine an aes th es ia  i t  was in s e r te d  in to  th e  conso lidated  lu n g . A 
twenty cubic cen tim etre  syringe was a ttach ed , and some lung ju ic e  ob ta ined  by 
su c tio n . The ju ic e  was in je c te d  in to  3 cubic cen tim etres  o f H artley ’ s b ro th , 
and one cubic cen tim etre  o f th is  in je c te d  in to  the  p e r ito n e a l c av ity  o f  a mouse. 
A fter tw enty-four hours the  mouse was k i l le d  and th e  p e r ito n e a l exudate 
obtained was typed in  the  usual manner. The r e s u l t s  ob tained  by th i s  method 
are  more s a t is fa c to ry  than those obtained  by pharyngeal o r la ry n g ea l swabbing, 
and the  r is k s  no g re a te r  then a f t e r  th o rac ic  a sp ira tio n  fo r  pus o r  a r t i f i c i a l  
pneumothorax. Thus in  2J00 cases Bullowa (1937) kad very few a cc id e n ts . 
Haemoptysis occurred on tv /en ty-five  occasions, a i r  embolism fo u r tim es, 
hem iplegia tw ice and sudden death  once. I t  i s  in te r e s t in g  to  n o te  th a t  in  
ch ild ren  ELacklock and G uthrie (1933) found lung puncture  o f  l i t t l e  value 
in  th e  e t io lo g ie s !  d iagnosis o f bronchopneumonia.
P la te  I  N egative re a c tio n .
P e rito n e a l f lu id  co n ta in in g  Type I I  pneumococci in  th e  
p resence o f Type I  a n tise ru n  ( x 1850 )•
[
P la te  I I  N eufeld re a c tio n .
P e r ito n e a l f lu id  co n ta in in g  Type I I  pneumococci in  th e  
p resence of Type I I  antiserum  ( x 1850 )
( b) Blood C u ltu res .
The H ood o f a l l  p a t ie n ts  was cu ltu red  on adm ission, snd i f  p o s i t iv e ,  
th e  examination was repeated  d a ily  u n t i l  th e  c u ltu re  was s t e r i l e  a f t e r  48 
hours growth. In  a l l  cases a blood c u ltu re  was taken before th e  in s t i tu t io n  
o f  trea tm en t, though a few cases had been given su lphapyrid ine  before  
admission to h o s p ita l .  The fo llow ing  was th e  method o f  blood c u l tu r e : -
Under s t r i c t l y  a se p tic  co n d itio n s , 10 c .c s .  o f  blood were removed from 
th e  median b a s i l i c  vein and tra n s fe r re d  in to  a s ix  ounce screw-cap b o t t le  
con tain ing  75 c .c s .  o f H artley ’ s b ro th . This b o t t le  con tain ing  th e  blood 
c u ltu re  was incubated  a t  37 degrees Centigrade fo r  24 hours, and then examined 
fo r  th e  presence o f pneumococci by the  d ir e c t  method o f typ ing . The method o f 
examination was s im ila r  to  th a t  employed fo r  sputum, only s ix  lo o p s fu l o f 
hLocd c u ltu re  were used in  p lace  o f s ix  f le c k s  o f sputum. All the  m ix tures 
were u t i l i s e d  owing to the p o s s ib i l i ty  o f d i f f e r e n t  types o f pneumococci 
being obtained  from th e  lung and blood stream.
In  8l l  cases in  which bacteraem ia was found, th e  organism is o la te d  from 
the  blood was the  same as th a t ob tained  from the  sputum. This su p p lie s  
suggestive  evidence th a t  the  type o f organism ob ta ined  from th e  sputum was 
the  pathogenic agent.
( c) The typing o f pneumococci o b ta in ed from sources 
o th e r than t he sputum o r blood.
I t  i s  p o ssib le  to  submit o th e r f lu id s ,  such as the  cereb ro sp in a l f lu id ,
ch est f lu id s  (serous o r  p u ru le n t) , o r  pus obtained  from in fe c te d  fo c i to  a
s im ila r  p rocess fo r  th e  purpose o f id e n tify in g  the  type o f in fe c t in g
pneumococcus. Thus, in  a s e r ie s  o f cases to be described , pneumococci wrere
typed from p a tie n ts  who, subsequent to  th e i r  pneumonia, developed v a rio u s  
com plications, such as empyema o r m en in g itis . In  such cases, organisms were 
typed from pus obtained  by a sp ira tio n  o f  the  ch es t, o r from th e  cereb ro sp in a l 
f lu id .
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D if f ic u l t ie s  encountered  during ty p in g :
O ccasionally  u n c la s s if ie d  pneumococci a re  i s o la te d  which belong to  
types above XXXIII, but which re a c t  n o n -s p e c if ic a lly  w ith  one o r  more o f  
the  types from X to  XXXIII. Thus a s t r a in  may be found which re a c ts  
w ith a serum m ixture, bu t n o t with any o f the  monovalent se ra  o f  th e  types 
in c luded  in  the  m ixture. Also, a s t r a in  may be found which re a c ts  
incom pletely  w ith a serum m ixture and a lso  w ith one o r  more monovalent se ra  
o f  th e  types included in  the  m ixture; o r a s t r a in  may n o t re a c t  w ith th e  
serum m ixtures but g ives an incom plete re a c tio n  w ith one o r  more monovalent 
s e ra .
O ther la b o ra to ry  a id s:
(a) Leucocyte counts:
As venous blood was withdrawn fo r  th e  purpose o f making a blood c u ltu re  
and fo r  th e  estim ation  o f the  sulphonamide p re sen t, i t  was decided to u se  
such blood fo r  leucocy te  counts. A ccordingly, a l l  leu co cy te  counts in  th i s  
work were performed u sin g  venous blood. The usual w hite c e l l  p ip e t te  and 
a Thoma Zeiss counting chamber were employed. The d i lu t in g  f lu id  co n sis ted  
o f 2 p e r cen t, e c e tic  ac id  w ith a tra c e  o f  b r i l l i a n t  green added. I f  
p o ss ib le , an i n i t i a l  count was performed before trea tm en t commenced. 
Subsequently, e l l  counts were performed from blood withdrawn between I .30  
and 2.0  p .m ., a t  which tim e the  blood was req u ired  fo r  sulphonamide e stim atio n .
(b) Urine exam ination:
P hysical and chemical examination o f  the u rin e  o f  a l l  p a t ie n ts  was made
as soon a f t e r  admission as p o ss ib le . Chemical t e s t s  were made to  d isco v e r th e
presence o f  albumen, blood, b i le ,  sugar, acetone, and ch lo rid e s . T h e rea fte r, 
during  sulphonamide therapy the u r in e  was examined d a ily , sp ec ia l no te  being 
made o f the  presence o f  albumen and blood.
3* Biochemical e s t im ation snd th e  measurement o f f lu id  in ta k e  
and u r in e  o u tp u t.
I t  was p rev io u sly  s ta te d  th a t  as soon a f t e r  adm ission as p o s s ib le , a 
specimen o f sputum was ob tained  and blood was withdrawn fo r  c u ltu re . Once 
a blood c u ltu re  had been taken then therapy w ith su lphapyrid ine  was i n s t i tu t e d .
The dosage o f su lphapyrid ine adm in istered  was 2 gm. followed by 1 gm. fo u r- 
hourly  fo r  a period  o f  about s ix  days. The ta b le ts  were given crushed w ith 
milk o r  w ater, but w ithout any s lk a l i s ;  the  tim es o f ad m in is tra tio n  being 
2 a .m ., 6 a .m ., 10 a .m ., 2 p .m ., 6 p.m. and 10 p.m. I f  th e  p a t ie n t  was 
extrem ely i l l  on admission an i n i t i a l  in travenous in je c t io n  o f 2 gm. o f  the  
sodium s a l t  was given.
(a) ft.flfr4 iflflM.on o f the  concen tra tion  of  drug i n th e blood and u rin e :
D aily samples o f blood were req u ired  throughout the  period  o f  therapy.
The samples were withdrawn between 1.30 and 2.0 p .m ., i . e .  about th re e  and
a h a lf  hours a f t e r  the  previous dose o f  su lphapyrid ine . This tim e o f  withdrawal
was adopted throughout. About 5 c. c. o f blood were withdrawn in to  sp e c ia lly
prepared  1 oz. screw-cap b o t t le s  con tain ing  1 drop o f 10 p e r cen t, potassium
o x a la te . These- b o tt le s  were p repared  by heating  in  an au toclave , w ith  th e i r
screw-caps in  p o s it io n . On removal from the  au toclave , the caps were
tig h ten ed , so th a t  on cooling a vacuum was c rea ted  in  the b o t t le .  A sh o rt
le n g th  o f  s t e r i l e  rubber tubing  was then f i t t e d  w ith a number 1 hypodermic
need le  a t  each end, and a screw down clamp in  the c en tre . One need le  was
plunged through a hole in  the  cap o f  th e  b o t t le  and through th e  rubber washer,
whence th i s  p a r t  o f tubing proxim al to the screw clamp co llapsed , thus
in d ic a tin g  th e  presence o f a vacuum in  the  b o t t le .  The o th e r need le  was
in s e r te d  in to  a vein a t  the elbow. On re le a se  o f  th e  clamp, blood was sucked
in to  the  b o tt le ,  approxim ately 5 c. c. being withdrawn. The n eed le  was withdrawn
from th e  vein , and the  b o tt le  shaken to mix the  blood w ith the  con ta in  fed 
potassium o x a la te .
The component p a r ts  o f the  b o t t le s ,  a b o t t le  ready fo r  use  and a 
b o t t le  con tain ing  blood a re  shown in  P la te  I I I .
D aily samples o f the  u r in e  o f a l l  p a t ie n ts  undergoing in v e s t ig a tio n  were 
a lso  sen t to the  la b o ra to ry , in  1 oz. screw-cap b o t t le s .  Having c o lle c te d  
th e  samples o f blood and u r in e , I  was in  a p o s itio n  to ca rry  ou t the  estim atio n  
o f  t h e i r  su lphapyrid ine  con ten t. As a lready  s ta te d , the  method adopted 
throughout was th a t  advocated by B ratton and M arshall (1939)* "**
(1) P rep a ra tio n o f blood:
2 c .c .  o f oxa lated  blood from the  1 oz. b o t t le s  were withdrawn and 
in je c te d  in to  100 c .c . con ica l f la sk s  con tain ing  33 c»c. o f saponin so lu tio n  
whose s tre n g th  was 0 .5  gm. p e r l i t r e .  These f la s k s  were shaken to  ensure 
th a t  l y s i s  was complete and 8 c .c . o f  15 p e r cen t, t r i c h lo r a c e t ic  acid  was 
added to  each f la s k , which was again shaken to cause complete p re c ip i ta t io n  
o f  th e  plasma p ro te in s . A fte r two m inutes the  con ten ts  o f the  f la s k s  were 
f i l t e r e d  in to  clean f la s k s  and the f i l t r a t e  ob ta ined  was then ready fo r  
subsequent exam ination. 10 c .c . o f t h i s  f i l t r a t e  were measured in to  la rg e  
pyrex  t e s t  tubes in  a s u ita b le  stand . Any number o f  bloods thus prepared 
were p laced  in  th e  f ro n t  row o f the  stand .
(2) P rep ara tion  o f u r in e :
1 c .c .  o f p ro te in - f re e  u r in e  was measured in to  a 100 c .c .  m easuring 
c y lin d e r con tain ing  some d i s t i l l e d  w ater. 5 c .c . o f  4 N hydroch lo ric  a c id  were 
added, and the  con ten ts d ilu te d  to 100 c .c . with d i s t i l l e d  w ater and thoroughly 
shaken. 10 c .c .  o f t h i s  u r in e  (d ilu te d  1 : 100) were then measured in to  la rg e ^
■*- P la te  IV, showing my bench a t  B uchill la b o ra to ry , g ives some idea  o f  the  
apparatus which was req u ired  fo r  the  determ ination  o f  blood and u r in e  le v e l s  
by B ratton  and M arshall’ s method.
NOTE: In  o rd er to  estim ate  th e  to t a l  amount o f drug p re sen t 10 c .c s .  o f 
blood f i l t r a t e ,  a f t e r  a c id u ia tio n  w ith  |  c .c .  o f 4LJ HC1, o r 10 c.cs*  of 
d i lu te d  u r in e  must f i r s t  be heated  f o r  I  hour in  a  b o ilin g  w a te r’b a th  befo re  
th e  various reagen ts  a re  added.
P la te  I I I . The apparatus used in  th e  w ithdraw al o f b lood , showing
in d iv id u a l p a r t s ,  a  b o t t l e  w ith  a  vacuum ready f o r  use and 
a  b o t t le  con ta in ing  b lood .
P la te  IV. The apparatus req u ired  f o r  th e  de te rm in a tio n  of th e  blood and
u rin e  le v e ls  by th e  method o f B ra tto n  and M arshall (1939). On 
th e  back stand  are  shown th e  f la s k s  used f o r  3 y sis  o f th e  blood 
and p re c ip i ta t io n  o f the  p ro te in s ,  measuring cy lin d e rs  f o r  th e  
d i lu t io n  and a c id u la tio n  of th e  u r in e , and th e  b o t t le s  co n ta in in g  
th e  s tandard  so lu tio n s  of su lp h ap y rid in e . At th e  r ig h t  hand s id e  
a re  th re e  b u re tte s  con tain ing  the  v a rio u s  reag en ts  to  be added
and in  th e  f ro n t  rack  a re  th e  so lu tio n s  ready f o r  c o lo r im e tr ic  * 
comparison.
6o.
la rg e  pyrex t e s t  tubes and p laced  in  th e  second row in  the  t e s t  tube reck 
behind the  corresponding blood f i l t r a t e .  O ccasionally  o th e r  u r in e  d i lu t io n s  
1 : 50 811 1 : 200 were req u ired .
(3) P rep a ra tio n  o f  standa rd so lu tio n s  o f  su lphapyrid ine .
In  th e  p rep a ra tio n  o f the  s tan d a rd s , a stock so lu tio n  o f  th e  pure drug was 
f i r s t l y  prepared . This was ob tained  by d isso lv in g  200 mgm. o f  su lphapyrid ine  
in  d i s t i l l e d  w ater which had been heated to 70°C. and d i lu t in g  to  one l i t r e .
This stock so lu tio n  con tain ing  200 mgms. o f  the  drug p e r l i t r e  keeps w ell in  
an ie e -c h e s t  fo r  sev e ra l months. By adding 2 .5  end 1 .0  c. cs. o f  th e  stock
so lu tio n  to  18 c .c . o f 15 p e r cen t, t r i c h lo r a c e t ic  ac id  and d i lu t in g  to 100 c .c . 
w ith d i s t i l l e d  w ater in  a stoppered graduated f la s k , standard  so lu tio n s  
con tain ing  1 .0 , 0 .5  find 0 .2  mgms.$. were thereby prepared . 10 c .c .  o f  each o f  
th e  th re e  s tandards were then measured in to  la rg e  t e s t  tubes and p laced  in  th e  
rack along w ith  th e  blood f i l t r a t e s  and u r in e .
(4) D iazotisation  o f  the so lu tion s containing: sulphapyridine and 
coupling with N-naphthvl-ethylene-diam ine-dihydrochloride:
To a l l  th e  f lu id s  in  the  rack , blood f i l t r a t e s ,  u r in e s  and standard  
so lu tio n s , 1 c .c . o f  0 .1  p e r cen t, sodium n i t r i t e  was added from a 50 c .c . 
b u re tte . The t e s t  tubes were a l l  shaken. A fte r two m inutes, 1 c .c .  o f  0 .5  
p e r cen t, ammonium sulphamate was added from another b u re tte  to  each o f th e  
tubes, which were again shaken. A fte r a fu r th e r  two m inutes 1 c .c .  o f  the  
coupling reagen t N -naphtJayl-ethylene-d ianine-d ihydrochloride was added to  
each tube from a th ir d  b u re tte  and a purp le  co lo u ra tio n  appeared a t  once.
(5) Comparison o f the  so lu tio n s :
The blood and u rin e  so lu tio n s  were n ex t compared w ith the standard  so lu tio n s . 
For th i s  purpose aDubosc'q co lo rim ete r was used. As a general ru le  fo r  blood 
comparisons th e  0 .2  mgm. p er cen t, standard  was found most s a t i s f a c to ry .  I t  
was p laced in  th e  l e f t  hand cup and the  reading  s e t  a t  the 20 mm. mark. The
/
The unknown blood was p laced  in  the  r ig h t  hand cup, the  co lo u rs  matched, 
and the  reading  ob ta ined . With u r in e s  the  1 .0  mgm. p er cen t, s tandard  
was used and th e  reading  s e t  a t  10 mm., a f t e r  which th e  unknown was 
matched and th e  read ing  ob ta ined . With very high  blood co n cen tra tio n s  
o r  low u rin e  le v e ls ,  i t  was found convenient to  use  the  0*5 p e r cen t,
standard .
(6) C a lcu la tion :
Mgm. p e r 100 c .c s . in  f lu id  being estim ated  = x S x Dr  Reading o f unknown ,
S = s tre n g th  o f standard  so lu tio n  ( i . e .  1 .0 , 0 .5  o r 0 .2 ) and j
D = d i lu t io n  o f  blood ( i . e .  20) o r  d ilu t io n  o f  u r in e  ( i . e .  5C, 100 o r  200)«
While th e  u sual d ilu tio n  o f the  u r in e  was 1 : 100, o cca s io n a lly  1 : JO j
j
o r  1 : 200 was found more s a t is fa c to ry . !
(b) Measurement o f the f lu id  intake and urine output:
That th i s  was p o ss ib le  was e n tir e ly  due to the  co -operation  o f  the  
S is te r s  o f  th e  pneumonia wards. In  the f i r s t  few days o f i l l n e s s  the  
p a t ie n ts  were e n tir e ly  on f lu id s ,  drink ing  w ater, barley  w ater, lemon o r 
orange ju ic e  o r m ilk. A fte r the  acute s tag e , l i g h t  d ie t  was given u n t i l  
therapy had ceased, a t  which time a f u l l  d ie t  was continued. The f lu id  
in ta k e  was c a re fu lly  recorded fo r  the  f i r s t  f iv e  o r  s ix  days in  h o s p ita l .  j
During th i s  period  the d a ily  u r in e  ou tpu t was a lso  recorded. j
4. The P rep a ra tio n  o f  Pneumococcus Vaccine.
The req u ired  type o f sputum was em ulsified  w ith  n u tr ie n t  b ro th  and one 
cubic cen tim etre  was in je c te d  in to  the  p e r ito n e a l cav ity  o f  a mouse. Twenty- 
fo u r hours l a t e r  a drop o f  h e a r t blood was p la te d  on chocolate  agar medium 
and a pure c u ltu re  thus ob ta ined . From th i s ,  singLe co lon ies  were picked 
o f f  and severa l tubes o f medium in o cu la ted . A fte r a fu r th e r  tw enty-four hours,
incubation  a t  37°C., the c u ltu re  was examined to v e r ify  th a t  th e  c o rre c t /
c o rre c t type o f  pneumococcus was p re se n t. The growth was then em ulsified  
in  s a lin e  and th i s  emulsion was d ilu te d  down, so th a t  the f in a l  s tre n g th  was 
50 m illio n  organism s p er cubic cen tim etre . This s tre n g th  was ob ta ined  u sin g  
Brown’ s standard  o p ac ity  tubes. The s a lin e  used contained 0 .2 5  Pe r  cen t, phenol.
S te r i l i s a t io n  o f th e  vaccine had nex t to be undertaken. The pneumococci 
were k i l l e d  by s t e r i l i s i n g  fo r  one hour a t  60°C. T h e rea fte r, th e  vaccine was
p u t in  ampoules in  one cubic cen tim etre  amounts. One such ampoule had to  be
te s te d  fo r  s t e r i l i t y .  This was perform ed by i t s  in o c u la tio n  in to  H a r tle y 's  
b ro th  and in cu b atin g  both a e ro b ic a lly  and an ae ro b ic a lly . Examination was made 
a t  24, 48 and 72 hours fo r  the  presence o f organism s. I f  the  c u ltu re  was 
s t e r i l e ,  th e  vaccine was ready fo r  use.
Each case received  a dose o f th re e  1 c. c. ampoules, one being 
adm in istered  on th e  day o f admission to  h o sp ita l and the  o th e rs  on the
fo llow ing  two days.
The method o f ad m in is tra tio n  was by in tram u scu lar in je c t io n .
CHAPTER IV.
The r e s u l t s  ob ta ined  from an a n a ly s is  o f 370 cases of__pneumococcal 
lo b a r  pneumonia t r eated  wi t h su lp hapy rid in e .
In  th e  f i r s t  chap ter I  surveyed the  fa c to rs  which were shown by 
p rev io u s  workers to be o f p rognostic  va lue  in  lo b a r  pneumonia. These 
fa c to rs  form the  b a s is  o f the  a n a ly s is  o f  the  cases about to  be d escribed , 
and each fa c to r  w ill th e re fo re  be considered in  tu rn , sp ec ia l emphasis 
being p laced  on the  r e s u l t s  o f therapy as gauged by th e  f in a l  outcome 
o f  th e  d isea se , i . e .  recovery o r  death .
An a n a ly s is  w ill  then be made o f the  c l in ic a l  re  spoil se as gauged 
by th e  re tu rn  o f  the tem perature to  normal by a study o f th e  tem peratures 
ob ta ined  during the f i r s t  ten  days in  h o sp ita l.
A f u l l  a n a ly s is  w ill  be made o f th e  com plications o f pneumonia 
which were encountered during therapy v i th  su lphapyrid ine . In  th e  sec tio n  
on delayed re so lu tio n  the  re su lts  ob tained  from a rad io g rap h ic  study o f 
the  p ro g ress  o f the  d isease  w ill be given.
A sep ara te  an a ly s is  w ill be made o f 61 cases, a lread y  inc luded  in  th e  
s e r ie s  o f 370 cases, who in  ad d itio n  to  su lphapyrid ine , a lso  received  
vaccine therapy.
F in a lly  a f u l l  a n a ly s is  w ill be made o f the  f a t a l  cases.
In  analysing  th e  r e s u l t s  s t a t i s t i c a l  t e s t s  were freq u en tly  employed 
and i f  th e  d iffe ren c e  between two percen tages was g re a te r  than tw ice 
the  s tandard  e rro r , then th e  d iffe ren c e  i s  regarded as being s ig n if ic a n t .
A. The r e s u l t s  o f  therapy as gauged by th e  F a ta l i ty  Hate:
( i )  The r e s u l t s  o f  therapy in  re sp e c t o f  th e  Type o f  th e  
in fe c t in g  pneumococcus.
As the  lype o f in fe c t in g  pneumococcus i s  one o€ th e  most im portan t
fa c to rs  in  p rognosis in  lo b a r  pneumonia, I  propose to study i t  in
some d e ta i l .  I  s h a ll  consider b r ie f ly  the Type d is t r ib u t io n  o f the
370 cases, th e  monthly and y e a rly  v a r ia tio n s  o f  th e  Types, and th e  age
and sex d is t r ib u t io n  o f  th e  cases in  re sp ec t o f  th e  Type o f in fe c t in g  
pneumococcus. In  th i s  sec tio n  I  sh a ll  a lso  d e sc rib e  very b r ie f ly  the  
manner by which the  type d iagnosis  was e s ta b lish e d . I  s h a ll  then analyse 
th e  r e s u l t s  o f therapy as gauged by the f a t a l i t y  r a te s  ob ta ined  in  
in fe c t io n s  due to  the  various types.
The inc idence  o f th e  vario u s  Types.
The d is t r ib u t io n  o f th e  370 cases o f pneumococcal 
lo b a r  pneumonia among Types I ,  I I ,  I I I  and Group IV i s  
shown in  Table I  and the r e s u l t s  a re  co n tra s ted  w ith a 
world wide c o lle c tio n  o f cases taken from Heffiron (1939)*
Table I .
Pneumococcal Lobar Pneumonia:
The d is t r ib u tio n  o f th e  370 cases among Types I ,  I I ,  I I I  
and Group IV, co n tra sted  w ith a world wide s e r ie s .
Type Author* s S e rie s World S erie s




No. o f  
Cases.
P ercentage 
(each ty p e ).
I 87 23-5 5,487 32.6
I I 128 34.6 3,330 19.6
I I I 18 4.9 1,844 10.8
Gp.IV 137 37.0 6,212 36.9
All types 370 100.0 16.813 100.0
Study o f  Table I  shows in  both s e r ie s  Types I  and I I  to g e th e r 
accounted fo r  over 50 p er cen t, o f s l l  types. In  my own /
own s e r ie s  34 .6  p e r cen t, o f a l l  cases were Type I I  
in fe c t io n s . Type I I I  in fe c t io n s  in  both s e r ie s  
accounted fo r  the  sm a lle s t number o f  cases. The 
in c id en ce  o f Group IV in fe c t io n s  was very s im ila r  
in  both s e r ie s .
Appendix I  shows the in c id en ce  o f  a l l  types o f 
pneumococci is o la te d  from the  37  ^ cases under review.
The r e s u l t s  a re  co n tra s ted  w ith  those o f 1000 typed 
cases (Bullows 1937). Study o f Appendix I  shows the  
o rd e r o f frequency o f th e  f i r s t  th re e  types in  my 
s e r ie s  i s  I I ,  I ,  I I I ,  and in  BmLlowa* s s e r ie s  i s  I ,  I I I ,  
I I .  Higher types in  o rder o f frequency in  my s e r ie s  
a re  V III, VII, IV, V, and XIV, th i s  being ex ac tly  the 
same as in  Bullowa*s la rg e r  s e r ie s .  In  both s e r ie s  
Types IV, V, VII and VIII accounted fo r  more than 50 
p e r cen t, o f a l l  h igher types.
The monthly v a r ia tio n  o f Types.
The monthly type 1 d is t r ib u t io n  o f cases was n ex t 
considered. The number o f cases o f Types, I ,  I I ,  I I I  
and VIII which occurred  monthly during the  y ear 1941 and 
fo r  the  f i r s t  two months o f  th e  y ear 1942 a re  shown 
in  Table I I .
Table I I .
Pneumococcal Lobar Pneumonia:
The monthly inc idence  o f Types I ,  I I ,  I I I  and V III.
- - “I 94I .  ............... ..........
Month o f the  Year.
1942.
Jan. Feb. Mch. Apr. May. Jun. J ly . Aug. Sep. Oct. Nov. Dec. Jan . Feb.
Type I 2 2 7 4 10 4 5 9 2 2 14 5 10 11
Type I I 9 6 18 14 9 9 6 5 8 10 10 9 8 7
Type I I I 1 1 0 1 1 3 0 5 0 3 1 1 1 0
Type VIII 2 0 2 5 1 2 1 3 2 2 6 1 3 6
Study o f  Table I I  shows th a t  the  number o f  cases o f  each type 
p e r month was small and no d e f in i te  conclusions could be 
drawn from the  above ta b le . I t  should be no ted , however, 
th a t  Type I I  appeared to  be th e  most p re v a le n t in d iv id u a l 
type throughout most months o f  the  y ear. This i s  in  agreement 
w ith  the  f in d in g s  o f  F in land  and S u t i i f f ,  (1934). Type I  showed 
very l i t t l e  un ifo rm ity  in  d is t r ib u t io n  throughout the  y ear. Type 
I I I  was f a i r l y  uniform ly d is t r ib u te d  throughout th e  y ear, bu t 
tended to  p re v a il  in  th e  summer months; w hile Type V III which was 
a lso  uniform ly d is tr ib u te d  throughout th e  y ear, tended to p re v a il  
in  th e  w in te r months.
The monthly inc idence  o f  Types I ,  I I ,  I I I  and V III a re  
rep resen ted  in  the form o f a histogram  (P ig . 1 ) .
The y early  v a r ia tio n  o f the  Types.
I t  was s ta te d  in  Chapter I  (p a g e ll) th a t  y ea rly  v a r ia t io n s  
in  type inc idence  a lso  occurred . Macgregor (1933) re p o rted  l e s s  
v a r ia tio n  in  type inc idence  in  Glasgow than d id  some workers in  
America. My own cases occu rrin g  during th e  p e rio d  1941-42 were 
co n tra sted  w ith the  type inc idence  o f cases which occurred  in  
B uchill H osp ital during th e  y ear 1940 and w ith  Macgregor* s 
r e s u l t s  ten  years p rev io u s ly , i . e .  1930- 32, as  shown in  







Table I I I .
Pneumococcsl Lobar Pneumonia:
The in c id en ce  o f  Types I ,  I I ,  I I I  and Group IV during  
the  p e rio d  1941-42 co n tra s ted  w ith th e  type inc idence  
during  1940 and during 1930-32.
Type Year
1941-42 1940 1930-32
N o.of cases %&ge No.of cases %&ge N o.of cases #age
I 87 23-5 41 15 .7 410 38,1
I I 128 34.6 86 32.8 388 36.0
I I I 18 4.9 27 10 .3 42 3-9
Gp. IV 137 37.0 108 41 .2 237 22.0
A ll types 370 100.0 262 100.0 1077 100.0
Study o f  Table I I I  shows th a t  Type I I  in fe c tio n s  have been 
p re v a le n t in  Glasgow during the  years  1930-32> 1940, and 1941-42 
and have accounted fo r  o n e -th ird  o f  a l l  types cases o f  lo b a r  
pneumonia during th ese  y ears . This high inc idence  o f  “type I I  
pneumonia, the  type which was most severe c l in ic a l ly ,  p o ssib ly  
ex p la in s  the  se v e r ity  o f Glasgow’ s pneumonia. In  every in s ta n ce  
Type I I I  in fe c t io n s  accounted fo r  the  sm allest number o f cases. 
Group IV in fe c tio n s  have been more p rev a len t in  th e  p a s t  two 
y e a rs  than they were ten y ears  ago.
The age d is t r ib u t io n  o f the  Types.
The frequency w ith which pneumococci o f  the  f i r s t  th re e  
types occurs in  lo b a r  pneumonia m  ad u lts  shows c e r ta in  
c h a r a c te r is t ic  v a r ia tio n s  depending on the age o f the  p a t ie n t .  
Thus Type I  in fe c t io n s  are common in  young a d u lts , w hile Type 
I I I  in fe c tio n s  a f f e c t  more freq u en tly  o ld e r people. The
in c id en ce  o f  Type I I  shows le s s  v a r ia tio n  w ith age. Appendix 
I I  shows the  d is t r ib u t io n  o f  the cases among Types I ,  I I ,  I I I
/
I l l  and Group IV when d iv ided  in to  f iv e —y e a r ly  age 
group p e rio d s . From the f ig u re s  in  Appendix I I  the  
age d is t r ib u t io n  by decades o f p a t ie n ts  w ith Types I ,  
I I ,  I I I  and Group IV in fe c t io n s  was a sc e rta in ed  as 
shown in  Table IV.
Table IV.
Age Group 
in  y ears .
Type I Type IX Type I I I Group IV
No. #age No. $age No. $age No. $age.
15-20 14 16. 2\ 19 14.9^ 1 5. 6> 29 21. 2\
21-30 12 ^ • 8 L 17 13 .3 (70 1 5.61 Rf) 17
31-40 27 Z z S [ 23 18.0  p 3 16.61 24 1 7 .5 (
41-50 17 19 . 5j ZP- 24.2 ) 4 22.2 J 38 28. 8 J
51-60 10 11.5 26 20.4 5 22=8 17 12.4
a - 70 6 6.9 11 8 .6 2 11.1 9 6.5
71 & over 1 1.1 1 0 .7 2 11.1 3 2.2
Apart from the  f i r s t  age group period  which i s  fo r  only s ix  
y e a rs  (15- 20) the  in c rease  in  each in s tan ce  i s  by ten y ears . 
Study o f Table IV shows th a t  the  g re a te s t  inc idence  o f Type I  
in fe c t io n s  i s  between 3L-40 y ears , o f iype I I  between 41-50 
y ears , and o f  Type I I I  between 51*~&) y ears . Group IV 
in fe c t io n s  resemble Type I I  in  having the  g re a te s t  inc idence  
between 41-50 y ears . These r e s u l t s  a re  c le a r ly  rep resen ted  
in  th e  form o f  a graph (F ig . 11).
Table IV a lso  shows th a t  o f  the  370 cases in  the  s e r ie s
277 or  75 p e r cen t, o f  the  p a t ie n ts  were under 50 y ears  o f 
age. Moreover, among in d iv id u a l types the  l a r g e s t  p ro po rtion  
o f  cases occurred in  p a t ie n ts  under 50 years  o f  age; the
percen tages in  in fe c tio n s  due to Types I ,  I I ,  I I I  and Group IV
70.

































IV being 81,70 ,50  end 79 re sp e c tiv e ly . Also o f  the  to ta l  
number o f  cases in  each type, Type I I I  showed th e  l a r g e s t  
p ro p o rtio n  (50 p e r  cen t.)  o f p a t ie n ts  over 50 y ea rs  o f  age* 
The sex d is t r ib u t io n  o f the  Types.
The d is t r ib u t io n  o f the  pneumococcus types among males 
and fem ales i s  shown in  Table V.
Table V.
Pneumococcal Lobar Pneumonia in  males and fem ales: 
The number and percentage d is t r ib u t io n  by type.
Type
Males Females
N o.of cases Percentages No.of cases Percentage
I 63 25-4 ]6 4 .2 24 19- 7 U . o
I I 96 38.8  J 32 26. 3 )
I I I 10 4.0 8 6 .5  ■
Gp.IV 79 31.8 53 47.5
All types 248 100.0 122 100.0
Study o f Table V shows th a t  th e re  was a h igher inc idence  o f 
Types I  and I I  among males than fem ales, the  d iffe ren c e  being 
most marked in  th e  case o f  Type I I  in f e c tio n s . In  women Type I I I  
and Group IV in fe c tio n s  were s l ig h t ly  more common than in  men, 
th e  d iffe re n c e  being most marked in  the case o f Group IV 
in fe c t io n s . I t  i s  in te r e s t in g  to note th a t  in  males Types I  
and I I  to g e th e r accounted fo r  64 p er cen t, o f  a l l  types and 
in  fem ales th ese  types accounted fo r  46 p e r cen t, o f  a l l  types.
The estab lishm en t o f the  Type d iagnosis!
In  th i s  sec tio n  on the  d is t r ib u t io n  of th e  cases according 
to  the  Type o f  in fe c tin g  pneumococcus, I  may conveniently  
d esc rib e  the  method by which th e  type d iagnosis  was e s ta b lish e d . 
I t  w ill  be remembered th a t  in  every case the  sputum was examined 
by the  d i r e c t  method, and i f  th i s  f a i le d  to y ie ld  a p o s it iv e  
r e s u l t  then th e  in d ir e c t  method o f  mouse in o c u la tio n  was 
perform ed. In  a small number o f cases in  which th e  type o f  
th e  in fe c t in g  pneumococcus was id e n t i f ie d  by the  d i r e c t  method, 
confirm atory evidence was ob tained  by mouse in o c u la tio n . The 
r e s u l t s  ob ta ined  are  shown in  Table VI.
Table VI .
Pneumococcal Lobar Pneumonia:
The number snd percentage o f the  various types which could 
n o t be typed by the d ir e c t  method o f typing  as app lied  
to  the  sputum.
Type I No.of cases 1 typed from sputum.| , „ .... , - -
No.not typab le  
by d ir e c t  method.
Percentage n o t 
typab le  d i r e c t ly .
I 86 16 18 .6
I I 123 8 6 .5
I I I 18 5 27.8
Gp.IV 137 30 22.0
A ll types 364 59 16 .2
Study o f  Table VI shows th a t  o f  th e  364 cases which were typed 
from the  sputum, 59 o r 16.2  p e r cen t, were typab le  only a f t e r  
mouse in o c u la tio n . I t  i s  in te r e s t in g  to n o te  th a t  only e ig h t 
o u t o f  123 Type I I  cases f a i le d  to type d i r e c t ly .  Six cases 
ou t o f  the  s e r ie s  o f  370 f a i le d  to produce any sputum, and in  
th ese  cases th e  type o f th e  in fe c tin g  pneumococcus was
determined by examination o f  the  blood. Five o f  th ese  s ix  cases 
had Type I I  in fe c tio n s  and the  remaining case was a Type I  in fe c t io n .
A ll s ix  p a t ie n ts  were p r a c t ic a l ly  moribund on adm ission 
and were q u ite  unable to s p i t .
In  a few cases more than one type o f  pneumococcus was 
found in  th e  sputum. I t  was decided to d i s t r ib u te  
such cases according to  th e  low est type p re se n t. The 
in d iv id u a l types p re sen t in  those cases from which more 
than one type o f  pneumococcus was found in  the  sputum 
a re  shown in  Table VII.
Table VII.
Pneumococcal Lobar Pneumonia:
The r e s u l t s  o f  typing in  cases from which more than 
one type o f  in fe c tin g  organism was is o la te d .
No. o f Sputum Typing Blood
Cases. D irec t In d ir e c t C ulture.
1 I & XIV I s t e r i l e
2 * negative I ,  XLX II, XV, XXII s t e r i l e
3 neg ativ e I I ,  XVI s t e r i l e
4 neg ative I I ,  XXVIII s t e r i l e
5 negative IV, IX, X s t e r i l e
6 negative XIV, XIX s t e r i l e
7 neg ativ e XX, XXIX s t e r i l e
8 I I I I I I ,  XXIV s t e r i l e
9 neg ativ e I I  & Haem.Strept. I I  & Haem.Strept
* A lung  p ic tu re  in  th is ' case y ie ld ed  a growth o f Type I  
pneumococcus.
Study o f  Table VII shows th a t  in  cases 1-8 more than one
type o f pneumococcus was is o la te d  from the  sputum, and in  a l l  
th ese  cases blood c u ltu re  was s t e r i l e .  I t  i s  in te r e s t in g  to 
n o te  th a t  n o t one o f these  e ig h t cases d ied  in  s p i te  o f  the
p o s s ib i l i ty  of m u ltip le  in fe c tio n . Case 9 , however, y ie ld ed  
Type I I  pneumococci and haemolytic s trep to co cc i from both /
both sputum and blood, and in  th i s  case th e re  was obviously  
a double in fe c tio n . In  Case 2 although fo u r types o f 
pneumo cocci were is o la te d  from the  sputum, a lung puncture  
y ie ld ed  a growth o f Type I  pneumococcus on ly , th i s  organism 
being presumably the cau sa tiv e  agent o f  the  d isease , the  
o th e r  type being commensals in  the  th ro a t.
Conclusion to be drawn from a study o f the  d is t r ib u t io n
o f th e  various Types.
A study o f the d is t r ib u t io n  o f the pneumococcus types 
in  the  370 cases shows much s im ila r i ty  w ith p rev ious s e r ie s  
rep o rted  from th is  C ity . The inc idence  o f Type I I I  in fe c t io n s  
i s  no tab ly  low.
In re sp ec t o f age? Type I  in fe c t io n s  tend to a f f e c t  the  
young a d u lt, while Type I I  in fe c tio n s  occur most freq u en tly  
between 41-50 y ears . In  the  small numbers o f Type I I I  
in fe c t io n s  the  maximum inc idence  i s  between 51-60 y e a rs , 
though q u ite  a few Type I I I  cases occur in  young a d u lts  
and such cases are  c l in ic a l ly  very m ild.
I t  i s  found th a t  Types I  and I I  tend to be more freq u en t 
in  male than in  female pneumonia.
The d ire c t  Neufeld method o f  typ ing  i s  e a s ily  c a r r ie d  
o u t and th e  r e s u l ts  a re  e f f ic ie n t ,  e sp e c ia lly  w ith spu ta  
con ta in ing  Type I I  pneumo cocci.
Only n ine  cases y ie ld ed  m u ltip le  organisms from the  sputum, 
bu t in  s p i te  o f th is  the s ix  pooled b o t t le s  o f se ra  should 
always be examined, fo r  otherw ise th e  p o s s ib i l i ty  o f m u ltip le  
in fe c tio n  would be missed.
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The r e s u l t s  of  therapy as gauged by the f a t a l i t y  r a te s  in  re sp e c t o f 
th e  type o f  the  in fe c tin g  pneumo coccus.
I t  i s  recognised  th a t  some types o f pneumo coccus a re  n e a rly  always 
a sso c ia te d  w ith  h igher case f a t a l i t y  r a te s  than o th e r types. In  f a c t ,  
Cruickshank (1933) s tre sse d  the  p ro g ress iv e ly  in c re a s in g  f a t a l i t y  r a te s  
from Type I  to  Type I I I  in fe c tio n s . As y e t l i t t l e  i s  known o f th e  f a t a l i t y  
r a te s  among the  h igher types. I t  i s  p o ss ib le  th a t  th e  r e la t iv e  a b i l i t i e s  
o f  pneumocccci to produce th e i r  s p e c if ic  capsu lar po lysaccharide  may 
s ig n if ic a n t ly  in flu en c e  the chance o f recovery. As th ese  substances can 
i n h ib i t  the  ac tio n  o f the  pneumococcal an tib o d ie s , the  f a t a l i t y  r a te  w ill 
tend  to  be minimal in  those types which produce l e a s t  po lysaccharide.
The f a t a l i t y  r a te  o f a l l  types i$  shown in  Appendix I I I .  From th ese  
f ig u re s  obtained  the  f a t a l i t y  r a te  o f Types I ,  I I ,  I I I  and Group IV were 
ta b u la te d  as shown in  Table V III. The r e s u l ts  were co n tra s ted  w ith those 
o b ta in ed  in  R uchill H osp ita l the  p rev ious year (1940) and w ith M acgregor's 
f ig u re s  ten years  p rev iously  (1930- 32)*
TahLe V III.
Pneumococcal Lobar Pneumonia:
The f a t a l i t y  ra te  o f Types I ,  I I ,  I I I  and Group IV during the p e riod  
1941- 42, co n trasted  w ith the f a t a l i t y  r a te  during 1940 and during 1930-32.
10£L-42 1040 -------- ----
No. of N o.of F.R. No.of No.of F.R. No.of No. o f F. R.Type cases. deaths. % cases. deaths % cases. deaths. %
I 87 5 5*7 41 1 2.4 410 44 10 .7
I I 128 16 12 .5 86 9 10.5 388 76 19*6
I I I 18 1 5.6 27 7 26.0 42 18 42.9
Gp. IV 137 6 4.4 108 10 9*3 237 20 8 .4
All types 370 28 7*5 262 27 10 .3 1077 158 14.7
Study o f Table VIII shows th a t  the f a t a l i t y  r a te  o f a l l  types was 7.5  p e r cen t.
This f ig u re  re p re sen ts  the  to ta l  f a t a l i t y  r a te  and i t  i s  n o t th e re fo re  a
tru e  in d ic a tio n  o f the e ffic acy  o f su lp h ap y rid in e ,fo r sev era l cases are
included  who died w ith in  the f i r s t  24 hours in  h o sp ita l before  su lphapyri dine
/
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su lphapyrid ine  could be expected to  ex ert a b e n e f ic ia l  a c tio n . In  the 
sec tio n  on the  an a ly s is  o f the  f a ta l  cases co rre c tio n  w ill be made fo r  
such d eath s.
Table VIII a lso  shows th a t  the  f a t a l i t y  r a te  o f Type I I  in fe c t io n s  
was much h ig h e r than th a t  o f a l l  o th e r types, and indeed i t  was more than 
double the  r a te  found in  Type I  in fe c t io n s . This high f a t a l i t y  r a te  o f 
Type I I  in fe c t io n s  i s  in  agreement w ith the  sev e rity  o f such cases noted 
# c l in ic a l ly .  The f a t a l i ty  r a te  in  Type I I I  in fe c t io n s  was e x tra o rd in a r ily  
low as th e re  was only one death among 18 cases. I t  should be remembered 
th a t  Type I I I  in fe c tio n s  may a tta ck  young a d u lts  as well as the  aged and i t  
was p rev io u s ly  shown th a t  n ine  o f th e  eigh teen  cases occurred  in  those  under 
50 y ea rs  o f  age, m ostly in  young fem ales. Group IV cases had the  low est 
f a t a l i t y  r a te .  Of the h igher types the  number o f deaths was so small th a t  
no g re a t value could be a ttached  to the  f a t a l i t y  r a te  among in d iv id u a l 
members o f  Group IV. There was one death among 20 Type VII in fe c t io n s , 
and two deaths among 36 Type VIII in fe c t io n s . One Type XII in fe c tio n  d ied  
o f  m en in g itis , and two Type XXII in fe c tio n s  a lso  d ied.
The r e s u l t s  o f typed cases o f pneumococcal lo b a r  pneumonia in  R uch ill 
H osp ita l in  1940 when sulphapyri dine was th e  chem otherapeutic agent employed, 
although in  ad d ition  some cases received  type sp e c if ic  anti-pneum ococcal 
r a b b it  serum, shows th a t  th e  f a t a l i t y  r a te  o f  a l l  types was j u s t  over 10 
p e r c e n t . ,  which i s  somewhat s im ila r  to the  f a t a l i t y  r a te  o f a l l  types in
my own s e r ie s  (10 .3  a g a in s t 7»5)» The f a t a l i t y  r a te s  o f Types I  and I I  
were s l ig h t ly  lower than in  my own s e r ie s , but the f a t a l i t y  r a te s  o f Type 
I I I  and Group IV were mugh h igher than in  my own s e r ie s .
Macgregor* s r e s u l ts  during the  period  I 93O-32  when trea tm en t was 
e n t i r e ly  symptomatic, show th a t the f a t a l i t y  r a te  o f a l l  types in  p re -
/
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prechem otherapeu tic  days was alm ost 15 p e r  c e n t. I t  should be noted  however 
t h a t  in  M acgregor's s e r ie s  o f 1077 cases  were inc luded  p a t ie n ts  of a l l  ages.
Of those  over 15 y e a rs  of age only 17 p e r  c e n t, were over th e  age of 45 y e a rs ; 
in  my own s e r ie s  33 p e r  c e n t, of p a t ie n ts  were over 45 y e a rs  of age. This 
d if fe re n c e  in  age would obviously  tend  to  in flu en ce  favourab ly  th e  f a t a l i t y  
r a te  in  M acgregor’ s s e r ie s .
C onclusion to  be drawn from a study o f th e  r e s u l t s  of th e rap y  as gauged by 
th e  f a t a l i t y  r a t e s  in  re sp e c t o f th e  type of th e  in fe d  t in g  pneumoooocus:
Sulphapyrid ine i s  an e f f i c i e n t  chem otherapeutic agent in  th e  trea tm en t of 
pneumococcal lo b a r  pneumonia and i t  has done much to  reduce th e  m o r ta l i ty  r a te  
of pneumonia to  i t s  p re se n t low le v e l .  The g re a te s t  red u c tio n  in  th e  f a t a l i t y  
r a t e  has occurred among in fe c tio n s  due to  th e  f i r s t  th re e  ty p e s , which a re  on 
th e  whole more severe  than  in fe c t io n s  due to  G-roup IV. Even w ith  su lp h ap y rid in e , 
a d if fe re n c e  i s  noted  in  the  f a t a l i t y  r a te  of th e  v a rio u s  ty p e s . Thus a t  p re sen t 
Type I I  in fe c t io n s  a re  th e  most severe  w ith  a f a t a l i t y  r a te  of over 10 p e r c e n t,
( i i )  The r e s u l t s  of therapy  in  re sp e c t of B acteraem ia.
B acteraeraia, l ik e  th e  type o f th e  in fe c tin g  pneumococcus, i s  a very  
im portan t p ro g n o s tic  f a c to r  in  lo b a r  pneumonia, so I  propose to  analyse  the  
cases  in  re sp e c t o f bacteraem ia in  some d e t a i l .  F i r s t l y ,  I  s h a l l  d e sc r ib e  i t s  
in c id en ce  among th e  v a rio u s  types and co n sid e r th e  f a c to r s  which m ight in flu en c e  
i t s  occurrence . Then I  s h a l l  c o n sid e r th e  e f f e c t s  of therapy  in  re sp e c t of 
bacte raem ia . This w i l l  inc lu d e  a s tudy  of th e  outcome of th e  d ise a se  in  b a c te r-  
aemic compared w ith  non-bacteraem ic case s , and a lso  an a n a ly s is  of th e  d u ra tio n  
of bacte raem ia .
The inc idence  of bacteraem ia and th e  f a c to r s  which in flu en c e  
Tfcs occurrence.
The inc idence  of bacteraem ia  among in d iv id u a l -types i s  shown in  
Appendix IV. From th e  f ig u re s  ob tained  the  inc idence  among 
Types I ,  I I ,  I I I  and Group IV was a sc e rta in e d  as shown 




The in c idence  o f bacteraem ia among Types I ,  I I ,  I I I  
and Group IV.
Type No. o f Cases.
No. w ith 
Bacteraem ia.
P ercen tage w ith 
Bacteraem ia.
I 87 9 10 .3
I I 128 42 32.8
I I I 18 0 -
Gp.IV 137 10 7.4
A ll types . 37D_J a 16 .5  |
Study o f Table IX re v e a ls  th a t  the  inc idence  o f bacteraem ia 
among a l l  cases was 16.5  p e r cen t. The maximum incidence  
was in  Type I I  in fe c tio n s , which as p rev io u sly  s ta te d  gave r i s e  
to  the  sev e re st pneumonia. The inc idence  o f bacteraem ia in  Type 
I  in fe c t io n s  was about o n e -th ird  o f th a t  in  Type I I  cases, and 
no Type I I I  in fe c tio n  was asso c ia ted  w ith  bacteraem ia. The 
inc idence  among Group IV in fe c tio n s  was 7*4 p er c e n t . ,  the 
only  h igher types y ie ld in g  p o s it iv e  blood c u ltu re s  being 
Types IV, V, VII, V III, and XIV.
Appendix IV, as well as showing the  inc idence  o f 
bacteraem ia among a l l  cases (reco v e rie s  and deaths) o f 
in d iv id u a l types, a lso  shows the  inc idence  o f bacteraem ia 
among f a ta l  cases. I t  was found th a t  among Type I  deaths 
20 p e r cen t, had bacteraem ia, w hile among Type I I  deaths th e  
f ig u re  reached 94 p er cen t. In o th e r  words, p r a c t ic a l ly  a l l  
deaths from Type I I  in fe c tio n s  had an invasion  o f th e  blood
stream . The only o th e r f a ta l  case a sso c ia ted  w ith bacteraem ia 
was a Type VII in fe c tio n .
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An a n a ly s is  w ill  now be made o f f a c to rs  which might 
in flu en c e  the  occurrence o f bacteraem ia o th e r  than the  
type o f th e  in fe c tin g  pneumococcus. (See Table X).
Study o f  Table X re v e a ls  th a t  36 p a t ie n t s ,o r  13  p e r 
cen t, o f  those under 50 y ears  o f age had bacteraem ia, 
and 25 p a t ie n ts  o r  27 p e r  cent, o f  those over 50 y ears  
o f  age had bacteraem ia. The percentage d iffe re n c e  (14) 
has a standard  e r ro r  o f + 4 .$ , so I  co n sid er th e  d iffe re n c e  
i s  s ig n if ic a n t .  Bacteraem ia i s  th e re fo re  more l ik e ly  to 
occur in  o ld e r  p a tie n ts  than in  younger ones.
Table X shows th a t  50 males o r 20 p er cen t, ex h ib ited
bacteraem ia, and-11 fem ales o r 9 p e r cen t, had th i s
com plication. The percen tage d iffe ren c e  (11) has a standard  
e r ro r  o f  + 30 ^he d iffe ren c e  i s  s ig n if ic a n t .  Bacteraem ia
i s  th e re fo re  more l ik e ly  to occur in  males than in  fem ales.
I t  w ill be observed th a t  40 p a tie n ts  o r 14 p e r cen t, o f those
w ith  only one lobe involved had bacteraem ia, and 21 p a t ie n ts  
o r  27 p e r cen t, o f those w ith more than one lobe  involved  
had bacteraem ia. The percen tage d iffe re n c e  (13) has a 
standard  e r ro r  o f  + 5*2 9 so ike  d iffe ren c e  i s  s ig n if ic a n t .  
Bacteraem ia i s  more l ik e ly  to occur when two o r  more lo b es  
a re  a ffe c te d  than when the d isease  i s  l im ite d  to only one lo b e .
Table X shows th a t  the  to ta l  number o f cases in  which 
th e  d u ra tion  o f i l l n e s s  p r io r  to admission to h o sp ita l was known 
w ith  c e r ta in ty  was 355. Thirty-tw o p a t ie n ts  o r  23 p e r cen t, o f 
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had bacteraem ia, and tw enty-nine p a t ie n ts  o r  13  p e r  cen t, o f
those  i l l  fo r  more than th re e  days b e fo re  admission
had bacteraem ia. The percentage d iffe re n c e  (10) has a
standard  e r ro r  o f + ,4 .3  so the d iffe re n c e  i£  s ig n if ic a n t .
Bacteraem ia i s  th e re fo re  more l ik e ly  to  be p re sen t in
p a t ie n ts  i l l  fo r  no t more than th re e  days than in  p a t ie n ts
i l l  fo r  longer than th ree  days before adm ission. This i s
in  agreement w ith the re s t i i ts  o f Cruickshank (1933) wh°
observed th a t  the  h ig h est inc idence  o f bacteraem ia was
in  p a t ie n ts  whose blood was cu ltu red  on the th i r d  day o f
i l l n e s s  and th e re  was then a sharp drop in  th e  inc idence
o f  bacteraem ia.
(Donelusion to be drawn from a study o f the in c idence  
o f  Bacteraem ia and the fa c to rs  whicn in flu en ce  i t s  
occurrence:
A study o f blood c u ltu re s  in  pneumococcal lo b a r  pneumonia 
re v e a ls  th a t  16. 5 p e r cen t, o f p a t ie n ts  have bacteraem ia on 
admission to h o s p ita l ,  and th a t  the g re a te s t  in c id en ce  i s  
in  Type I I  in fe c t io n s .
As age advances the outlook fo r  successfu l recovery from 
pneumonia becomes p ro g ressiv e ly  poorer and th i s  i s  doub tless  
due to the  occurrence o f a g en era lised  decrease in  the  
re s is ta n c e  o f th e  h o s t, fo r  the  inc idence  o f bacteraem ia 
i s  h igher in  those over 50 y ears  o f  age than in  those  under 
t h i s  age.
B acteraem ia i s  much more common in  males than in  
fem ales.
The inc idence  o f bacteraem ia i s  h igher i f  two o r  
more lo b es  are  involved  than i f  th e  d isease  i s  l im ite d  
to  only one lo b e , and i t  i s  h igher in  cases adm itted  
by the  th ir d  day o f  i l l n e s s  than in  cases adm itted a t  
a l a t e r  stage o f  the  i l ln e s s .
The r e s u l t s  o f therapy as gauged by th e  f a t a l i t y  r a te s  in  bacteraem lc 
and non-bacteraem ic cases.
The f a t a l i t y  ra te s  in  cases w ithout and w ith bacteraem ia among the  
in d iv id u a l types are  shown in  Appendix V and fatom the  f ig u re s  ob ta ined  the  
f a t a l i t y  r a te s  o f a l l  types w ithout and with bacteraem ia were a sc e rta in ed  
as shown in  Table XI.
Table XI.
Pneumococcal Lobar Pneumonia:
The f a t a l i t y  r a te  in  cases w ithout and w ith bacteraem ia.
No. o f  Cases No. o f Deaths. F a ta l i ty  Rate %•
Gases w ithout bacteraem ia 309 11 3 .6
Cases w ith bacteraem ia a 17 27.0
A ll cases. 370 28 7.5
Study o f  Table XI confirms the  w e ll-e s ta b lish e d  f a c t  th a t  the  f a t a l i t y  r a te  
i s  much h igher in  bacteraem ic cases than in  those w ith s t e r i l e  blood c u ltu re s .
Appendix V shows th a t  in  Type I  in fe c tio n s  the  f a t a l i t y  r a te  was 
doubled in  bacteraem ic cases; while in  Type I I  in fe c tio n s  th e  f a t a l i t y  r a te  
in c reased  from 1 .6  :to 36.O p e r cent, in  the  presence o f bacteraem ia. In  
Type VII in fe c tio n s  no death  occurred w ithout bacteraem ia, w hile among two
cases w ith bacteraem ia th e re  was one death.
The r e s u l t s  o f therapy as gauged by th e  d u ra tio n  o f bacteraem ia:
Many cases who had a p o s i t iv e  blood c u ltu re  on admission had a fu r th e r  




The r e s u l t s  ob ta ined  from repeated  blood c u ltu re s .
I I I
Type o f  in fe c tin g  pneumo coccus 
IV V VII VIII XIV A ll types.
No. +ve on 
adm ission. 9 42 2 1 2 4 1 a
R ecultured a f t e r  
24 hours. 8 19 2 1 1 4 1 36
S te r i l e  a t  
24 hours. 7 14 2 1 0 4 1 29
S t i l l  +ve a t  
24 hours. 1 5 0 0 0 0 7............ — .............. .
Study o f  Table XII shows th a t  o f the 6l cases having bacteraem ia on adm ission, 
only  36 p a t ie n ts  had more than one blood c u ltu re  taken, s ix  cases having 
d ied  and n in e teen  o th e rs  u n fo rtu n a te ly  had only an i n i t i a l  blood c u ltu re  
taken. Of the  36 cases who had bacteraem ia on admission and who had th e i r  
blood re-exam ined, 29 had s t e r i l e  blood c u ltu re s  and 7 had s t i l l  p o s i t iv e
c u ltu re s  a f t e r  24 hours o f therapy.
Of th ese  7 cases who had s t i l l  organisms in  th e i r  blood 24 hours a f te r  
commencement of therapy, 3 Ctypes I ,  I I  and VII) made f a i r l y  normal 
reco v eries ; w hile a fo u rth  (Type I I )  who developed empyema subsequently
recovered. The remaining 3 cases were Type I I  in fe c t io n s , one o f  which 
developed m en in g itis , and a l l  d ied. The tw enty-nine cases whose blood 
c u ltu re  was s t e r i l e  a f te r  24 hours o f therapy a l l  recovered. The degree o f 
p e rs is te n c e  o f bacteraem ia in  pneumonia i s  th e re fo re  an im portan t fa c to r , 
death  occu rrin g  in  th ree  o f the  seven cases w ith p e r s is t in g  bacteraem ia. The /
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The s e r ie s  i s  u n fo rtu n a te ly  too small to c o n tra s t the  f a t a l i t y  r a te  in  
cases w ithout bacteraem ia, in  cases w ith a p o s i t iv e  blood c u ltu re  on 
adm ission on ly , and in  cases w ith th e i r  blood c u ltu re  s t i l l  p o s i t iv e  
24 hours a f t e r  the  commencement o f therapy.
Conclusion to be drawn from a study o f  the  r e s u l t s  o f
therapy  in  re sp ec t o f  bacteraem ia;
The presence  o f  bacterapm ia adversely  in flu e n c e s  the  p rognosis in  
lo b a r  pneumonia fo r  the  f a t a l i t y  r a te  i s  much h ig h er in  cases w ith  p o s it iv e  
blood c u ltu re  than in  those w ith s t e r i l e  blood c u ltu re s .
Study o f  th e  du ra tion  o f bacteraem ia shows th a t  su lphapyrid ine  in  
most cases le a d s  to  th e  disappearance o f bacteraem ia w ith in  24 hours. The 
p e rs is te n c e  o f bacteraem ia a f t e r  the  in s t i tu t io n  o f  trea tm en t i s ,  however, 
an im portan t p ro g n o stic  fa c to r , fo r  ou t o f seven p a tie n ts  who s t i l l  had 
p o s i t iv e  blood c u ltu re s  24 hours a f t e r  the commencement o f  therapy, th ree  
d ied .
( i i i )  The r e s u l t s  o f therapy in  re sp ec t o f th e  ex ten t of  
the  pulmonary Involvement.
(a) The number o f lo b es  involved.
The cases were divided according to the  number o f lo b es  involved , and the  
in c id en ce , number o f deaths, and f a t a l i t y  r a te  c a lcu la ted  in  each in s ta n ce  
as shown in  Table X III.
Table X III.
Pneumococcal Lobar Pneumonia:
The inc idence  and f a t a l i t y  ra te  according to the ex ten t o f Pulmonary 
Involvement:
h o .o f  lo b es  involved. No. o f  cases. Incidence %. No. o f  Deaths. F a ta l i ty  
Rate %.
1 281 76.0 14 5.0
2 73 19-7 9 12 .3
3 14 3.8 4 28.5
4 2 0 .5 1 50.0
5 — — -
, 85.
Study o f  Table XIII shows th a t  about 75 Pe r cent* o f  th e  cases had only
one lo b e  involved , w hile a fu r th e r  20 p e r  cen t, had th re e  o r fo u r lo b es
a f fe c te d . In  no case was th e re  involvem ent o f ©11 f iv e  lo b es .
I t  w ill be observed th a t as the  degree o f  pulmonary involvem ent
in c re a se d , th e  f a t a l i t y  r a te  a lso  in c reased . Thus i t  was 5 P©r cen t, when
th e re  was involvem ent o f one lobe only , but i t  reached 16 p e r cen t, in  the
89 cases w ith two o r more lobes involved . The percen tage  d iffe re n c e
s t a t i s t i c a l l y  (11) has a standard e r ro r  o f £ 4 .1  so th e  d iffe ren c e  i s
s ig n if ic a n t .  Appendix VI shows th a t  th is  re la tio n sh ip  o f  f a t a l i t y  r a te
to  the  e x ten t o f the pulmonary le s io n  a lso  held w ith Types I ,  I I  and Group
IV; w hile in  Type I I I  in fe c tio n s  the  only death  occurred in  a p a t ie n t  who
had on ly  one lobe  a ffe c te d .
(b) The side  involved.
The cases we re  nex t d iv ided  according to whether the  r ig h t  lung , l e f t  lung ,
o r  both lungs were involved; and the inc id en ce , number o f  deaths, end
f a t a l i t y  r a te  a sce rta in ed  in  each in s ta n ce  as shown in  Table XIV.
Table XIV.
Pneumococcal Lobar Pneumonia:
The in c id en ce  and the f a t a l i t y  ra te  according to the  s ide  o f 
Pulmonary Involvement.
Side involved. No.of cases. Incidence%. No.of Deaths. F a ta l i ty  Rate %•
E ight 181 49.0 13 7.2
L e ft 158 42.5 9 5.7
Both 3L 8.5 6 19 .4
Study o f  Table XIV shows th a t the  r ig h t  lung was a ffe c te d  s l ig h t ly  more 
freq u e n tly  than the  l e f t ,  and in  l e s s  than 10 p e r cen t, o f  th e  cases the  
le s io n  was b i l a t e r a l .  Comparison o f the  f a t a l i t y  r a te s  rev ea ls  very
s l ig h t  d iffe ren c e  between r ig h t-s id e d  and le f t - s id e d  le s io n s , but b il& te ra l /
b i l a t e r a l  involvem ent was a sso c ia ted  w ith an ap p aren tly  h igher f a t a l i t y  
r a te  (19*4) than u n i la te r a l  involvem ent. When te s te d  s t a t i s t i c a l l y ,  the  
percen tage  d iffe re n c e  (12 . 9) has a standard  e r ro r  o f  +7*2. so the  
d if fe re n c e  in  th e  f a t a l i t y  r a te  o f cases w ith u n i la te r a l  involvem ent as 
compared w ith b i la te r a l  le s io n s  was n o t found to be s ig n if ic a n t .  The 
p re se n t s e r ie s  i s  n o t s u f f ic ie n t ly  la rg e  to perm it o f a comparison o f the  
f a t a l i t y  r a te  in  cases having two lobes o f one lung  involved w ith cases 
having b i la te r a l  involvement.
Appendix VII rev ea ls  th s t  in  both Type I  and I I  in fe c tio n s  th e  r ig h t  
lung  was involved  more freq u en tly  than the  l e f t ,  and in  Type I I I  in fe c t io n s  
th e  r ig h t  lung  was involved in  seven cases and the l e f t  in  eleven. In 
Group IV in fe c t io n s  th e  number, o f  cases w ith r ig h t  and l e f t  sided le s io n s  
wa.3 very s im ila r.
Conclusion to be drawn f rom the  study o f the r e s u l ts  o f therapy
in  rep p ect o f t he ex ten t pf_.t.he. P.ulm onaiy_inyply_^
In  approxim ately 75 Pe r cen t, o f th e  cases the  con so lid a tio n  i s  l im ite d  
to  one lo b e  and in  the  o th e r  25 p e r cen t, o f cases the  le s io n  invo lves two 
o r  more lo b e s . The ex ten t o f the pulmonary le s io n  in flu en c es  th e  p rognosis 
because the  f a t a l i t y  r a te  in c rease s  as th e  d isease  in v o lves an in c re as in g  
number o f lobes.
In  about 90 p er centt. o f cases e i th e r  the  r ig h t  o r  the  l e f t  lung i s  
invo lved , w ith  r ig h t  sided le s io n s  predom inating s l ig h t ly ,  and in  about 10 
p e r cen t, o f cases both lungs are  involved. The d iffe re n c e  in  th e  f a t a l i t y  
r a te s  in  cases w ith  u n i la te r a l  and b i la te r a l  le s io n s  i s  n o t s ig n if ic a n t  
owing to the  small number o f cases w ith b i la te r a l  involvem ent.
I t  would appear th a t  the type o f  the  in fe c tin g  pneumo coccus has
l i t t l e  r e la t io n  to the  ex ten t o f pulmonary involvement o r  to  the  s id e  a ffe c te d .
The s l ig h t ly  more frequen t involvement o f the r ig h t  s ide  i s  p robably  due
to  the  la r g e r  s ize  and s tra ig h te r  course o f  the  bronchus on th a t  s id e .
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( iv )  The re s u lt# o f  th e rapy in  re sp e c t o f the  day o f i l l ness 
a t  the  t i me o f  admission to h o s p i ta l .
The cases were d iv ided  according to the  du ra tion  o f i l ln e s s  a t  th e  
tim e o f  admission to  h o s p ita l .  F igure I I I  shows in  the  fonn o f  a 
histogram  the  d is t r ib u t io n  o f cases according to the day o f i l l n e s s  o r 
the  day on which trea tm en t was in s t i tu te d .  Study o f F igure I I I  shows th a t  
th e  m a jo rity  o f cases had trea tm ent i n s t i tu t e d  during th e  second, th ir d  
o r  fo u r th  day o f i l l n e s s ,  and th e re a f te r  th e re  was a f a i r l y  rap id  f a l l  in  
th e  number o f cases; com paratively few cases being adm itted to h o sp ita l 
a f t e r  th e  seventh day o f i l ln e s s .  Thus in  137 cases trea tm en t commenced 
during  th e  f i r s t  th ree  days of i l ln e s s  and in  195 cases betv/een the  fo u r th  
and seventh  day o f i l l n e s s .  In  23 cases trea tm en t was in s t i tu te d  sometime 
during the  second week o f i l l n e s s .  In 15 cases the  p a t ie n ts  were unable to 
s ta t e  w ith  any degree o f accuracy the date  o f th e  o n se t o f i l l n e s s  and 
such cases had th e re fo re  to be exdluded. Such cases were, as a ru le ,  m ild
in fe c t io n s  and the p a t ie n ts  were g en era lly  i l l  fo r  some considerab le  time 
b efo re  admission. No deaths occurred among th ese  15 cases.
Cases in  which trea tm en t commenced during the  f i r s t  th re e  days o f  
i l l n e s s  may be ca lled  e a r ly  cases and the  f a t a l i t y  r a te  o f such cases may be 
compared w ith th a t  o f l a t e  cases in  which treatm ent commenced a f t e r  the  
th i r d  day o f i l l n e s s .
Table XV.
Pneumococcal Lobar Pneumonia:
The number o f cases, inc idence , deaths, and f a t a l i t y  r a te  in  cases 
t r e a te d  ea rly  and l a t e .
No.of Cases. Percentage o f Cases. No.of deaths. F a ta lity
Rate
Cases tre a te d  e a r ly 137 39 7 5.1
























Study o f  Table XV shows th a t  in  only 39 per cen t, o f  the  355 cases 
therapy  commenced during the  f i r s t  th re e  days o f  i l l n e s s ,  and th a t  in  
61 p e r  cen t, trea tm en t was not i n s t i tu te d  t i l l  a f t e r  the  th ir d  day o f 
i l l n e s s .  Table XV also  shows th a t  seven deaths occurred  among th e  137 
cases in  which trea tm en t commenced during the f i r s t  th re e  days o f  i l l n e s s ,  
and tw enty-one deaths occurred among 218 cases t r e a te d  a f te r  the th i r d  day 
o f  i l l n e s s .  The f a t a l i t y  r a te  in  the former group o f  cases was 5*1 p e r 
cen t, and in  th e  l a t t e r  group 9*6 p e r c e n t.,  thus suggesting an advantage 
from the  ea r ly  trea tm ent o f p a t ie n ts .  The percen tage  d iffe re n c e  (4 .5) has 
a standard  e r ro r  o f  £  2.J so the  d iffe ren ce  i s  n o t s ig n if ic a n t .
Types I  and I I  in fe c tio n s , the  most severe c l in ic a l  types, were 




The number o f cases, death s, and f a t a l i t y  ra te  in  Type I  and I I  




Type I  . Type I I Types I  and I I
No. o f  No. o f  F a ta l i ty  
cases, deaths. Hate
No. o f No.of F a ta l i ty  
cases, deaths.R ate  %9
No. 0 f  No. 0 r  'F a ta li iy 
cases .d ea th s .R a te  %
Early
Late
25 0 0 . 0  
55 5 9.1
53 4 7.5
72 1 2  1 6 . 5
78 4 5.1 
1 2 7  1 7  I 3 . 4
Study o f  Table XVI shows th a t  among 78 Type I  and I I  in fe c t io n s  tre a te d  by 
th e  th ir d  day o f i l l n e s s ,  th e re  were fo u r deaths, g iv ing  a f a t a l i t y  r a te
o f  5*1 p e r c e n t . , and among 127 Type I  and I I  in fe c tio n s  tre a te d  a f t e r  the  
th ir d  day o f  i l l n e s s  th e re  were seventeen deaths, g iv ing  a f a t a l i t y  r a t e  o f
I 3 . 4  p e r  cent. The percentage d iffe ren c e  ( 8 . 3 )  has a standard  e r ro r  o f 
+. 3.9 so th e  d iffe ren c e  i s  s ig n if ic a n t.
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Conclusion to be drawn from a study o f the r e s u l ts  o f therapy in  
re sp e c t o f the  day o f i l ln e s s  a t  the time o f adm ission to h o s p ita l .
I t  i s  in te r e s t in g  to no te  th a t  only 137 p a t ie n ts  o r  39 p e r cent, o f
th e  cases, in  which the  d a te  o f the o n se t o f the i l l n e s s  i s  known w ith
c e r ta in ty ,  a re  adm itted to h o sp ita l during  the  f i r s t  th re e  days o f the
i l ln e s s ;  and 218 p a t ie n ts  o r 61 per cen t, a re  adm itted a f t e r  the  th ird  day
o f  i l l n e s s .
Wo s ig n if ic a n t  d iffe ren c e  in  the f a t a l i t y  r a te  o f cases t re a te d  early  
and l a t e  i s  found when a l l  the cases are  considered; but when Type I  and 
I I  in fe c t io n s  to g e th e r, the  most severe c l in ic a l  types, a re  analysed, i t  i s  
found th a t  the  f a t a l i t y  r a te  o f cases tre a te d  ea rly  i s  low er than th a t  o f 
cases t re a te d  l a t e  in  the  i l l n e s s .  An advantage i s  th e re fo re  to be gained 
from the  ea rly  trea tm en t o f Type I  and I I  in fe c tio n s .
(v) The r e s u l ts  o f therapy in  re sp e c t o f the  age o f the  p a ti en t.
All p a t ie n ts  in  the  s e r ie s  were over th e  age o f 15 y ea rs . The p a t ie n ts  
were d is tr ib u te d  in to  f iv e  y early  age group periods as shown in  Table XVII.
Table XVII.
Pneumococcal Lobar Pneumonia:
The d is tr ib u ti& n  o f cases by age groups.













71 & over 7
Study o f  Table XVII re v e a ls  th a t  pneumonia was r e la t iv e ly  common in  young 
ad o lescen ts  from 15-20 y ears  o f age. From the  age o f  21 y ears  onwards th e re  
was an in c re a se  in  the  inc idence  o f  pneumonia up to  the  age o f 45 y e a rs , 
a f t e r  which the number o f cases f e l l  q u ite  considerab ly . Apart from high 
in c id en ce  from 15-20 y ea rs , pneumonia was found to  be p re v a len t between 
41»45 years  o f age.
The prognosis o f lo b a r pneumonia i s  g en era lly  regarded as becoming 
in c re a s in g ly  unfavourable as age advances. The f a t a l i t y  r a te  o f a l l  cases 
d is t r ib u te d  according to age a re  shown in  Table XVIII.
Table XVIII.
Pneumococcal Lobar Pneumonia:
The number o f  deaths and f a t a l i t y  r a te  according to age d is t r ib u t io n .
Age in  Years. No. o f Cases. No. o f death s. F a ta l i ty  Rate %,
15-35 143 2 1 .4
76-55 166 16 9 .6
56-75 & over
.
61 10 16 .4
Study o f Table XVIII shows th a t  the  f a t a l i t y  r a te  was markedly in fluenced  by 
th e  age o f  th e  p a t ie n t ,  in c re a s in g  considerably  as age advanced.
The cases were nex t d iv ided  in to  those under and over 50 y ears  o f age and 
the  number o f  deaths and f a t a l i t y  r a te  c a lc u la te d  in  each in s ta n c e  as shown 
in  Table XIX.
Table XIX.
Pneumococcal Lobar Pneumonia:
The number o f deaths and f a t a l i t y  r a te s  in  cases under and over 50 y ea rs  o f  age.
Age in  Years. No. o f Cases. No. o f  deaths. N ata lity  Rate %•
Under 50 277 13 4 .7
Over 50 93 15 I 6 .3
Study o f  Table XIX shows th a t  in  those over 53 y ears  o f age th e re  was a marked
in c re a se  in  the  f a t a l i t y  r a te .  The percen tage d iffe ren c e  (11.6) has a 
standard  e r ro r  o f t  4-0 so the d iffe ren ce  i s  s ig n if ic a n t .
Conclusion to be drawn from a study o f the r e su lts  o f therapy 
in  respect o f  the age o f  the p atien t.
Pneumococcal lo b a r  pneumonia i s  a d isease  which can occur a t  any age. 
I t  i s  freq u en tly  encountered in  young ado lescen ts  and in  those between 41- 
45 y ears  o f  age in  th e  "prime o f  l i f e " ,  a f t e r  which th e re  i s  a f a l l  in  i t s  
in c id en ce .
The age o f th e  p a t ie n t  has a marked in flu en c e  on p rognosis, which
worsens as age advances. The cause o f  th is  i s  p o ssib ly  due to the  low ering
o f  re s is ta n c e  to  b a c te r ia l  in fe c tio n  as age advances.
( v i) The r e s u l t s  o f therapy in  re sp ec t o f th e  sex o f the  p a t ie n t . '
The cases were adm itted  in to  male and female wards o f  s im ila r  s i i e .  The
p a t ie n ts  were adm itted from a la rg e  area o f Glasgow and the d is t r ib u t io n
o f  cases was th e re fo re  f a i r ly  re p re se n ta tiv e  o f the  d isease  as i t  a ffe c te d
e i th e r  sex. The number o f cases and the f a t a l i t y  r a te  o f male and female
cases i s  shown in  Table XX.
Table XX.
Pneumococcal Lobar Pneumonia:
The number o f cases, deaths, and f a t a l i t y  r a te  in  males and fem ales.
Sex No. o f Cases. No. o f  deaths. F a ta l i ty  Rate %,
Male 248 19 7.6
Female 122 9 7 .3
Study o f  Table XX shows th a t  248 males and 122 females were adm itted to 
h o sp ita l su ffe r in g  from lo b a r  pneumonia, and th a t  the  f a t a l i t y  r a te
(in c lu d in g  a l l  deaths) was s im ila r  in  both sexes.
Conclusion to be drawn from a study o f the resu lts  o f therapy in  
respect o f the sex o f the patient.*
I t  i s  im portan t to remember th a t  the above c ite d  cases r e f e r  only to
th e  h o sp ita lis e d  p a tie n ts  so the tru e  s ig n if ic a n ce  o f sex in  r e la t io n  to 
prognosis i s  n o t xnown, fo r  the  proportion  o f a l l  cases in  e i th e r  sex in  
any community i s  unknown. The only conclusion to  be drawn from the  study /
study o f sex i s  th a t  in  h o s p ita lis e d  cases th e  inc idence  o f pneumonia i s  
tv/ice as g re a t in  males as in  fem ales, y e t no ap p rec iab le  d if fe re n c e  i s  
found in  th e  f a t a l i t y  r a te .
(v i i )  The r e s u l t s  o f therapy in  re sp ec t o f th e  p u lse  r a te .
Appendix VIII shows the  p u lse  r a te  d is t r ib u t io n  o f Types I ,  I I ,  I I I
and Gp. IV in  both sexes. The r a te s  compared were the  second read ings on
th e  four-hourly  c h a r ts , i . e .  the  minimum time in  h o sp ita l before  such
read in g s  were obtained  was four hours. From Appendix VIII th e  number and
percen tage  o f cases, number o f deaths, and f a t a l i t y  ra te  o f a l l  types having
p u lse  r a te s  under and over 120 were a sce rta in ed  as shown in  Table XXI.
Table XXI.
Pneumococcal Lobar pneumonia:
The number and percentage o f cases, number o f deaths and f a t a l i t y  r a te  
o f  a l l  types in  cases w ith a p u lse  r a te  under and over 120 p e r m inute.
P u lse  r a te No. o f $&ge. No. o f F a ta l i ty  Rate
(p er m in .) . Cases. o f Cases. Deaths.
Under 120 320 86 .4 20 6 .2
Over 120
50
17 .6 8 16.0
Study o f Table XXI shows th a t  86 per cent, o f cases had a p u lse  r a te  not 
exceeding 120 p e r minute, and 14 p e r cent, had a p u lse  r a te  exceeding 
th i s  f ig u re . The f a t a l i t y  r a te  in  the former group was found to be 6.2  
p e r  c e n t.,  and in  the  l a t t e r  16.0 p e r cent. The percentage d iffe re n c e  (9*8) 
has a standard  e rro r  o f 1 5*3* I  consider th i s  d iffe ren ce  i s  n o t s ig n if ic a n t .
Conclusion to be drawn from a study o f the  r e s u l ts  o f  therapy in  
re sp ec t o f  th e  pu lse  r a te r
No d e f in i te  inform ation concerning prognosis i s  ob tained  from the 
p u lse  r a te  ob tained  sh o rtly  a f t e r  admission to  h o s p ita l .  There i s  a s l ig h t
tendency fo r  su lphapyrid ine therapy to be l e s s  successfu l in  those having 
a pu lse  r a te  over 120 per minute than in  those having a p u lse  r a te  below /
below t h i s  f ig u re . The p u lse  r a te  obviously depends on the  day o f  i l l n e s s  
a t  the  time o f admission to h o s p ita l ,  so u n le ss  th i s  fa c to r  i s  taken in to  
account the  p u lse  r a te  by i t s e l f  i s  o f l i t t l e  value in  p rognosis.
( v i i i )  The r e s u l t s  o f therapy in  re sp e c t o f the  re s p ira t io n  r a te .
Appendix IX shows th e  re s p ira tio n  r a te  d is t r ib u t io n  o f  Types I ,  I I ,  I I I
»
and Group IV. The read ings compared were the  second ones on the  fo u r-h o u rly
ch artp , i . e .  the  minimum time in  h o sp ita l before such read ings were ob ta ined
was fo u r hours. The cases were then grouped according to  whether the
re s p ira t io n  ra te  was under o r over 40 p e r minute as shown in  Table XXII.
Table XXII.
Pneumococcal Lobar Pneumonia:
The number and percen tage  o f cases, number o f death s, and the  f a t a l i t y  
r a t e  in  cases w ith a re s p ira tio n  ra te  under and over 40 p e r  minute.




% o f No. o f F a ta l i ty  Rate
(p e r min.) Cases. Cases. Deaths. %.
Under 40 282 76*3 15 5-3
Over 40 88 2'3*7 13 14.8
Study o f  Table XXII shows th a t  in  262 cases o r 76 p e r cent, the  re s p ira tio n
r a te  d id  no t exceed 40 p e r minute, and in  88 cases o r 24 p e r cen t, the  r a te
exceeded th ie  f ig u re . The f a t a l i t y  r a te  in  th e  former group was 5*3 Pe r  cen t.
and in  the  l a t t e r  14.8 p e r cen t. The percen tage d iffe ren c e  (9*6) has a
standard  e r ro r  o f * 4.0 so the  d iffe ren ce  i s  s ig n if ic a n t .
Conclusion to be drawn from a study o f the  r e s u l ts  o f therapy 
in  re sp e c t o f the re s p ira tio n  r a te .
A study o f the  re s p ira tio n  ra te  sh o rtly  a f t e r  admission to  h o sp ita l 
shows th a t  trea tm en t w ith su lphapyrid ine i s  more l ik e ly  to  be successfu l 
in  p a t ie n ts  who have a re s p ira tio n  ra te  under 40 p er minute than in  those who
have a r a te  exceeding 40 p e r m inute. The re s p ira t io n  r a te  obviously depends on 
th e  ex ten t o f  the  pulmonary involvement and so by i t s e l f  i s  o f l i t t l e  value 
in  prognosis.
( i x) The r e s u l t s  o f therapy in  re sp e c t o f the  presence 
o f l a b ia l  herpes.
The inc idence  o f l a b ia l  herpes was in v e s t ig a te d  because Lord ( I 925) 
observed th a t  i t  was g en era lly  regarded as a favourab le  sign.
Table XXIII.
Pneumococcal Lobar Pneumonia:
The number o f cases having la b ia l  herpes in  a l l  cases and in  
death s among in d iv id u a l and a l l  types.
Type No. o f 
Cases.
No. w ith 
Herpes.
% w ith  
Herpes.
' No."“o f ......
Deaths.
No. w ith 
Herpes.
I 87 17 19 .5 5 0
I I 128 20 15.6 16 3
I I I 18 3 16.6 1 0
Gp. IV 137 13 9 .5 6 2
All types 370 53 14 .4 28 5
Study o f  Table XXIII shows th a t  herpes was encountered s l ig h t ly  more
freq u en tly  in  Type I  in fe c tio n s  than in  Type I I  and I I I  in fe c t io n s , and
th a t  i t  was l e a s t  freq u en tly  encountered in  Group IV in fe c tio n s . Among
the  28 deaths th e re  were f iv e  cases o f  herpes.
Conclusion to be drawn from a study o f the  r e s u l t s  o f therapy in  
re sp e c t o f the  presence o f la b ia l  herpes.
The s e r ie s  i s  so small th a t  no d e f in i te  conclusion can be drawn as to 
th e  p ro g n o stic  s ig n ific a n ce  o f l a b ia l  herpes. I t  would appear, however, 
th a t  in  th e  trea tm en t o f  lo b a r pneumonia w ith su lphapyrid ine the  p resence 
o f  herpes cannot always be regarded as a favourable s ign .
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(x) The r e s u l t s  o f therapy in  re sp ec t o f th e  presence o f d e liriu m .
The inc idence  o f de lirium  among the  various types was a sc e r ta in e d  as shown 
in  Table XXIV.
Table XXIV.
Pneumococcal Lobar Pneumonia:
The number o f cases having delirium  in  a l l  cases and in  deaths among 
in d iv id u a l and a l l  types.
Type No.of Cases.
No. wi th  
Delirium .
io w ith 
Delirium.
No. o f 
Deaths.
No. wi th  
Delirium .
I 87 7 8.0 5 1
I I 128 22 17 .2 16 7
I I I 18 1 5 .6 1 0
Gp. IV 137 8 5.8 6 2
All types 370 38 10.3 28 10
Study o f Table XXIV shows th a t  delirium  was more freq u en tly  encountered in  
Type I  and I I  in fe c tio n s  than in  in fe c t io n s  due to Type I I I  and Group IV.
I t  was,moreover, much more common in  Type I I  in fe c t io n s , which were the 
most severe c l in ic a l ly ,  than in  any o f the  o th e r types. Among the  28 deaths 
th e re  were ten  cases o f de lirium , seven o f th ese  occurring  in  Type I I  
in fe c t io n s .
Conclusion to be drawn from a study o f th e  r e s u l t s  o f therapy 
in  re sp ec t o f the presence o f delirium ?
The s e r ie s  i s  so small th a t  no d e f in i te  conclusion can be drawn, U it 
i t  may be s ta te d  th a t  delirium  i s  commoner in  Type I I  in fe c t io n s  than in  any 
o th e r  type. In  the  treatm ent o f lo b a r  pneumonia w ith su lphapyrid ine  the 
presence o f de lirium  can gen era lly  be regarded as an unfavourable sign.
The presence o f delirium  w ill be in fluenced  by the  dura tion  o f the  i l ln e s s
and so i t  i s  no t a valuab le  sign in  prognosis.
(x i)  The r e s u l t s  o f therapy in  re sp ec t o f the  leucocy te  count.
In  th i s  study o f 37^ cases o f pneumonia, d a ily  leucocy te  counts were
performed in  the 161 cases in  which blood and u rin e  su lohapyrid ine le v e ls  were
/
were determ ined. In  some cases i t  was n o t found p o ss ib le  to  perform 
leu co cy te  counts on the  day of admission as i t  was freq u e n tly  l a t e  in  th e  
evening when the  p a t ie n ts  were adm itted. However, a l l  p a t ie n ts  had d a ily  
counts performed from the  second day in  h o sp ita l onwards throughout the 
p e rio d  o f su lphapyrid ine  ad m in is tra tio n . The r e s u l t s  ob ta ined  from the  161 
cases s tud ied  a re  shown in  Appendix X. From the  f ig u re s  in  Appendix X
th e  average d a ily  leucocy te  counts o f in d iv id u a l types were c a lc u la te d  as
shown in  Table XXV.
Table XXV.
Pneumococcal Lobar Pneumonia:
The average d a ily  leu co cy te  counts, expressed in  thousandths p e r cubic mm.,
o f  Types I ,  I I ,  I I I  and Gp. IV.
Type Day in  HospiLtal1 2 3 4 5 6 7 8
I - 15.1 11.9 10.0 10.1 10.0 10 .6 9 .2
I I - 14.0 11.8 10.9 11.1 12.9 12.0 11 .2
I I I - 12.0 8.8 8 .5 9 .2 8 .9 8 .9 9 .9
Gp.IV - 12.0 8 .8 7.3 8 .1 8 .0 8 .6 9.0
Study o f Table XXV shows th a t  the  h ig h est i n i t i a l  leucocy te  counts occurred 
in  T^rpe I  and I I  in fe c tio n s . In f a c t ,  throughout therapy the counts in  
in fe c t io n s  due to these  types were h igher than those in  in fe c t io n s  due to 
Type I I I  and Group IV.
In  a l l  types the i n i t i a l  count was the  h ighest ob tained  and by the  
fo u r th  day in  h o sp ita l th e  counts had f a l le n  to normal le v e l s .  T h e rea fte r
throughout th e  period  o f  therapy the  leucocy te  counts remained f a i r ly  steady .
The in flu en ce  o f the  leucocy te  count on the  f a t a l i t y  r a te  was nex t 




The d is t r ib u t io n  o f cases showing reco v eries  and deaths, o f  Types I ,  I I ,  




Recoveries & Deaths. Recoveries. Deaths.
I II I II Gp.IV All
types
I II III Gp.IV All
types
I II I l l Gp.IV All
. t o .8
Under 10,000 7 20 7 22 56 6 17 6 20 49 1 3 1 2 7
10 -  15,000 14 17 1 25 57 12 17 1 25 55 2 - - - 2
15 -  20,000 9 9 1 6 25 9 8 1 6 24 - 1 - - 1
20 -  25,000 6 3 1 2 12 6 3 1 2 12 - - - - -
25 -  30,000 2 4 1 - 7 2 4 1 - 7 - - - . - -
Over 30,000 1 1 - 2 4 1 1 - 2 4 - — — -
The counts compared in  Table XXVI were the  ones ob tained  on the  second day in  
h o sp ita l. Study o f Table XXVI shows th a t  113 cases o r 70 p e r  cen t, had an 
i n i t i a l  leu co cy te  count under 15,000 p e r cubic mm., and 48 cases o f p e r cen t, 
had a count over th i s  f ig u re . Among the 151 cases who recovered the f ig u re s  
were 69 and 31 Per cen t, re sp ec tiv e ly ; w hile 9 o f the  10 cases who died had 
i n i t i a l  counts under 15,000 p e r  cubic mm.
The f a t a l i t y  r a te  in  those  w ith a count under 15,000 p e r cubic mm. was
12.4  p e r c e n t . ,  and in  those w ith a count over 15,000 p e r cubic mm. was 2.1 
per cen t. The percentage d iffe ren c e  (10.3) has a standard  e r ro r  o f  t  3 . 7, so 
the  d iffe ren c e  i s  s ig n if ic a n t .
Although a high i n i t i a l  leucocy te  count was a  favourab le  s ign , i t  i s  
n ev e rth e le ss  seen th a t  recovery took p lace  in  many cases when th e  i n i t i a l  
leucocy te  count was under 15,000  p e r cubic mm.
Conclusion to be drawn from a study o f the  r e s u l t s  
o f  therapy in  re sp e c t o f th e  leu co cy te  count.
P a t ie n ts  most sev ere ly  i l l  w ith pneumonia have e i th e r  a Type I  o r  
I I  in fe c tio n  and bacteraem ia i s  most freq u en tly  encountered in  I^pe I I  
in fe c t io n s .  Accordingly, i t  i s  n o t su rp r is in g  th a t  the  h ig h est leu co cy te  
counts a re  found in  p a t ie n ts  who are  r e a l ly  se r io u s ly  i l l ,  and the  
low est counts in  Type I I I  and Group IV cases who are on the  whole le s s  
se r io u s ly  i l l .  These fin d in g s  are  n o t e n tir e ly  in  agreement w ith the  
r e s u l t s  ob ta ined  by Fleming (1936)> who found the  h ig h est counts in  
Type I  and Group IV in fe c t io n s .
A leu co c y to s is  in  the ea rly  s tages o f  the  i l l n e s s  i s  a favourable  
p rognostic  s ign , and the  f a t a l i t y  r a te  i s  h igher in  p a t ie n ts  w ith an 
i n i t i a l  count under 15,000 p e r cubic mm. than i t  i s  in  those w ith a 
count exceeding th is  f ig u re . The leucocy tes a re  im portan tly  concerned 
in  the d e s tru c tio n  o f the invading  organisms and th e i r  phagocytic 
func tions obviously a id  recovery. However, recovery o ften  takes p lace  
in  those having, an i n i t i a l  leucocy te  count even under 10,000 p e r cubic mm., 
so th a t  in  prognosis undue dependence cannot be p laced on leu co cy te  counts 
alone.
B. The r e s u l t s  o f therapy as gauged by the  response o f  the  Temperature.
One o f  th e  most s tr ik in g  o b servations made was the  frequency w ith 
which the  i n i t i a t i o n  o f drug therapy was followed w ithin  a pe rio d  o f 
36-72 hours by a c r i t i c a l  drop in  tem perature. This rap id  drop in  
tem perature was in  a general way a sso c ia ted  w ith am elio ra tion  o f the 
p a t ie n ts ' cond ition .
The tem perature ch a rts  o f a l l  patienl£s-i?!fere s tud ied  to no te  i f  any 
marked d iffe ren c es  were p re sen t in  the  response o f  in fe c t io n s  due to  
d i f f e r e n t  types o f pneumococcus to  su lphapyrid ine therapy. From th e  
h o sp ita l tem perature ch a rts  the h ig h est d a ily  tem perature during the  f i r s t  
ten days in  h o sp ita l was recorded. From the f ig u re s  obtained  the  average 
tem peratures o f Types I ,  I I ,  I I I  and Group IV in fe c t io n s  during th e  f i r s t  
ten  days in  h o sp ita l were c a lc u la te d  as shown in  Table XXVII.
Table XXVII.
Pneumococcal Lobar Pneumonia:
The average tem peratures o f Types I ,  I I ,  I I I  and Group IV in fe c tio n s  
during th e  f i r s t  ten days in  h o sp ita l.
Dav in  H ospital
1 2 3 4 5 6 7 8 9 10
Type I 101.5 100.5 98.8 98.0
I
| 98.1 98.0 98.0 98.0 98.0 97.8
" I I 101.3 100.4 98.7 98.2 98.1 98.2 97*8 98.0 97.9 97.9
n I I I 100.6 100.1 98.8 97.9 97.9 97.8 97.6 97.3 97.9 97.6
Gp.IV 101.0 100.1 98.6 98 .3 98.1 98.1 98.0 97.9 97.9 97.9
Study o f  Table XXVII shows very l i t t l e  d iffe ren ce  e x is ted  between the
tem perature o f the  d if f e r e n t  Types on the  day o f admission and during
trea tm en t with su lphapyrid ine. Type I I I  cases tended to have s l ig h t ly  lower
tem peratures than o th e r types during the f i r s t  two days in  h o s p ita l ,  but 
from the  th ird  day onwards no appreciab le  d iffe ren c e  ex is ted  among the
vario u s  types. The average tem peratures on the day o f admission o f  the  /
IQ I.
th e  various types ranged from 100.6 tp  101.5 degrees F ahrenheit, w hile 
on the  second day in  h o sp ita l the tem peratures ranged from 98 .6  to 98*8 
degrees F ahrenheit. During th e  f i r s t  24 hours in  h o sp ita l th e re  had 
been a f a l l  in  tem perature n o t exceeding 1 .0  degrees F ah ren h e it, and during  
th e  second 24 hours the  f a l l  in  tem perature was about 1 .5  degrees. The 
average tem perature o f a l l  Types reached normal between 48 and 72 hours 
a f t e r  adm ission.
F igure IV shows in  the  form o f  a graph the  average tem peratures o f 
Types I ,  I I ,  I I I  and Group IV during the f i r s t  ten  days in  h o s p ita l .
The d u ra tio n  o f Primary Pyrexia:
From th e  h ighest d a ily  tem perature recorded during the f i r s t  ten 
days in  h o sp ita l (p rev iously  obtained  from the  h o sp ita l tem perature ch arts) 
the  d u ra tion  o f  primary pyrex ia  was a sc e rta in ed  fo r  a l l  p a t ie n ts .  This 
period  o f prim ary pyrex ia  was the dura tion  in  days o f  p y rex ia  u n t i l  the 
tem perature had reached normal and remained a t  th is  le v e l fo r  24 hours.
I t  should be noted th a t  the m ajo rity  o f p a t ie n ts  were adm itted to h o sp ite l 
in  the  l a t e  afternoon o r  evening. In sp ite  o f the f a c t  th a t  they might only 
have been in  h o sp ita l fo r  a period  o f s ix  hours o r le s s  on the  day o f 
admission they were n ev e rth e le ss  c re d ited  w ith having had py rex ia  on th a t 
day. Also pyrex ia  might have ceased in  the  morning, y e t such a p a tie n t  
was again c re d ited  with one day* s pyrex ia .
I t  w ill  be seen th e re fo re  th a t  in  a ssess in g  the  p e rio d  o f prim ary
pyrex ia  in  terms o f days, although th is  pe rio d  may be regarded as n o t 
\
exceeding two o r th re e  days, in  ac tu a l f a c t  in  many cases i t  w ill be 
severa l hours le s s ;  depending on the time a t  which the  p a t ie n t  was 
adm itted to  h o sp ita l and on the time a t  which th e  pyrex ia  ceased.













ty p es, exclud ing-deaths, i s  shown in  Table XXVIII. Cases whose tem perature 




The d u ra tion  in  days o f prim ary pyrex ia  o f in d iv id u a l and a l l  types among 
cases which recovered.
Type Days o f  Pr]i/nary Pyrexia
1 2 3 4 3 6 7 8 9 10 A feb rile  cases
I 4 3L 22 8 3 2 1 0 0 6 .5
I I 5 56 34 9 0 2 1 1 0 3 l
I I I 3 6 5 1 l 0 0 0 0 1 0
Gp.IV 17 54 27 5 5 4 l 1 2 8 7
All types 29 147 88 23 9 8 3 2 2 18 13
From Table XXVIII the  percen tage o f cases o f in d iv id u a l and a l l  types having 
primary p y rex ia  no t exceeding two and th ree  days was a sc e rta in ed  as shown 




The percentage o f in d iv id u a l and a l l  types having prim ary pyrex ia  n o t 
exceeding two and th re e  days.
Type Percentage whose tem perature was normal by 2 days.
Percentage whose tem perature 
was normal by 3 days.
I 44.0 75.5
I I 56.0 86 .6
I I I 47.0 82 .2
Gp. IV 57.5 80.0
A ll types 53.3 8I .5
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Study o f  Table XXIX shows th a t  in  about 50 p e r  cen t, o f a l l  cases
th e  prim ary py rex ia  d id  n o t exceed two days, and in  about 80 p e r cen t, o f
cases th e  prim ary pyrex ia  d id  n o t exceed th re e  days.
The d u ra tio n  in  days o f  prim ary py rex ia  o f a l l  types i s  rep resen ted  
in  the  form o f  a h is to g ran , F igure V, which c le a r ly  shows th a t  by f a r  th e  
g re a te s t  number o f  cases had prim ary py rex ia  o f  2 days* d u ra tio n , and th s t  
by the  end o f the  th ir d  day in  h o sp ita l th e  m a jo rity  o f  cases were 
ap y rex ia l.
Study o f Table XXIX a lso  shows th a t  among in d iv id u a l types th e re  was 
very s l ig h t  v a r ia tio n  in  the percen tage o f cases having pyrex ia  n o t 
exceeding two and th re e  days' d u ra tio n . The e f fe c t  o f .sulphapyridine in  
reducing pyrexia  was n o t th e re fo re  s ig n if ic a n t ly  r e la te d  to the type 
o f  in fe c tin g  pneumococcus.
I t  was nex t decided to a sc e r ta in  i f  the  period  o f  prim ary pyrex ia  
was in  any way re la te d  to the day o f i l ln e s s  on adm ission, i . e .  to the  
day on which trea tm en t was in s t i tu te d .
Table XXX.
Pneumococcal Lobar Pneumonia: •
The duration  o f prim ary pyrex ia  c o rre la te d  w ith  th e  day o f  i l l n e s s .



































Study o f  Table XXX shows th a t ,  excepting the  cases t r e a te d  on th e  f i r s t  
day o f i l l n e s s ,  more cases had prim ary pyrex ia  o f two days’ du ra tion  
than o f any o th e r p e rio d , q u ite  i r r e s p e c t iv e  o f  the  day on which therapy 
was in s t i tu te d .
The cases were d iv ided  according to  whether trea tm en t commenced 
during  the f i r s t  th re e  days o f i l l n e s s  (e a r ly  cases) o r  during th e  fo u rth  
to  seventh day o f  i l l n e s s  ( l a te  cases), and the percen tage having pyrex ia  
o f  one to seven days was a sce rta in ed  fo r  cases tre a te d  e a r ly  and l a t e  in  
i l l n e s s ,  as shown in  Table XXXI.
JaJsOrS-Xm*
Pneumococcal Lobar Pneumonia:
The percentage d is t r ib u t io n  o f days o f prim ary pyrex ia  in  cases 
tr e a te d  ea rly  and l a t e .
N ature o f Case Days o f  Prim ary Pyrexia.
1 2 3 4 5 6 7
Early 7.4 43*? 34.7 7.4 4.1 1 .7 0.9
Late 9 .4 52-5 24.4 7*5 1 ,9  1 3-1 1.2
Study o f Table XXXI shows th a t  in  p a t ie n ts  in  which trea tm en t commenced 
during the f i r s t  th ree  days o f i l ln e s s  51.5 p e r  cen t, 'had py rex ia  not
exceeding two days and 84 .7  p e r cent, had p y rex ia  n o t exceeding th ree  days.
In those cases tre a te d  between th e  fo u rth  and seventh day o f  i l l n e s s  the 
f ig u re s  were 61.9 and 86 .3  p e r cent, re sp ec tiv e ly . These f ig u re s  show 
c le a r ly  th a t the  du ra tion  o f prim ary p y rex ia  did  n o t depend on the  day 
o f i l l n e s s  at the  time o f admission to h o sp ita l.
Conclusion to be drawn from a study o f the  r e s u l t s  o f therapy in
re sp ec t o f the  Temperatu r e Response.
The g re a t m ajo rity  of cases o f a l l  types o f pneumococcus pneumonia
had pyrex ia  on admission to  h o sp ita l. Sulphapyridine i s  an e f fe c t iv e  
chem otherapeutic agent in  the  reduction  o f p y rex ia , and the  type o f  /
o f in fe c t in g  pneumococcus does n o t appear to in flu en ce  i t s  e f fe c t .
In  a few cases, however, su lphapyrid ine has no e f f e c t  in  th e  red u c tio n  
o f  py rex ia . A ssociated w ith th i s  reduction  o f pyrex ia  th e re  i s  in  a 
general way an improvement in  th e  p a t ie n t ’ s w ell-being .
The p eriod  o f prim ary pyrex ia  i s ,  as a ru le ,  o f two o r  th re e  days’ 
d u ra tio n . The du ra tion  o f prim ary pyrex ia  i s  no t re la te d  to the  type 
o f in fe c tin g  pneumococcus o r  to  the  day o f i l l n e s s  a t  the tim e o f 
admission to  h o s p ita l . Thus su lphapyrid ine i s  equally  e f fe c t iv e  
whether the  cases a re  tre a te d  e t  an ea rly  o r a l a t e  stage o f  the  
i l ln e s s -  as f a r  a s  the  reduc tion  o f py rex ia  i s  concerned.
C. The r e s u l t s  o f therapy as gauged by the  occurr ence o f the 
Com plications o f  pneumonia.
( a) Delayed R esolution:
Delayed re so lu tio n  was said  to occur i f  th e re  was evidence o f
%
co n so lid a tio n  th re e  weeks from the  onset* o f  the  pneumonia. In  such •
cases th e re  were p h y sica l signs o f a v a ria b le  amount o f  co n so lid a tio n
and o ccasio n a lly  th e re  were general m an ife s ta tio n s  such as py rex ia .
The inc idence  o f delayed re so lu tio n  among the  342 p a tie n ts  who
recovered i s  shown in  Table XXXII.
Table XXXII.
Pneumococcal Lobar Pneumonia:
The number and percentage o f cases e x h ib itin g  delayed re so lu tio n  
among in d iv id u a l and a l l  types.
Type No. o f Cases.
No. w ith Delayed 
R eso lu tion . .
Percentage w ith 
Delayed R eso lu tion .
I 82 17 20.8
I I 112 24 21.4
I I I 17 4 23.6
Gp.IV 13L 16 12 .2
All types 342 61 17.8
Study o f  Table XXXII shows th a t  the  incidence o f delayed re so lu tio n  
among the  342 p a tie n ts  who recovered was f a i r ly  high (17.8  p e r c e n t .) ,  
and indeed the f ig u re  was h igher than th a t  ob ta ined  in  pre-chem otherapeutic 
days. Among in d iv id u a l types i t  w ill  be seen th a t  th e re  was p r a c t ic a l ly  
no d iffe ren c e  in  the  inc idence  o f  delayed re so lu tio n  among the  f i r s t
th re e  types. Group IV cases, which were m ilder in fe c tio n s  c l in ic a l ly ,  
had a S lig h tly  lower inc idence  o f delayed re so lu tio n .
In  view o f th e  r e la t iv e  frequency o f delayed re so lu tio n  in  cases o f 
pneumonia tr e a te d  with sulphonamides, i t  was decided to  make a 
complete a n a ly s is  o f those fa c to rs  which might favour i t s  occurrence. 
I t  has already  been shown th a t  the type o f  in fe c t in g  pneumococcus 
does no t appreciab ly  a f f e c t  i t s  development. Bacteraem ic cases 
were th e re fo re  s tu d ied  to no te  i f  a blood stream in fe c tio n  in  any 
way favoured the  development o f delayed re so lu tio n .
Table  XXXIII.
Pneumococcal Lobar Pneumonia:
The occurrence o f delayed re so lu tio n  among in d iv id u a l end a l l  types 
in  bacteraem ic and non-bacteraem ic cases in  p a tie n ts  who recovered.
Types Bacteraemic Cases Non-Bacteraemic CasesAll Cases Delayed R esolution All Cases Delayed R esolution
I 8 4 74 13
I I 27 8 . 85 16
I I I 0 0 17 4
Gp.IV 9 3 122 13
All types 44 15 298 46
Study o f  Table XXXIII shows th a t  15, o r 34 p e r cen t, o f th e  44 bacteraem ic 
cases who recovered developed delayed re so lu tio n , and only 46, o r  15 
p e r  cen t, o f  the 298 non-bacteraem ic cases who recovered developed th i s  
com plication. The percen tage d iffe ren c e  (19) has a standard  e r ro r  o f 
+ 7«5 th e  d iffe ren ce  i s  s ig n if ic a n t.
The e f f e c t  o f the  age and sex o f the  p a t ie n t ,  and o f  th e  ex ten t o f 
pulmonary involvement and o f the  day o f i l l n e s s  a t  the time o f  in s t i tu t io n  
o f  trea tm en t on the  inc idence  o f delayed re so lu tio n  were a sc e rta in ed  as 
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Study o f Table XXXIV shows th a t  th e  age o f  the  p a t ie n t  was found to 
in flu en c e  the  inc idence  o f delayed re so lu tio n . Thus 15 p e r  cen t, o f  the 
264 p a t ie n ts  under 50 y ears  o f age had delayed re so lu tio n , end 27 p e r 
cen t, o f th e  78 p a t ie n ts  over 50 years  o f age had th i s  com plication.
The percen tage  d iffe ren c e  (12) has a standard  e rro r  o f  + J . J  so the 
d iffe re n c e  i s  s ig n if ic a n t .
No appreciab le  d iffe re n c e  in  the inc idence  o f delayed re so lu tio n  was 
observed in  the sexes, 19 p e r cent, o f males and 16 p e r cen t, o f  fem ales 
having the  com plication. Among the 267 cases who had only one lobe 
involved , 12 p e r cen t, developed delayed re so lu tio n , and among 75 cases 
w ith more than one lobe  involved , 39 p er cen t, developed delayed re so lu tio n . 
The percen tage d iffe ren ce  (27) has a standard  e r ro r  o f + 5*9 so the 
d iffe ren c e  i s  s ig n if ic a n t.
Comparison of the inc idence  o f delayed re so lu tio n  in  cases tre a te d  
ea r ly  (w ith in  the  f i r s t  th re e  days o f i l ln e s s )  and cases t r e a te d  l a t e  ( a f te r  
the  th ir d  dsy o f  i l ln e s s )  gave ra th e r  in te r e s t in g  r e s u l t s .  Delayed 
re so lu tio n  was p re sen t in  8 p e r cen t, o f the I 30 cases tre a te d  ea rly  in  
i l l n e s s ,  and in  26 p e r cent, o f th e  197 cases tre a te d  l a t e  in  i l ln e s s .
This d iffe re n c e  (18) has a standard  e rro r  o f  ± 3*9 so the d iffe re n c e  i s  
s ig n if ic a n t .
I t  i s  thus seen th a t advancing age, spread o f the  d isease  to more 
than one lo b e , and l a t e  trea tm en t a l l  tend to  favour the  occurrence o f 
delayed re so lu tio n .
The r e s u l t s  ob tained  from a rad iog raph ic  study o f th e  
p ro g ress  o f l o ba r  pneumonia when t re a te d  by su lp h ap y rid in e.
At th i s  p o in t I may conveniently  d esc rib e  the r e s u l t s  
which were ob tained  in  215 p a t ie n ts  who had rad iographs 
taken a t  some period  during the course o f the  i l l n e s s .  
U nfortunate ly , a p o rta b le  X-ray apparatus was no t 
a v a ila b le  and the  p a t ie n ts  had to be tra n s fe r re d  from 
t h e i r  wards to  a sep ara te  to iild ing  before radiographs 
could be ob tained , so the  p rogress o f the  spread o f 
th e  conso lida tion  in  the  early  stages could th e re fo re  
n o t be s tud ied .
The re s u l ts  o f Davies, Hodgson and Whitby (1935) 
show c le a r ly  th a t  v a r ia tio n  in  the  manner o f spread 
occurs among in fe c tio n s  due to the various types. Thus 
in  Types I  and I I  th e  conso lidation  u su a lly  spreads from 
th e  hilum to the perip h ery , while in  Type I I I  and Group 
IV  in fe c tio n s  the spread i s  u su a lly  in  the rev erse  d ire c tio n . 
These workers noted th a t  the co n so lid a tio n  g en era lly  
reached i t s  maximum about the seventh day o f i l l n e s s  end 
then re so lu tio n  occurred with a le sse n in g  in  the d en sity  
o f th e  rad iograph ic  shadow. The ra te  o f  re so lu tio n  was 
found to  depend on the  ex ten t o f  the  conso lida tion  and 
on i t s  den sity . Types I  and I I  were o ften  a sso c ia ted  
w ith  w ell marked signs o f conso lidation  and w ith dense 
opacity  o f the rad iographs, and in  Type I I  in fe c tio n s  
re so lu tio n  was o ften  followed by s l ig h t  in c re a se  in  the  
d en s ity  and ex ten t o f the  pulmonary s t r i a e .  The /
The radiographs o f iny own p a t ie n ts  were taken about 
th e  end o f  the  f i r s t  week in  h o s p ita l ,  by which tim e 
th e  co n so lid a tio n  would probably e i th e r  have reached 
i t s  maximum ex ten t o r re so lu tio n  would have commenced. 
The r e s u l t s  w ill ,  however, show th e  degree o f 
co n so lid a tio n  which was p re sen t among in fe c tio n s  due 
to  the  various types.
Table XXXV.
Pneumococcal Lobar Pneumonia:
The ra d io lo g ic a l fin d in g s  o f 215 p a t ie n ts  X-rayed 
a t  about the  end o f the  f i r s t  week in  h o sp ita l.
ty p e
No. o f 
Cases.
No abnorm ality 
D etected.
S lig h t
conso lida tion  
o r  p le u ra l 
th icken ing .
Marked
consol­






I 56 5 15 29 3 4
I I 62 9 16 5L 4 2
I I I 13 0 7 ■5 1 0
G p.IV 84 19
. . J 7 _ .  .  ,
23 3 2
Study o f Table XXXV shows th a t  co n so lida tion  tended to be
more marked in  in fe c tio n s  due to Types I  and I I  than 
in  those due to  Type I I I  and Group IV. In  e ig h t 
cases pulmonary d isease  o th e r than th a t  due to the 
p re sen t i l ln e s s  was detec ted . Six o f these  cases had 
pulmonary tu b e rc u lo s is , one had sarcomatous d ep o sits  
in  th e  lungs, and th e  o th e r had b ro n ch iec ta s is .
Conclusion to be drawn from the rad iograph ic  study o f 
th e  p rogress o f lo b a r  pneumonia when tre a te d  by 
sulphapyridine?
I t  should be noted th a t  the radiographs were ob tained  
a t  d if f e r e n t  s tages o f the i l l n e s s .  The f ig u re s  /
f ig u re s  obtained  show th a t  in fe c t io n s  due to 
Types I  and I I ,  which as a ru le  a re  severe 
c l in ic a l ly  with marked signs o f co n so lid a tio n , 
have ra d io lo g ic a l evidence o f more marked 
con so lid a tio n  than in fe c tio n s  due to Group IVj 
and in  such types delayed re so lu tio n  i s  most 
freq u en tly  encountered.
(b) S te r i le  P le u ra l e ffu sio n .
The d iagnosis o f a p le u ra l e ffu sion  re s ted  on th e  dem onstration o f  
evidence o f f lu id  hy physica l signs, by X -rays, and by th e  withdrawal o f  
some f lu id  by a sp ira tio n . Doubtless many cases o f p le u ra l  e ffu sion  are  
m issed c l in ic a l ly  and commonly the amount o f f lu id  p re se n t i s  so small as 
to  render i t s  d e tec tio n  o f no p a r t ic u la r  im portance. The inc idence  o f 
s t e r i l e  p le u ra l e ffu sion  among Types I ,  I I ,  I I I  and Group IV i s  shown 
in  Table XXXVI.
Table XXXVI.
Pneumococcal Lobar Pneumonia;
The inc idence  o f s t e r i l e  p le u ra l e ffu sio n  among in d iv id u a l and a l l  types.
Type No. o f  Cases.
No. w ith 
E ffusion .
Percentage w ith 
E ffusion.
I 87 3 3-5
I I 123 5 3-9
I I I 18 1 5.5




Study o f  Table XXXVI shows th a t  the incidence o f s t e r i l e  e ffu sio n  was ju s t  
over 3 p e r cen t, in  a l l  cases. There i s  p ra c t ic a l ly  no d iffe ren c e  in  the  
type inc idence  although, as in  the  case o f delayed re so lu tio n , th e re  were 
fewer cases w ith s t e r i l e  effu sion  among Group IV in fe c t io n s  than among /
115-
among the  o th e r ty p es. The number o f cases w ith  s t e r i l e  e ffu s io n  i s  
too small to perm it o f a c o rre la tio n  w ith f a c to rs  such as bacteraem ia, 
e x ten t o f pulmonary involvem ent, and the  day o f il ln e s s ,w h ic h  was p o ss ib le  
in  those having delayed re so lu tio n .
None o f the  12 p a t ie n ts  who had s t e r i l e  p le u ra l e ffu sio n  d ied .
(c )  Empyema.
The d iag n o sis  o f empyema re s te d  on the dem onstration o f  f lu id  as in  
th e  case o f s t e r i l e  p le u ra l e ffu s io n , and on th e  presence o f pus c e l l s  
and pneumococci in  the  f lu id  obtained  by a s p ira tio n . The in c id en ce  o f 
empyema among the  various types i s  shown in  Table XXXVII .
Table XXXVII.
Pneumococcal Lobar Pneumonia:
The inc idence  o f empyema among in d iv id u a l and a l l  types.





I 87 4 4 .6
I I 128 2 1 .6
I I I 18 0 0 .0
Gp. IV 137 0 0 .0
A ll types 370 6 1 .6
Study o f Table XXXVII shows th a t  s ix  cases o f empyema were p re sen t in  the  
s e r ie s ,  fou r being Type I in fe c tio n s  and two Type I I  in fe c t io n s . In  one 
Type I  in fe c tio n  I  was unable to i s o la te  pneumococci from the chest f lu id  
a f t e r  repeated  a ttem pts to c u ltu re  the organism on chocolate  agar. Type I
pneumococci were, however, is o la te d  from both the  sputum and blood o f th is  
case so th a t organism was undoubtedly causative  o f the  d isea se , a lthough i t  
could no t be is o la te d  from the pus a sp ira te d  from the  chest. Such a case 
can ju s t i f i a b ly  be c a lled  an empyema in  sp ite  o f the  s t e r i l e  chest f lu id .
I l6 .
In  a l l  o th e r cases th e  organism is o la te d  from the  ch est f lu id  corresponded 
w ith th a t  ob tained  from the  sputum.
Paterson  (1922) rep o rted  a seasonal v a r ia tio n  in  the  inc idence  o f 
empyema which was found to be more p rev a len t in  sp ring  and w in ter than 
in  summer o r autumn. I t  i s  a lso  rep o rted  as being commoner in  m ales than 
in  fem ales, and under the  age o f  50 years  than above th is  age. The p re sen t 
s e r ie s  i s  small h i t  i t  should be noted th a t  a l l  s ix  cases occurred in  
m ales under 50 y ears  o f age.
There were two deaths among the  s ix  p a t ie n ts  w ith empyema, tu t  
the  cause o f death  was no t a t t r ib u ta b le  to the empyema. One o f the  deaths 
occurred in  a p a t ie n t  with sarcomatous d ep o sits  in  the lung , and the  
o th e r  died  o f acute in te s t in a l  o b s tru c tio n .
(d) M eningitis.
Two cases o f m en ing itis  occurred in  the s e r ie s .  One was a male
p a t ie n t  63 years  o f  age who had a Type XII pneumonia, and the  o th e r was
a female p a tie n t  aged 45 years  who had a Type I I  pneumonia w ith
bacteraem ia. D espite in te n s iv e  trea tm en t, both esses succumbed.
Conclusion to be drawn from a study o f the r e s u l ts  o f therapy as 
gauged by the  occurrence o f the com plications o f  pneumonia?
Delayed re so lu tio n  i s  the most freq u en tly  encountered com plication 
o f  lo b a r  pneumonia. Admittedly i t  i s  no t so Serious as the  o th e r 
com plications, but i t  i s  n ev e rth e le ss  a com plication which re q u ire s  
in v e s t ig a tio n . The presence o f bacteraem ia and advancing age tend to 
favour i t s  development. Also the ex ten t o f th e  pulmonary le s io n  and the  
day o f i l ln e s s  a t  the  time o f admission to h o sp ita l in flu en ce  i t s  
occurrence, as i t  i s  le s s  freq u en tly  encountered in  cases w ith only one
lo b e  involved than in  those w ith more ex tensive involvem ent and in  cases 
t re a te d  ea rly  compared w ith those tre a te d  l a t e  in  i l ln e s s .
S te r i le  p le u ra l  e ffu sion  i s  no t a common com plica tion ,occu rring  
in  only  3 p e r cen t, o f  cases. The presence o f a s t e r i l e  p le u ra l  
e ffu s io n  does n o t d im inish  the  chance o f  recovery.
Bnpyema i s  encountered s l ig h t ly  l e s s  freq u en tly  than s t e r i l e  
p le u ra l  e ffu sio n . I t  i s  most l ik e ly  to  occur in  Type I  in fe c t io n s , 
e sp e c ia lly  in  males under 50 years  o f  age. Although the  u ltim a te  
is su e  in  a case o f  empyema i s  good, th e  p e riod  o f  s tay  in  h o sp ita l 
i s  g re a tly  lengthened.
Pneumococcal m en in g itis  i s  ra re  but d e sp ite  in te n s iv e  therapy i s  
l ik e ly  to  be a sso c ia ted  w ith a f a ta l  is su e .
I I 8 .
D. The r e s u l t s  o b ta in ed in  6i cases re c e iv in g  Sulphapyridine 
and Vaccine Therapy,
The to ta l  number o f cases s tud ied  was 373 and th i s  in c lu d es  61 cases 
who, in  ad d itio n  to su lphapyrid ine, rece ived  pneumococcus vaccine.
In Chapter I I  (page49 ) * s ta te d  my reasons fo r  adopting th i s  form o f  
therapy . The number o f cases tre a te d  by combined chemotherapy and 
vaccine therapy was u n fo rtu n a te ly  sm all. In  o rder to estim ate  the 
e ff ic a c y  o f  th i s  mode o f trea tm ent, cases rece iv in g  vaccine therapy 
( t r e a te d  group) were compared with cases who received  su lphapyrid ine 
along (c o n tro l group). As the type o f in fe c t in g  pneumococcus i s  
perhaps the  most im portan t s in g le  fa c to r  in  p rognosis, i t  was decided 
th a t  the  cases would be chosen by p u ttin g  a l te rn a te  in fe c t io n s  due 
to  Types I ,  I I ,  I I I  and Group IV in  the  tre a te d  group and in  the  
co n tro l group.
The d is tr ib u tio n  o f the  cases among in d iv id u a l types in  the 
tre a te d  and con tro l groups i s  shown in  Table XXXVIII.
Table XXXVIII.
Pneumococcal Lobar Pneumonia:
The number o f cases o f Types I ,  I I ,  I I I  and Group IV in  the 
tr e a te d  and con tro l groups,
Type Treated group. Control group.
I 17 17
I I 22 22
I I I 5 5
Gp.IV 17 17
A ll types 61 a
From Table XXXVIII th e  percentage o f  cases due to Types I ,  I I ,  I I I  and
Group IV were found to be 28, 38, 8 and 28 re sp e c tiv e ly , th i s  d is t r ib u t io n  
being very s im ila r  to  th a t  o f the s e r ie s .
119.
The presence o r absence o f  bacteraem ia was shown to in flu en c e  very
markedly the  p rognosis, so the  inc idence  o f bacteraem ia among Types I ,
/
I I ,  I I I  and Group IV in  the tre a te d  and co n tro l groups was a sc e r ta in e d .
Table XXXIX.
Pneumococcal Lobar Pneumonia:
The inc idence  o f bacteraem ia in  the  tre a te d  and co n tro l groups.
TYPE







Wi thou t 
Bacteraem ia
5 I 2 15 4 13
‘ I? 9 13 7 15 1
I I I 0 5 0 5
Gp. i v 2 15 1 16
All types 13 48 1 2 49
Study o f Table XXXIX shows th a t  the inc idence  o f bacteraem ia in  the 
tr e a te d  group was 27 p e r cent, and in  the  con tro l group 25 p er cent.
The age d is t r ib u tio n  in  the  tre a te d  and con tro l groups was 
n ex t considered.
Table XL.
Pneumococcal Lobar Pneumonia:
The number o f cases under and over 50 years  o f age in  the 
t r e a te d  and con tro l groups.
TYPE Treated Group. Control GroupUnder 50 y ears Over 50 years Under 50 y ears Over 50 y ears
I 13 4 14 3
I I 18 4 16 6
I I I 2 3 2 3
Gp.IV 13 4 1 2 5
A ll types 46 15 _..........1 44 17
Study o f  Table XL shows th a t  25 p e r cen t, o f the cases in  the  t re a te d  group 
and 28 p e r  cen t, o f  those in  the  co n tro l group were lo v e r  the age o f 
50 y ears .
The sex d is t r ib u t io n  o f the  cases was nex t analysed. 120.
Table XLI.
Pneumococcal Lobar Pneumonia:
The number o f m ales and fem ales in  the  tre a te d  and co n tro l groups.
TYPE Treated Group Control GroupMales Females Males Females
I 15 2 15 2
I I 19 3 17 5
I I I 3 2 3 2
Gp.IV 11 6 11 6
A ll types 48 13 46 15
Study o f  Table XLI shows th a t  78 p er cen t, o f the cases in  the  tre a te d  
group and 75 Pe r cent, in  the  con tro l group were males.
I t  i s  thus seen th a t  by adopting the  type o f the  in fe c tin g  
pneuraococcus as the  b a s is  fo r  s e le c tin g  the cases, the  inc idence  o f 
bacteraem ia, the age d is t r ib u tio n , and the  sex d is t r ib u t io n  in  both 
th e  tre a te d  and the  con tro l groups was very s im ila r . At the same tim e, 
i t  w ill  be seen th a t  d i f f ic u l ty  i s  encountered in  o b ta in in g  an even 
d is t r ib u t io n  o f the cases in  the tre a te d  and con tro l groups as f a r  as 
p ro g n o stic  fa c to rs  a re  concerned. Thus in  the  tre a te d  group 3 
Type I I  in fe c tio n s  had bacteraem ia, while in  the  con tro l group only 7 
Type I I  in fe c tio n s  had bacteraem ia. The presence o f these  ad d itio n a l 
Type I I  cases in  the  tre a te d  group w ill tend to a f fe c t  unfavourably the  
r e s u l ts  in  th i s  group. Advancing age i s  a lso  an unfavourable p rognostic
fa c to r  and the  presence o f two a d d itio n a l p a t ie n ts  over 50 years  o f age in  
th e  con tro l group w ill tend to a f f e c t  unfavourably the  r e s u l ts  in  th i s  
group. Although d i f f i c u l t i e s  are encountered i t  w ill  be seen th a t  on the
whole by adopting the  type of in fe c tin g  pneumococcus as the  b asis  fo r
s e le c tin g  the cases, a f a i r ly  even d is tr ib u tio n  was obtained  as regards 
f a c to rs  o f p rognostic  s ig n ific an ce .
I t  was nex t decided to analyse  the  response to therapy as gaugedby
th e  f a t a l i t y  r a te ,  the  f a l l  in  py rex ia , and th e  occurrence o f the
com plications o f pneumonia in  the  tre a te d  and the  con tro l groups. As
Wynn (1936) po in ted  o u t  the im portance o f t r e a t in g  the  p a t i e n t s 'a s
e a r ly  as p o ss ib le  w ith vaccine therapy , i t  was considered adv isab le  in
analysing  the cases to take in to  account whether trea tm en t commenced
w ith in  the f i r s t  th re e  days o f i l l n e s s  o r a f te r  th is  tim e.
(a) The f a t a l i t y  r a te  in  the tre a te d  and co n tro l groups.
The number o f cases and number o f deaths occurring  among Types I ,  I I ,  I I I
and Group IV i s  shown in  Table XLII.
Table XLII.
Pneumococcal Lobar Pneumonia;
The number o f cases and number o f deaths in  the  tre a te d  and con tro l groups.
TYPE Treated Group Control Grouo
No. o f cases N o.of deaths No.of cases No.of deaths
I 17 0 17 2
I I 22 1 22 3
I I I 5 0 5 1
Gp. IV 17 1 17 1
A ll types 61 • 2 a 7
Study o f Table XLII shows th a t  two deaths occurred in  the  tre a te d  group, 
g iving a f a t a l i t y  r a te  o f  3*3 Pe r c o a t., and seven deaths occurred  in  the 
co n tro l group, g iving a f a t a l i t y  r a te  o f  11 .5  p e r cen t. Excluding deaths 
occurring  w ithin 24 hours o f  admission to h o s p ita l , the f ig u re s  were found 
to  be 1 .7  and 8 .5  per cen t, re sp ec tiv e ly .
122.
(b) The duration  o f prim ary py rex ia .
The d u ra tion  o f prim ary pyrex ia  in  the  tre a te d  and in  the  con tro l 
groups, th e  cases being d is tr ib u te d  according to whether trea tm en t 
commenced up to the th ir d  day of i l l n e s s  (e a r ly  cases) o r a f t e r  th e  
th i r d  day ( l a t e  cases) i s  shown in  Table XLIII.
Table XLIII.
Pneumococcal Lobar Pneumonia:
The d u ra tio n  o f primary pyrex ia  in  the  tre a te d  and co n tro l groups 
o f  cases who recovered.
Duration o f Pyrexia Treated Group Control Group,Early cases L ate cases ' Early cases Late cases
48 hours 9 19 11 12
96 » 16 6 8 16
144 " - 1 1 0
Mo e f fe c t 2 4 1 3
A febrile 0 _ l 2 1 2 °
Study o f  Table XLIII shows th a t  th e re  was very s l ig h t  d iffe ren c e  in  the
d u ra tio n  o f pyrexia in  the tre a te d  and in  the con tro l groups. Thus in  the
tre a te d  group 23 cases had a normal tem perature by 48 hours and 50 cases
by 96 hours. In  the con tro l group the f ig u re s  were 23 snd 47 re sp e c tiv e ly .
Table XLIII also  shows th a t no apparent advantage was gained by the
ad m in is tra tio n  o f vaccine during the f i r s t  th re e  days o f i l l n e s s .
(c) The com olications o f pneumonia which were encountered in  the 
tre a te d  and con tro l groups.
Table XLIV.
Pneumococcal Lobar Pneumonia:
?he com plications encountered in  the tre a te d  and con tro l groups.
Compli c a tio n s . Treated Group. Control Group.
Early cases Late cases Early cases L ate cases
Delayed R esolution 4 8 0 12
S te r i le  P leu ra l
Effusion 1 2 0 1
Einpyema 0 1 0 1
M eningitis 0 0 0 0
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Study o f  Table XLIV shows th a t  in  both the  tre a te d  and co n tro l groups
12 cases o f  delayed re so lu tio n  occurred; and even in  cases tre a te d  ea r ly
w ith  vaccine therapy th e re  were 4 cases o f delayed re so lu tio n . Three cases
o f  s t e r i l e  p le u ra l e ffu sio n  occurred in  the tre a te d  group and one in  the
co n tro l group, and one case o f empyema occurred in  both groups.
Conclusion to  be drawn from a study o f combined su lphapyrid ine and 
vaccine therapy :
D if f ic u lty  i s  experienced in  securing an even d is t r ib u t io n  o f the 
cases as regards fa c to rs  o f p rognostic  s ig n if ic a n ce  in  the tre a te d  and 
co n tro l groups, tort the type o f in fe c tin g  pneuraococcus i s  perhaps the 
most u se fu l fa c to r  fo r  s e le c tin g  the  cases.
In  th e  comparison o f the  f a t a l i t y  r a te s  one must n o t be m isled by 
the  apparen tly  lower f a t a l i t y  ra te  in  the  tre a te d  group compared with th a t  
in  the  co n tro l group. I t  should be noted th a t  th ree  o f the  cases in  the 
co n tro l group (Types I I ,  I I I  and VII) were extremely i l l  on admission to 
h o sp ita l and survived fo r  3> 811(1 3 days re sp e c tiv e ly . Recovery in  such
very i l l  p a t ie n ts  was n o t expected, and even i f  vaccine had been adm inistered 
in  such cases i t  i s  very doubtfu l i f  i t  would have in flu en ced  the  u ltim a te  
is su e . Excluding these th re e  cases then th e re  i s  l i t t l e  to choose between 
th e  two forms o f therapy.
The r e s u l t s  obtained c le a r ly  show th a t  vaccine therapy does n o t appear 
to shorten  the  duration  o f primary pyrexia , even i f  trea tm en t i s  in s t i tu te d  
during the  f i r s t  th ree  days o f  i l l n e s s .
Com plications o f lo b a r  pneumonia, delayed re so lu tio n , s t e r i l e  p le u ra l 
e ffu s io n , and ©npyema are a l l  encountered in  cases rece iv in g  vaccine therapy.
The r e s u l t s  o f vaccine therapy are fran k ly  d isappo in ting  and indeed 
no advantage appears to be derived from the  combination o f  chemotherapy 
and vaccine therapy.
There were tw en ty -e igh t deaths among the 370 cases o f  pneumococcal 
lo b a r  pneumonia, g iv ing  a f a t a l i t y  r a te  o f 7.5  p e r cen t. This f ig u re  
in c lu d es  cases who d ied  w ithin 24 hours o f admission to h o s p ita l ,  and 
chemotherapy in  such cases could n o t be regarded as v a lu e le ss  fo r  the 
p a t ie n ts  were p ra c t ic a l ly  moribund on admission and recovery was n o t 
expected. There were a lso  four deaths among p a t ie n ts  su ffe rin g  from 
a sso c ia te d  d isea se  as well as pneumonia and in  such cases the a sso c ia ted  
d isea se , and n o t the  pneumonia, was d ire c t ly  resp o n sib le  fo r  the  death. 
Making c o rre c tio n s  fo r  such fa c to r s ,  the fo llow ing f a t a l i t y  r a te s  a re  
' ob ta ined .
( i )  Exclusion o f deaths occurring  w ithin  24 hours o f admission 
to  h o sp ita l.
There were s ix  such deaths among the 28 f a ta l  cases. One o f  these 
cases was a Type I  in fe c tio n  who died 45 m inutes a f te r  adm ission. The 
f iv e  o th e rs  were Type I I  in fe c tio n s , th ree  occurring  in  males and two in  
fem ales. The du ra tion  in  h o sp ita l o f these cases varied  from 3 hours to 
22 hours. All these  s ix  cases had bacter'aem ia  on adm ission. Four o f the  
s ix  cases had two o r more lobes involved and f iv e  o f  the s ix  cases were 
f iv e  o r more days i l l  before admission to  h o s p ita l ,  thus in d ic a tin g  the  
p rognostic  s ig n ific an ce  o f the  ex ten t o f pulmonary involvement snd th e  
im portance o f commencing therapy ea r ly  in  the  i l l n e s s .  Excluding th ese  
s ix  cases who d ied  w ithin 24 hours o f admission to  h o s p ita l ,  the  co rrec ted  
f a t a l i t y  r a te  i s : -
Mo. o f Cases ^64, Deaths 22. F a ta l i ty  Rate 6 .0  p e r cen t.
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( i i )  Exclusion o f  cases dying o f  a sso c ia te d  d isease :
There were fo u r such p a t ie n ts .  Two o f  them d ied  suddenly o f  card io ­
v a sc u la r  d ise a se . A male p a t ie n t  (Type I I  in fe c tio n )  who had m yocard itis  
and a u r ic u la r  f i b r i l l a t i o n  d ied  o f  c e reb ra l embolism; w hile a female 
p a t ie n t  (a lso  a Type I I  in fe c tio n )  had on th e  fo u rth  day in  h o s p ita l  
a severe haemorrhage, which was subsequently  shown a t  post-mortem examination 
to  have been caused by the  ru p tu re  o f  a d is s e c t in g  aneurysm o f  th e  a o rta .
The o th e r  two cases d ied  a f t e r  more than th i r t y  days in  h o s p ita l .  Both 
were Type I  in f e c t io n s  who developed empyema. One p a t ie n t  had had h is  
l e f t  arm amputated on account o f osteogen ic  sarcoma and he now had m u ltip le  
secondary d e p o s its  in  both lu n g s . Death in  th i s  case was from m alignant 
toxaem ia, as th e  ch est was f r e e  from pus, and th e  pneumonic co n so lid a tio n  
was re so lv in g . The o th e r  p a t ie n t  had a sm all encysted r ig h t  basa l 
empyema. Closed drainage was e s ta b lish e d  and he was p ro g ressin g  
s a t i s f a c to r i ly .  He then developed acu te  abdominal pain  and became d istended  
and vomited f re q u e n tly . Duodenal in tu b a tio n  was i n s t i tu te d ,  and the  
p a t ie n t  was given in travenous s a l in e s .  In  s p i te  o f th i s  th e  p a t i e n t ’ s 
cond ition  d e te r io ra te d  and he d ied . A post-mortem exam ination revealed  
an o b s tru c tio n  o f the  sm all bowel due to  f ib ro u s  adhesions. These 
p a t ie n ts  obviously  died  o f th e  a sso c ia te d  co n d itio n  and n o t o f the  pneumonia. 
Excluding th ese  fo u r cases who d ied  from a sso c ia te d  d ise a se , th e  co rrec ted  
f a t a l i t y  r a te  i s : -
Mo. o f  Cases 3^0* No. o f  Deaths 18. F a ta l i ty  Rate 5*0 Pe r cen t. 
This i s  th e  tru e  f a t a l i t y  r a te  among p a t ie n ts  su ffe r in g  from pneumo­
coccal lo b a r  pneumonia, in  whom recovery  might be expected. In  th e se  
e igh teen  d ea th s , th e  cause was d i r e c t ly  a t t r ib u ta b le  to  th e  pneumonia, and 
chemotherapy f a i le d  to  bring  about recovery .
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In  two o f  th e se  cases m en in g itis  developed and th i s ,  r a th e r  than 
th e  pneumonia, was th e  u ltim a te  prim ary fa c to r  re sp o n sib le  fo r  death . 
The cause o f  death  in  the  o th e r s ix teen  cases was e i th e r  profound 
toxaemia o r  card iac  co llapse .
A b r ie f  h is to ry  o f the  tw en ty -e igh t deaths w ill  be given, a f t e r  
which a summary o f the  autopsy f in d in g s  o f n ine  cases in  which p o s t­
mortem examination was granted w ill  be included.
Case No. 1.
Age 49 y rs .  Sex Male. Date o f  admission 26.11.41.
Sputum n o t o b ta in ab le . Blood c u ltu re  p o s i t iv e  (Type I ) .
Day o f i l l n e s s .  6th .
Extent o f pulmonary involvement ;  Whole o f r ig h t  lung ( th re e  lo b e s) . 
B rie f h is to ry ; On admission to  h o sp ita l th i s  p a t ie n t  was comatose 
and p ra c t ic a l ly  moribund. The tongue was dry, fu rred  and f is su re d .
Toxaemia was marked. A lung puncture y ie lded  Type I  pneumococci.
Death occurred a f te r  45 minutes in  h o sp ita l.
Case No. 2. (See Post-Mortem Summary),
Age “52 y rs . Sex Male. Date o f admission 29. 3 .41 .
Sputum Type I .  Blood c u ltu re  s t e r i l e .
Day o f i l l n e s s .  6th .
Extent o f  pulmonary involvem ent: L e ft lower lobe  (one lo b e ) .
B rie f h is to ry : On admission th i s  p a t ie n t  was noted as being acu te ly  i l l .
The tongue was dry, fu rred  and f is su re d . Toxaemia was o f  moderate degree. 
Marked dulness was noted a t  the l e f t  base, and th e  tem perature f a i le d  to  
s e t t l e .  On 4 .4 .41 , pus containing Type I  pneumococci was a sp ira te d  from 
th e  ch es t. Closed drainage was then in s t i tu te d .
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This p a t ie n t  has had h is  l e f t  arm amputated 19 months p rev io u sly  on 
account o f  osteogenic sarcoma o f th e  humerus. An X-ray o f  th e  chest 
revealed  the  presence o f  b i la te r a l  sarcomatous d e p o s its . His general 
cond ition  d e te r io ra te d  and he died  on 4 .5 .4 1 , a f t e r  37 days in  h o s p ita l .
Case No. (See Post-Mortem Summary).
Age 58 y rs . Sex Male. Date o f admission 20.3*41*
Sputum Type I .  Blood c u ltu re  s t e r i l e .
Day o f i l l n e s s  6 th .
Extent o f  pplmnnarv Involvement: Right low er lobe (one lo b e ) .
B rie f h is to ry : The p a tie n t  was only m oderately i l l ,  su ffe r in g  from a
r ig h t  basal pneumonia. His tem perature had s e t t le d  and he was allowed up 
although s l ig h t  dulness p e rs is te d  a t  the r ig h t  base. An X-ray examination, 
however, revealed  a lo c a lis e d  c o lle c tio n  o f f lu id  a t  the base. On 
a sp ira tio n , pus contain ing Type I  pneumococci was obtained . In te rc o s ta l  
drainage was subsequently e s ta b lish e d . He was p rogressing  s a t i s f a c to r i ly  
u n t i l  19 .4 .41  when he complained o f abdominal p a in . Marked abdominal 
d is ten sio n  was noted and the  p a t ie n t  vomited freq u en tly . Duodenal 
in tu b a tio n  was in s t i tu te d  and in travenous s a lin e s  were adm in istered . His 
general condition  d e te r io ra te d  and he died on 23*4.41 o f in te s t in a l  
o b s tru c tio n , 34 days a f te r  admission to  h o sp ita l.
Case No. 4.
Age 34 y rs . Sex Male. Date o f  admission 20 .1 .42 .
Sputum Type I .  Blood c u ltu re  s t e r i l e .
Day o f  i l l n e s s  4 th .
Extent o f  pulmonary involvement: L e ft lung and R ight Lower lobe
(th re e  lo b e s) .
128.
B rie f  h is to ry : The p a tie n t  was only m oderately i l l  on adm ission, and
th e re  was s l ig h t  conso lida tion  a t  th e  l e f t  base. The tem perature remained 
u n s e tt le d  and th e re  was no improvement in  the  p a tien t*  s general co n d itio n . 
He became very to x ic , being q u ite  d e l ir io u s  and p e rsp ir in g  f re e ly  a t  n ig h ts . 
The l e f t  lower lobe c lea red , but the  p a t ie n t  remained d esp e ra te ly  i l l .
S lig h t dulness was however noted a t  the  r ig h t  base, where the  re s p ira to ry  
murmur was dim inished and there  were c re p ita t io n s .
There was no evidence o f meningeal i r r i t a t i o n ,  and lumbar phncture 
revealed  a normal cerebrosp inal f lu id . The h e a r t was abso lu te ly  normal. 
Abdominal d is ten sio n  was f i r s t  observed on 4 .2 .4 2 . The tongue remained 
dry and fu rred . The spleen was n o t pa lp ab le . A gglu tination  t e s t s  were 
n eg a tiv e  fo r  B ac illu s  typhosus, B ac illu s  paratyphosus B, and B ac illu s  
Abortus. Urine and faeces on examination fo r the e n te r ic  group y ie ld ed  
neg a tiv e  r e s u l ts .  A blood c u ltu re  was s t e r i l e .  The leucocy te  count 
was 14,000 p er cubic m.m., and the e ry th ro cy te  count was 4,000,000 per 
cubic m.m. The abdominal d is ten sio n  became more marked and th e re  was 
some gen era lised  tenderness. Abdominal p a racen te s is  y ie ld ed  no f lu id .
The c l in ic a l  appearances were those o f e i th e r  pneumococcal p e r i to n i t i s  
o r  tuberculous p e r i to n i t i s .
Marked dulness was then detec ted  a t  the r ig h t  base. On a s p ira tio n ,
50 c .c s .  o f yellow ish f lu id  were ob tained . No organisms were found on 
d i r e c t  examination o r on cu ltu re . The p a t i e n t 's  general condition  
d e te r io ra te d  and he died 29 days a f te r  admission to  h o sp ita l. Before 
death  th e re  was patchy conso lidation  o f the  l e f t  upper lobe . The cause o f 
death  in  th i s  case remains u n ce rta in , but the  toxaemia and excessive 
p e rsp ir in g  a re  suggestive o f the condition  being tubercu lous in  o r ig in . 
Perm ission fo r  autopsy was u n fo rtu n a te ly  refused  in  th is  case.
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Case No. 5.
Age 47 y rs . Sex Male. 
Sputum Type I I .
Date o f  adm ission 27.6 .41.
Blood c u ltu re  p o s i t iv e  (Type I I ) .
Day o f i l l n e s s .  3rd,
Extent o f pulmonary involvement; B ight middle and lower lo b es  (two lo b e s) . 
B rie f  h is to ry : The p a tie n t was adm itted to h o sp ita l p r a c t ic a l ly  moribund.
The tongue was dry, fu rred  and f is su re d . Toxaemia was marked and th e  
p a t ie n t  was q u ite  d e l ir io u s . The h e a r t sounds were s o f t  and th e  pu lse  
im p ercep tib le . No signs o f improvement occurred , and the p a tie n t  died  
a f t e r  3 days in  hospital*
Note th i s  p a tie n t  su ffe red  from lo b a r  pneumonia (Type V III) two months 
p rev io u s ly .
Case No. 6.
Age 52 y rs . Sex Male. Date o f admission 1 4 .1 .4 1 .
Sputum Type I I .  Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f  i l l n e s s . 8 th .
Extent o f pulmonary involvement: L e ft lower lobe and r ig h t  lower lobe
B rie f h is to ry : The p a t ie n t  was very acu te ly  i l l .  The tongue was dry ,
fu rred  and f is su re d , and toxaemia was marked. The h e a r t sounds were o f poor 
q u a lity  and a u ric u la r  f i b r i l l a t i o n  was p re sen t. The pneumonic process was
B rie f h is to ry : The p a tie n t  was very acu te ly  i l l  on adm ission, and th e re
(two lo b e s) .
re so lv in g  when death occurred on "5L.1.41 due to  cereb ra l embolism?atf«T
Case No. 7.
Age 41 y rs . Sex Male. 
Sputum Type I I .
Date o f admission 5. 3 .41 .
Blood c u ltu re  p o s i t iv e  (Type I I ) .
Day o f i l l n e s s .  5th.
Extent o f pulmonary involvement: L eft lower lobe  and r ig h t  lower lobe
(two lo b e s ) .
/
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th e re  was marked cyanosis and dyspnoea. The tongue was dry and fu rred , 
and toxaemia was marked. Death occurred, e ig h t days a f t e r  admission to 
h o s p ita l ,  from toxaemia.
Case No. 8 .
Age 53 y rs . Sex Male. Date o f  admission 10 .10 .41 .
Sputum n o t o b ta in ab le . Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f i l l n e s s .  2nd.
Extent o f pulmonary involvements L e ft lower lobe and r ig h t  middle and
low er lo b es  ( th re e  lo b e s ) .
B rie f h is to ry : The p a tie n t  was veiy acu te ly  i l l  and p r a c t ic a l ly  moribund
on admission to  h o s p ita l .  The tongue was dry , fu rred  and f is s u re d . Dyspnoea
and cyanosis were p re sen t, and toxaemia was profound. Death occurred a f t e r
3 hours in  h o sp ita l.
Case No. 9.
Age 52 y rs . Sex Male. Date o f admission 20 .1 .41 .
Sputum lype I I .  Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f i l l n e s s .  4 th .
Extent o f  pulmonary involvement: L e ft low er lobe and r ig h t  low er lobe
(two lo b e s) .
B rie f  h is to ry ; On admission th is  p a t ie n t  was acu te ly  i l l .  The tongue 
was fu rred  and dry, and toxaemia was marked. The h e a r t sounds were o f poor 
q u a li ty . Improvement was s l ig h t  and the  p a tie n t  co llapsed  and died a f t e r  
6 days in  h o sp ita l.
Case No. 10.
Age 52 y rs . Sex Male. Date o f admission 14 .3 .41 .
Sputum Type I I .  Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f  i l ln e s s .  4 th .
Extent o f pulmonary involvement: Bight low er lobe (one lo b e ) .
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B rie f  h is to ry : On admission to  h o sp ita l t h i s  p a t ie n t  was f a i r l y
acu te ly  i l l .  The tongue was fu rred  and d ry , th e re  was dyspnoea and 
cyanosis, and toxaemia was marked. The h e a r t sounds were o f  poor q u a lity  
and on 3Q.3*41 th e  p a t ie n t  co llapsed  and d ied ,a^e 'r in
Case No. 11.
Age 58 y rs . Sex Male. Date o f adm ission 29.3.41.
Sputum Type I I .  Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f  i l ln e s s  ^,rd.
Extent o f pulmonary involvement; Right lower lobe  (one lo b e ).
B rie f  h is to ry : The p a tie n t  was m oderately i l l  on adm ission, su ffe rin g
from s l ig h t  dyspnoea. Toxaemia was no t marked. There was tuberculous 
i n f i l t r a t i o n  o f the  l e f t  upper lobe  w ith c a v ita tio n  p re sen t. There was 
m yocard itis  w ith a u r ic u la r  f i b r i l l a t i o n  p re sen t. The p a tie n t  was very 
r e s t l e s s  and exhausted him self. He died on 5* 4.41, &c/o.i^ s W bosf>«W.
Case No. 12.
Age 46 y rs . Sex Male. Date o f  admission 15.3*41.
Sputum Type I I .  Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f i l l n e s s  6 th.
Eyt.ent o f pnlmnnary involvement; L e ft low er lobe  (one lo b e ) .
B rie f h is to ry : F a ir ly  acu te ly  i l l  on admission w ith s l ig h t  dyspnoea but
no cyanosis. The tongue was dry and fu rred , and toxaemia was marked. The 
h e a rt sounds were o f poor q u a lity  due to m yocard itis . The p a t ie n t  was 
para lysed  on the  l e f t  s id e , the  r e s u l t  o f a c e reb ra l haemorrhage th ree  
months p rev io u sly . No improvement occurred, and the p a tie n t  d ied  o f 
card iac  co llap se  on 20.3*41,
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Case No. 1*5.
Age 45 y rs .  Sex Male. Date o f  admission 29*6.41.
Sputum Type I I .  Blood c u ltu re  p o s i t iv e  (Type I I ) .
Day o f i l l n e s s  6 th .
E xten t o f pulmonary involvement: R ight low er lo b e  (one lo b e ).
B rie f  h is to ry : On admission th i s  p a t ie n t  was p r a c t ic a l ly  moribund. The
tongue was dry and fu rred , and toxaemia was profound. The sputum was o f  
the  "p ru ne-ju ice"  v a rie ty . Death occurred a f t e r  8 hours in  h o sp ita l.
Case No. 14. (See post-mortem summary).
Age 45 y r s .  Sex Male. Date o f admission 1 .12 .41 .
Sputum Type I I .  Blood c u ltu re  p o s it iv e  (Type I I ) ,
Day o f i l l n e s s  $th.
Extent o f pulmonary involvement: Right middle and lower lobes (two lobes)
B rie f  h is to ry : This p a tie n t  was very acu te ly  i l l  and p ra c t ic a l ly
moribund on admission. The tongue was dry, fu rred  and f is su re d . He was 
dyspnoeic and cyanosed. The pu lse  was im percep tib le . Death occurred 
a f t e r  21 hours in  h o sp ita l.
Case No. 15.
Age 65 y rs . Sex Male. Date o f admission 20.10.41.
Sputum Type I I I .  Blood c u ltu re  s t e r i l e .
Day o f i l l n e s s  2nd.
Extent o f pulmonary involvement: L e ft upper lobe (one lo b e ) .
B rie f h is to ry : This p a tie n t  was very acu te ly  i l l  on adm ission. The
tongue was dry and fu rred . There was s l ig h t  dyspnoea and cyanosis, and 
toxaemia was marked. The p a tie n t  was d e l ir io u s  a t  tim es. The h e a rt sounds 
were s o f t  and sometimes i r r e g u la r .  No improvement occurred in  s p ite  o f 
in travenous su lphapyrid ine, and death occurred a f t e r  1\  days in  h o sp ita l.
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Case No. 16. (See Post-Mortem Summary).
Age 61 y r s .  Sex Male. Date o f  admission 22 .6 .41 .
Sputum Type V III. Blood c u ltu re  s t e r i l e .
Day o f  i l l n e s s  8 th .
E xten t o f  pulmonary. Involvem ent: R ight m iddle and low er lo b es  (two lobes)
B rie f h is to ry : This p a t ie n t  was acu te ly  i l l  on admission w ith  dyspnoea
and marked cyanosis. The h e a rt was enlarged and the  sounds were o f poor 
q u a lity . No signs o f improvement were ev id en t, and he d ied o f  toxaemia 
a f t e r  3 days in  h o sp ita l.
Case No.
Age 51 y rs . Sex Male. Date o f admission 26.3*41.
Sputum Type VII. Blood c u ltu re  p o s it iv e  (Type V II).
Day o f  i l l n e s s  7bb.
Extent o f pulmonary involvement? L e ft lower lobe (one lo b e ) .
B rie f h is to ry : This p a tie n t  was f a i r ly  acu te ly  i l l  on adm ission, having
dyspnoea, cyanosis and marked toxaemia. The tem perature f e l l  to  normal very 
slowly. Any improvenent was s l ig h t .  The mouth was very d i r ty  and re te n tio n  
o f  s a liv a  in  th e  r ig h t  subm axillary gland occurred , though th e re  was no 
ca lcu lus pa lp ab le . Death occurred from card iac  co llap se  14 days a f te r  
admission to  h o sp ita l.
Case No. 18. (See Post-Mortem Summary).
Age 63 y rs . Sex Male. Date o f admission 13*3*41*
Sputum Type XII. Blood c u ltu re  s t e r i l e .
Day o f i l l n e s s  "^rd.
Extent o f  pulmonary involvement: Right lower lobe  (one lo b e ).
B rie f h is to ry : This p a tie n t was no t very i l l  on admission, but th e re  was
marked conso lidation  o f the r ig h t  lower lobe . The tem perature did n o t 
s e t t l e ,  the p a tie n t became r e s t le s s  and d e lir io u s , and h is  general condition  
d e te r io ra te d . No evidence o f meningeal i r r i t a t i o n  was p re sen t. Marked
/
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Marked trem ors occurred  on 6 ,4 .41  and a lumbar puncture  revealed  tu rb id  
f lu id  con tain ing  Type XII pneumococci. In  s p i te  o f  in travenous 
su lphapyrid ine, death  occurred a f t e r  26 days in  h o s p ita l .
Case No. 19.
Age 43 y rs . Sex Male. Date o f admission 12 .6 .41 .
Sputum Type X X II.. Blood c u ltu re  s t e r i l e .
Day o f i l l n e s s  4 th .
Extent o f pulmonary involvement; Whole o f r ig h t  lung ( th re e  lo b e s) . 
B rie f h is to ry : This p a t ie n t  was m oderately i l l  on adm ission. B reathing
was n o t d is tre s s e d  but s l ig h t  cyanosis was p re sen t. The p a tie n t  was gassed 
in  the  l a s t  War. He hadi a barre l-shaped  chest and chronic pulmonary 
f ib r o s is  was p re sen t. The p a tie n t was o f the  asthm atic  type. By th e  end 
o f the  f i r s t  week h is  tem perature had s e t t le d ,  but a spread occurred on the  
10th  day a f t e r  admission. His tem perature was s e t t l in g  when he co llapsed  
suddenly and died a f te r  22 days in  h o sp ita l.
Case No. 20.
Age 67 y rs . Sex Female. Date o f admission 18 .8 .41 .
Sputum Type I .  Blood c u ltu re  s t e r i l e .
Day o f  i l ln e s s  11th .
Extent o f pulmonary involvement: L e ft lung (two lo b e s ) .
B rie f h is to ry : This p a tie n t was f a i r l y  acu te ly  i l l  on adm ission, w ith
marked toxaemia. The tongue was dry, fu rred  and f is su re d . P a r o t i t i s  
developed on 24.8.41. A spread occurred to  th e  l e f t  upper lobe and the  
p a tie n t  became d e lir io u s . Death occurred on 3*9»41, from toxaem ia, ajfpxl^clo^s.
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Case No. 21.
Age 36 y rs . Sex Female. Date o f admission 23*7.41.
Sputum Type I I .  Blood c u l tu re .p o s i t iv e  (Type I I ) .
Day o f  i l ln e s s  3rd.
Extent o f  pulmonary involvem ent; L e ft lung  (two lo b e s) .
B rie f h is to ry : This p a tie n t  was m oderately i l l  on adm ission. She was
q u ite  d e l ir io u s  a t  tim es, the tongue was dry and fu rred , and toxaemia was 
marked. A spread occurred to the  l e f t  lower lobe  on 28 .7 .41 . The blood 
c u ltu re  remained p o s it iv e  u n t i l  death  on 3*8* 41?aj.ffr l2c(aijS in
Case No. 22.
Age 70 y rs . Sex Female. Date o f admission 23.8.41.
Sputum no t o b ta in ab le . Blood c u ltu re  p o s i t iv e  (Type I I ) .
Day o f i l l n e s s  5^h.
Extent o f pulmonary involvement: L e ft upper lobe  (one lo b e ).
B rie f  h is to ry : This p a tie n t was very acu te ly  i l l  on adm ission, w ith
marked delirium  and toxaemia. She was a poorly  developed woman w ith 
s c o lio s is  and kyphosis o f th e  sp ine. The h e a rt was enlarged and a s y s to lic  
a p ica l murmur p re sen t. Recovery was no t expected, death  occurring  w ithin 
22 hours o f admission to h o sp ita l.
Case No. 23. (See Post-Mortem Summary).
Agft 61 y rs . Sex Female. Date o f admission 7*1-42.
Sputum n o t o b ta in ab le . Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f i l l n e s s  8 th .
Fi-rt.pnt. o f  pulmonary involvement: Whole o f  r ig h t  lung  ( th re e  lo b e s) .
B rie f h is to ry : This p a tie n t  was p ra c t ic a l ly  moribund on adm ission. Her
tongue was dry, fu rred  and f is su re d . Toxaemia was marked. Death occurred 
a f t e r  6 hours in  h o sp ita l.
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Case No. 24.
Age 45 y rs . Sex Female. Date o f  admission 5*9*41.
Sputum no t o b ta in ab le . Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f i l l n e s s  4 th .
Extent o f pulmonary involvement: R ight lower lobe (one lo b e ).
B rie f h is to ry : This p a tie n t  was very acu te ly  i l l  w ith marked toxaemia
and de liriu m . There was head re tra c t io n  and nuchal r ig i d i ty ,  and K ernig1s 
sign was p o s i t iv e . Lumbar puncture revealed  tu rb id  f lu id  con tain ing  Type 
I I  pneumococci. The p a t ie n t  did no t respond to in travenous su lphapyrid ine 
and anti-pneumococcal ra b b it  serum ( 230,000 u n its )  and she died a f te r  2 
days in  h o sp ita l.
Case No. 25. (See Post-Mortem Summary).
Age 48 y rs . Sex Female. Date o f admission 2 .6 .41 .
Sputum Type I I .  Blood c u ltu re  s t e r i l e .
Day o f i l l n e s s  8 th .
Extent o f pulmonary involvement; Whole o f  l e f t  lung (two lo b es) .
B rie f h is to ry : This p a t ie n t  was m oderately i l l  and toxaemia was no t
marked. She was d e lir io u s  a t  n ig h ts . The tem perature had s e t t le d  and th e  
p a t ie n t  showed signs o f improvement when she took a sudden f a ta l  haemorrhage 
on 6 .6 .41 . A post-mortem examination revealed  the presence o f  a rup tured  
aneurysm.
Case No. 26.
Age 66 y rs . Sex Female. Date o f admission 2 .1 .41 .
Sputum Type I I .  Blood c u ltu re  p o s it iv e  (Type I I ) .
Day o f i l ln e s s  3rc**
Extent o f pulmonary involvement: L eft low er lobe  (one lo b e ).
B rie f h is to ry : This p a tie n t was f a i r ly  acu te ly  i l l  on adm ission, w ith
moderate toxaemia. She had been bed-ridden fo r  the  p a s t f iv e  y ears  on account 
o f rheumatoid a r t h r i t i s .  Her tem perature, which was never sharp ly  e leva ted , 
was s e t t l in g  when she collapsed suddenly a f te r  9 days in  h o sp ita l.
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Case No. 27. (See Post-Mortem Summary).
Age 50 y rs . Sex Female. Date o f admission 2 .6 .41 .
Sputum Type XXII. Blood cul t u r e  s t e r i l e .
Day of  i l l n e ss 3rd *
Extent o f  pulmonary involvement: E ight low er lobe (one lo b e ) .
B rief  h i s to ry : This p a t ie n t  had co llapsed  on 31*5*41, complaining o f
lo s s  o f power o f the  lower lim bs. On admission to  h o sp ita l th e re  was 
pneumonic conso lidation  o f the r ig h t  lower lo b e . There was p a re s is  o f 
both lower lim bs, w ith exaggerated tendon re f le x e s  and b i l a t e r a l  ex tensor 
p la n ta r  response. Lumbar puncture revealed  no abnorm ality in  the 
cereb rosp ina l f lu id .  Blood examination revealed  no abnorm ality . The 
Wassermann re a c tio n  was n eg a tiv e . B.P. 148/70 mm. o f mercury. There was 
some oedema o f the  l e f t  le g  due to thrombosis o f the  l e f t  i l i a c  vein.
P yuria  was p re sen t owing to  the  need o f c a th e te r is a t io n . Death occurred
a f t e r  23 days in  h o sp ita l.
Case No. 28. (See Post-Mortem Summary).
Age 75 y rs .  Sex Female. Date o f admission 22.11.41.
Sputum Type V III. Blood c u ltu re  s t e r i l e .
Day o f i l l n e s s  4 th .
Extent o f pulmonary in volvement: Whole o f  r ig h t  lung ( th re e  lo b e s) .
B rie f h is to ry : M oderately i l l  on admission w ith involvement o f  the
r ig h t  lung . The h ea rt sounds were o f poor q u a lity . She was ra th e r
dyspnoeic a t  tim es. The p a t ie n t  co llapsed  and died of. ca rd iac  f a i lu re
a f t e r  4 days in  h o sp ita l.
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Summary o f  Post-Mortem F indings:
Case No. 2.
The body was th a t  o f  a w ell nourished  in d iv id u a l. On opening th e  chest 
c a v ity , numerous adhesions were p re se n t on bo th  s id e s . No f lu id  was p re sen t. 
There were numerous sarcomatous masses p re se n t in  bo th  lu n g s, e sp e c ia lly  on 
th e  l e f t  s id e , where most o f th e  l e f t  upper lo b e  was rep laced  by sarcomatous 
t i s s u e .  The pericard ium  was g re a tly  th ickened and contained l£  ozs. o f  serous 
f lu id .  The myocardium was f a i r l y  normal. The l i v e r  and spleen ex h ib ited  
s ig n s  o f chronic  venous congestion . The k idneys, su p ra ren e ls , stomach 
and in te s t in e s  were a l l  normal. No evidence o f  sarcoma was found in  the 
bone marrow examined.
Case No. 3.
The body was th a t  o f a w ell b u i l t  and w ell nourished  in d iv id u a l. On 
opening th e  ch est c av ity , th e re  were some sdhesions p re se n t in  the  r ig h t  
low er and l e f t  upper lo b e s . The l e f t  lung  was emphysematous a t  the  apex 
but o therw ise  normal. The r ig h t  upper lo b e  was a lso  emphysematous a t  the  
apex. The low er lobe  ex h ib ited  s igns o f delayed re s o lu tio n . No pus was 
p re se n t a t  th e  r ig h t  base. The pericard ium  and h e a r t were normal.
On examining the  p e r ito n e a l c av ity , th e  jejunum and proxim al p a r t  o f the  
ileum were g ro ssly  d is tended  and congested. An o b s tru c tio n  was p re sen t th re e  
f e e t  from th e  i le o -c a e c a l  v a lve . This was caused by f ib ro u s  adhesions to 
th e  a n te r io r  abdominal w a ll, which may have been caused by an o ld  l e f t  sided  
in g u in a l a d e n i t is .  S ix  in ches o f  the  ileum  proxim al to  th e  o b s tru c tio n  
were gangrenous, as was a sm all p a r t  o f  th e  jejunum. The l i v e r ,  sp leen , 
k idneys and su p ra ren a ls  were s l l  w ith in  normal l im i t s .
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Case No, 14.
The body was th a t  o f a well b u i l t  and w ell nourished  in d iv id u a l. On 
opening the  chest c av ity , numerous p le u ra l adhesions were found on both s id e s . 
The r ig h t  low er and middle lobes were in  th e  stage o f red  h e p a tisa tio n , while 
the  upper lobe  was normal. P leu ra l th icken ing  was p re sen t in  the  l e f t  low er 
lo b e , while the  l e f t  upper lobe was normal. The h e a rt was f a i r ly  normal, but 
th e re  was atheroma o f  the  a o r t ic  arch. The stomach and in te s t in e s  were normal. 
The l i v e r  was g rossly  enlarged and rid d led  w ith m u ltip le  small c y s ts , obviously  
congen ita l in  o r ig in . Both kidneys were a lso  tremendously en larged , being 
nine inches in  len g th . They were c y s tic  and very l i t t l e  ren a l t is s u e  was 
p re sen t. The spleen was o f normal s iz e  but s o f t .
Case No. 16.
The body was th a t  o f a well b u i l t  but poorly nourished in d iv id u a l. On 
opening the  chest c av ity , numerous adhesions were p re sen t over both lungs.
There was pneumonic conso lida tion  o f the  r ig h t  lower and middle lo b es, these  
being in  the stage o f grey h e p a tisa tio n . There was some sca rrin g  a t  the  
r ig h t  apex, and several a c tiv e  tuberculous fo c i were a lso  p re sen t. There was 
evidence o f o ld  in a c tiv e  tu b e rcu lo sis  o f  the  l e f t  apex. The h e a r t ex h ib ited  
signs o f f a t ty  degeneration. The stomach, in te s t in e s ,  l i v e r ,  spleen, 
kidneys and suprarenals were a l l  normal.
Case No. 18.
The p a tie n t  was a th in  su b jec t o f average s ta tu re .  On opening the  ch est 
cav ity , th e re  were numerous p leu ra l adhesions a t  the  r ig h t  base, th e  r ig h t  
lower lobe  being firm ly  a ttached  to the  diaphragm. This lobe  ex h ib ited  s igns 
o f delayed re so lu tio n . The r ig h t  upper and middle lo b es , and th e  l e f t  lung  
were normal. The h eart was somewhat enlarged, snd the a o r ta , which ex h ib ited
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ex h ib ited  atheroma, was d ila te d . The stomach, in te s t in e s ,  l i v e r  end 
spleen were normal. The kidneys ex h ib ited  d i la ta t io n  o f  th e  ren a l pelves. 
This was caused by an enlarged f ib r o t ic  p ro s ta te  gland, and th e re  was a lso  
d i la ta t io n  o f th e  b ladder and u re te r s .
Case No. 2^.
The body was th a t  o f a f a i r ly  well nourished in d iv id u a l. There was 
p le u r isy  o f  both s id e s , w ith numerous adhesions a t  the  r ig h t  base. The 
whole o f the r ig h t  lung was in  the stage  o f grey h e p a tisa tio n  and the  
l e f t  lung , which was congested, had a smell area  o f conso lida tion  a t  the  
base. The h e a rt was o f normal s iz e . The cusps o f the  m itra l velve were 
somewhat thickened. There was atheroma o f  the a o rta . The l i v e r  ex h ib ited  
chronic venous congestion. The spleen was s o f t  and septicaem ic in  type.
The stomach, in te s t in e s ,  Kidneys and suprarenals were normal.
Case No. 25.
The body was th a t  o f a well nourished in d iv id u a l. A small q u an tity  o f
f lu id  was p resen t in  both p le u ra l sacs. Both lobes o f the  l e f t  lung were
in  the  stage o f red h e p a tisa tio n . The r ig h t  lung was normal.
This p a t ie n t  died suddenly o f haemorrhage, and the  cause o f th i s  was found
to  have been a la rg e  aneurysm o f the  a o r t ic  arch. This took the  form o f  a
d is se c tin g  aneurysm o f  the ao rta , and i t  tracked down the oesophageal wall
and involved the card iac  end o f the stomach. The aneurysm had p e rfo ra te d
the  oesophageal wall and much c lo tte d  blood was found in  th e  stomach. There
was ex tensive  atheroma o f the th o rac ic  and abdominal a o rta . The smell
in te s t in e  contained c lo tte d  blood, but was o therw ise normal. The l i v e r  was 
c i r r h o t ic  and small in  s ize . The spleen was normal. The kidneys and
sup rarena ls  were normal in  s ize  and s tru c tu re .
The body was th a t  o f a well b u i l t ,  obese fem ale. The only abnorm ality  
found on opening the  chest cav ity  was delayed re so lu tio n  a f fe c tin g  th e  r ig h t  
low er lobe . The h e a r t exh ib ited  f a t ty  degeneration , and th e re  was atheroma 
o f th e  a o r t ic  arch w ith a c a lc if ie d  plaque a t  the o r i f i c e  o f the  l e f t  
coronary a r te ry . The stomach was normal, bu t the  jejunum was somewhat 
congested. The l i v e r ,  spleen, kidneys and sup rarenale  were a l l  normal.
There was thrombosis o f  the l e f t  i l i a c  vein , and a sso c ia ted  w ith th i s  
th e re  was oedema o f the  l e f t  leg .
Case No. 28.
The body was th a t  o f a well nourished female. There was a considerab le  
q u a n tity  o f f lu id  in  both p le u ra l c a v it ie s .  Pneumonic conso lidation  involved 
the  r ig h t  lower, m iddle,and lower h a lf  o f the upper lobe . The l e f t  lung was 
normal. The h ea rt was g rossly  enlarged. The muscle was markedly 
hypertrophied . E ndocard itis  o f both the m itra l and a o r t ic  valves was 
p re se n t. Numerous c a lc if ie d  plaques were p re sen t on the  a o r t ic  arch.
The coronary v esse ls  were atheromatous.
A Meckel* s diverticulum  was p re sen t, but the  stomach and in te s t in e s  were 
o therw ise  normal. The l i v e r  and spleen exh ib ited  chronic venous congestion. 
The kidneys showed a r te r io s c le r o t ic  changes. The sup rarena ls  were normal.
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CHAPTEK V.
(A). The Absorption and Excretion o f th e  Sulpfaonamides.
(1) A study o f  th e  absorp tion  and excre tion  o f sulphanilam ide, 
su lphapyrid ine  and sulph& thiazole, when adm inistered  to  normal su b jec ts  
in  rep eated  and varying dosage.
in  th e  P reface  I  s ta te d  th a t as a p re lim in ary  to  the  study o f the  
absorp tion  and excretion  of the  sulphonamide drugs when used in  the  trea tm en t 
o f  the  acu te  in fe c tio n s , I  made a b r ie f  study o f  th e i r  absorp tion  and 
ex cre tio n  when adm inistered  in  varying dosage to normal in d iv id u a ls . The 
r e s u l t s  obtained  in  th is  e a r l i e r  study may ap p ro p ria te ly  be given a t  th i s  
p o in t before  considering  the  l a t e r  work c a rr ie d  out upon p a tie n ts  su ffe rin g  
from lo b a r  pneumonia.
The su b jec ts  used were convalescent d ip h th e ria  p a t ie n ts  in  th e i r  
fo u rth  week o f i l l n e s s .  Sulphanilam ide, su lphapyrid ine and su lphath iazo le  
were th e  drugs s tu d ied , and the dosage employed varied  from 2 gm. to 6 gm. 
p e r diem. The drugs were u su a lly  adm inistered fo r a p e riod  o f  seven days. 
Throughout the  t r i a l  period  a l l  p a t ie n ts  received  a normal convalescent d ie t ,  
and th e  d a ily  f lu id  in ta k e  was kep t as co nstan t as p o ss ib le .
The concen tra tion  o f the  drug in  th e  blood and u r in e  (bd th  the  f re e  and 
to ta l  drug) was determined on th e  day a f t e r  adm in is tra tio n  commenced, on each 
subsequent day throughout th e  period  o f ad m in is tra tio n  and fo r  sev era l days 
a f t e r  adm in is tra tio n  had ceased. The method adopted in  th i s ,  as in  the  
l a t e r  experiments fo r  th e  determ ination o f  th e  concen tra tion  o f th e  drug in  
th e  blood and u rin e  was th a t  o f  B ratton and M arshall (1939)* The in d iv id u a l
r e s u lt s  obtained, the dosage employed and the exact period  o f  adm inistration  
are shown in  Appendix XX.
143.
(1 ) .  Sulphanilam ide.
Method;
Twelve persons were used in  th is  study. They were d iv ided  in to  four 
groups o f th re e  in d iv id u a ls . The groups received  a d a ily  dose o f 
dulphanilam ide o f  2, 3, 4 and 5 grams re sp e c tiv e ly . The d a ily  dose was 
d iv ided  in to  s ix  equsl p a r ts ,  one being given every fou r hours, th e  f i r s t  
specimens o f blood and u rin e  were obtained fo r  examination 24 hours a f te r  
ad m in is tra tio n  had commenced, as i t  was n o t found p o ss ib le  to  malse hourly 
estim atio n s  on such su b jec ts . T hereafte r d a ily  specimens o f blood and 
u rin e  were examined fo r  about ten days. As shown in  Appendix XI, most cases 
received  th e  drug fo r only seven days but fu r th e r  estim ations were c a rr ie d  
ou t during the  period  o f the  e lim ination  o f the  drug from the  body.
In o rd e r to  express the  r e s u l ts  as su cc in tly  as p o ss ib le , the  mean o f 
th e  th re e  estim ations was ca lcu la ted  fo r  each group on succeeding days.
This f ig u re  was regarded as the  mean d a ily  le v e l o f f re e  o r to ta l  sulphanilam ide 
fo r  th a t  p a r t ic u la r  t e s t  dose.
R esu lts :
Table I .
The mean d a ily  le v e l o f f re e  and to ta l  sulphanilam ide in  the  
blood o f in d iv id u a ls  rece iv in g  varying dosage o f the drug.
Dosage.
Mean .tree Sulphanilamide 
 mgms. p e r 100 c .c .






























Mean Total Sulphanilam ide 
mgms. p e r 100 c .c .  _
1 _
Day o f  O bservation.
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Table I I .
The mean d a ily  le v e l  o f  f r e e  and to ta l  sulphanilam ide in  th e  
u rin e  o f  in d iv id u a ls  rece iv in g  varying dosage o f  th e  drug.
Dosage. Mean Free Sulphanilam ide 
mgms. p e r 100 c .c .
Mean T otal Sulphanilam ide 
mgms. p e r 100 c. c.
i Day o r O bservation. Day 01 O bservation.
* 1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 : 7 n or— 
182 gm. — 71 112 147! H 91
116 99 61 13 3 - 76 188 266 >68 225 jl73 111 40
3 gm* _ 59 109 128 i l l 64 91 69 55 25 - 97 190 203 169 L09 1138 108 95
1 1 
'40}
4 gm. - 38 173 194 184J160 189 121 112 48 - 173 342 3911344 265 367 236 206 9 7 1i
5 gm- 73 122 162 253jl59 152 121 49 - 129 222 295 473 259 270 192 129
1
J
Study o f Table I  shows th a t  in  t  general way as the  dose o f sulphanilam ide 
was in c reased  the le v e l o f the  drug in  the  hlood ro se . A high le v e l  waa u su a lly  
reached in  about 24-48 hours, a f te r  which the le v e l remained f a i r ly  stdady u n t i l  
the drug was w ithheld when i t  dropped rap id ly .
From the  r e s u l ts  obtained  in  a l l  th e  cases, i r r e s p e c t iv e  o f  dosage,
(Appendix XI), the  mean le v e ls  fo r  each day o f both f re e  and to ta l  sulphanilam ide 
in  the  blood were c a lcu la ted , and from the  f ig u re s  obtained  the  mean d a ily  
p ro po rtion  (per c en t.)  o f ace ty la ted  sulphanilam ide was a sce rta in ed . The 
r e s u l t s  ob ta ined  a re  shown in  Table I I I .
Table I I I .
The mean d a ily  fre e  and to ta l  sulphanilam ide in  th e  blood o f 
a l l  cases, and the mean proportion  (per cen t.)  o f  a ce ty la te d  drug.
Day o f  O bservation.
1 2 3 4 5 6 7 8 9 10
Mean f re e  sulphanilam ide 
mgns. p e r 100 c .c . - 4.0 4.8 4.4 5-2 5.4 4 .5 2. 7 I 1 .2
-i
Mean to ta l
sulphanilam ide mgms. p e r 
100 c .c .
5-5 6.8 6.1 7-0 7-8 6 .6 4 .3 2.0
Mean percen tage o f 
ace ty la ted  sulphanilam ide - 27 29 28 26 * 32 37 40 -
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The fig u res  in  Table III  show that during the period o f  adm inistration  
the amount o f acetylated  drug in  the blood remained fa ir ly  constant at 
about 3  ^ per cen t., to r is e  somewhat on the 8th  and 9 th  days a fter  
adm inistration had ceased. This mean proportion o f  acetylated  drug, obtained  
as i t  i s  from observations resu ltin g  from varying dosage, probably represents 
a fa ir ly  accurate p ictu re o f the usual amount o f acetylated  drug to be found 
in  the blood. A study o f  the individual r esu lts  (Appendix XI) suggests to 
me th at the d a ily  proportion o f  acetylated drug i s  much the same with any 
o f  the amounts o f the drug given.
Study o f Tables I and II  show that in  a general way as the le v e l  o f the 
drug in  the blood rose rdth increasing dosage, so did the output o f  both 
free  and to ta l drug in  the urine. The urine le v e l ,  r is in g  during the firB t  
few days o f  administration remained at a fa ir ly  constant le v e l ,  to f a l l  only 
when the drug was withheld. Traces were s t i l l  present in  the urine three 
days a fter  the drug was withheld.
From the resu lts  obtained in  a l l  cases, irresp ectiv e  o f dosage, (Appendix XI) 
the mean le v e ls  for each day o f  both free  and to ta l sulphanilamide in  the urine  
were calcu lated , and from the figu res obtained the mean daily  proportion (per 
cen t.) o f  acetylated sulphanilamide was ascertained. The resu lts  are shown 
in  Table IV.
Table IV.
The mean d a ily  free and to ta l sulphanilamide in  the urine, and the 
mean proportion (per cen t.) o f acetylated  drug.
Day o f Observed .on.
1 2 3 4 5 6 7 8 9 10.
Mean f re e  sulphanilam ide 
mgms. p e r 100 c .c .
- 60 129 158 167 125 133 93 57 25
Mean to ta l  sulphanilam ide 
mgms. p e r 100 c. c. 119 235 289 312 214 237 162. . . . 117 48
Mean percen tage o f 
a ce ty la te d  sulphanilam ide - 50 45 45 4 6 42 42 43 51 48
The fig u re s  in  Table IV show th a t  during th e  p e rio d  o f  ad m in is tra tio n  
and a f t e r  the  drug was w ithheld the  amount o f  a c e ty la te d  drug in  the  u r in e  
remained f a i r l y  steady a t  about 45 p e r cen t. This mean p ro p o rtio n , ob ta ined  
from o bservations re s u l t in g  from varying dosage, probably re p re se n ts  a  f a i r l y  
a ccu ra te  p ic tu re  o f the  usual amount o f  a ce ty la te d  drug to  be found in  the 
u r in e .
The f ig u re s  shown in  Tables I I I  and IV a re  expressed in  the  form o f  
graphs (F igures I  and I I ) ,  which give a f a i r ly  c le a r  p ic tu re  o f  the  
behaviour o f the  drug.
Conclusions:
Sulphanilam ide, given a t  fou r-hou rly  in te rv a ls  in  to t a l  d a ily  dosage 
o f  from 2 - 5  grams, produces well su sta ined  blood le v e ls  ranging from 
3 - 8  8gB3. per 100 c .c . o f the fre e  drug. With a constan t f lu id  in ta k e  
th e  ex cre tion  o f the  drug runs roughly p a r a l le l  to  the  blood le v e l .  Even 
w ith  th e  low est range o f  dose high le v e ls  o f the  f re e  drug are  obtained  
in  th e  u rin e . The amount o f drug in  th e  u rin e  drops sharply  a f t e r  i t s  
ad m in is tra tio n  i s  stopped. The p roportion  o f a ce ty la te d  drug in  the  
blood remains f a i r ly  steady throughout i t s  ad m in is tra tio n , namely a t  about 
30 p e r  c e n t . ; and th e  p roportion  o f th e  a ce ty la te d  drug in  th e  u r in e  
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( I I )  Sulphapyridine.
Method:
Twelve persons were employed in  th i s  study. They were d iv ided  in to  
fo u r groups, each group rece iv in g  a d a ily  dosage o f  su lphapyrid ine o f  2, 3> 4 
and 6 grams re sp e c tiv e ly . As in  the  case o f  sulphanilam ide, th e  d a ily  dose 
was d iv ided  in to  s ix  equal p a r ts ,  one being given every fou r hours. As before , 
th e  f i r s t  specimens o f  blood and u rin e  were obtained  fo r  examination 24 hours 
a f t e r  ad m in is tra tio n  commenced, And th e re a f te r  d a ily  specimens were fo r  about 
ten  days. In  most cases, as shown in  Appendix XI, the  drug was adm inistered  
fo r  a pe rio d  o f s ix  days. The mean o f  the  estim ations was c a lcu la ted  fo r  
each group on succeeding days. This f ig u re  was regarded as the  mean d a ily  
le v e l  o f  f re e  and to ta l  su lphapyrid ine fo r  th a t  p a r t ic u la r  t e s t  dose.
Ke s u i ts :
Table V.
The mean d a ily  le v e ls  o f f re e  and to ta l  su lphapyrid ine in  the 
blood o f in d iv id u a ls  rece iv in g  varying dosage o f  the  drug.
Dosage
Mean Free Sulphapyridine 
mgms. per 100 c. c.
Mean Total Sulphapyridine 
mgms. p e r 100 c .c .
o6Q f Observej.tioi1. D*y  of otisen ratio n.
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 L0
2 gm. - 2.1 2 .3 1 .6 1 .6 2.2 1 .7 0 .3 - 2 .5 3 .7 2.2 2.7 4.1 3.4 0 .9
3 ©a* - 2.2 3.8 1 .7 3 .2 3.0 2.4 1 .7 0 .0 - 2 .3 4.9 2 .6 5.1 5.0 4 .7 4 .4 2.0
4 gm. - 2.0 4.0 3*9 3.9 4 .6 4 .3 2.1 0 .1 - 3.0 6 .6 5.1 6.4 6 .7 5.4 3 .7 0 .9
6 gm. - 4-3 5 .3 5. 2. 4 .4 3-2 2.1 0.8 - 5.8 7.1 7 .2 5.9 5.5 3 .2 2.0
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Table VI.
The mean d a ily  le v e ls  o f f re e  and to t a l  su lphapyrid ine in  the  u r in e  
o f  in d iv id u a ls  rece iv in g  varying dosage o f  the  drug.
Dosage
Mean Free Sulphapyridine 
mgms. p e r 100 c .c .
Mean T otal Sulphapyridine 
mgms. per 100 c. c.
ipay o f  O bservation. Day o f  O bservation.
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
2 gm. - 37 44 46 52 52 8o 36 19 20 - 114 98 179 122 177 175 142 59 103
3 g®* - 44 100 50 66 40 74 36 15 6 - 110 232 244 200 195 222 95 40 8
4 gm. - 25 104 98 113 103 88 48 17 5 - 41 m 190 229 211 177 108 34 9
6 gm. - 84 96 162 148 125 64 37 - 143 204 312 287 224 145 73
Study o f  Table V shows th a t  as was the  case w ith sulphanilam ide, the  blood 
le v e ls  o f  both fre e  and to ta l  su lphapyrid ine increased  s l ig h t ly  as the dosage 
increased . The le v e l o f  su lphapyrid ine reached a maximum 48 hours a f te r  
adm in istra tion  commenced. Throughout th e  period  o f ad m in is tra tio n  the  blood le v e l ,  
although e x h ib itin g  some v a r ia tio n , tended to remain f a i r l y  steady. When the  drug 
was w ithheld  the  le v e l dropped rap id ly  but tra c e s  o f su lphapyrid ine were s t i l l  
p re sen t in  the  blood two days l a t e r .
From th e  r e s u l ts  obtained  in  a l l  the  cases, i r r e s p e c t iv e  o f dosage, (Appendix 
XI), the  mean le v e ls  fo r  each day o f both fre e  and to ta l  su lphapyrid ine were 
c a lc u la te d , and from the  fig u res  obtained  th e  mean d a ily  proportion  (p e r c en t.)  o f
a ce ty la te d  sulphapyridine was a sce rta in ed . The r e s u l t s  a re  shown in  Table VII.
Table VII.
The mean d a ily  f re e  and to ta l  sulphapyrid ine in  th e  blood o f a l l  cases, 











Mean f re e  sulphapyridine 
mgms. p e r 100 c. c. — 2.6 3.8 3.1 3 .3 3 .2 2.6 1 .2 0 .1 —
Mean to ta l  sulphapyridine 
mgms. p e r  100 c .c . 3-4 5.6 4 .3 5.0 5 .3 4 .2 2 .7 1 .4 —
Mean percentage o f a ce ty la te d  sulphapyridine. - 23 32 28 34 40 38 55 70 -
151.
Study o f  Table VII re v e a ls  th a t  during the  p e rio d  o f ad m in is tra tio n  
th e re  was considerab le  v a r ia tio n  in  the  amount o f  a ce ty la te d  drug p re sen t.
Thus 23 p e r cen t, o f  su lphapyrid ine was p re sen t in  th e  ace ty la te d  form 24 
hours a f te r  ad m in is tra tio n  began and th e  amount in c reased  as high as 40 p er 
c en t, during the  period  o f ad m in is tra tio n . A fter the  drug was w ithheld 
th e  amount o f  a c e ty la te d  su lphapyrid ine in  the  blood rose  sharp ly  to 
70 p e r cen t. As was argued in  the  case o f sulphanilam ide, i t  i s  again 
suggested th a t  the mean p roportion  o f the a ce ty la ted  drug obtained from 
o b serv a tio n s  re s u lt in g  from varying dosage probably rep re sen ts  a f a i r ly  
accu ra te  p ic tu re  o f  th e  usual amount o f ace ty la ted  su lphapyrid ine to be 
found in  th e  blood.
Long and V einstone (193^) found 10-20 p er cen t, o f  the drug in  the  
blood in  the  conjugated form, while Kinsman e t  a l .  (1939) rep o rted  33 Pe r cen t. 
My own f ig u re s  a re  very s im ila r  to those obtained  by these  l a t t e r  workers 
in  th a t  over J)  p e r cen t, o f sulphapyridine in  the blood a f t e r  the  f i r s t  24 
hours o f adm in istra tion  was p re sen t as the  ace ty la te d  d e r iv a tiv e . A fter 
withdrawal o f the  drug my own fig u re s  agree c lo se ly  w ith those o f o th e r 
workers in  th a t  tra c e s  o f  su lphapyrid ine were p re sen t in  th e  blood fo r  
severa l days and th a t  the  fre e  form was excreted  more ra p id ly  than th e  
conjugated foxm.
Study o f  Tables V and VI show th a t  as was th e  case w ith su lphan il amide, 
in  a  general way as th e  le v e l  o f su lphapyrid ine in  the  blood rose  w ith 
in c re a s in g  dosage, so did  th e  output o f both fre e  and to ta l  su lphapyrid ine 
in  the  u r in e  in c rease . The u rin e  le v e l ,  r is in g  during the  f i r s t  two days 
o f  ad m in is tra tio n , remained a t  a f a i r ly  constan t le v e l  throughout the  p e rio d
o f  ad m in is tra tio n . When the  drug was w ithheld th e re  was a gradual f a l l  in
th e  u rin e  le v e l  and tra c e s  were p resen t even th ree  days a f t e r  the  drug was
stopped.
152.
As in  the case o f the blood le v e ls ,  from the r e su lts  obtained in  a l l ,  
ir re sp ec tiv e  o f dosage (Appendix XI), the mean le v e ls  for  each day o f  both 
the free  and to ta l sulphapyridine in the urine were calcu lated  and from 
these fig u res  the mean d aily  proportion per cent* o f  the acetylated  drug 
was ascertained. The r e su lts  are shown in  Table VIII.
Table VIII.
The mean d a ily  free  and to ta l sulphapyridine in  the urine o f  
a l l  cases, and the mean proportion (per cent.) o f  acetylated  drug.
Dav oJ ObssrvfitioQ*
1 2 3 4 5 6 7 8 9 10
Mean f re e  sulphapyrid ine 
mgms. p e r 100 c .c . — 47 86 89 95 80 76 39 17 11
Mean to ta l  su lphapyridine 
mgms. p e r 100 c. c. - 102 176 231 210 209 180 104 44 40
Mean percentage o f 
a ce ty la te d  sulphapyridine - 54 50 61 55 62 58 62 61 73
The f igures  in Table VIII show that during the period o f administration  
the amount o f acetylated sulphapyridine in the urine remained fa ir ly  steady 
at between 50 -  60 per cent. I t  increased to over 70 per cent, when the 
drug was stopped.
As already stated, the mean proportion obtained from observations 
resu ltin g  from varying dosage probably represents a fa ir ly  accurate p icture  
o f  the usual amount o f acetylated sulphapyridine to be found in  the urine.
The figu res shown in  Tables VII and VIII are expressed in  the form o f  
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With eq u iv a len t d a i ly  doses the  mean blood, le v e ls  w ith  su lphapyrid ine  
a re  low er than  those  obtained w ith  su lih an ilam id e . Maximum le v e ls  a re  
u su a lly  obtained  24 -  48 hours a f t e r  ad m in is tra tio n  commences and the  
le v e ls  remain f a i r l y  constan t throughout the  p e rio d  o f a d m in is tra tio n . 
F u rth e r , in c rease  o f dosage does n o t n e c e s sa r ily  in c rease  the  blood le v e ls ,  
a t  l e a s t  to  the  same ex ten t as w ith  su lphanilam ide.
The ex cre tio n  o f the  drug tends to  run p a r a l le l  to  the  blood le v e l .
The p ro p o rtio n  o f a ce ty la te d  drug in  the  blood remains f a i r l y  steady 
throughout i t s  ad m in is tra tio n  a t  about 33 Pe r  cen t, and th e  p roportion  
o f a c e ty la te d  drug in  th e  u rin e  remains f a i r l y  steady a t  about 60 p e r c en t.
A fte r  the  drug i s  w ithheld  the  f re e  drug seems to  pass out of the  blood
stream  much more ra p id ly  than the a c e ty la te d  drug , fo r  on the n in th  day
the  mean p ro p o rtio n  of the  drug in  the  conjugated o r a c e ty la te d  form 
reached 70 P©r  cen t.
The excre tio n  o f su lphapyrid ine ta p e rs  o f f  more slowly than does th a t  
o f sulphanilam ide, and the a ce ty la te d  drug i s  excreted  more slowly than 
th e  f r e e  drug.
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( I l l )  S u lphath iazo le:
Method:
Six  persons were used in  th i s  study. Three in d iv id u a ls  received  
a d a ily  dose o f  5 grams and th ree  a d a ily  dose o f 10 grams. The d a ily  
dose was d iv ided  in to  f iv e  equal p a r ts  given every fou r hours, no drug 
being adm inistered a t  2.0 a .m ., « t  which time the  p a t ie n ts  were n o t 
d is tu rb ed . The f i r s t  specimens o f blood and u rin e  were obtained  fo r  
examination 24 hours a f te r  adm in is tra tio n  had commenced and th e re a f te r  
d a ily  specimens were obtained fo r  the  ensuing e ig h t o r n ine days. As 
shown in  Appendix XI most cases received  the drug fo r  fiv e  o r s ix  days.
The 10 gram d a ily  dose was given because Spink and Hansen (1940) 
had s ta te d  th a t  w ith s im ila r dosage sulphanilam ide reached h igher le v e ls  
in  the  blood than did su lp h a th iazo le , end they suggested th a t  th is  was 
due to the  d i f f ic u l ty  in  m ain tain ing  equ ivalen t concen tra tions owing to 
th e  rap id  excretion  o f su lp h a th iazo le . By in c re a s in g  the dose I  hoped to 
show th a t high concen tra tions o f su lphath iazo le  could re a d ily  be obtained , 
i f  indeed such high le v e ls  were re a l ly  e s s e n tia l  in  the treatm ent o f 
severe in fe c tio n s .
The mean o f the  th ree  estim ations was c a lcu la ted  fo r  the  t?/o groups 
on succeeding days. This fig u re  was regarded as the mean d a ily  le v e l  o f 
f r e e  and to ta l  su lphath iazo le  fo r  th a t  p a r t ic u la r  group.
R esu lts :
Table IX.
The mean d a ily  le v e ls  o f  f re e  and to ta l  su lp h ath iazo le  in  the  
blood o f in d iv id u a ls  receiv in g  varying dosage o f  the  drug.
Dosage.
Mean Free Sulphath iazole  
mgms. per 100 c. c.
Mean Total Su lphath iazo le  
mgms. p e r 100 c .c .
1
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The mean d a ily  le v e ls  of f r e e  and t o t a l  su lp h a th iazo le  in  the  u r in e  
o f in d iv id u a ls  rece iv in g  varying dosage of the  drug.
Dosage.
Mean f re e  su lp hath iazo le  
mgms. p e r 100 c .c s .
Mean t o t a l  su lp h a th iazo le  
m©ns. p e r 100 c .c s .
Day of observation Day of observation
1 2 3 4 5 6 7 8 9 10 I 2 3 4 5 6 7 8 9 10
5 gm* - 303 194 318 258 229 217 200 141 - - 376 234 360 306 257 264 228 187
10 gm. - 257 303 320 363 340 167 42 3 - 299 362 366 443 419 185 53 8 -
Study o f Table IX shows th a t the  blood le v e ls  of both f r e e  and t o t a l  su lphath ­
ia z o le  w ith  a d a ily  dose of 10 ©n. were approxim ately double the le v e ls  
obtained  v/ith a 5 ©n. dose. Blood le v e ls  of su lp h a th iazo le  would th e re fo re  
appear to  be f a i r l y  p ro p o rtio n a l to  dosage. The co n cen tra tio n  of su lp h a th iazo le  
in  th e  blood reached a f a i r l y  high le v e l 48 hours a f t e r  ad m in is tra tio n  
commenced,and i t  was w ell su sta ined  throughout the  period  of a d m in is tra tio n . 
A fte r  th e  drug was w ithheld the  le v e ls  f e l l  f a i r l y  ra p id ly  and only minute 
amounts of the  drug were d e tec ted  in  the blood 48 hours a f te r  ad m in is tra tio n  
ceased.
Prom the  r e s u l ts  obtained in  a l l  c a se s , i r re s p e c tiv e  of dosage,
(see Appendix XI) the mean le v e ls  f o r  each day of both f re e  and to t a l  
su lp h a th iazo le  were c a lc u la te d  and from the  f ig u re s  obtained the  mean 
d a ily  p ro p o rtio n  (per c e n t.)  of ace ty la ted  su lp h ath iazo le  was a sc e rta in ed .
The r e s u l t s  a re  shown in  Table XI.
Table XI.
The mean d a ily  f re e  and to t a l  su lp h a th iazo le  in  th e  blood of a l l  oases, 
and the  mean p ro po rtion  (per c en t.)  o f a ce ty la ted  drug.
Day of observation .
I  2 3 4 5 6 7 8 9 10
Mean, f r e e  su lp h a th iazo le  
mgms. p e r 100 c .c s . -  4.2 5.6 5.8 6 .4 4.5 2.1 1 .4 1.0
Mean to t a l  su lp h ath iazo le  
m©ns. p e r  100 c .c s . -  5.0 6.7 7.3 7.5 5.3 2 .9 1 .8 2.5
Mean percentage of 
a ce ty la te d  su lp h a th iazo le . -  16 16 20 15 15 27 22 60 -
158.
Study o f  Table XI re v e a ls  th a t  throughout th e  p e riod  o f  ad m in is tra tio n  
the  amount o f  a ce ty la ted  su lp h a th iazo le  in  th e  blood v aried  from 1 5 - 2 0  p e r  
c e n t . , and a f t e r  the  drug was w ithheld the amount increased  to  60 p e r cen t. 
These f ig u re s  agree c lo se ly  w ith those o f  Spink and Hansen (1940), who in  
a la rg e  s e r ie s  o f pneumonia p a tie n ts  recorded th a t  20 p e r cen t, o f the  drug 
in  the  blood was p resen t in  the a ce ty la ted  form during therapy.
The mean proportion  o f ace ty la ted  drug obtained  from the  d if f e r e n t  
dosages w ill  rep resen t f a i r ly  accu ra te ly  the  usual amount of su lp h ath iazo le  
to  be found in  the blood.
Study o f Tables IX and X shows th a t  as the  le v e l o f the  drug in  the 
blood ro se  w ith in c reasin g  dosage, so did  the  ou tpu t of both fre e  and to ta l  
drug in  the  u r in e  in c rease . Sulphath iazole  was rap id ly  excreted  as 
evidenced by the high u r in e  le v e ls  24 hours a f te r  ad m in is tra tio n  commenced. 
During the  period  o f ad m in is tra tio n  high u r in e  le v e ls  were m aintained 
although th e re  was considerable  d a ily  v a r ia tio n  in  the le v e ls .  When the 
drug was w ithheld i t  was rap id ly  excreted and the  u rin e  le v e ls  consequently 
f e l l  sharp ly , although tra c e s  were s t i l l  p re sen t th re e  days a f te r  
ad m in is tra tio n  ceased.
T'rom the  re s u l ts  obtained  in  a l l  cases, i r r e s p e c tiv e  o f dosage 
(Appendix X I), the  mean le v e ls  fo r  each day o f both fre e  and to ta l  
su lp h a th iazo le  in  the u r in e  were ca lcu la ted  and from the f ig u re s  
ob tained  th e  mean d a ily  p roportion  (p e r c en t.)  o f  a ce ty la te d  drug was 
a sce rta in ed . The r e s u l t s  a re  shown in  Table XII.
159.
Table H I .
The mean d a ily  f r e e  and to ta l  su lp h a th iax o le  in  th e  u r in e  o f  a l l  
cases and the  mean proportion  (p e r c en t.)  o f  a c e ty la te d  drug.
Day o f O bservation.
1 2 3 4 5 6 7 8 9 10
Mean f re e  sulpha­
th ia z o le . 280 248 319 510 284 192 181 72
mgms. p e r 100 c .c .
Mean to t a l  sulpha­
th ia z o le . 337 298 363 374 338 224 140 97
mgms. p e r 100 c .c .
Mean percentage o f 
a ce ty la te d  sulpha­
th ia z o le .
- 17 17 12 17 16 14 13 26 -
Study o f Table XII shows th a t  during the  period  o f ad m in is tra tio n  
th e  amount o f a ce ty la ted  su lphath iazo le  in  the  u rin e  remained f a i r ly  constan t 
a t  between 12 -  17 per cen t. When the drug was w ithheld i t  increased  to 26 
p er cen t. This mean proportion  probably rep resen ts  the  itsual amount o f 
a ce ty la te d  su lphath iazo le  to be found in  the  u rin e .
The r e s u l t s  o f Tables XI and XII a re  expressed in  th e  form o f graphs 
(F igures V and VI) which show c le a r ly  the behaviour o f su lp h a th iazo le .
Conclusion:
S u lphath iazo le  given a t  fou r-hourly  in te rv a ls  in  to ta l  d a ily  dose o f 
5 grams and 10 grams re s u lts in  w ell susta ined  blood le v e ls .  With the  la rg e r  
dose r e la t iv e ly  high concen tra tions o f  su lp h a th iazo le  in  the  blood can 
be obtained .
The ex cre tio n  o f su lp h ath iazo le  shows s l ig h t  d a ily  v a r ia tio n  but tends 
to  run p a r a l le l  to  the  blood le v e l .  A fter .the  drug i s  w ithheld i t  d isappears 
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The p ro po rtion  o f a ce ty la ted  drug in  th e  blood remains f a i r l y  steady 
throughout adm in is tra tio n  a t  about 15 p e r c e n t . ,  and the  p ropo rtion  o f 
a c e ty la te d  drug in  the u r in e  remains a t  about a s im ila r  percen tage .
Summary o f conclusions to  be drawn from the  comparison o f the  
absorp tion  and excretion  of sulphanilam ide, su lphapyrid ine 
and sulphathiazole*
( i )  With a l l  th ree  sulphonamides the concen tra tion  o f the  drug in  th e  
blood i s  p ro p o rtio n a l to the  dosage, although s l ig h t ly  h igher concen tra tions 
a re  obtained  w ith sulphanilam ide and su lp h ath iazo le  than w ith su lphapyrid ine.
( i i )  During the period  o f ad m in is tra tio n  the concentra tion  o f the drag 
in  th e  blood remains f a i r ly  steady. The concen tra tion  ob ta ined  with 
sulphanilam ide i s  h igher than th a t  obtained  w ith s im ila r dosage o f 
su lphapyrid ine  o r su lp h ath iazo le .
( i i i )  During the  period  o f adm in istra tion  of the  drugs th e re  i s  s l ig h t  
v a r ia tio n  in  the  amount o f a ce ty l d e r iv a tiv e  p re sen t w ith the  th ree  drugs.
In  th e  case o f sulphanilam ide the  mean proportion  (per c en t.)  o f  ace ty l 
d e r iv a tiv e  during ad m in istra tion  i s  29 (range 26- 32) ,  while in  th e  case o f 
su lphapyrid ine  i t  i s  33 (range 23-40), and in  the case o f su lp h ath iazo le  
i t  i s  16 (range 15-20). A fter ad m in istra tion  ceases th e  a ce ty l d e riv a tiv e  
o f  sulphapyridine,ow ing to i t s  g re a te r  r e la t iv e  in s o lu b il i ty ,  p e r s i s t s  in  the  
blood stream fo r  severa l days.
( iv )  The concentration  o f  the  drug in  th e  u r in e , as in  the case o f  blood, 
i s  roughly p ro p o rtio n a l to dosage w ith  a l l  th ree  sulphonamides, bu t th e  
concen tra tion  o f th e  drufc in  the u r in e  i s  a t  a much h igher le v e l  than in  
th e  blood.
(v) Throughout ad m in istra tion  the  le v e l o f the  drug in  the  u rin e  remains 
f a i r l y  steady. Higher concen tra tions a re  obtained w ith sulphaihiazoie £&. 
s im ila r  dosage than w ith the  o th e r drugs.
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(v i)  The amount o f a ce ty l d e r iv a tiv e  excreted  e x h ib its  considerab le  
v a r ia t io n  w ith the  th re e  drugs. In  the  case o f  sulphahilam ide th e  mean 
p ro p o rtio n  (p e r c en t.)  o f  ace ty l d e r iv a tiv e  p re sen t during ad m in is tra tio n  
i s  45 (range 42-50), w hile in  the  case o f su lphapyrid ine i t  i s  57 (range 
50-62), and in  the  case o f su lp h ath iazo le  i t  i s  16 (range 12- 17)*
Ch:'
■> i  r . y i  V; t ’
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( I I )  Ihe  absorp tion  and excretion  o f su lphapyrid ine in  th e  
trea tm en t o f  161 p a tie n ts  su ffe rin g  from pneumococcal lo b a r  pneumonia.
(a) The Absorption o f Sulphapyridine:
A s a t is fa c to ry  system o f dosage o f su lphapyrid ine has been d i f f i c u l t  to  
e s ta b lis h  owing to  g rea t v a ria tio n  in  the  absorp tion  o f  th e  drug. Owing to  
th i s  v a r ia tio n  among d if f e r e n t  persons on the same dosage, Long and B lis s  (1939) 
s ta t e  th a t  " i t  i s  b e s t to d iscuss dosage in  terms o f concen tra tion  o f  the  
drug in  the  b lo o d ." An optim al concen tra tion  o f su lphapyrid ine in  the  blood 
fo r  th e  trea tm en t o f pneumonia has no t y e t been e s ta b lish e d  conclusively , 
although Long and B liss  (1939) advocate a blood concentra tion  o f from 4 - 6  mgms. 
p e r 100 c .c s . fo r  the e ffe c tiv e  therapy o f  moderately i l l  p a t ie n ts  and a 
co n cen tra tion  o f from 7 - 1 0  mgms. per 100 c .c s . fo r  severe ly  i l l  p a t ie n ts .  
Abemethy, Dowling and Hartmann (1939) s ta t e  th a t  a mean concen tra tion  o f 
6 mgms. p e r 100 c .c s . o r  h igher in  the blood i s  d e s irab le .
The aim o f th is  study was to confirm the g rea t v a r ia b i l i ty  in  blood le v e ls  
noted by o th e r workers, to  endeavour td  f in d  out why th e re  should be th is  
v a r ia b i l i ty ,  and to  in v e s t ig a te  the  r e s u l t s  o f therapy in  resp ec t o f the 
varying le v e ls  of the drug in  the  blood.
Method:
Throughout th i s  study the  dosage o f sulphapyridine employed was an i n i t i a l  
dose o f  2 grams followed by 1 gram every fou r hours, continued in  the m a jo rity  
o f  cases t i l l  the  end o f the seventh day in  h o sp ita l. In  some o f the  le s s  
severe ly  i l l  p a tie n ts  the drug was stopped on the 5th day in  h o sp ita l;  w hile in  
severe ly  i l l  p a t ie n ts ,  e sp ec ia lly  in  those developing com plications such as 
empyema, the  drug was sometimes continued fo r  more than seven days. In  a few 
cases i t  had to  be w ithheld on account o f  the  appearance o f  to x ic  m an ife s ta tio n s .
The /
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The tim es o f  ad m in is tra tio n  o f su lphapyrid ine were 2 a .m ., 6 a .m ., 10 a .m .,
2 p .m ., 6 p.m. and 10 p.m. I t  should be noted  th a t  throughout th e  p e rio d  
o f  therapy th e re  was no reduction  in  the d a ily  amount o f drug adm inistered , 
the  6 grams p e r day being employed throughout.
in  Chapter I I I  i t  was s ta te d  th a t specimens o f blood were withdrawn 
d a ily  between 1.33 and 2.0 p.m. fo r  th e  estim ation  o f th e  concen tra tion  o f 
su lphapyrid ine . The f i r s t  specimen o f  blood was ob tained  on the day 
a f t e r  admission to h o sp ita l and fu r th e r  specimens were obtained  on subsequent 
days throughout the period  o f therapy. Daily specimens o f  u rin e  were a lso  
ob ta ined  during the period  o f therapy fo r  the estim ation  o f the concen tra tion  
o f  su lphapyrid ine, the  f i r s t  specimen being obtained on the day a f te r  
admission to h o sp ita l, as in  the case o f blood. Trora these  specimens the 
blood and u rin e  le v e ls  o f fre e  sulphapyrid ine were determined by the method 
o f B ratton  and M arshall (1939)*
Throughout the  period  o f therapy the  d a ily  f lu id  in tak e  and u rin e  output
o f  the  p a tie n ts  were a lso  measured in  ounces per diem.
(1) K esults showing the v a ria tio n  in  blood le v e ls  w ith standard 
dosage o f sulphapyridine:
Appendix X II shows the r e s u l ts  obtained from the  study of the absorp tion  
and excretion  o f sulphapyridine in  161 p a tie n ts  su ffe rin g  from pneumococcal
lo b a r  pneumonia. The d a ily  blood le v e ls ,  u r in e  le v e l s ,  f lu id  in ta k e  and 
u r in e  ou tpu t during the  period  o f therapy are given and in c id e n ta lly  the  
number o f  days during which the drug was adm inistered are  included .
A c a re fu l study o f Appendix XII shows th a t very marked v a r ia tio n  in  he 
blood le v e ls  o f d if f e r e n t  p a tie n ts  occurred during therapy w ith su lphapyrid ine . 
This v a r ia tio n  o f the  blood le v e l in  the  treatm ent o f  p a t ie n ts  su ffe r in g  from 
lo b a r  pneumonia has been noted by numerous workers, in c lu d in g  Long and B lis s
(1939), Abernethy e t  a l . , (1939)* and Kinsman e t  a l , ,  (1939).
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Study o f Appendix XII a lso  shows th a t  in  many p a t ie n ts  considerable 
v a r ia tio n  e x is te d  in  the  blood le v e l from day to  day. However, as was 
found when su lphapyrid ine was adm inistered to normal in d iv id u a ls , in  a 
g re a t many cases the  h ig h est concen tra tion  o f  the  drug in  the blood was 
reached 48 hours a f te r  therapy commenced. T h e rea fte r in  some cases the 
concen tra tion  of the drug in  the blood remained a t  a f a i r ly  steady le v e l ,  
although s l ig h t  f lu c tu a tio n  o f the le v e l occurred from day to day; while 
in  o th e r  cases the  le v e l tended to  f a l l  somewhat towards the 7th day o f 
therapy . The d is tr ib u tio n  o f  the  cases according to the day on which the 
h ig h est concen tra tion  o f su lphapyridine was reached i s  shown in  Table XIII,
Table X III.
The d is tr ib u tio n  o f cases according to the  day in  which the  
h ig h est concen tra tion  o f su lphapyridine in  th e  blood was obtained .
Day in  H ospital
No. o f Cases. 
Percentage o f  Cases. -  16 40
-------4
Study o f  Table XIII shows th a t  in  40 p e r cen t, o f th e  cases the  h ig h est 
concen tra tion  of sulphapyridine was obtained a f te r  48 hours o f  therapy, and 
th a t  in  74 p er cen t, o f cases the  h ig h est blood le v e l  occurred during the  
f i r s t  th ree  days in  which estim ations were performed.
In  comparing the  cases in  o rder to endeavour to fin d  ou t th e  reasons fo r  
th e  v a r ia b i l i ty  in  the  blood le v e l and the  r e s u l ts  o f therapy in  re sp e c t o f 
th e  varying blood le v e l ,  I  decided to use the  mean concentra tion  o f the 
drug ca lcu la ted  from the  estim ations performed on the  second, th i r d  and /
l6 j i
and fo u rth  days in  h o sp ita l. By u sin g  the mean o f  the f i r s t  th re e  
estim atio n s  o f su lphapyrid ine in  th e  blood the  f ig u re  obtained  w ill  be 
f a i r l y  re p re se n ta tiv e  o f the concen tra tion  o f the  drug p re sen t in  the  
blood dwring the  acu te  stage o f the i l l n e s s .  I t  i s  during the e a r ly  days
o f  therapy th a t sulphapyrid ine i s  l ik e ly  to ex ert i t s  b e n e f ic ia l e f fe c t ,  
e sp e c ia lly  i f  bacteraem ia i s  p re sen t, and I  consider th a t  the mean o f  the 
f i r s t  th re e  estim ations o f the blood concen tration  i s  more l ix e ly  to give 
an accu ra te  estim ate  o f the ac tu a l amount o f drug in  the blood than the 
mean o f e l l  estim ations performed during the period  o f therapy, owing to 
th e  tendency o f the blood le v e ls  to f a l l  somewhat towards the end o f  the 
p e rio d  o f therapy. Accordingly, from the  estim ations performed on the 
second, th ir d  and fo u rth  days in  h o sp ita l the mean blood le v e ls  o f  a l l  
cases were a sce rta in ed . The r e s u lts  obtained  ere  shown in  Appendix X III, 
which a lso  shows the mean u rin e  le v e ls  obtained from estim ations performed 
during th e  period  o f  therapy and the mean f lu id  in tak e  snd u rin e  output 
throughout therapy.
From the fig u res  in  Appendix XIII the  cases were grouped according 
to  vario u s  mean blood le v e ls  (0 -2 .0 , 2 .1 -4 .0 , 4 .1 -6 .0 , 6 .1 -8 .0 , 8 .1 -1 0 .0 , 
1 0 .1 -12 .0  mgms. per 100 c .c s . ) .  The r e s u l ts  obtained  are  shown in  Table XIV.
Table XIV.
The d is tr ib u tio n  o f cases according to the mean blood le v e l 
o f  f re e  sulphapyridine obtained w ith standard dosage.
Mean Blood Level No. o f Cases. Percentage o f
mgms. p e r 100 c .c . cases.
0 -  2.0 17 10 .5  •)
2.1 -  4.0 56 34.8 s 78.3
4.1 -  6.0 53 33-o )
6.1 -  8 .0 28 17-4 )
8 .1  -  10.0 6 3-7  \ a .  7
10.1 -  12.0 1 0 .6  )
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Study of Table XIV shows th a t  th e  m a jo rity  of oases had a mean blood 
le v e l  under 6.0 mgms. p e r 100 c .c s .  ; in  f a c t  in  about 80 p e r c e n t, of 
th e  cases th e  mean blood le v e l d id  not exceed 6.0 mgms. p e r 100 c . c s . ,  w hile 
in  ju s t  over 20 p e r cen t of p a tie n ts  the  mean blood le v e l  exceeded th i s  
f ig u r e .  The percentage of p a tie n ts  w ith  mean blood le v e ls  over 6 .0  mgms. 
p e r  100 c .c s .  i s  th e re fo re  lower than  th a t  rep o rted  by o th e r workers 
(Kinsman e t  a l .  1959)•
C onclusion;
In  th e  trea tm en t of lo b a r pneumonia w ith standard dosage of su lphapyrid ine 
th e re  i s  marked v a r ia tio n  in  the  con cen tra tio n  of the  drug in  the  blood among 
d i f f e r e n t  in d iv id u a ls . In  about 80 p e r  c en t, of cases the mean blood le v e l ,  
ob tained  from estim atio n s  performed on the second , th i r d  and fo u rth  days 
in  h o s p ita l  does not exceed 6 .0  mgms. per 100 c . c s . ,  and in  20 p e r c e n t, of 
cases the  mean blood le v e l exceeds 6.0 mgms. per 100 c .c s .
The le v e l  of the  drug in  th e  blood, in  the  same in d iv id u a l, e x h ib its  
some v a r ia t io n  from day to  day, but in  the  m ajo rity  of cases the  h ig h est 
co n cen tra tio n  of the  drug in  th e  blood i s  reached during the  f i r s t  th ree  
days of therapy and as a ru le  the  le v e l remains a t  a f a i r l y  constan t le v e l 
during  th e  period  of therapy .
( i l )  The reasons fo r  the  v a r ia tio n  in  th e  blood le v e ls :
The reasons fo r  the marked in d iv id u a l v a r ia b i l i ty  in  the  blood le v e ls  
of su lphapyrid ine are  not c le a r ly  understood, but th e re  are p o ssib ly  sev e ra l 
fa c to rs  which might a f fe c t  the blood co n ce n tra tio n .In  pneumonia those  fa c to r s  
which might in flu en ce  the  blood le v e ls  can be considered under"three  headings: 
( i )  The in fluence  of the p a ra s i te  on the  blood le v e l .
( I I )  The in flu en ce  of the host on the  blood le v e l .
(h i ) The in flu en ce  of sub sid ia ry  therapy on the  blood le v e l .
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An answer to each o f th ese  fa c to rs  w ill  be sought by making a c a re fu l 
a n a ly s is  o f the  r e s u l ts  obtained . In  the  f i r s t  p la ce , th e  e f f e c t  o f  th e  
type o f  in fe c tin g  pneumococcus and the  presence o r  absence o f  bacteraem ia 
on th e  blood le v e l w ill be d iscussed . Secondly, th e  age and sex o f the  
p a t ie n t  and the le v e l  o f  g a s tr ic  a c id ity  w ill be d iscussed  in  re la t io n  to 
th e  blood le v e l .  f in a l ly ,  the e f fe c t  o f th e  f lu id  in ta k e  on the blood 
le v e l  w ill be considered.
(I )  The e f fe c t  o f the Type o f in fe c tin g  pneumococcus on 
the  blood concentration .
Table XV.
The d is tr ib u tio n  o f lypes I ,  I I ,  I I I  and Gp. IV 
among various blood le v e ls .
Mean Blood Level 
mgms. p e r 100 c .c s . I 11
fpe.
I l l Gp.IV All types
0 -  2.0 4 10 1 2 17
2.1 -  4.0 16 19 4 17 56
4.1 -  6.0 12 17 2 22 53
6.1  -  8 .0 5 7 2 14 28
8 .1  -  10.0 2 1 1 2 6
10.1  -  12.0 - - 1 - 1
From Table XV the percentage o f Types I ,  I I ,  I I I  and Gp. IV having mean blood 
le v e ls  under and over 6.0 mgms, per cent, was ca lcu la ted  as shown in  Table XVI.
Table XVI.
The number and percentage of Types I ,  I I ,  I I I  and Gp. IV, 
having mean blood le v e ls  under and over 6.0 mgms. p e r cen t.





mgms. per 100 c .c s . No. £age. No. £age. No. Mge. No. £age No.
6.0 and under. 32 82 46 85 7 64 41 64 1 2 6 1
6.1 and over. 7 18 8 15 4 36 16 36 35 1 2J
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Study o f  Table XVI shows th a t  in  each type many more p a t ie n ts  had blood 
le v e ls  under 6.0 mgms. p e r 100 c .c s . than above th i s  f ig u re , end the
d iffe re n c e  was most marked in  Types I  and I I .
from the  f ig u re s  in  Appendix XII the  d e ily  mean blood le v e ls  o f
Types I ,  I I ,  I I I  and Gp. IV during the  period  o f  therapy were ca lcu la ted  
as shown below.
Table XVII.
The d a ily  mean blood le v e ls  o f Types I ,  I I ,  I I I  and Gp. IV.
Type
Day in  H osp ital
1 2 3 4 5 6 7
I - 3.6 4 .7 4 .3 4.0 3-5 3-5
I I - 3-7 4 .4 4.1 3.6 3-1 2.8
I I I - 4 .5 5.8 5.2 5.0 4 .3 2.9
Gp. IV - 3-9 5.4 5.2. 5.0 4 .7 4.5
Study o f  Table XVII re v e a ls  th a t  Types I  and I I  tended to have lower blood
le v e l  curves than Type I I I  and Group IV; in  f a c t  Type I I I  cases had the
h ig h est le v e ls  o f the various types. In each in s ta n ce  the  blood concentra tion
rose  from between 3 .5  to 4 .5  mgms. p e r 100 c .c . on the day a f te r  admission
by 1 mgm* p e r 100 c .c . o r more during the nex t 24 hours. This read ing ,
ob ta ined  on the th ir d  day in  h o sp ita l, was in  a l l  cases the  h ighest one and
a f t e r  th i s  the blood concentration  tended to f a l l  very slowly during the
subsequent days o f therapy. The sudden f a l l  in  Type I I I  le v e ls  on the  7th
day was due to to x ic  symptoms which appeared in  severa l cases who had high
concen tra tio n s , so th a t  therapy was stopped sooner than u su a l. The r e s u l t s
shown in  Table XVII a re  expressed in  the form o f a graph (F igure VII) which 
shows c le a r ly  the blood le v e l curves o f  the  various types.
^  K* N
' o ' o  O O I
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Conclusion:
In  Types I ,  I I ,  I I I  and Gp. IV, as among a l l  types, more p a t ie n ts  have 
mean blood le v e ls  under 6.0 mgras. p e r 100 c .c s . than above th is  f ig u re . I t  
i s  in te r e s t in g  to note th a t  Type I I  in fe c t io n s , g en era lly  the most severe, 
a re  a sso c ia ted  w ith the  low est bicod le v e ls .  This fin d in g  which w ill be 
d iscussed  l a t e r ,  i s  probably due to the  la rg e r  f lu id  in ta k e  o f such 
p a t ie n ts  which makes excretion  more rap id  than normal. The d iffe ren ce  of 
th e  blood le v e l  curves o f in d iv id u a l types i s  very s l ig h t  and o f no 
s ig n if ic a n c e . The type o f in fe c tin g  pneumococcus does n o t appear to 
in flu en c e  the  le v e l o f f re e  su lphapyridine in  the blood o f pneumonia p a tie n ts .
( I I )  The e f fe c t  o f bacteraem ia on the  blood concen tra tion :
Table XVIII .
The d is tr ib u tio n  o f cases with and w ithout 
bacteraem ia among the various blood le v e ls .




0 -  2.0 11 6
2.1 -  4.0 48 8
4.1 -  6.0 42 11
6.1 -  8 .0 23 5
8 .1  -  10.0 5 1
10.1 -  12.0 l 0
J?'rom Table XVIII the number and percentage o f cases with and without 
bacteraemia, having blood le v e ls  under and over 6.0 mgms. per 100 c .c s . was 
ascertained as shown in  Table XIX.
Table XIX.
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The number and percentage o f cases vdth and w ithout bacteraem ia 
having mean blood le v e ls  under and over 6.0 mgms. p e r 100 c .c s .
---
Mean Blood Level 
mgms. p e r 100 c .c s .




ses w ith 
cteraem ia.
Mo. Percentage. No. Percentage. No. Percentage.
Under 6.0 126 78 101 78 25 81
Over 6.1 35 22 29 22 6 19
StAdy o f  Table XIX shows th a t among the cases w ith bacteraem ia 19 p e r c m t. had
a blood concen tra tion  o f more than 6.0 mgms. p e r 100 c .c s . ,  and th a t  among non- 
bacteraem ic cases 22 p er cent, had a le v e l over 6.0 mgms. per 100 c .c s . The 
percen tage d iffe ren c e  (3) has a standard  e rro r  o f i  8.0* so the  d iffe ren ce  i s  
n o t s ig n if ic a n t.
Conclusion:
There i s  no evidence to  show th a t  the presence o f bacteraem ia lowers the 
degree o f absorp tion  o f sulphapyridine thereby causing a dim inution of the 
concen tration  o f the drug in  the blood.
( I I I ) .  The e f fe c t  o f age on the blood le v e l:
Table XX.
The mean blood le v e ls  d is tr ib u te d  according to 
the  age o f the  p a tie n t.
Mean Blood Level 
mgms. p e r 100 c .c s . 1 5 - 2 0 2 1 - 3 0
i
3L -  40
ige in  Y<
51 -  5c
sars.
5 1 - 6 0 6 1 - 7 0 over
0 -  2.0 7 0 5 2 1 0 2
2.1 -  4.0 8 5 14 13 10 4 2
4.1 -  6.0 9 6 13 12 10 3 0
6.1  -  8 . 0 5 7 2 4 5 4 1
8 . 1  -  10 .0 0 0 1 2 1 2 0
10 .1  -  12 .0 0 0 0 0 0 1 0
j 74.
Study o f  Table XX shows th a t  the  number o f  cases in  each age group was 
sm all, h i t  in  each in s tan ce  the  number o f cases w ith mean blood le v e ls  under 
6.0  mgms. p e r 100 c .c s . was g re a te r  than those w ith le v e ls  above th i s  value, 
th e  a c tu a l percen tage o f  cases in  the  former group varying from 67 to 89 
p e r  cen t.
As the  number in  each decade was small i t  was considered d e s ira b le  to 
group cases in to  those under and over f i f t y  years o f age; and to c o n tra s t 
these  two age groups w ith varying blood concen tra tions.
Table XXI.
The number and percentage o f cases under and over 50 y ea rs , 
having mean blood le v e ls  under and over 6.0 mgms. per 100 c .c s .
Mean Blood Level Under 50 y rs . Over 50 y rs .
mgms. p e r 100 c .c s . ho. Percentage No. Percentage
Under 6.0 94 82 32 70
Over 6.1 21 18 14 33
Study o f Table XXI shows th a t  under 50 y ears  o f age th e re  were 115 p a t ie n ts  
o r 72 p e r c e n t . ,  and above th is  age 46 p a tie n ts  o r  28 p e r c e n t.;  th is  being very 
s im ila r  to  th e  re sp ec tiv e  f ig u re s  fo r  age d is t r ib u t io n , o f 75 p e r cen t, and 25 
p e r cen t, fo r  th e  whole s e r ie s  o f 370 cases. Table XXI a lso  rev ea ls  th a t 18 
p er cen t, o f  those under 50 years  o f age had blood le v e ls  over 6.0  mgms. p e r 100 
c .c s . ,  and th a t  30 p e r cen t, o f those over 50 years  o f age had blood le v e ls  
over 6.0 mgms. p e r  100 c .c s . The percentage d iffe ren ce  (12) has a standard  
e r ro r  o f  ±-7*6. I  do n o t consider th is  d iffe ren ce  as s ig n if ic a n t.
Conclusion:
Very s l ig h t  v a r ia tio n  in  the  blood le v e ls  i s  found according to  the  age 
o f  th e  p a t ie n t ,  and such v a ria tio n  as i s  found i s  no t o f any s ig n ific a n ce .
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(4) .  The e f fe c t  o f sex on the blood le v e l :
Table XXII,
The mean blood le v e ls  d is tr ib u te d  according to th e  aex o f  the  p a t ie n t .
Mean Blood Level 
mgms. p e r  100 c .c s .
No. o f Males. No. o f  Females.
0 -  2.0 15 2
2.1 -  4.0 47 9
4.1  -  6.0 38 15
6.1 -  8 .0 12 16
8 .1  -  10.0 2 4
10.1  -  12 .B 0 1
Study o f Table XXII shows th a t  114 males and 47 fem ales were Included in  the  | 
s e r ie s  undergoing in v e s t ig a tio n . The cases were then grouped according to j
whether the mean blood le v e l was under o r  over 6.0 mgms. per 100 c .c s . as shown 
in  Table XXIII.
Table XXIII.
The number and percentage o f  cases o f e i th e r  sex, having 
mean blood le v e ls  under and over 6.0 mgms. p e r 100 c .c s .
Mean Blood Level Males Females
mgms. p e r 100 c .c s . No. Percentage No* Percentage
Under 6.0 100 88.0 26 55-0
Over 6.1 14 12.0 21 45.0
Study o f Table XXIII shows th a t  although only 12 p er cen t, o f a l l  males 
s tu d ied  had mean blood le v e ls  exceeding 6.0 mgms. p e r 100 c .c s . ,  y e t  45 per cen t.
o f  fem ales had mean blood le v e ls  exceeding th is  f ig u re . The percentage 
d iffe re n c e  (33) has a standard e r ro r  o f  t .  7*9 so the  d iffe ren ce  i s  s ig n if ic a n t. 
Owing to  the h igher mean blood le v e ls  in  females than in  males i t  was decided 
to  compare the  d a ily  mean blood le v e l  o f males and fem ales.
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Table XXIV.
The d a ily  mean blood le v e ls  o f the sexes.
Sex Day in  H ospital
1 2 3 4 5 6 7
Male - 3 .4 4 .3 4.0 3 .7 3-2 2.7
Female - 5-3 6.4 5.9 5.3 5-4 4.8
Study o f  Table XXIV shows that throughout therapy the hlood le v e ls  were higher 
in  females than in  males. In both sexes the maximum concentration was 
obtained on the third day in  h osp ita l, and thereafter during therapy the 
le v e l s  remained fa ir ly  steady.
To study th is  apparent d ifference further i t  was decided to compare 
the d a ily  mean blood le v e l o f individual types in males and females.
Table XXV.
The daily  mean blood le v e l o f Types I , I I ,  I II  and 
Gp. IV in  males and females.
Free Sulphapyridine 
mgms. per 100 c .c s .
Type Sex
D«ay in  Ho sp it al
1 2 3 4 5 6 7
I Male - 3.3 4 .3 3.9 3.4 3.0 3.0
I I ti - 3-2 3.8 3.7 3.4 2.9 2.7
I I I n — 3-7 4.0 4.0 3 .6 2.8 1 .4
Gp. IV it - 3-5 5.1 4.5 4 .3 4.2 3.8
I Female - 4.8 6.2 6.1 6.4 5.5 6 .2
I I n - 6.4 6.0 5.4 4.6 4.7 2.9
I I I it - 5.5 7.6 6.3 6.3 5-7 4 .3
Gp. IV it - 4.4 5.9 6.0 5.9 5.5 5.7
Study o f Table XXV reveals that in  Types I , I I ,  I II  and Group IV the da ily  mean 
blood level^higher i n f e m a l e s  than in  males. I t  w ill  also be noted that in  




In  fem ales th e  mean hLood le v e ls ,  c a lc u la te d  from the  f i r s t  th ree  
estim atio n s  o f the  concentra tion  o f su lphapyrid ine in  the blood, as well 
as the  d a ily  mean blood le v e l tend to  be h igher than in  m ales. This 
re la tio n s h ip  i s  a lso  apparent among Types I ,  I I ,  I I I  and Group IV. The 
d iffe ren c e  i s ,  however, s l ig h t ,  and as w ill be shown l a t e r ,  i t  may be 
a t t r ib u te d  to the  lower f lu id  in ta k e  o f fem ales.
(5) The e f fe c t  o f g a s tr ic  a c id i ty  on the blood le v e l:
Hobson and jiilcQuaide (192$) o th e r workers noted th a t g a s tr ic  a c id i ty
had l i t t l e  o r  no e f fe c t  on the absorp tion  o f su lphapyrid ine. These workers 
in  studying the  in d iv id u a l v a r ia tio n  in  the capac ity  to absorb sulphapyrid ine 
no ted  th a t  blood concen trations in  p a tie n ts  w ith ach lorhydria  were w ithin 
normal l im ite ,  w hile in  p a t ie n ts  with low blood concen tra tions f ra c tio n a l 
t e s t  meals revealed  a normal a c id ity . The r e s u l t s  o f  twenty f ra c tio n a l 
t e s t  meals performed on pneumonia p a tie n ts  may th e re fo re  be described  
conveniently  a t  th i s  p o in t. The p a tie n ts  se le c ted  had ord inary  f ra c tio n a l 
t e s t  meals performed a t  the  end o f  the f i r s t  week in  h o sp ita l.
The group o f  twenty p a tie n ts  was q u ite  re p re se n ta tiv e  as regards the  
v a rio u s  fa c to rs  o f p rognostic  s ig n ific an ce . I t  included  s ix  Type I ,  seven 
Type I I ,  one Type I I I  and s ix  Group IV in fe c tio n s . During the  a tta ck  o f 
pneumonia four p a t ie n ts ,  o r 20 p e r c e n t.,  had bacteraem ia and the  o th er 
s ix te en  p a tie n ts  had s t e r i l e  blood cu ltu re s . As regards age, f i f te e n
p a t ie n ts  were under 50 years  o f age and f iv e  p a t ie n ts  were over th i s  age.
Ten p a tie n ts  o f  e i th e r  sex were included in  the  group fo r  g a s tr ic  
an a ly s is .
The r e s u l ts  obtained in  the  twenty g a s tr ic  analyses performed are  shown 
in  Appendix XIV. The cases were grouped according to the le v e l o f  f re e
hydroch lo ric  acid . G astric  a c id i ty  was considered w ithin  normal l im i ts
(B ennett and Byle 1921) o r th e re  was hypochlorhydria o r hyperch lo rh y iria .
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Table XXWI.
The mean blood le v e ls  o f twenty cases d is tr ib u te d  according 
to  th e  g a s tr ic  a c id ity .
Mean Blood Level 
mgms. p e r 100 c .c s . Low A cid ity . Normal A cid ity . High A cid ity .
0 - 2 . 0  ! 4
2.1 -  4.0 3 2 -
4 .1  -  6.0 1 3 2
6 .1  -  a o _ 3 1
8 .1  -  10.0 - - —
10.1  -  12.0 1- ■........— ■ ■ ■ —- 1 -----------------------------,
Study o f  Table XXVI rev ea ls  th a t  in  th ir te e n  o f  th e  twenty cases the  
g a s t r ic  a c id i ty  was considered w ith in  normal l im i t s ,  f iv e  cases exh ib ited  
hypochlorhydria and th ree  had d e f in i te  l^yperacidity. In  the various groups 
o f  a c id i ty  the  cases were f a i r ly  well d is tr ib u te d  over the  various blood 
le v e ls .
Conclusion:
I t  cannot be s ta te d  th a t  low a c id i ty  i s  a sso c ia ted  w ith poor absorption 
o f  su lphapyridine and consequently low blood le v e ls ,  o r th a t  high a c id ity  
i s  a sso c ia ted  w ith good absorption and high blood le v e ls .  From th i s  small 
s e r ie s  i t  would appear th a t  the absorp tion  o f su lphapyrid ine bears no 
re la tio n sh ip  to the g a s tr ic  a c id ity .
(6 ) . The e f fe c t  o f subsid iary  therapy ( f lu id  intake}- on the  blood le v e l :
In  Chapter I I I  i t  was s ta te d  th a t  during th e  acute stage o f th e  i l ln e s s
th e  f lu id  in ta k e  o f the p a tie n ts  undergoing in v e s tig a tio n  was c a re fu lly  
measured. As a ru le  the f lu id  in ta k e  was recorded fo r  the  f i r s t  f iv e  days 
in  h o sp ita l but the  exact period  i s  shown in  Appendix XII. From th ese  
f ig u re s  the  mean f lu id  in ta k e  was ca lcu la ted  and th e  f ig u re s  ob tained  w ill 
be found in  Appendix XIII as was p rev iously  s ta te d .
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R esu lts;
The mean f lu id  in ta k e  in  ounces d is tr ib u te d  according to  
th e  various blood le v e ls .
Mean Blood Level 
mgms. p e r 100 c. c.
m s a r s ilsksT Ih buncos p er diem
40-50 51-60 61-70 71-80 81-90 91-100 loi-ilo 111-120
0 - 2.0 0 1 3 4 8 1 0 02.1 - 4.0 0 4 7 15 19 8 2 1
4.1 - 6.0 1 4 7 21 12 7 1 06.1 - 8.0 3 3 4 12 4 1 1 0
8.1 - 10.0 3 2 0 0 0 0 1 0
10.1 - 12.0 0 0 1 0 0 0 0 _____Q___
From Table XXVII th e  cases were d iv ided  according to whether the  blood le v e l  was
under o r  over 6.0 mgms. p e r 100 c .c s . ,  as shown in  Table XXVIII.
Table XXVIII.
The number o f  cases w ith varying f lu id  in ta k e  having blood 
le v e ls  under and over 6.0 mgms. per 100 c. cs.
Mean Blood Level f lu id  iIntake n ounces p er diem.
mgms. p e r 100 c .c s . 40-50 51-60 61-70 71-80 81-90 91-100 101-110 111-120
6.0 and under 1 9 17 40 39 16 3 1
6.1 and over 6 5 5 12 4 1 2 0
Percentage over 6.0 86 36 23 23 9 6 - -
Study o f Table XXVIII re v e e ls  th a t  p a t ie n ts  w ith a low f lu id  in ta k e  tended to
have high blood le v e ls .  Thus o f the seven p a tie n ts  whose mean f lu id  in ta k e  did 
n o t exceed 50 ounces p e r diem, s ix  had mean blood le v e ls  exceeding 6.0 mgms. per 
100 c .c s . ,  and only one had a le v e l below th is  f ig u re . As the d a ily  f lu id  
in ta k e  in c reased , the percentage o f  cases w ith le v e ls  over 6.0 mgms. p e r 100 
c .c s .  decreased fo r  each 10 ounces o f f lu id  in c rease  up to 100 ounces p e r diem. 
Table XXVIII a lso  shows th a t  the  most common f lu id  in ta k e  was 70-80 ounces 
p e r diem.
In  d iscussing  various fa c to rs  which might a f fe c t  the  blood le v e l i t  was 
noted  th a t  s l ig h t  v a r ia tio n  occurred among the types and in  the sexes. I t  was 
th e re fo re  considered d e s irab le  a t  th is  stage  to  no te  i f  the  f lu id  in ta k e  varied  
among the  types and in  the sexes.
Table XXIX.
The d is tr ib u tio n  o f cases having a f lu id  in ta k e  under and over 
80 ounces p e r diem among Types I ,  I I ,  I I I  and Gp. IV.
Type F lu id  in ta k e  
l e s s  than 80 ozs.
f lu id  in ta k e  
more than 80 ozs.
Percentage o f  cases 
w ith high in ta k e .
I 23 16 41
I I 27 27 50
I I I 7 4 36
Gp. IV 38 19 33
Study o f Table XXIX shows th a t  50 p e r cen t, o f Type I I  cases drank more than 
80 ounces o f  f lu id  p e r diem, but only 33 Pe r cen t, o f Group IV cases drank 
a s im ila r  q u an tity .
Table XXX.
The d is t r ib u t io n  o f cases having a f lu id  in ta k e  under and 
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Study o f Table XXX shows th a t  53 Pe r cent, o f males had a f lu id  in tak e  o f more 
than 80 ounces p e r diem, but only  13 p er cen t, o f females had a f lu id  in tak e  
exceeding 80 ounces. The percentage d iffe ren ce  (40) has a standard  e rro r  
o f ^  6.8 so th e  d iffe ren ce  i s  s ig n if ic a n t.
Conclueion:
The f lu id  in ta k e  i s  an im portant fa c to r  in  co n tro llin g  the  blood le v e l 
because i t  has been shown th a t as the  f lu id  in ta k e  in c re a se s  then the  blood 
le v e l  decreases. ll?ith a la rg e  f lu id  in tak e  the  sulphapyridine i s  rap id ly
"washed out" o f the  t is s u e s , and hence the  blood le v e ls  are  low, and as w ill 
be seen l a t e r ,  the  u rin e  le v e ls  a re  a lso  low although a la rg e  q u an tity  o f the  
ding i s  a c tu a lly  elim inated from th e  body.
I8 l .
The s l ig h t  v a r ia tio n  in  blood le v e ls  noted among Types I ,  I I ,  I I I  and 
Group IV i s  la rg e ly  due to the  high f lu id  in ta k e  o f  Type I I  cases, th i s  
causing a low ering o f  the  blood le v e ls .
The v a r ia tio n  o f  blood le v e ls  noted in  the  sexes i s  a lso  c e r ta in ly  
due to  the  h igher f lu id  in tak e  o f male p a t ie n ts  which causes a low ering o f 
th e  blood le v e l  by promoting a more rap id  e lim ina tion  o f su lphapyrid ine 
from the body.
( I I I ) .  The s ig n ific an ce  o f  the v a r ia tio n  o f  the b lood le v e ls :
I t  i s  im portant to know i f  th e re  i s  an optimal blood le v e l  fo r  th e  
trea tm en t o f p a tie n ts  su ffe rin g  from pneumonia. I t  i s  th e re fo re  e s s e n tia l  
to  c o rre la te  the blood le v e ls  w ith various fa c to rs  to d iscover i f  one blood 
le v e l  i s  more b en e fic ia l than another.
( i )  The c l in ic a l  response as gauged by the method o f the  f e l l  in  
tem perature:
In  considering  the  c l in ic a l  response, the cases were d ivided in to  those 
ex h ib itin g  a c r i t i c a l  f a l l  in  tem perature o r a c r i s i s  w ithin  the f i r s t  48 
hours in  h o sp ita l, and those ex h ib itin g  a gradual f a l l  in  tem perature, o r ly s i s .  
C ertain  o th e r cases f a i le d  to  respond to therapy, and in  a few cases the 
p a tie n ts  although ex h ib itin g  pneumonic conso lidation  were a fe b r i le  from the 
time o f  admission.
Table XXXI.
The c l in ic a l  response as gauged by the  method o f the  f a l l  
in  tem perature in  cases whose mean blood le v e l was under 
and over 6.0 mgms. p e r 100 c .c . among cases who recovered.
Response.
Mean Blood Level 
mgms. p e r 100 c .c s .
6.0 and under. 6.1 and over.
No. Percentage. No. Percentage.
C r is is 45 3? 13 42
L ysis 58 51 15 48
No e f fe c t 12 10 3 10
A febrile 5 - - -
182.
Study o f  Table XXXI rev ea ls  th a t  about 40 p e r  cen t, o f p a t ie n ts  having 
pyrex ia  a t  th e  time o f admission to h o sp ita l responded with a c r i s i s  w ithin 
48 hours o f admission; a lthough in  cases w ith le v e ls  exceeding 6.0 mgms. p e r 
100 c .c s . the  response was very s l ig h t ly  more marked than in  cases w ith le v e ls  
under th i s  f ig u re . The a c tu a l percentages were 39 sad 42 re sp e c tiv e ly , but 
th i s  d iffe re n c e  i s  n a tu ra l ly  no t s ig n if ic a n t. The number o f cases responding 
by ly s i s  was consequently very s l ig h tly  le s s  in  the cases w ith the higher le v e ls .  
The percen tage o f cases in  which sulphapyridine was in e f fe c t iv e  in  reducing 
pyrex ia  was s im ila r  in  both groups, thus showing th a t  in  c e r ta in  cases in  s p ite  
o f  high blood concen tra tions sulphapyrid ine was an in e f fe c t iv e  drug as f a r  as 
reducing pyrexia was concerned. In  f iv e  cases o f the low blood le v e l group 
no pyrexia was p resen t from the tLrae o f admission.
( i i )  The c l in ic a l  response as gauged by the  time taken fo r  the 
tem perature to re tu rn  to normal.
Tahle XXXII.
The c l in ic a l  response as gauged by the  time taken fo r  th e  tem perature 
to re tu rn  to  normal in  cases whose mean blood le v e l was under snd 
over 6.0 mgms. p e r 100 c .c s . among cases who recovered.
Response. Mean Blood Level mgms. p er 100 c .c ...... __6. 0 and under. 6~.: . and over.
No. Percentage. No. Percentage.
Temperature normal by 48 h rs . 56 49 19 61
n normal by 98 h rs. 101 88 27 87
w normal by 144 h rs . 103 90 28 90
No E ffec t. 12 10 3 10
A feb rile . 5 - - -
Study o f Table XXXII rev ea ls  th a t  among p a tie n ts  w ith pyrexia a s l ig h t ly  g re a te r  
percentage whose blood le v e ls  exceeded 6.0 mgms. p e r 100 c .c . had normal
tem peratures a t  th e  end o f 48 hours in  h o sp ita l than had p a tie n ts  whose blood
le v e ls  were under th is  f ig u re . By the end o f 96 and 144 hours, however, 
p r a c t ic a l ly  the  same percentage had normal tem peratures in  both blood le v e l
groups. In  10 per cen t, o f p a t ie n ts  in  both blood le v e l groups su lphapyrid ine 
was in e f fe c tiv e  in  reducing the pyrexia.
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Conclusion:
Sulphapyridine i s  an e f fe c t iv e  chem otherapeutic agent in  th e  reduction  
o f p y rex ia  in  pneumonia. In  ju s t  over 50 p e r cen t, o f p a t ie n ts  who had pyrex ia  
on admission and who subsequently recovered the  tem perature i s  normal w ithin  
48 hours. By the  end o f 96 and 144 hou rs ,88 and 90 p a r cen t, re sp e c tiv e ly  o f  
p a t ie n ts  have normal tem peratures. In  f i f te e n  cases, o r 10 per cen t, o f the 
p a t ie n ts  ex h ib itin g  pyrex ia , su lphapyrid ine i s  in e f fe c t iv e  in  the  reduction o f  
p y rex ia . The response by c r i s i s  i s  very s l ig h tly  g re a te r  in  cases whose blood 
le v e l s  exceed 6.0 mgms. per 100 c .c s . than in  cases whose le v e ls  a re  under th is  
f ig u re , but th i s  apparent advantage i s  o f no s ig n ific an ce .
( i i i )  The e f fe c t  o f blood le v e ls  on the occurrence o f the 
com plications o f pneumonia:
In  Chapter IV i t  was s ta te d  th a t  60 cases, o r  17*6 per cen t, o f a l l  
p a t ie n ts  ex h ib ited  physical signs o f conso lidation  th ree  weeks a f te r  the onset 
o f  th e  i l ln e s s .  I t  was considered im portant to no te  i f  the  blood le v e ls  
a ffe c te d  in  any way the  process o f  re so lu tio n .
Table XXXIII.
The number o f cases ex h ib itin g  delayed re so lu tio n  
d is tr ib u te d  according to mean blood le v e ls .
Mean Blood Level 
mgms. p e r 100 c. c.
No. o f 
Cases.
" “Ho. wTtH
delayed re so lu tio n .
0 -  2.0 17 2
2.1 -  4.0 56 13
4.1  -  6.0 53 9
6.1 -  8 .0 28 5
8 .1  -  10.0 6 1
10.1 -  12.0 1 1
Study o f  Table XXXIII re v e a ls  th a t among the  l ^ l  p a t ie n ts  who recovered, 31 o r 
20.5 p e r  cen t, showed signs o f delayed re so lu tio n . The cases were then grouped 
according to  whether the  mean bLood le v e l  was under o r  over 6.0 mgms. p e r
100 c .c s . , a s  shown in  Table XXXIV.
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Table XXXIV.
The number and percentage o f  cases ex h ib itin g  delayed re so lu tio n  
in  p a t ie n ts  w ith mean blood le v e ls  under and over 6.0 mgms. p e r 100 c .c s .
Mean Blood Level No. o f No. w ith delayed Percentage w ith
mgms. p e r 100 c .c . Cases. re so lu tio n . delayed re so lu tio n .
6.0 and under 120 24 20.0
6.1 and over 31 7 22.6
Study o f Table XXXIV shows th a t  20.0 per cent, o f those having mean blood le v e ls  
under 6.0 mgms. p e r 100 c .c s . and 22.6 p e r cen t, o f those having mean blood 
le v e ls  over th i s  f ig u re  had delayed re so lu tio n . This s l ig h t  d iffe ren ce  i s ,  
however, o f no s ig n ific an ce .
In  f iv e  out o f the  twelve p a tie n ts  who developed a s t e r i l e  p le u ra l 
e ffu s io n , the concen tra tion  of sulphapyridine in  the  blood was determined. Two 
o f such p a tie n ts  had a mean blood le v e l  between 6.0 and 4.1 mgms. p e r 100 c .c s . ,  
one case had a mean blood le v e l between 4.0 and 2.1 mgms. per 100 c .c s . ,  and in  
two cases the  mean blood le v e l was under 2.0 mgms. p e r 100 c .c s .
In  th re e  o f the  s ix  cases who developed empyema, the  concentra tion  o f 
su lphapyrid ine in  the blood was determ ined. One case had a mean blood le v e l 
between 6.0 and 4.1 mgms. p e r 100 c .c s . ,  one case had a le v e l between 4.0 and 
2.1 mgms. p e r 100 c .c s . ,  and in  the  remaining case the  mean blood le v e l was 
under 2.0 mgms. p e r 100 c .c s .
Conclusion:
The number o f cases developing com plications who had blood le v e l 
e stim atio n s  performed was u n fo rtu n a te ly  small. I t  i s ,  however, in te r e s t in g  to
n o te  th a t  delayed re so lu tio n  occurs in  those having a high concentra tion  o f 
su lphapyrid ine in  the blood as well as in  those w ith a low concen tra tion . The 
p rocess o f re so lu tio n  would appear th e re fo re  to be un affec ted  by the concen tra tion  
o f  su lphapyrid ine in  the  blood. S te r i le  p le u ra l e ffu s io n s  and erapyemata aL so 
occur in  cases with h igher le v e ls  as well as in  those w ith lower le v e ls  and th e re
/
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/ th e r e  i s  no p roof th a t  the presence o f  a high blood le v e l  p reven ts 
th e  o n se t o f  such com plications o f pneumonia.
(iv ) The e f f e c t  o f blood le v e ls  on the  F a ta l i ty  Rate:
The f a t a l i t y  r a te s  among p a tie n ts  with d if f e r e n t  blood le v e ls  were 
c a lc u la te d  as shown in  Table XXXV.
Table XXXV.
The f a t a l i t y  r a te s  among the  various blood le v e l groups.
Mean Blood Level 
mgms. p e r  100 c. c. -
No. o f 
Cases.
No. o f 
Deaths.
F a ta l i ty  
Rate %.
0 -  2.0 17 0 0.0
2.1 -  4.0 56 5 8.9
4.1  -  6*0 53 1 1.9
6.1  -  8 .0 28 3 10.7
8 .1  -  10.0 6 1 16 .7
10.0  -  12.0 1 0 0 .0
Study o f Table XXXV rev ea ls  th a t  ex ce llen t c l in ic a l  recovery took p lace in
p a t ie n ts  w ith  low mean blood le v e ls .  In  fa c t ,  in  17 cases whose mean blood
le v e l  did n o t exceed 2.0 mgms. p e r 100 c .c s . ,  th e re  were no deaths. C ontrasting
th e  f a t a l i t y  r a te s  in  cases whose mean bldod le v e ls  were under 6.0  mgms. p e r
100 c .c s . w ith those whose le v e ls  exceeded th is  f ig u re , i t  was found th a t the
r a te s  were 4.8 and 11.4 re sp ec tiv e ly . There were, however, only 35 cases
w ith  le v e ls  exceeding 6.0 mgms. per 100 c .c s . ,  and o f the fou r deaths which
occurred in  th is  group, one p a tie n t ,  a Type I I I  in fe c tio n , was very acu te ly
i l l  on admission and recovery was no t expected. The percentage d iffe ren ce  ( 6. 6)
has a standard  e rro r  o f ± 5* 7 so the d iffe ren ce  i s  n o t s ig n if ic a n t.
Conclusion:
A f a ls e  im pression may be taken from the  apparently  h igher f a t a l i t y  r a te  in
cases w ith mean blood le v e ls  exceeding 6.0  mgms. p e r 100 c .c s . ,  in  the absence 
o f  a knowledge o f the sev e rity  o f the i l l n e s s  o f two o f  the  four deaths in  this
group. One p a tie n t  died a f te r  3D hours in  h o sp ita l and recovery was no t expect­
ed in  th i s  case. The /
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/The s l ig h t  d iffe ren c e  in  the  f a t a l i t y  r a te s  i s ,  however, o f  no 
s ig n ific a n c e  and recovery from pneumonia takes p lace  i r r e s p e c t iv e  o f 
the  concen tra tion  o f su lphapyrid ine in  the blood.
Summary o f  conclusions to be drawn from a study o f the  
absorp tion  o f  su lphapyridine.
( I )  There i s  marked in d iv id u a l v a r ia tio n  in  the  absorp tion  o f  su lphapyrid ine 
on standard  dosage.
( I I )  In  75 p e r cen t, o f cases the  h ig h est concen tra tion  of sulphapyridine 
in  the  blood i s  reached during the  second, th ir d  o r fo u rth  day in  h o sp ita l, 
and th e re a f te r  the  concentration  remains f a i r ly  steady throughout the  period  
o f  therapy.
( I I I )  In  80 p e r cen t, o f cases th e  mean blood le v e l ,  ca lcu la ted  from 
estim atio n s  o f the  drug concen tration  performed on th e  second, th i r d  and 
fo u r th  days in  h o sp ita l, does n o t exceed 6.0 mgms. p e r 100 c .c s . and in  only 
20 p e r  cen t, o f cases does the  mean blood le v e l exceed th is  f ig u re .
(IV) The type o f in fe c tin g  pneumococcus does n o t appear to in flu en ce  the  levd . 
o f  f r e e  su lphapyrid ine in  the  blood o f  p a tie n ts  su ffe rin g  from pneumonia.
The s l ig h t ly  lower blood le v e ls  o f  p a t ie n ts  su ffe rin g  from Type I  and I I  
in fe c t io n s , e sp ec ia lly  Type I I ,  can be explained by the  h igher f lu id  in tak e  
o f  such p a tie n ts .
(V). The presence o f bacteraem ia does no t appear to in flu en ce  th e  absorption 
o f  su lphapyrid ine.
(VI) Age does n o t appear to a f f e c t  in  any way the  concentra tion  o f 
su lphapyrid ine in  the  blood.
(VII) The blood le v e ls  in  females are h igher than in  males. This i s  due to  
th e  low er f lu id  in tak e  o f females compared w ith males.
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(V III) The concen tra tion  o f  su lphapyrid ine in  th e  blood i s  n o t re la te d  
to g a s tr ic  a c id i ty .
(IX) The f lu id  in ta k e  i s  an im portan t fa c to r  in  c o n tro llin g  the  
concen tra tion  o f  su lphapyrid ine  in  the  blood, and cases w ith a low f lu id  
in ta k e  tend  to have high blood le v e ls .  This probably exp lains the  low er 
blood le v e ls  in  Type I  and Type I I  in fe c t io n s  compared w ith Type I I I  and 
Group IV, and also  the  h igher le v e ls  in  fan a le s  compared w ith males.
(X) The c l in ic a l  response as gauged by the  time taken fo r  the  tem perature 
to  re tu rn  to normal does n o t appear to be re la te d  to the  blood le v e l .
In  a few cases ev&sn w ith high blood le v e ls  su lphapyrid ine i s  in e f fe c t iv e  
in  reducing pyrex ia .
(XI) Complications o f pneumonia occur ir r e s p e c tiv e  o f the 
blood le v e l .
(XII) There i s  no reduction  in  the f a t a l i t y  r a te  in  cases w ith  high 
blood le v e ls ,  and e x ce lle n t c l in ic a l  recovery takes p lace  in  cases whose 
mean blood le v e ls  do n o t exceed 2.0 mgms. p e r  100 c .c s .
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(b ) . The excretion  o f  Sulphapyridine*
The u rin a ry  ex cre tio n  o f su lphapyrid ine i s  an extrem ely im portan t 
f a c to r  in  c o n tro llin g  the blood le v e l .  M arshall e t  &L. (1937) p o in ted  ou t 
th a t  in  p a t ie n ts  w ith ren a l impairment the  blood le v e ls  a re  o ften  amazingly 
high? even w ith a r e la t iv e ly  small dose o f a sulphonamide. In  studying  th e  
ex cre tio n  o f su lphapyrid ine i t  was found e s se n tia l to know the  p a tien t*  s 
f lu id  in ta k e  and u r in e  output. The r e s u l ts  obtained  in  estim ating  the  
d a ily  f r e e  u rin a ry  sulphapyridine in  l 6 l  cases o f pneumococcal lo b a r  
pneumonia, to g e th e r w ith the d a ily  f lu id  in tak e  and u rin a ry  ou tpu t a re  
shown in  Appendix XII, as was p rev iously  s ta te d . The mean u rin a ry  
su lphapyrid ine , f lu id  in tak e  and u rin a ry  output a re  shown in  Appendix X III.
I t  now remains to be shown th a t  i f  the f lu id  in ta k e  i s  r e s t r ic te d ,  
thereby dim inishing th e  u rin e  volume, then the u rin a ry  excretion  o f the  
drug i s  dim inished (though the  ac tu a l concentration  o f the drug in  the 
u r in e  i s  increased) and the blood le v e ls  are  consequently high. I f  f lu id s  
a re  fo rced  then th e re  i s  a rap id  excretion  o f the drug and the blood le v e ls  
a re  low.
R esu lts :
Table XXXVI.
The mean u rin a ry  su lphapyrid ine in  mgms. p e r 100 c. cs. 
c o rre la te d  w ith various blood le v e l groups.
Mean Blood Level 
mans. Der 100 c .c s .
Orine Bui ohaoyri d ine meras, per 10C c .c s .
io *0. -  100 101 -  1% X % --2 Q Q . 201. -  .250
0 -  2.0 10 6 1 0 0
2.1 -  4.0 10 41 5 0 0
4.1 -  6.0 1 20 23 9 0
6.1 -  8 .0 0 5 l i 7 5
8 .1  -  10.0 1 1 2 2 0
10.1 -  12.0 0 0 0 0 1
From the  f ig u re s  obtained the  cases were then grouped according to whether the  




The mean u rin a ry  su lphapyrid ine in  mgms. p e r 100 c. cs. in  cases 
w ith blood le v e ls  under and over 6.0 mgms. p e r 100 c .c s .
Mean Blood Level J  U rine Sulphapyridine mgms. p e r 100 c. cs.
mgms. p e r  100 c .c s . JO -  50 51 -  100 101 -  150 151 -  200 201 -  J50
6.0 and under 21 29 9 0
6.1 and over 1 6 1-7 9 6
Percentage over 6.0 5 8
31
50 100
Study o f Table XXXVII shows th a t as the  u r in e  su lphapyrid ine le v e l in creased  
then the  percentage o f  cases w ith a mean blood le v e l over 6.0 mgms. p e r 100 
c .c s . in c reased . Thus only 5 P©r  cen t, o f cases w ith a u r in a iy  le v e l n o t 
exceeding 50 mgms. per 100 c .c s . had a blood le v e l over 6.0 mgms. per 100 c .c s . ,  
y e t  100 p e r cen t, o f cases UtLth a u rin a ry  le v e l exceeding 200 mgms. p e r 100 
c .c s .  had a blood le v e l over 6.0 mgms. p e r 100 c .c s .
Conclusion:
I t  i s  found th a t  th e  lower the blood le v e ls  a re  then the lower the  u rin e  
le v e ls  tend to  be. This i s  to  be expected fo r  none o f the  161 cases 
undergoing in v e s tig a tio n  showed signs o f  ren a l impairment. I t  would thus 
seem th a t  i f  the drug i s  poorly  absorbed from the alim entary t r a c t  then the  
blood le v e ls  a tta in e d  are  low and the u rin a ry  le v e ls  are  a lso  low. I f  in  
any o f  th e  cases th e re  had been renal impairment then although absorption 
had been poor the slow excretion  o f the drug would have le d  to a r e la t iv e ly  
high blood le v e l .
Table XXXVIII.
The f lu id  in tak e  in  ounces p e r diem c o rre la te d  w ith 
various u rin e  le v e ls .
Mean Urine Level F lu id  in ta k e  in ounces p g r digm.
mgms. p er 100 c. cs«| 40-50 . ^ - q p . i S - 7 1 . 71-80 81-90 91-100 I 101-110 111-32
0 -  50 1 i l l ! 5 12 0 1 H 1
51 - 100 1 4 i 12 | 27 16 12 j 1 0
101 - 15° 2 4 3 1 13 14 3 | 3 0151 - 200 1 5 5 5 0 2 0 0201 - .250 _ ____ o 1 1 ! 2 1 -  0 1 0 0
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From th e  f ig u re s  ob tained  the  cases were then grouped according to  whether 
the  u r in e  le v e l  was under o r  over 100 mgms. p e r 100 c .c s . ,  as shown in  Table XXXDE
Table XfflX ,
The f lu id  in ta k e  in  ounces per diem in  cases w ith u r in e  
le v e ls  under and over 100 mgms. p e r 100 c .c s .
Mean U rine Level 
mgms. p e r 100 c. cs.
100 and under
101 and over 
Percentage over 100













Study o f Table XXXIX re v e a ls  th a t  as the  f lu id  in tak e  increased  then the 
percentage o f cases w ith a u rin a ry  le v e l  o f more than 100 mgms. per 100 c .c s . 
decreased. Thus 43 cases, or 45 per c e n t . ,  ou t of 95 w ith a f lu id  in tak e  n o t 
exceeding 80 ounces per diem had a mean u rin a iy  le v e l o f more than 100 mgms. 
p e r 100 c .c s . ,  and 23 cases, o r 35 Pe r c e n t . ,  ou t o f 66 w ith a f lu id  in ta k e  
o f more than 80 ounces p e r  diem had a u rin a iy  le v e l o f more then 100 mgms. per 
100 c. cs.
Conclusion;
As the  f lu id  in tak e  in c rease s  then the u rin e  le v e ls  tend to decrease.
This i s  to be expected fo r  as the f lu id  in tak e  in c rease s  then the blood le v e ls  
decrease and i t  has been shown th a t the  blood and u rin e  le v e ls  tend to run 
p a r a l le l .  Accordingly, in  p a tie n ts  who d id  no t drink well th e re  i s  a tendency
fo r  both blood and u rin e  le v e ls  to be high.
Table XL.
The u rin e  output in  ounces p e r diem c o rre la te d  w ith 
various u rin e  le v e ls .
Mean
mgms
Urine Level ~T ' F lu id  ou tp u t i n ounces per diem.
. p e r 100 c .c s . j 20 -30 p ft-4cT j  41-50~r ^ 7 0 ___




4 9 1 5 2
12 ; 15 7
10 16 I  13 1
7 7 3 0
2 1 !  1 0
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From th e  f ig u re s  ob ta ined  the  cases were then grouped according to whether 
th e  u r in e  le v e ls  were under o r over 100 mgms. p e r 100 c .c s . ,  as shown 
in  Table XLI.
Table XLI.
The u r in e  ou tpu t in  ounces p e r diem in  cases w ith 
u r in e  le v e ls  under and over 100 mgms. p e r 100 c .c s .
Mean u e in e  le v e l Urine output in  ounces per diem.
mgms. p e r 100 c .c s . 20-30 31-40 41-50 51-60 61-70
100 and under 10 16 40 20 9
101 end over 5 19 24 17 1
Study o f Table XLI shows l i t t l e  re la tio n sh ip  between the u r in e  output and 
th e  u rin e  le v e l  i f  the u r in e  outpu t did no t exceed 60 ounces p e r diem. 
However, i t  should be noted th a t  in  the ten cases excreting  more than 
60 ounces o f u r in e  p e r diem, only one had a u rin a ry  concen tra tion  o f 
su lphapyrid ine  exceeding 100 mgms. per 100 c .c s . ,  thus suggesting a 
tendency fo r  cases with a high u rin a ry  ou tpu t to  have low u rin e  le v e ls . 
Table XLI shows th a t 48 cases, o r 42 per cen t, o f those w ith a u rin a ry  
ou tpu t n o t exceeding 50 ounces p e r diem had a mean u rin a ry  le v e l  over 
100 mgms. p e r  100 c .c s . ,  and 18 cases, o r 38 p e r cen t, o f those with a 
u rin a ry  ou tpu t o f more than 50 ounces p e r diem had a u r in e  le v e l o f more 
than 100 mgms. p e r 100 c .c s .
Conclusion:
The u r in e  le v e l does no t depend to any marked degree on the  u rin a ry  
ou tpu t. There i s  a tendency fo r  a high u rin a ry  outpu t to  be accompanied 
by a low u r in e  le v e l .
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Summary o f  conclusions to be drawn from a study o f  the  
ex cre tio n  o f  su lphapyrid ine.
(1) The u r in e  le v e l s  tend to run p a r a l le l  to the  blood le v e ls ,  a lthough 
a t  a much h igher concen tra tion .
(11) The f lu id  in ta k e  as well as in flu en c in g  the  blood le v e l has an e f fe c t  
on the  u r in e  le v e l .  I f  the  f lu id  in ta k e  i s  low then both blood and u rin e  
le v e ls  a re  high.
( I l l )  The u r in e  output has n o t a marked in flu en ce  on the u r in a iy  • 
concen tra tion  o f  the  drug, although as a ru le  a high u rin a iy  output i s
accompanied by a low u r in e  le v e l .
B. Toxic  e f fe c ts  encountered during Sulphapyridine Therapy:
Of th e  numerous sulphonamides a v a ilab le  fo r  use  in  the trea tm en t o f 
lo b a r  pneumonia, i t  cannot be sa id  th a t  su lphapyridine i s  the  l e a s t  to x ic .
In  a few p a t ie n ts  th e re fo re  i t  was found necessary  to  w ithhold th e  drug on 
account o f to x ic  m an ife sta tio n s . Many to x ic  m an ifesta tio n s  may occur 
during therapy , some o f then extremely serio u s  and sometimes f a t a l .  Such 
cases are  th e  exception ra th e r  than the ru le .
From th i s  study o f 370 cases o f  lo b a r  pneumonia tre a te d  w ith
su lphapyrid ine , I  do n o t h e s i ta te  to s ta te  th a t  sulphapyrid ine although
being an e ffe c t iv e  chemotherapeutic agent, i s  n ev erth e le ss  r e la t iv e ly
non -to x ic . This r e la t iv e  absence o f to x ic i ty  was f i r s t  noted by Evans
and G aisford  (1938) who, in  th e i r  c l in ic a l  t r i a l  o f su lphapyrid ine in
pneumonia, reported  the  occurrence o f nausea, vomiting, and cyanosis, as
th e  only untoward e f fe c ts  o f admini s tr a t io n  o f the drug. Although
these  m an ifesta tio n s  were encountered in  my own s e r ie s , they caused l i t t l e  
d i f f ic u l ty  during therapy. Drug fever and drug rashes were also  encountered; 
bu t th e  more serious m an ifesta tio n s  such as haem aturia, anaemia and 
ag ranu locy tosis  repo rted  by o th e r workers were no t found in  th e  p re sen t s e r ie s .
193-
The frequency o f the to x ic  m anifestations encountered was recorded 
and the importance o f each discussed, sp ecia l atten tion  being paid to 
the incidence o f tox ic  e ffe c ts  in  rela tion  to the blood le v e l .
Anyone who has taken sulphapyridine w ill admit that i t  generally  
causes s l ig h t  m alaise, but th is  i s  rarely serious and was not counted as 
a to x ic  e f fe c t . S lig h t nausea i s  very common, and i t  also  was excluded 
from tox ic  m anifestations, as nausea unaccompanied by vomiting was not taken 
as an ind ication  for the cessation o f therapy. The tox ic  m anifestations to 
be studied include vomiting, cyanosis, drug rashes and drug fever. No 
renal upset or blood dyscrasias were encountered.
Vomiting;
The incidence o f vomiting, graded as mild, moderate, or severe, among 
the various types and the sexes i s  shown below.
Table XLII.
The incidence o f vomiting in  males and females among
Types I , I I , I I I and Gp. IV.
Degree
o f
Males Females Males & Females
Tvoe Typip __IXP-S....-
Vomiting. I I I I I I Gp.IV I I I I l l _.Gp_JLV| I XX XXX _Gd . IV .
Mild - - 1 - 1
Moderate 2 2 - - 1 1 1 1 3 3 1 1
Severe 2 1 2 4 1 - - 7 3 l 2 11
From Table XLII the incidence of womiting in  both sexes and among a l l  types
was ascertained as shown in  Table XLIII.
Table XLIII.
The incidence o f vomiting among a l l  Types.





Study o f  Table XLIII shows th a t  the number o f cases in  which vom iting 
was regarded as being m ild o r  moderate was com paritively  sm all, and in  
such cases therapy was continued. In  about double th is  number the  
vom iting was so severe o r frequent th a t  therapy had to be d iscon tinued ,
The inc idence  o f such severe vomiting was 17 in  the  37^ cases s tu d ied , 
o r only 4 .6  p e r cen t. I t  w ill be noted th a t  vom iting was d is tr ib u te d  
f a i r l y  eveftly over a l l  types and f a i r ly  evenly among the sexes. A few 
fem ales su ffe r in g  from Group IV in fe c tio n s  had the drug stopped on 
account o f p e r s is te n t  vomiting. Many such in fe c tio n s  were r e la t iv e ly  
m ild and th e re  was a tendency to stop the drug i f  vomiting was p e r s is te n t  
in  the  early  s tages o f therapyj although in  the more severe Type I I  
in fe c t io n s  one was re lu c ta n t to withhold the drug and consequently in  
some cases in  which there  was i n i t i a l l y  a moderate degree o f vomiting 
th i s  c leared  i f  therapy was continued.
In  ten o f th e  seventeen cases with vomiting blood le v e l determ inations 
were made, and the mean blood le v e ls  o f such cases were tab u la ted  as 
shown in  Table X LIV .^
Table XLIV.
The mean blood le v e ls  in  cases e x h ib itin g  vomiting.
Degree o f Vomiting. No. o f Cases. Mean Blood Level mgms. p e r 100 c. c 3.
Mild 1 2.9
Moderate 4 4.6, 5. 3, 5. 3, 7.7
Severe 5 2. 3, 2. 8 , 3-5, 5-o, 7-4
Study o f  Table XLIV shows th a t  e ig h t cases ou t o f the ten whose blood le v e ls  
were determined had a mean concentration  of under 6.0 mgms. p e r 100 c .c s . ,  
and two cases had concentra tions exceeding th i s  f ig u re . The presence o f
vom iting was n o t a sso c ia ted  w ith high blood le v e ls ;  and indeed i t  was only
n a tu ra l  th a t  le v e ls  should be low in  p a tie n ts  who were vom iting, fo r  in  such
cases the  absorp tion  o f sulphapyrid ine was undoubtedly dim inished.
M The blood le v e ls  cor.pared were the laean levels calculated from estimations 
performed throughout the period of therapy.
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Cyanosis:
Marked cyanosis a t t r ib u ta b le  to sulphapyridine was noted in  only two 
o f  the  370 cases* In  both in s tan ces  i t  was marked and the  drug was stopped 
th ree  days a f t e r  the  onset o f therapy. Both cases occurred in  males, one 
being a Type I I  in fe c tio n  and the o th e r a Group IV in fe c tio n . The mean 
blood con cen tra tio n  in  the Type I I  case was 2 .7 mgms. p e r 100 c .c s . ,  the 
o th e r n o t having had the  blood le v e l determined.
Drug Rashes:
Table XLV.
The inc idence  o f drug rashes among Types I ,  I I ,  I I I  and Gp. IV.
Sex. —  f
Type
I I I I I I Gp.IV All Types.
Male 2 0 - 4 6
Female 1 2 - 7 10
Males & Females 3 2 - 11 16
Study o f  Table XLV shows th a t drug rashes appeared in  16 o f the 370 cases
s tu d ie d , o r  in  4 .3  p e r cen t, o f a l l  cases. Drug rashes were s l ig h t ly  more
freq u e n tly  encountered in  females than in  males, s ix  o f 248 males and 10 o f
122 fem ales to whom the  drug was adm inistered developing rashes. The
ty p ic a l ra sh  was a m orbilliform  one, u su a lly  commencing w ith a flu sh ing  o f
the  face  and th o i extending to the trunk and lim bs. More ra re ly  the rash
f i r s t  appeared on the buttocks and backsof the th ighs, and remained more o r
l e s s  confined to th is  area without becoming generalised . On one occasion
the  ra sh  assumed the  form of a generalised  punctate  erythema. The onset o f
such ra sh es  was a t  about the end of the f i r s t  week in  h o sp ita l, the e a r l i e s t
being no ted  5 days a f te r  treatm ent commenced. Six o f the  p a tie n ts  who 
developed rashes had th e i r  blood le v e l determined. The mean concentration  
expressed in  mgms. per 100 c .e s . ,  o f the  p a tie n ts  developing rashes was:- 
6 .1 , 6 .6 , 7 .1 , 7 .1 , 7 .8 , 9 .8 . A ll cases had blood le v e ls  exceeding 6.0 mgms.
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mgms. p e r  100 c . c s . , and the  rash  in  such p a tie n ts  was undoubtedly a 
to x ic  m an ife s ta tio n  re s u lt in g  from the  high blood concen tra tion .
Drug P yrex ia:
In  many p a tie n ts  developing rashes, the onset o f such was suspected 
by a sharp e lev a tio n  o f tem perature in  a p a tie n t o therw ise p rogressing  
favourab ly . I n a few cases the tem perature was only elevated  by 1 °F ., bii; 
i t  was much more frequen t to fin d  a tem perature o f 103°F. o r 104°F. marking 
th e  o n se t o f  a rash . Of the s ix teen  p a tie n ts  who developed a drug rash , 
eleven had a lso  drug fev er, while in  one p a tie n t who subsequently developed 
m e n in g itis , the  tem perature remained u n se ttle d  throughout the i l ln e s s ,  and 
i t  was im possib le to regard the fever as a tox ic  m an ifesta tion  o f the drug.
In  th e  rem aining four cases having rashes, no e leva tion  of tem perature 
accompanied the  presence o f the drug rash .
Haematuria:
Not one case was recorded, although th e  u rin e  was examined d a ily  
fo r  th e  presence o f blood throughout sulphapyridine therapy.
Blood d y sc ras ia s :
In  severa l cases during therapy leucopenia was p re sen t, b i t  i t  was 
never so severe th a t sulphapyridine had to be w ithheld. No case o f 
haem olytic anaemia o r agranulocytosis occurred throughout th is  s e r ie s . 
Conclusion:
The treatm ent o f cases o f pneumococcal lo b a r pneumonia with 
su lphapyrid ine  i s  accompanied by r e la t iv e ly  few to x ic  m an ifesta tions.
Vomiting i s  the  most common tox ic  m an ifesta tion  encountered during therapy, 
but in  only 4 .6  p e r cen t, o f cases i s  i t  so severe as to n e c e s s ita te  tne
cessa tio n  o f  therapy. Cyanosis does no t prove a troublesome com plication.
Drug rash es  and drug pyrex ia  occur in  about 5 Per cent, o f cases and are found
/
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found in  cases w ith high hLood le v e ls .  These l a t t e r  to x ic  m an ife sta tio n s  
a re  undoubtedly th e  r e s u l t  o f  high blood concen tration , but vom iting 
and cyanosis a re  n o t a t tr ib u te d  to  high blood le v e ls .
CHAPTER VI. x98.
D iscussion.
Lobar pneumonia has in  the p a s t proved both a common and a se rio u s  d isea se . 
In  some in s ta n c e s , even under the most favourable circum stances, i t  may s t i l l  
th re a te n  l i f e .  I t  i s  a d isease  whose sev e rity  and m o rta lity  vary g re a tly  from 
y e a r  to  y e a r and from p lace to  p lace . The p resen t study has shown th a t  during 
th e  y ears  1941 and 1942 lo b a r pneumonia was f a i r l y  p reva len t in  Glasgow and, 
as judgedby th e  type of the in fe c tin g  pneumococcus, conformed to  the severe 
type o f the  d isea se  c h a ra c te r is t ic  of the C ity . Even w ith chemotherapy i t  was 
a sso c ia te d  w ith  a f a t a l i t y  ra te  o f 7*5 Pe r  cen t. The re s u lts  whicli have been 
given in  the  preceeding chapters suggest th a t  the  th ree  most im portant 
co n d itio n s  a f fe c t in g  the outcome are  the type of the in fe c tin g  pneumococcu3, 
th e  presence o r absence of bacteraeraia, and the age o f the p a t ie n t .
( i )  The Type o f the  in fe c tin g  pneumococcus.
A knowledge o f th e  type of the in fe c tin g  pneumococcus must stand out as being 
o f prime importance in  the treatm ent of lo b ar pneumonia because type sev e rity  
and m o rta lity  vary  so very considerably , more than one th ir d  o f the 370 cases 
in  th i s  s e r ie s  were due to  Type I I  in fe c tio n s , a f ig u re  much h igher than th a t  
rep o rted  from o th e r p a r ts  o f th is  countiy o r from America. Type I I  pneumococcus 
was moreover found to  be the most p reva len t in d iv id u a l type throughout most 
months o f the y e a r . In fec tio n s  due to  th is  type were considered c l in ic a l ly  to  
be much more severe than those due to  a l l  o th e r types .That th is  was so i s  b o n e  
out by th e  f a t a l i t y  ra te  which Y/as found to  stand a t  the  high fig u re  o f 12*5 
p e r c en t; the  remaining types considerea to g e th er only showed a ra te  o f 5*0 
p e r  c en t. I t  i s  in te re s t in g  to  consider the p o ssib le  d iffe ren ces  wnich e^cist 
between Type' I I  and the  o th er type in fe c tio n s .
The incidence o f bacteraem ia among Type I I  in fe c tio n s  was 3 2 .8  p e r  cen t b u t 
among a l l  o th e r types i t  was only 7*9 Pe r  cen t. I t  w i l l  l a t e r  be shown th a t  
bacteraem ia /
bacteraem ia ex e rc ise s  a considerable e f fe c t  upon the  f a t a l i t y  r a te ;  the  marked 
d iscrepancy  between the  incidence o f the blood invasion suggests a p o ssib le  
reason f o r  th e  high  f a t a l i t y  ra te  encountered in  Type I I  cases. Type I I  
in fe c t io n s  occurred a t  a l l  ages, bu t they were most common between the ages 
o f 41— 50 y e a rs . This co n tra s ts  w ith Type I  in fe c tio n s  which were more freq u en tly  
encountered a t  an e a r l i e r  age. I t  i s  th e re fo re  apparent th a t  Type I I  in fe c tio n s  
a re  more l ik e ly  to  be asso c ia ted  w ith bacteraem ia than a l l  o th e r types and they 
a re  most l ik e ly  to  a tta c k  those in  the "prime of l i f e " .  The high incidence and 
h igh  f a t a l i t y  r a te  o f Type I I  in fe c tio n s  probably explains the se v e r ity  of 
lo b a r  pneumonia in  th i s  C ity .
Although Type I I  in fe c tio n s  are  c l in ic a l ly  so severe i t  i s  apparent th a t  th is  
s e v e r i ty  i s  n o t due to  a more extensive pulmonary involvement fo r  only 22 per 
cen t, o f a l l  Type I I  in fe c tio n s  had more than one lobe involved whereas 25 per 
cen t, o f a l l  o th e r types had more than one lobe involved.
The d u ra tio n  o f the  i l ln e s s  a t  the time of admission to  h o sp ita l s ig n if ic a n tly
(jPpf>Age89)
a ffe c te d  the  r e s u l t s  of therapy in  the case of Typeb-II infections/,. The f a t a l i t y
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ra te  in  53 Type I I  in fe c tio n s  tre a te d  before the th ird  day of i l ln e s s |7 .5  
p e r cen t; in  the  72. Type I I  in fe c tio n s  tre a te d  a f t e r  the th ird  day of i l ln e s s  
i t  was 16.5  p e r  c e n t . I t  i s  worth drawing a tte n tio n  to  the f a c t  th a t  only I 37 
p a t ie n ts  (o r  37 P®r cent, of the to ta l)  were adm itted to  h o sp ita l during the f i r s t  
th re e  days o f i l l n e s s .  Although th is  emphasises the delay in  making a d iagnosis 
i t  a lso  suggests th a t  the f a t a l i t y  ra te  might be fu r th e r  reduced i f  p a tie n ts  
were t re a te d  a t  an e a r l i e r  stage of th e i r  i l ln e s s .  General p rac tio n e rs  are 
n a tu ra l ly  unw illing  to  recommend h o sp ita l treatm ent fo r  th e i r  p a tie n ts  u n t i l  
unecuivocal s igns such as dulness on percussion and tu b u la r breath ing  have devel— 
-oped.More re lia n c e  might be placed on the c la s s ic a l  symptoms of r ig o r ,p a in  in  
the  chest,dyspnoea and cough occurring suddenly in  a p rev iously  healthy  
in d iv id u a l; /
in d iv id u a l;  i f  t h i s  were done many more cases of lo b a r pneumonia would be 
h o s p ita l is e d  a t  an e a r l i e r  stage of the i l ln e s s .  E a r l ie r  admission to  h o s p ita l ,  
w ith  e a r l i e r  in s t i tu t io n  of chemotherapy, would undoubtedly bejin the b e s t 
in t e r e s t s  of th e  p a t ie n t . I  fu l ly  apprecia te  , however , th a t  in  many in s tances 
the  g en era l p ra c tio n e r  i s  no t summoned to  the i l l  p a tie n t u n t i l  the d isease  i s  
a lread y  w ell e s ta b lish e d .
Type I  in fe c tio n s  were a lso  f a i r ly  severe c l in ic a l ly  w ith w ell marked signs 
o f co n so lid a tio n , bu t they tended to  be more common in  younger persons than 
Type I I  in fe c tio n s  and they were assoc ia ted  w ith a much lower f a t a l i t y  r a te .  
Type I I I  in fe c tio n s  were ra th e r  uncommon and as a ru le  were a sso c ia ted  vrith 
a le s s  w e ll defined  c l in ic a l  p ic tu re . Such in fe c tio n s  a re  not n e ce ssa rily  
accompanied by a high f a t a l i t y  ra te  but in  the aged they are s t i l l  severe 
and high  f a t a l i t y  r a te s  have been reported . Group IV in fec tio n s  a lso  were 
a sso c ia te d  w ith  a le s s  w ell defined consolidation  than e i th e r  Types I  o r I I .
The f a t a l i t y  r a te  of Group IV in fec tio n s  was not high. I t  i s  hard ly  f a i r  to  
co n sid er a l l  members of Group IV toge ther, because among in d iv id u a l types in  
t h i s  group th e re  i s  marked v a ria tio n  in  the sev e rity  and in  the f a t a l i t y  ra te .  
However, th e  p re sen t s e r ie s  i s  too small to  perm it of a comparison of the 
in d iv id u a l types included in  Group IV.
The typ ing  of pneunococci by the Neufeld method of capsular sw elling i s  
e a s i ly  c a r r ie d  ou t and should I  th in k  be performed in  a l l  cases o f pneumococcal 
lo b a r  pneumonia. The find ing  of a Type I  o r I I  pneumococcus in  the sputum i s  
p r a c t ic a l ly  conclusive evidence th a t  the in fe c tio n  i s  due to  the type of 
pneumococcus is o la te d  because these  organisms are  ra re ly  found in  the  th ro a ts  
o f normal persons (Heffron 1939) *1 f e e l  however th a t  the physician  should no t 
be s a t i s f i e d  w ith  th e  diagnosis of lo b a r pneumonia u n t i l  the id e n t i ty  of the 
organism /
organism causing th e  d isea se  i s  e s ta b lis h e d . The tim e taken f o r  th e  
b a c te r io lo g ic a l  exam ination o f th e  sputum i s  c e r ta in ly  w e ll sp en t. The 
a d d i t io n a l  knowledge gained concerning th e  p o ss ib le  outcome o f th e  d isea se  
i s  q u ite  apparen t when Type I  and I I  in fe c tio n s  a re  compared. In  th e  absence 
o f  complete f a c i l i t i e s  f o r  typ ing  i t  would seem very  d e s ira b le  t h a t  exam ination 
f o r  th e  f i r s t  th re e  types a t  l e a s t  be a ttem pted .
( i i )  The presence or absence of Bacteraemia.
B acteraem ia was p re se n t in  16.5  p e r  cen t o f a l l  c a se s , and as p re v io u s ly  
s ta te d  i t  was more fre q u e n tly  encountered in  Type I I  in fe c tio n s  than  in  a l l  
o th e r  ty p e s . I t  a lso  was more fre q u e n tly  encountered in  those over 50 y ears  
o f age than  in  th o se  under th i s  age, th e  f ig u re s  being 27 p e r  cen t, and 13 
p e r  c e n t .r e s p e c tiv e ly .
The f a t a l i t y  r a te  in  bacteraem ic cases was 27 p e r  cen t and in  non-bacteraem ic 
cases was 3 Pe r  c en t. I t  i s  in te r e s t in g  to  n o te  th a t  no le s s  than  15 o f th e  
16 death s due to  Type I I  in fe c tio n s  occurred in  p a t ie n ts  w ith  i n i t i a l  
bacteraem ia.T he presence o f an inv asio n  o f the  blood stream  obviously  in d ic a te s  
a  severe  in fe c t io n  and must be regarded  as a very  unfavourable s ig n . Q uite 
a p a r t  from i t s  obvious im portance in  re sp e c t o f outcome bacteraem ia a lso  tends 
to  in flu en ce  th e  development o f the  com plications o f pneumonia. Thus delayed 
re s o lu tio n  was more fre q u e n tly  encountered in  bacteraem ic than in  non- 
bacteraem ic case s . The f ig u re s  fo r  o th e r  com plications a re  n o t la rg e  enough 
f o r  a n a ly s is .  A knowledge of th e  presence o r absence o f bacteraem ia i s  
c le a r ly  o f g re a t value in  o ffe r in g  a prognosis in  lo b a r  pneumonia.
( i i i )  The Age o f the p a tien t.
The age o f th e  p a t ie n t  i s  the th i r d  f a c to r  which I  co n sid e r to  be o f s p e c ia l 
im portance in 'p ro g n o s is ; as age advances th e  f a t a l i t y  r a te  in c re a s e s . Thus 
i r r e s p e c t iv e  o f th e  type o f the  in fe c tin g  pneumococcus th e  f a t a l i t y  r a te  in  
th e  15-35 years  age group period  ua.s 1 .4  p e r  c en t, in  th e  3^-55 y ears  age 
group /
group 9.6  p e r c en t, and in  the  56-75 y ears  age group p erio d  16.4 p e r  c en t.
I  have a lread y  shown th a t  Type I I  in fe c tio n s  we re  most freq u e n tly  encountered 
between th e  ages o f 41-50 y ears  and th a t  bacteraem ia was more freq u e n tly  
encountered in  those over 50 years  o f age than in  those under th i s  age. 
Consequently as age advances the  outlook fo r  su ccessfu l recoveiy  from 
pneumonia becomes p ro g ress iv e ly  poorer and th is  i s  doub tless due to  a 
g e n e ra lise d  decrease in  the  re s is ta n c e  o f the  h o s t.
The o th e r fa c to rs  which were analysed ( the  sex of the  p a t ie n t ,  the  ex ten t 
o f the  pulmonary involvem ent, the day o f i l ln e s s  a t  the  time of adm ission 
to  h o s p i ta l ,  the  pu lse  and re s p ira t io n  ra te s  obtained sh o rtly  a f t e r  adm ission, 
th e  presence o f herpes and of de liriu m , and the leucocyte count)although 
th ese  g ive a d d itio n a l knowledge concerning prognosis which might prove u se fu l 
a re  by them selves of l i t t l e  value in  prognosis in  the absence of a knowledge 
o f th e  th re e  fa c to rs  which I have d iscussed  more ex ten s iv e ly .
A study o f th e  d a ily  tem peratures during the f i r s t  ten  days in  h o s p ita l  
shows th a t  sulphapyridinew as an e ffe c t iv e  drug in  the  reduction  o f p y rex ia ; 
in  50 p e r  cent, o f cases tne  d u ra tion  of prim ary pyrex ia  d id  n o t exceed 48 
hours. I t  i s  in te re s t in g  to  no te  th a t  the  period  ,of prim ary pyrex ia  was n o t 
re la te d  to  the  day of i l ln e s s  a t  the  time therapy commenced. Lobar pneumonia 
was p rev iously  a sso c ia ted  w ith  pyrex ia  of about seven days d u ra tio n ; the  
use of sulphapyrid ine has considerably  shortened th i s .
Delayed re so lu tio n  was the  com plication most freq u e n tly  encountered. In  
q u ite  a few in stan ces  patien ts,w ho s t i l l  ex h ib ited  p h y sica l signs such as 
dulness on percussion  and tu b u la r  b rea th in g , were dism issed a fe b r i le  and 
otherw ise w e ll. Even some months a f t e r  d ism issa l a few p a tie n ts  who were 
followed up had s t i l l  signs o f incom plete re so lu tio n . There was l i t t l e  
d iffe ren c e  in  the  incidence of th is  com plication among the  various ty p es,
but i t  was more common in  bacteraemic than in  non-bacteraemic cases and 
in  those over 50 years o f age than in  those Under th is  age. The incidence 
o f delayed resolu tion  too i s  s l ig h t ly  lower in cases treated  early ( up to  
the th ird  day o f i l ln e s s  ) than in  cases treated la te  ( a fte r  the th ird  day 
of i l ln e s s ; t h i s  i s  a further argument fo r  the ea r lie r  h o sp ita lisa tio n  of 
p atien ts  suffering from lobar pneumonia. S te r ile  p leural effusion  and empyema 
occurred in  a small number of cases but these complications were not as a 
rule fa t a l ,  although they lengthened considerably the period of convalescence. 
Pneumococcal m eningitis complicating pneumonia was fortunately  rare ; both 
cases proved fa ta l .
In  Chapter II  I stated  that the vaccine treatment of lobar pneumonia 
had been advocated by several workers both in  th is  country and abroad. From 
the availab le  reports i t  appears im possible to  evaluate the merit of vaccine 
in  the treatment of lobar pneumonia, because in  many instances the e t io lo g ic a l  
diagnosis of the d isease was not established and often the cases were not 
controlled  with a non-vaccinated se r ie s . The treatment of an ex istin g  in fec tio n  
by vaccination has not been proved to be of value in any other d isease and 
there i s ,  in consequence, no support by analogy for  i t s  use in pneumococcal 
pneumonia. None the le s s ,th e  few advocates of vaccines are quite emphatic 
in  th e ir  approval. Barach (1931) demonstrated antibodies in the serum of 
p atien ts  three days a fte r  the adm inistration o f vaccine, so that there 
would appear to  be a more rapid and a lso  a greater production o f antibody 
than i s  usually  found in cases not receiving vaccine therapy. This greater  
production o f antibody might tend to influence favourably the course o f the 
d isease .
Sulphapyridine i t s e l f  provides an extremely e ffica c io u s  form of therapy 
fo r  lobar pneumonia, and T i l le t t  (1942) has shown that i t  does not s ig n if ic a n t­
ly  a ffe c t  e ith er  the antigen ic in teg r ity  of the in fec tin g  pneumococci or the 
immunological /
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immunological responsiveness of patien ts suffering from lobar pneumonia.
One would expect therefore that the two forms o f therapy when used in  combination 
might g ive extremely b en efic ia l r e su lts . In fa c t MacLean, Rogers and Fleming 
(1939) showed that in  experimental pneumococcal in fection s in mice the 
combination o f chemotherapy and vaccine therapy was d e fin ite ly  advantageous.
Unfortunately only 6l  cases of the ser ies  of 370 received combined 
sulphapyridine and vaccine therapy. However, careful- comparison with a 
control group o f 6l  cases receiving only sulphapyridine showed that the 
adm inistration o f type sp ec if ic  pneumococcus vaccine had no appreciable 
in fluence on the immediate c lin ic a l response as gauged by the duration of 
the primary pyrexia, on the occurrence of the complications of pneumonia 
or on the f in a l outcome of the disease.The re la tiv e  in effectiven ess of  
vaccines in  the combined treatment of pneumococcal in fection s in man 
compared with in  mice might suggest that the action of sulphapyridine in  
man i s  not exactly  sim ilar to i t s  action in mice. The resu lts  of combined 
chemotherapy and vaccine therapy were frankly disappointing.
The resu lts  obtained in  the study of the absorption and excretion of
sulphapyridine show c lea r ly , as has been noted by many other workers, that
drug
very marked variation  in  the amount of free jin  the blood was . noted when the 
drug was administered in standard, dosage to d ifferen t ind iv iduals. The mean 
blood le v e ls  obtained in my ser ies  are rather lower than those reported by other 
workers. Thus only 20 per cent of my cases had a mean blood le v e l over 6 .0  mgras. 
per 100 c . c s .  yet Kinsman e t a l .  ( 1939) reported that about 40 per cent of 
th e ir  patien ts  had a mean blood le v e l exceeding th is  figu re.
An endeavour was made to find out wny there should be such variation  of 
the concentration of the drug in  the blood. A study ox the parasite ( the type 
o f the in fec tin g  pneumococcus and the presence or absence of bacteraemia )
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and c e r ta in  a t t r ib u te s  o f the  h o s t ( th e  age and sex o f th e  p a t ie n t  and 
th e  le v e l  of g a s t r ic  a c id i ty )  f a i l e d  to  exp la in  th e  v a r ia t io n  in  th e  blood 
lev e ls .T h e  f lu id  in ta k e  was however found to  be an im portan t f a c to r  in  
c o n tro llin g  the  co n cen tra tion  of the  drug in  the  blood. I  am le d  to  conclude 
th a t  th e  v a r ia tio n  noted in  th e  blood le v e ls  depends la rg e ly  on th e  in d iv id u a l 
v a r ia t io n  in  the  cap ac ity  to  absorb th e  drug. Why c e r ta in  in d iv id u a ls  absorb 
su lphapyrid ine much more re a d ily  than o th e rs  remains to  be exp lained .
The high f lu id  in tak e  which I  achieved w ith my p a t ie n ts ,  by in flu en c in g  
th e  r a te  o f ex cre tio n  of the drug, probably exp lains why the  con cen tra tio n  
o f su lphapyrid ine in  the blood was s l ig h t ly  lower than th a t  rep o rted  by 
o th e r  w orkers. From th e  time of adm ission to  h o s p ita l  I  encouraged my 
p a tie n ts  to  d rink  la rg e  q u a n tit ie s  of f lu id s  and as a r e s u l t  t h e i r  f lu id  
in tak e  was on the  whole- r e la t iv e ly  h igh . The drug was ra p id ly  excreted  
thereby  tending to  lower the concen tra tion  in  the  blood. A fu r th e r  fa c to r  
which might exp lain  why h igher le v e ls  a re  obtained by American workers i s  
th e  warmer c lim ate o f th a t  country . Such a clim ate  might tend to  in c rease  
p e rsp ira tio n  and th i s  might w ell cause an in c rease  in  the con cen tra tio n  
o f the  drug in  the  blood.
I t  has freq u en tly  been s ta te d  th a t  a sulphonamide drug should be 
adm inistered  in  a c e r ta in  dosage in  o rder to  produce a c e r ta in  co n cen tra tio n  
of th e  drug in  the  blood . For example in  the  trea tm en t o f lo b a r  pneumonia long & 
B lis s  (1939*) advocate th a t  fo r  m oderately i l l  p a t ie n ts  a blood le v e l  o f 
6 .0  mgms. p e r 100 c .c s .  i s  d e s ira b le  and fo r  sev ere ly  i l l  p a t ie n ts  a  le v e l  
o f 7 -  10 mgms. p e r 100 c .c s .  i s  d e s ira b le . This id ea  o f a d e s ira b le  
concen tra tion  of a  sulphonamide drug in  the  blood i s  being expressed re p e a t­
ed ly ; no one has y e t  shown, fo r  the  various in fe c t io n s , ju s t  what c o n s ti tu te s  
a s u ita b le  blood le v e l .  T h e o re tic a lly  i t  has been suggested th a t  to  ob ta in  
one hundred p e r cen t, cure in pneumonia the concentration of the sulphonamide 
drug /
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drug in  the blood should be above a certain  fig u re . I f  death occurs in  
lobar pneumonia the question a r ise s , are such deaths due to the fa c t  that 
the concentration o f the drug in  the blood i s  too low to be e ffec tiv e?  I f  
such i s  the case then in  order to ensure maximum recovery in  lobar pneumonia 
carefu l and repeated control of the blood le v e ls  must be carried out. I t  
must f i r s t  be shown however that a correlation  e x is t s  between the blood 
le v e l  and the outcome of the d isease .
The fa t a l i ty  rate in  cases whose mean blood le v e l  did not exceed 6 .0  mgms. 
per 100 c . c s .  was 5*5 Per cent ; in  those whose mean blood le v e l exceeded 
th is  figu re i t  was 8 .5  per cent. None o f the deaths occurred during the 
f i r s t  24 hours in  h o sp ita l. Two o f the deaths in  the lower blood le v e l  
group resulted  from associated d isease which would further reduce the 
f a t a l i t y  rate. The other eight p atien ts survived fo r  more than 30 hours 
a fte r  therapy commenced so that the sulphapyridine had had a su ff ic ie n t  
time to exert a b en e fic ia l action . The resu lts  would appear to show that 
the f a t a l i ty  rate in  pneumonia i s  not dependent on the concentration 
o f the drug in  the blood.
I have a lso  shown in Chapter V that the duration o f the primary pyrexia 
and the occurrence o f the complications pf pneumonia could not be correlated  
with the concentration o f the drug in  the blood. In fa c t ex ce llen t c l in ic a l  
recovery occurred in  17 cases whose mean blood le v e l  did not exceed 2 .0  mgns. 
per 100 c .c s .  These 17 cases would appear to  be worthy o f further consideration  
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Study o f Table I  shows th a t  in fe c tio n s  of a l l  types were included  among 
th e  17 p a t ie n ts ,  and th a t  10 o f the p a tie n ts  su ffe red  from a Type I I  
in f e c t io n .  S ix  p a t ie n ts  o r  35 p e r cent, had bacteraem ia. Only 3 o f the 
p a t ie n ts  were over 50 years of age but 5 were over 40 years o f age. However, 
i t  i s  worth n o tin g  th a t  among these f iv e  cases was a male p a tie n t  72 years  
o f age su ffe rin g  from a Type I in fe c tio n  w ith bacteraem ia of th re e  days 
d u ra tio n , and a male p a tie n t 71 years of age su ffe rin g  from a Type I I I  
in fe c t io n . Although I  fu l ly  ap p recia te  how si;iall th is  s e r ie s  i s  y e t i t  must 
be emphasised th a t  in  th is  group of 17 cases were included some r e a l ly  i l l  
p a t ie n ts .  That no deaths occurred among these p a tie n ts  in  sp ite  o f the  f a c t  
th a t  the  mean blood le v e l did n o t exceed 2.0  mgms. per 100 c .c s .  must be 
regarded as o f some in te r e s t .
Table I  a lso  shows th a t  the dura tion  of the primary pyrexia was no t 
lengthened by the  presence of a low blood le v e l fo r  in  8 cases o r alm ost 
50 p e r  c e n t . i t  d id  n o t exceed 48 hours and in  13 cases o r 77 p e r c e n t . i t  
d id  n o t exceed 96 hours. In  only 3 cases d id  the primazy pyrexia exceed 
6 days. Cases however with p ro lo n g e d  fev er were encountered w ith h igher 
le v e ls  o f the drug in  the blood.
Two cases o f delayed re so lu tio n , two of s t e r i l e  p le u ra l e ffu sio n  and one of 
empyema were included in  the 17 cases who had low blood le v e l s . Both p a tie n ts  
( one Type I  and one Type I I  in fe c tio n  ) who developed delayed re so lu tio n  
had bacteraem ia, and one of the p a tie n ts  ( a Type I I  in fe c tio n  ) who- 
developed a s t e r i l e  p le u ra l e ffu sion  a lso  had bacteraem ia. The case o f 
empyema ( a Type I  in fe c tio n  ) was bacteraem ic and pus was p re sen t in  h is  
ch est a t  the  time o f adm ission-to h o s p ita l .  The com plications which occurred 
among th e  17 p a tie n ts  in  th is  group a l l  in d ic a te  th a t  the d isease  was severe .
.tron th i s  study ox th e  absorp tion  and excretion  o f su lphapyrid ine I  am 
le d  to  conclude th a t  tne immediate c l in ic a l  response as gauged by the  
d u ra tio n  o f th e  prim ary pyrex ia , the occurrence of the com plications of 
pneumonia and the  f a t a l i t y  ra te  are  no t d ir e c t ly  c o rre la te d  w ith  the  
co n cen tra tio n  of the  drug in  the blood.
I t  i s  obvious th a t  sulphapyridine provides an extrem ely e f fe c t iv e  th e ra ­
p e u tic  agent fo r  use in  the treatm ent of lo b a r pneumonia; i t  has done much 
to  reduce the f a t a l i t y  ra te  of th is  t r u ly  im portant d isease  to  i t s  p re sen t 
low f ig u r e .  However I  f e e l  th a t  we have s t i l l  much to  le a rn  about sulphapyr­
id in e  and o th e r sulphonamides, e sp e c ia lly  concerning th e i r  mode o f a c tio n .
I t  has been shown th a t  the sulphonamide drugs a re  b a c te r io s ta t ic  and the 
work o f Woods (1939) t F ild es  (1940) and o thers  suggests th a t  th i s  b a c te r io ­
s t a t i c  ac tio n  nay be the r e s u l t  o f in te rfe re n c e  w ith th e " lin e  o f  e s s e n tia l  
metabolism "of the b ac te ria .B u t su re ly  th is  cannot be the so le  explanation 
o f t h e i r  b e n e f ic ia l  a c tio n , e sp e c ia lly  as i t  would seem p o ssib le  th a t  the 
concen tra tion  o f sulphapyridine in  the blood does no t a f f e c t  the e ff ic a cy  
o f therapy .
In  America th e re  i s  an ever growing tendency to  perform estim ations o f 
th e  concen tra tion  of the drug in  the  blood o f a l l  p a tie n ts  receiv ing  sulphon- 
am ides. U nfortunately  in  th is  countiy  ro u tin e  estim ations of the  concen tra tion  
o f th e  drug in  the  blood are  seldom c a rr ie d  out during sulphonamide therapy .
A considerab le  time would be spent in  perform ing accu ra te  estim ations o f the 
cohcen tra tion  o f the drug in  the  blood and u rin e ; but I  f e e l  th a t  in  the chemo­
therapy  o f lo b a r pneumonia, as in  the treatm ent of o th e r in fe c tio n s  w ith  su lph- 
onamides the  concen tra tion  of the drug in  the blood should c e r ta in ly  be 
determ ined a t  l e a s t  fo r  the  f i r s t  th ree  days a f t e r  therapy commences. The 
p re sen t s e r ie s  of l 6l  cases i s  u n fo rtu n a te ly  sm all and only by c o lle c tin g  a 
la rg e  s e r ie s  of cases we s h a ll  gain fu r th e r  inform ation concerning the  value 
o f a  knowledge of the concentra tion  of the drug in  the  blood and in  th is  way 
help  in  th e  so lu tio n  of the  mode of ac tio n  of the  sulphonamide drugs.
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No r e a l ly  se rio u s  to x ic  m an ife sta tio n s  were encountered in  th e  trea tm en t 
of th e  370 cases of lo b a r pneumonia w ith  su lphapyrid ine . Vomiting and cyanosis 
d id  n o t prove troublesom e. Drug rashes and drug fe v e r were found in  about 5 P©r  
cen t, o f a l l  cases, and among those who had th e i r  blood le v e l  determ ined such 
to x ic  m an ife sta tio n s  were always a sso c ia ted  w ith  a high blood le v e l .  I t  would 
appear to  me th a t  drug rashes a re  no t due to  p h o to se n s itis a tio n  o f th e  sk in  
as was suggested by Hallara (1939) bu t a re  the  r e s u l t  o f a  high concen tra tion  
of th e  drug in  the  blood. No blood d y scras ia s  o r re n a l u p se t were encountered.
I  a t t r ib u te  th e  low incidence o f to x ic  m an ife sta tio n s  to  the  la rg e  f lu id  in tak e  
of my p a t ie n ts  during the  period  o f therapy .
The r e s u l ts  obtained in  the  trea tm ent of th e  370 cases o f pneumococcal 
lo b a r pneumonia are  very g ra tify in g  in  th a t  the  f a t a l i t y  ra te  was low, the  
com plications were r e la t iv e ly  few and no r e a l ly  serio u s  to x ic  m an ifesta tions 
were encountered during therapy w ith  su lphapyrid ine . However, in fe c tio n s  due to  
c e r ta in  types o f pneumococcus a re  very severe e sp e c ia lly  in  the  aged and i f  
a sso c ia ted  w ith  an invasion  of the  blood stream . I  f e e l ,  th e re fo re , th a t  lo b a r 
pneumonia should be regarded as a medical emergency; an accu ra te  d iagnosis 
should be made as e a r ly  as p o ssib le  and trea tm en t should be in s t i tu te d  im mediately 
fo llow ing d iag n o sis . The ease o f ad m in is tra tio n  of the sulphonamides and the 
ready response o f the  p a tie n ts  to  these  drugs might lead  to  a g re a te r  number of 
cases being tre a te d  a t  home. We have, however, s t i l l  much to  le a rn  about the 
chemotherapy of lo b a r pneumonia and I  would s tro n g ly  recommend th a t  p a t ie n ts  
su ffe rin g  from lo b a r pneumonia should be tre a te d  in  h o s p ita l  where f a c i l i t i e s  
a re  a v a ila b le  f o r  pneumococcus ty p ing , f o r  tak in g  blood c u ltu re s  and fo r  
perform ing estim ations o f the  concen tra tion  o f th e  sulphonamide drug in  
th e  blood.
APPENDIX I . 211.
Showing th e  in c id en ce  o f the  various Types o f  the  author* s T]0 cases. 
The in c id en ce  i s  c o n tra s te d  w ith a s e r ie s  o f 1,000 cases o f  Bullowa.
Type
Author*s S e rie s  \ Bullowa* s S e rie s .
No. o f cases*
,jP ercentage. No. o f cases. Percen tage .
I 87 23.6  ! 253 25.3
I I 128 35-6 | 79 7.9
I I I 18 4.9 .! 115 11 .5
IV 17 4*6 j 65 6.5
V 6 1 .6  i 60 6.0
VI 1 0 .3 29 2.9
VII 20 5.4 69 6.9
V III 36 9 .7  ; 98 9 .8
IX 5 1 .3 25 2.5
X 5 1 -3  j 8 0.8
n 3 0.8  ! 6 0 .6
XII 1 4 0 .8  1 14 1 .4
m i 4 0.8 8 0.8
XIV 6 1 .6  1 45 4 .5
XV 1 0 .3  j 1 0.1
XVI — -  1 4 0 .4
XVII - )t 8 0 .8
XVIII 4 0.8  j 24 2.4
XIX 4 0 .8  1 16 1 .6
XX 3 0 .8  j 11 1.1
XXI 3 0.8  1 13 1 .3
XXII 4 0.8  ) 16 1 .6
XXIII - ! 3 0 .3
XXIV 1 0.3 1 3 0 .3
XXV - 2 0 .2
XXVI — -  1 - -
XXVII 1 0 .3  i 2 0 .2
XXVIII 5 1-3 9 0.9
XXIX 2 0 .5 5 0 .5
XXX - 1 2 0 .2
XXXI 2 0 .5 3 0 .3
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APKSSDIX I I I 213.
Sho'siing th e  number o f d eath s and th e  f a t a l i t y  r a te s  o f  a l l  Types.
TYPE MALES FEMALES MALES & FEMALES
No .o f N o.of ; Fat.Rate No.of No. o f Fat.Rate N o.of No. o f Fat. Rate
Cases Deaths : * Cases jDeaths : % Cases Deaths ! %
i  ! 63 4 : 6 .3 24
1 11
| 1 ; 4.2
00 5 5-7
H  j 96 10 i 0.4 32 6 ; 18.8 128 16 12.5
III | 10 1 10.0 j 8 0 0 .0 18 l 5 .6
IV I 10 0 0 .0 7 0 0 .0 17 0 0 .0
v I 4 0 0 .0 2 0 0.0 6 0 0 .0
VI ♦ 1 0 0 .0 1 0 0 .0
VII ! 14 1 7.1 ! 6 0 0 .0 20 1 5.0
v n i 22 1 : 4-5 14 1 7.1 36 2 i 5,6
IX 1 0 ° - ° 4 0 0 .0 5 0
0 .0
X 2 0 0.0  1 3 0 0 .0 ! 5 0 0 .0
n 3 0 0 .0  | - - - ! 3 0 0 .0
H I 2 1 50-°  I 2 0 0 .0 i 4 1 25.0
xm 1 0 0 .0  | 3 0 0 .0 4 1 0 0 .0
XEV 5 0 0 .0 1 0 0 .0 6 S 0 0 .0
XV - 1 0 0 .0 1 0 0 .0
XVI - j _ 1 - - - ” — 1
XVII _ i — . - - - -
1
xvm 2 0 0 .0 2 0 0 .0 4 0 0 .0
XIX 1 1 0 0 .0 3 0 0 .0 4 0 I 0 .0
XX 2 0 0.0 1 0 0 .0 3 0 0 .0
XXI 2 1 0 0 .0 l 0 0 .0 3 0 0 .0
XXII 3
!
1 33.3 l 1 100.0 4 2 50.0
xxm — _ _ : - - - * -
XXIV — — 1 0 0 .0 1 0 0 .0
XXV — - - - - - -
XXYE _ - - - - -
xxvn 1 i 0 0 .0 - - - 1 0 0 .0
xxvm 3 I 0 0 .0 2 0 0 .0 5 0 0 .0
xxix 1
[
1 0 0 .0 1 0 0 .0 2 0 1 0 .0
XXX ... i — — - - _ 1i —
XXXI
i "
2 0 0 .0 2 0 ] 0 .0
xxxn j * — - - - -
i —
xxxm !
J -Z ____ - -




Shovdng th e  in c id en ce  o f  B acteriaem ia among a l l  cases and among dea th s .
  A ll Cases-_____________
No. o f  'No. w ith  % w ith
iCases B acteriaem ia B acteriaem ia.
I 87 ! 9 10.3
II 128 ! 42 32.8
III 18 i 0 0 .0
IV I 17  i 2 11.8
\
V 1 6 1 16.6
VI j 1 i 0 0.0
VII 1 20 j 2 10.0
VIII I 36 1 4 11.1
IX S 5 0 0.0
x ! 5 0 0.0
XI I 3 0 0.0
XII | 4 0 0.0
• n i l  j 4 0 0.0
1 n v  | 6 1 16.6
XV I 1 0 0.0
XVI I - - -
XVII — - -
XVIII 4 0 0.0
XIX 4 0 0.0
! XX 3 0 0.0
x n 3 0 0.0
XXII 4 0 0.0
XXIII — - -
XXIV 1 0 0.0
XXV - - -
XXVI — - -
XXVII 1 0 0.0
XXVIII 5 0 0.0
XXIX 2 0 0.0
XXX — — -











































Showing th e  F a ta l i ty  Rate in  cases w ithout and w ith B acteriaem ia.
j
TYPE Cases without,
Bacteriaemia. Cases with Ba
No. o f | 
Cases
No. o f  
Deaths.
F a ta lity  Rate No. o f  
C a a e a




4 ! 5 .2 9 1
II 86 I 1 1 .6 42 15
III 18 1 5.6 - -
IV 15 0 0.0 2 0
V 5 0 0.0 1 0
VI 1 0 0.0 - -
VII 18 0 0.0 2 1
VIII 32 - 2 6.3 4 0
IX 5 i 0
0 .0 - -
X 5 ! 0 0 .0
- -
n 3 | 0 0 .0 - -
XII 4 | 1 25.0 - -
n n 4 i 0 0 .0 - -
XIV 5 0 0 .0 1 0
XV 1 0 0 .0 - —
XVI - - - - -
XVII - - - -
XVIII 4 0 0 .0 - -
n x 4 0 0 .0 - -
XX 3 0 0 .0 - -
XXI 3 0 0 .0 - —
XXII 4 2 50.0 - —
XXIII - - - —
XXIV 1 0 0 .0 —
1 xxv - - -
XXVI _ - - —
XXVII 1 0 1 0 .0 - —
XXVIII 1 5 0 1 0 .0 — -
XXIX 2 0 1 0*0 - —
XXX 1 _ I —
XXXI ! 2 0 0 .0 —
XXXII _ — I -
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Showing th e  d a ily  leu co cy te  counts o f  l 6 l  p a t ie n ts ,  
expressed in  thousandths to th e  n e a re s t  p la c e , during  
th e  p e rio d  o f  su lphapyrid ine  ad m in is tra tio n .
Cases Nos. 1 - 39 are  lype  1 in fe c t io n  &
tt 40 - 93 « " 11 it
11 94 - 104 « « 111 n
ti 105 - 161 " Group IV n
DAI IN HOSPITAL
Case 8No. 1 2 3 4 5 6 7
1 16.4 5*2 10.4 25.0 23.O 20.0 18.2
2 — 15.0 16.4 19.0 19.0 27.O 16.0 22.03 8.4 6.8 6.6 2.8 4.6 4.0 7*0
4 10.4 7.6 5*2 6.4 11.4 6.8 8.6
5 13.8 9.0 8.4 5.6 11.0 10.2 13.O
6 a .4 13.0 6.6 6.6 8.0 7-6 8.0
7 '21.0 a.o 7.0 7*0 5*5 7*0 8.5 7*08 23.0 20.5 20.0 16.5 9*0 11.0 8.0 9*0
9 18.0 8.0 9.0 6.0 7*5 10.0 7*010 10.0 9.5 6.5 7.0 3.0 5.5 6.011 16.0 15*5 16.0 15*5 7.5 8.0 6.012 16.0 22.5 20.0 8.5 10.0 14.0 12.0
13 _ 11.0 9.5 7.0 5.0 6.0 11.0 10.0
14 31.0 13-5 9*0 10.0 4.0 6.5 7*0 9*0
15 — 27.0 15.0 8.0 8.0 7*5 9.0 8.0
16 L - 13-5 6.0 5.0 7*0 9.0 7.5 10.5
17 13.0 15.5 15.5 14.0 14.0 9*0 8.018 a .5 19.0 i i -5 7*0 8.5 8.0
19 ...* 7.5 6.5 12.0 11.5 13*5 9.5 10.020 — 19.0 9*0 5.0 7*0 9*5 11.0
a 23.0 13.0 7.0 7*0 10.5 8.0 3*5
22 16.0 9.0 13.0 14.5 12.0 8.5 8.0
23 12,0 7*5 7.2 14.0 14.5 a.o 13.024 _ 10.0 9.4 11.0 13.0 10.0 12.2 12.025 14.0 14.0 16.0 13*5 13.0 13.0 12.5~~26r 25.O 3L.0 38.0 18.5 18.0 a.o 16.5
27 18.0 15.0 9.0 7*5 7.0 7*5 !3*528 19.0 12.0 10.5 7*0 8.5 10.0 13.0
29 I6.5 12.0 23*5 19.0 20.5 15.5 16.0
33 15.0 9.0 7.5 11.0 8.5 14.0 10.0
3L 12.2 10.6 7.8 8.6 8.0 9*2
32 8.0 8.5 8.0 8.0 6.5 5*5
33 8.0 6.0 7*0 8.5 5.0 3*5 4.0
34 — 27.5 10.5 8.0 8.0 5.0 5*5 4.0
35 10.5 14.0 6.5 6.0 7*o 8.5 5.0/  —
36 — 5.0 6.5 10.0 6.5 6.5 7.0 6.5

















No 1 2 3 4 5 6 7 8
38 11 .5 13.0 9.0 8.0 11.5 7 .5 7.0
3 — 12.0 11.0 12.0 20.5 19 .O a . o 33.0
40 10.0 8 .6 5.0 4.0 6 .4 8 .4 7.4
41 9 .2 11.2 10.6 9 .6 13.6 10 .4 8 .4- -42
43
10.8 20.2 8 .2 16 .4 12.6 15.0 10.0
9 .6 12 .4 9.0 7.0 6.0 9 .4 6.8
44 — a .o 15 .6 7.6 4.4 7.6 14.0 13.4
45 — 14.0 12.0 7.5 15.5 27.O 36.5 a . o
4 6 — 10.0 7 .5 10.5 8 .5 8 .0 5.0
47 — 15.0 8.0 5*5 6.5 5.0 5*o 7*o
48 — 15.5 9.0 5.0 10.5 6.0 10.5 8 .5
49 27.5 12.0 5.0 4.5 5.0 5*0 5-5
50 — 14.0 13.0 6.0 19.0 4.5 7*5 8.0
51 _ 6.5 12.0 11.0 8.0 14.0 14.0 17.5
52 — 12.0 13.0 22.0 21.5 a .o 17*5 28.0
53 __ 16.0 11.0 12.0 15 .O 12.0 9*0 8 .5
54 — 19 .5 13.0 8 .5 10.0 10.0 6 .5 7*5
55 — 13.0 6.0 7.5 5.0 5.0 6 .5 4.056 10.0 8.0 4.0 5*5 4.0 5*5
57 17.0 16.5 11.0 10.5 10.5 10.5 11.0
. 58 — 19.0 19 .5 10.0 13.0 22.5 16.0 19.0
59 — 9.0 10.0 22.5 9.0 12.0 14.5 11.0
60 — 12.0 17.0 33.0 16.5 12.0 10.5
61 11.5 10.0 10.5 7 .5 9.0 8*5
62 — 9 .5 7.0 10.0 7.5 8 .5 10.5 10.0
63 — 18.0 10.0 14.5 22.0 15.5 8.0
8.064 — 6.0 5.0 4.5 6 .5 3.0 5.0
65 — 12.0 10.5 10.0 13.0 11.5 12.0 11.5
66 _ 15*5 10.0 18.5 14.5 18.5 13*5 10.5
67 _ 10.0 7.0 7.0 7.0 10.5 5*0 7.0
68 11.0 11.0 10.0 13-5 11.5 10.0 9*o
69 27.O 18.0 8.0 9 .0 11.0 15.0 13.0
70 _ 7-0 7.0 6.5 13.0 a . 5 a .o 17.0
71 7.0 4.0 7.0 7*5 7.0 7.5 6.0 9*0
72 25.0 27.0 20.5 34.5 14.0 14.0 8.0 7*0




10.0 7.8 7.6 8.0 8 .2 8 .6
12.576 a .o 18.5 19.2 23.0 20.0 16.4
77 _ 12.5 13-0 14.2 10.6 14.0 7*2 20.578 16.5 a .o 18.5 19.4 20.0 22.4
79 . 8.0 8 .6 9 .2 7.6 10.0 8. 2 9 .4
80 27.5 26.0 24.0 26.2 27.2 31.0 7.681 10.5 10.0 8 .4 8 .6 8.2 7.0
82 m 10.2 9 .8 8.0 8.0 10.0 9 .2 7 .683 15.0 14.2 10.0 9 .8 8 .4 8.2 8.0
84 12.5 13.0 10.5 8.0 7.6 8.0 7.4













8'No 1 2 3 4 5 6 7 9 10
86 _ 16.5 9.0 8 ,5 6.5 7.0 3-0 6.0 7*0 5-5
- J 7 j_ _ 10.0 3.0 7.0 7.0 8.0 8.0 6.0
1 T F  i — 22.0 7.0 5-5 6.5 3-5 10.0
|  89 — 9.0 11.0 4.5 6.0 7.5 8.0 9*0
ir 90 — 6.0 5.5 5.0 5-5 5-5 4.5 4.5 5*0
91 — 8.0 7.5 12.5 10.5 12.O 12.0 11.0
92 — 13.0 12.0 8.5 9.0 7.0 8.0 8.5
93 — 10.0 12.5 6.5 25.O 95.0 57*0 51.0 59*0 49.Oa % — 15.5 13.0 17.0 11.5 21.0 27.0 27.0 22.0
95 — 12.0 10.5 12.0 13.5 13.0 8.5 8.0 8.0
J 6 — 7.5 9 .5 9.0 9-0 7.0 5*5 7*0
97 — 6.0 6.5 6.0 9.8 9.0 8.0
' 98 — 9.0 4.5 7.0 6.0 6.5 10.0\ 99 — 5.0
100 7.4 5.6 8.4 9.2 6.6
8.0flOl ; — 33.0 14.5 11.0 13.0 7.5 7-0'
,1102 10.0 10.0 9.5 5-5 6.0 7*o 8.0
fi03' _ 25.O 8.0 6.0 6.0 5-5 8.0 5*5 7*5 6.5
[104 5.0 5-5 9.0 8.5 6.5 7*5 7*0
3 105 _ 12.0 11.2 29.O 23.0 15.0 11.4 15.6
! rio6 12.5 5*5 . .5-0 25.O 13.5 12.5 9*5
3107 14.0 8.5 16.0 8.0 3.0 11.5 8*5\ 108' —. 17.0 7.5 10.0 6.5 14.5 23.0 11.5 8.0109 11.0 7.0 6.5 6.0 7.0 6.0 5*5 7*0
110 — 15.5 8.5 6.5 8.5 7.5 8.0 4.5 4*5 7-5
jL 111 — 20.5 15.0 14.0 7.0 13.0 12.0 9*0
10.0ii 112"' 14.0 19.0 11.0 9.5 4.0 6.5 5*0
'.113 ! 17.0 10.0 8.5 7.0 6.5 8.5 9*5
114 ; 14.5 7.5 5-5 9.0 8.0 14.5 16.0
;.U 5..i" _ 10.5 8.0 8.5 17.0 15.5 16.5 18.5
116 I5.5 9.0 7.0 9.5 11.0 10.0 13*5
1,117 4.5 9.0 8.0 10.5 16.0 11.0 9*5 9*0
IU8 6.0 4.5 5.0 7.0 ..7-0 9*o 11.0
i'LU9 9*5 6.0 8.5 7.0 4.5 .-5-0 - 4.0 3*5 4.5 5-5.120 10. *5 9.5 9.0 5.0 4.0 5*5 9*5 11.5
|-.ia 4.5 4.0 9.0 7.0 10.0 11.5 12.0
___l22
-/
14.5 17*5 11.0 10.5 8.0 7*5 7*0 9*0
■J& 11.0 8.0 5*5 8.5 4.5 7*0 5.0/  _ 3*5
12.0 4.0 4.5 3*5 5.0 3.0 7.0
125 y 5*5 6.0 4.5 4.0 7.0 11.0 6.5126 _ 21.0 9*5 7.5 4.0 6.5 4.0
1^ 7 _ 13.0 14.0 7.0 8-5' 9.5 11.0





































































































































4 5 6 7 8 9
9.0 7*0 7*5 6.5 4 .5
6.8 6.0 13.6
5.6 5.6 .5-J 6.8 5.0
7.2 8 .2 7.6 -L
9.0 4.5 6.0 T  6 .5 5*0
7.0 2.5 6.0 7.5 5*0 5.0
4.5 4.0 3*5 4.0 3*5
12.5 5*o 12.0 11.0 15 .O 11 .5
8.0 15.0 8 .5 5.0 12.0
5.0 4.0 4.5 6.0 7*5
5.0 8 .5 4.5 9*o 10.0
9.0 6.0 5*0 6.0 9*5
9.0 4.5 3*5 12.0 10.0
5-5 6.5 7*0 9*o
3.0 4.0 4.0 5*5 4*5 3*5
6.0 5*5 8.0 7*5 8 .5
3.0 6.0 5*5 6.0
4.0 10.0 7*5. 7*5
5*0 4.0 6.0 5.0 5*0
5*5 13.0 10.0 9*5 9*0
8.0 9*0 8 .5 10.5 8.0
9*0 9*0 8.0 7*5 8 .5
4.0 5.0 12.0
6.0 5*5 8.0 9 .5
12.0 9.0 5*0 7*0 3*5 7*0
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AHHBBPC XII*
Showing th e  r e s u l t s  o b ta ined  in  a study o f  the  
ab so rp tio n  and ex cre tio n  o f  su lphspyrid ine 
adm in istered  to  l 6 l  cases o f  pneumococcal lo b a r  
pneumonia.
1 . D aily blood le v e l  in  mgm. p e r  100 c .c .
2. D aily u i in e  le v e l  in  mgm. p e r 100 c .c .
3 . D aily f lu id  in ta k e  in  ozs.






s p i t a l
per 100 c .c .
6 7 8 9 10 1
URINE LEVELS mgm. per 100 c . c .
2
Day in
4 6 7 8 9 10
1 -  3 .7  7.4  4.0  4 .6  4.9

















4.3  6.1 6 .6  5.0 4.4  
2.9 4.8 2.0 1.8  1.1
25.4 6.1 7*8 6.









6 .7  4.6
-  8 .5 U .4  6 .6  5.9 5.0 6 .5
-  4.1 2 .2 1 .9  2.8 3 .4  l . o
7
8
9 -  4.9  5.4  4.7  4 .7  7.1 4.0
10 -  1.7  1.8  4.0 3 .7
i l l  -  -  0 .8  1 .7  2.9





4.1 4.0  4.4  4.5
)
C .  
2.1 1.8-  2.7 3.9 2.8 1 .7
-  2.3 4.4  4 .3  2.4  2 .2  2 .2
-  3 .4  6 .7  7.0 3*9 4.8 5.6
-  1 .9  5.0 2.1 1 .4  1,8  1.1
-  3 .7  2.4  1.7  1 .0  1 .8  1.517
18
•  •  • ■ 4 .  •  - •  -
19 -
20 -








2.3  4.8  5 .6  5.2
3 . 1 :3-3  5 .3  5.5  





2.9  3.0 1.1
1.9
1 .7
O.5 1 .3  1 .4  1 .2  1 .4  1 .5
2.7  5.6 5.3  3.9  3 .3  3.8
-  3.3  3.0 4.7  5.0 4.2
-  1 .9  3.3 1.3  1 .
2 . 2
1.8
4 .2  2.2  1 . 2
3 .3  2.8 1.7  0 .9  2.1 0 .9
1.8  2.6 2 .3  7 .2  2.2
« •  • •
1 .9
-  5.0 6.1 7.1 4.9  5.6 4 .9  5.5
0 .8  1 .5  1 .61 .2  1 .5  1 .7  1 .4
2.9 2.8
1.8
3 L  -
32 -
1 .4  2.5
2.6  1 .4
1 .7  1 .2
4.2  5.7  5-0 5 .3
2.9 1 .6  1 .4  1 .5
-  7 .6  9-4  7 .6  7 .4  6 .5  7-3
-  5.4  8 .0  7 .6  8 .8  9.5  6 .5
35 -  5 .4  6 .1  6.1 5.6 4 .3  4 .5
-  5 .6  5.1 6.8 6.8 6 .7  9 .1
-  4.0  7 .2  8 . 131.4  7 .3  8 .8
-  5.0 4.7  4.2  2.0 1.0
-  4 .5  7 .3  7 .2  7 .3
















6.8 4.7 7 .4  5.6
-  2.8 5 .2  6 .5  7.0
-  3.0 4 .5  3.9 2.9
-  1 .0  1 .6  2.1 3.2
-  3 .6 4.1  1 .7  1.1  
- 2 . 2  3.9 4 . 4  4.0
2.2 1 .3  1 .2  1 .5











1 .3  1 .4  
2.9  2.2  1 .6  








1 .450 -  2.8 4 .2  5.8
51 -  4 .5  4 .6  3 .6  4.7 3.8 5.5




66 161 137 78 124
74 114 97 100




79 109 74 49 44 20
35 95 192 200 182 137
108 159 200 155 93 83
48 100 166 55 149 312
95 74




















51 102 119 111 82 105 














17 93 108 13L 76 
71 110 96 200 121 59








































-  80 119 103 105 108 50
35 65 58 68 114 97
70 185 143 115 128 98
-  23 57 97 185 92 64
49 104 169 143 286 185





89 175 400 
5655 70  53 
87 133 166 185 147 
22 137 147 ill 83
.25 238 250 188 143
49 90 103 125
43 125 254 182 100


















68 100 114 143 166 149
20
87 99 122
10 66 77 5
166 178 91
127 193 130
; 54 48 40 64
FLUID INTAKE, ozs. per diem.
I 2 3 4 5 6 7 8 9
22 96 85 90 65 90
-  79 8 6 75 78 86 70
62 90 98 79 96 65
51 168 86 86 85 81
64 85 69 89 63 63
68 68 90 83 77 77
84 130 99 116 109 77
15 91 94 88 127 68 73
78 101 78 90 87 72
43 107 86 88 76 73
-  -  86 94 100 102 86 88 92
41 97 108 127 115 82
72 102 108 107 87 100
L27 96 108 92 82 78 86
30 73 81 74 76 83
18 94 78 87 74 68
27 79 58 72 80 75
16 87 136 87 76 65 60
8 104 94 92 86 92
50 98 96 72 65 85
48 85 87 102 91 102
40 91 97 103 79 82
47 109 94 91 89 84 66
76 86 71 70 77 89 104
22 90 95 72 79 69 92
40 104 102 102 65 102 90
32 85 93 87 104 82 94
47 89 81 69 52 61
— 106 58 88 8 l  113 90
46 90 87 89 94 92
— 56 86 90 92 74 70
24 50 66 64 86 60 68
— 56 74 40 36 57 67
36 109 68 110 54 69
— 64 44 71 54 86
— 36 86 64 64 60 64 66
20 76 92 76 71 48
— 43 70 71 47 64
— 62 69 56 54 74 74
36 35 86 69 60 64 60
32 90 70 90 71 84
47 71 86 72 74 84
66 52 101 92 106 70
47 80 75 65 85
78 101 95 96 98 103 86
86 90 92 95 81 66 66
44 75 118 i l l 93 86 78
26 39 96 87 71 44
66 62 74 102 77 76
•79
/ i - 93 94 82 74 66 67
42 76 106 68 85 75
71 140 98 112 156 111 100 111
226.
URINE OUTPUT, ozs. per diem.
Day in  H ospital.
10 1 2 3 4 5 6 7 8 9
19 65 64 44 74 77
48 56 58 50 56 56 
48 62 57 61 74 52
34 97 80 75 56 74
60 49 49 51 36 51
52 54 53 76 46 55
35 68 60 37 71 49
6 44 37 40 35 40 28
37 57 70 70 54 86
16 34 27 46 42 52
72 -  -  40 49 77 66 66 62 68
20 40 59 76 75 65
34 40 55 46 58 45
75 61 50 72 64 65 66
14 48 40 52 50 55
8 43 47 65 67 44
16 79 24 78 52 50
9 40 4 2 54 54 63 41
72 36 42 40 64
3L 56 69 47 59 88
24 46 44 56 58 64
16 80 61 50 62 49
25 52 48 57 65 52 56
56 67 47 36 48 33 45
.17 37 27 44 32 76 40
25 45 50 51 50 45 41
20 48 56 56 56 54 56
18 60 55 37 30 36
47 33 37 34 102 64
30 59 62 3E3 52 67
76 54 52 62 55 53
51 10 25 78 16 34
23 32 31 20 45 40
4 42 53 40 40 57
-  31 33 31 23 12
-  18 45 33 30 37 43 43
45 36 49 65 17
5 P  37 33 25
38 37 44 36 50 48
24 26 52 54 41 52 42
24 45 68 80 56 56
37 71 50 48 62 60
38 40 46 78 51 44
30 42 56 40 48
6 7J 46 18 28 39 41
30 68 66 64 70
18 61 47 55 61 59 67
12 37 3  44 34 42
19 4~ 40 77 36 34
50 8 4 45 60 56 58 51
17 5 ‘ 61 59 56 53
j 40 52 87 7'* 65; 90 68 54
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1 .6  2.1 l . l  1 .5  2.0 1 .3  
4 .9  6 .9  5 .6  5 .7  6 .5  5 .4
1 .5  2.0 1 .7  1 .6  1 .8  1 .9
2.^ 1 .7  2 .4  1 .9  1 .5  1 .7
2 .8  1 .4  1 .4  1 .3  1 .2  0 .8  
0 .8  2 .0  2 .4  1 .8  1 .3  3 .2  
1 .4  2 .2  1 .1  1 .1  1 .8  2 .5
1 .8  3.O 4 .0
5 .3  5.3. 2.8 1 .8  2 .1  2.8
3 .4  3 .4  3 .3  3 .7  2.1 2 .6
1 .3  3 .4  1 .5  1 .4  1 .4  1 . 1 .
3 .8  5 .5  3-9  4 .2  4 .5  5.0
3 .4  5 .0 4 .3  4 .6  2 .9  1 .5
2.9 5-5  5-1  4 .9  3*9 4 .3
2 .6  4 .6  6 .1  5*6 7*1 5*2
3 .3  3 .6
4 .1  5 .5  5 .3  4 .1  4 .1
5*9 4 .7  3*3 2.9 2.5
1 .7  2 .4  1 .9  2 .1  2 .6
4 .3  3*5 3 *6 ; 2 .3  1 .9  
> 1  6 . 6 3 . 4 : 4 . 2  1 .4
"2*5 ..7 :.” . 0  7
3 .4  3 .1  3 .1  1 .8  1 .3
2 .5  3 .1 3 .6  4 .1  2 .5
2 .6  2.0 1 .4  1 .5  1 .2
7 .6  8 .3  8 .0  4 .2  3 .6
4 .0  4 .0  2.0  2 .0  3 .6
3 .3  4.7 3*5 1 .7  2.0
4.6  7 .0 7 .0  8.6 3.8
2.9 3*9 3*1 4 .2  3 .2
2 .6  3 .2  5 .9  3 .8  1 .6
5.1 4 .8  6 .1  4 .4  4 .2
2 .5  4 .5  3 .0  1 .5  1 .3  
5.3D .O  8 .6  5 .2  7 .1
1 .4  1 .1  0 .7  0 .5  0 .7
4 .9  6 .1  8 .0  6 .5  5 .7
4 .6  6.7: 5 .8  4 .7  3*3  1 .8  
7.2. 8 .3  6 .6  6 .4 1 0 .0
7 .1  7*5 6.8 8.0 6.8
3*7
2 .5
1 .9  1 .6  1 .4  1 .5  











4 .5  6 .6  8 .0  
0 .7
.106
2.8 3 .7  3*5 2 .5  3 .2
2.0 2 .6  3 .7  2 .3  1 .9
3*5 4 .3  3*5 1 .8  1 .7
-  1 .4  5 .0  5 .2  5 .5
5.1 6 .9  7*6 7*8 6 .7
1 .1  1 .0  0 .5  0 .7  0 .8  0 .7
8.8
LO.4 1 3 8 i l .  413.1
3 .7  3 .6 :2 1 . 1 .8  1 .6  2 .5  
4 .0  7 .6  8 .7  6 .2  7 .0 5.1
4 .7  6 .9 1 5 .9  6 .4  8 .5  5 .4  4 .6
5 * 5  & * 5 ; 0  S :5:100! 9*3
5 . 216 . 5 1 4 .3  4 .8  3 .0 3 .7
1 .3  j l .  51 4 .4  1 .3  1.1; 1 .3
6.6
1 . 2
2 .4  5 . 4 D .9  H.4  
2.1
1 .4  2 .3  1 .6
-  15 49 52 34 33 33
-  69 60 140 182 166 145
-  30 59 54 93 63 58
-  25 34 3L 76 39 66
44 37 28 40 48 19
-  12 75 92 120 75 59
3 51 62 78 75 58
7 45 120
-  27 .95 _.73 42 45 33
-  65 112 122 128 95 81
-  18 61 77 60 50 64 ___
-  12 72 82 81 147 143
6 47 43 104  61 41
2 80 156 161 159 135
-  16 80 100 90 143  149
-  14  51
-  77 81 94  100135 137 
140 118 101 67 56 63
8 38 69 48 67 119 126 118 n
72 64 76 95 66 56











113 90 100 91 65
50 63 83 157 76
21 42 33 13 12
51 74 185 121 96
41 68 51 47 38
44 66 81 87 56
50 84 337 181 117
128 126 149 120 153
29 107 120 210 112
185 164 169 222 250
30 76 80 74 40
78 192 375 222 149 145 105 85 
53 48 56 49 43 51
38 14-7 166 222 200 
24 54 71 100 95 36 
6 5 1270 275 312 239 
125 163 167 156 172 149 
67 67 76 64 72 80
3 > 50 57 43 40
5 48 57 50 65
5 64 87 42 78
6 38 84 147
18 122 164 147 115
33 37 42 28 26
5°188 182 156 312
60 83 100 105 125 111
100 199 277 217 285 263
50 85 150 178 238 200 76
100 144 66 40 ^
5 60 9 5 95 111 95 
2H07 126 107 100 85









61 90 97 92 87 84 
103 75 71 50 65 70 
46 82 87 74 65 64 
84 112 105 100 102 100 
17 116 113 78 82 10 40 
52 82 87 96 95 70 
42 105 90 124 96 62
37 10 79 95 100 88
28 83 88 96 82 72 81 
-?*. 84 87 70 86 68 
56 74 115 95 90 84 
72 80 104 100 90 82 
23 98 86 88 104 101 
45 64 96 105 93 84 
32 80 101 92 66 55 
60 88 68 138 96 70 102
48 114 104 116 101 122
60 95 92 90 106 106
12 109 114 99 105 104 64
78 74 98 91 112 93  100
14 137 72 93 104 70 58
_ 70 90 86 82 88 88
- 65 96 84 73 76 74 .
80 96 100 82 85 73
— 62 76 80 78 61 69
- 80 105 92 84 89 78
- 26 97 92 86 78 89
96 88 85 72 55
95 85 110 102 98 78 67
- 80 105 110 96 89 74
— 88 120 89 92 96 91
— 80 92 78 72 68 66
- 65 63 45 54 40
— 60 60 68 70 70
28 28 69 36
_ .86 62 84 84 63
— 10 97 86 100 68 96 98
- 87 80 85 77 64 5°
- - 21 27 35 54 62
64 110 80 140 120 105 102 88
45 120 87 94 95 86
29 133 105 88 75 86 80
18 112 102 84 56 86 86
60 90 86 100 98 72106
54 72 66 86 75
3D 40
36 33 12 80 88 75
-  80 52 40 64 62 66
15 32 49 47 54 56 44
33 99 86 82 81 79 46
5 2 1 0 3  86 92 90 95 78
77 75 92 65 70 48
40 91 92 95 83 80 82
s i  91 94 101 84 80 85
22 7 .
9 10 1 2 3  4 5 6 7 8 9  10
32 58 55 57 65 86
'■' 25 ' 45 45 53 37 47
24 "“ 39 55 48 52 68
46 66 61 ’ 60 79 86
16 48 53 58 49 52 42
10 44 48 55 61 56
17 48 48 46 39 51
27 52 48 47 38 55
-  59 56 48 50 52 62
-  41 46 58 81 71
33 38 38 45 46 51
21 66 80 61 54 85
18 52 48 52 58 56
12 33 60 58 62 78
16 57 63 45 50 50
3 26 16 32 19 26 39
15 60 67 59 43 56
36 62 60 54 88 80
38 65 75 65 64 75 40
36 33 26 32 70 62 64
49 50 46 53 4 2 46
-  38
54 62 66 63 59 58
-  44 60 55 52 49 64
40 62 48 5? 51 47
39 48 54 52 48 53
40 58 52 48 46 44
20 54 66 50 38 48
19 58 54 48 46 45
57 42 63 66 48 62 61
42 54 60 53 57 41
46 64 59 63 62 60
42 48 54 49 43 40
20 34 42 38 53 43
33 36 ~4> '4  39
19 18 18 49 39
-  35 43 25 40 46
72 62 38 62 39 19 80
52 24 33 40 54 47
-  -  24 33 22 26 23
22 61 52 74 36 55 6<
17 53 53 61 35 32
20 66 51 44 50 52 40
12 44 47 32 42 50 38
32 50 40 58 62 55 56
-  48 46 62 30 34
10 61
23 33 8 15 21 40
36 16 14 44 24 46
12 i  33 27 37 34 39
8 24 19 31 71 65 32
48 60 40 80 62 56 62
54 50 48 47 5? 48
36 68 52 63 61 64 98























































2 ^ 4 5 6 7 8 9  10 
2.6 5 .4  3 .5  2.1 2.2 1.7
4 .3  8 .7  6 .4  8 .0  8 .3  7 .6
5 .3  4 .4  4 .6  4 .2  5 .0  3 .6
4 .8  6 .2  6 .5  3 .0  4 .1  2 .6
4 .5  5 .8 3 .4  2 .6  3 .4  4 .0
3 .5  4 .6  3 .2  5 .0  4 .0  4 .2
3 .0  4 .5  2 .6  3 .7  3 .0  4 .2
5 .5  8 .8  6 . 8  7 .7  0 . 6  4 .0
3 .4  2 .6  2 .3  2 .4  1 .5  0 .6
2.6  4 .4  6 .7  5 .4  4 .4  5.1
3 .2  3 .4  4 .0  2 .7  3 .0  3 .7  
'5.5 7*1 8 .9  4 .1  8 .6  6 .1
2 .6  2 .0  2 .1  1 .7  2 .3  3 .4
2 .6  21. 1 .2  2 .8  1 .5  1 .3
2.9 6 .0  3 .7  6 .5  5 .0  4 .7
1 .7  4 .7  3 .3  5*8 5 .8  5 .4  5 .7
5.1 6 .1  6 .8  7 .6  7 .4  6 .1
3 .7  3 .2  6 .4  8 .4  7 .1  6 .0
2.1 3 .3  2.1 2 .1  1 .3  1 .0
2.9 4 .3  3 .5  1 .3  1 .1  1 .3
2.9 6 .8  5 .3  4 .1  2 .8  2 .9
4 .3  4 .0  4 .7  3 .4  3 .5  3 .7
4.1 6 .8  6 .1  6 .5  7 .3  5 .3  
0 .5  1 .8  1 .1  1 .7  1 .4  1 .4
2.3 9*2 7.3 7 .7  6 .3  5 .9  5-1 5 .9  4.8
4 .3  4 .2  3-5  3 .5  3*3 1-8  21. 3-5  3-6
2.2  2 .6  2 .1 1 .2  1 .5  1 .4
5.1 8 .0
5.1  5 .8  8 .6 1 0 .0
4 .7  6 .5  3 .2  1 .7  1 .7  3 .% -
1 .2  4 .4
5.9 6 .0  6 .3  6 .5  4 .5  4 .3
5.8 9 -6  5 .8  9 -2  8 .0  9 -4
3.8 3 .3  6 .2  6 .5  5 .9  5 .9
4 .6  6 .1  8 .8  7 .6  7 .3  8 .0
4.1 9 .4  3 .8  6 .8  5 .2  5 .4
4 .1  5 .8  3 .8  6 .9  5 .2  5.0
1 .8  4 .0  3 .1  1 .7  3-6  3 .3
4 .9  7 .4  7 -3  6 .9 D . 810 .0
6 .5  9 .5  8 .3  7-6  7-0 7-6
4 .8  5 .4  7 .7  6 .6  6 .3
7 .2  6 .7  6 .0  5 .6  4 .1  6 .8  5 .4
3.9  4 .3  5 .6  3 .8  6 .5  6 .0
6 .2  6 .2  6 .6  7-2
2.8 4 .3  4 .2  7-9  4 .6  2 .5
4 .2  5.0 5 -3  2 .9  3 -3  4 .9
2.0 2.6
3 .8  1 .8  2 .3  2.0 2 .7  1-5
5 .2  6 .1  6 .8  5-6  4 .8
5 .7  5 .3  4 .3  4 .6
3 .6  6 .6  7-3  4 .5  4 .1  3 .2
3 .8  4 .3  4 .5  3 .6  2 .6  4 .1  3 .5  3 .6  4 .6
6.1  D . l  3 . 910 . 5 1 L 4 1 L 9
2.1  4 .1
2 3 4 5 6 7 8
10 125 167 167 93  20 
50 6l 13? 200 100 250 
58 97 166 128 177 111 
63 143  152 122 139 65
4 73 81 38 125 153 
7 212 154 192 149 137
33 70 87 100 87 84
41 84 161 217 416 154
2 91 78 54 56 38
5 104 163 74 137 188 
126 82 333 135 1 28 119
6 l 74 161 166 200 147 
136 66 49 34 34 71 
45 73 39 55 55 26 
2 55 34 61 126 32
1 43 100 98 100 135 123
13  166 141 181 144 I33
36 110 92 133  119 141
2 62 91 192 45 20
21 81 133 65 31 38 
2 50 8 3  117 61 72 
75 113  117 111 93  78










46 45 57 57 50
112 128 138 149 114
97 67 77 58 49








93 100 69 116
128 1 72 1 70 .212 158 156
172 208 200 263 200 166
20 106 94 120 200 25O
104 166 285 200 282 181
95 189 166 166 131 200
20 126 I85 170 227 200
10 22 42 59 45 78
38 82 I85 212 150 190
25 312 250 172 263 167
10 137 123 181 144
257 400 285 153 200 333 119
64 175 193 149 227 53
143  192 104 134
41 143  143 105 200 95
77 143 78 97 86 93
34 57
95 82 54 77 42 111
133 232 95 217 181
100 133 97 135
149 200 270 65 31 58
12 115 113 212 107  166 307 208 151
36 147 208 222 270 204
74 110 |
228 .
I 2 3 4 5 6  
30 78 80 86 66 
88 95 85 95 97 102 
97 97 106 115 84 72 
50 111 98 84  83 68 
47 128 108 106 114 78 
7 154 118 84 66 75 
52 84 75 89 83 77 
62 92 102 62
7 8 10
34 99 96 63 74 96
28 94 82 88 60 78
33 72 100 98 96 75
75 87 70 92 99 112
99 HO 93 133 112 113
68 88 82 66 H
74 98 1 24 100 106
123 87 78 58 86
6544 92 94 105 85
55 96 100 84 76 84
22 92 80 71 79 64
16 74 74 94 92 70
57 89 82 87 67
12 72 73 67 70 74
72 88 110 116 77 107
33 80 82 82 92 74
42 97 H 6 74 115 119 133
56 108 87 80 90 75
35 77 44
80 46 78 54 68
34 94 90 68 63
74 134 138 78 60
4651 70 66 44 62
5827 3 - 39 47 38 76
_ 68 90 90 72 62
9830 72 70 96 70 114
73 68 67 69 86 69
41 62 60 79 64 62
56 60 87 82 76 90
80 60 76 70 88 80
— 60 63 43 58 52 64
27 48 28 55 37
6854 86 89 69 79
_ 76 82 86 87 70 72
_ 70 92 86 92
83 78_ 42 65 49 47
_ 72 64 88 60 47 94
21 92 73 73 86 94 110
— 98 74
28
62 102 98 72
53 58 68 48 66 78
14 40 59 65 58 72 88
— 96 52 49 48
5855 56 68 57 45 50
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42 57 65 





















54 40 39 
47 62 68 
10 35 62
38 36 47 
20
54 47 47 88
51 48 54
55 o34 48 44






45 33 51 36 48 
35 27 37
APPENDIX X III.
Showing I .  The mean blood le v e l  in  mgms. p e r  100 c .c s .  , c a lc u la te d  from
estim a tio n s  perform ed on th e  2nd, 3 rd  and 4 th  days in  h o s p i ta l . '
2 . The mean u r in e  le v e l  in  mgms p e r  100 c .c s .
3« The mean F lu id  In tak e  in  ozs. p e r  diem.
4 . The mean U rine Output in  ozs. p e r  diem.
Case No. B.L. U.L. F . I . u .o . Case W0 . B.L. U.L. F . I . U.O.
I 5.0 100 . 75 56 41 6 .0 168 73 552 4 .3 83 79 54 42 6 .3 102 72 55
3 5.7 116 82 59 43 4 .8 125 81 434 ? ‘2 63 93 69 44 3*8 68 70 435 6 .4 140 72 49 45 1.6 48 88 28
6 3-5 126 77 54 46 3*1 54 82 59
7 8.8 138 102 53 47 3*5 91 86 52
8 2.7 82 79 33 48 1.6 60 61 35
9 5-0 93 84 62 49 5*6 123 76 3510 2.5 57 79 36 50 4 .3 102 87 58
I I 1 .8 126 90 62 •51 4 .2 126 75 5012 4 .3 77 93 56 52 3 .0 48 112 62
13 3.1 61 95 46 53 1.6 36 85 5914 3-7 95 95 65 54 5*8 127 72 42
5.7 116 70 43 55 1.7 60 70 47
16 . 3 .0 66 69 44 56 2.1 45 101 66
17 2.6 85 65 36 57 1-9 3^ 86 45
18 4 .2 73 75 43 58 1-7 72 80 46
19 3 .9 85 79 43 59 1.6 55 86 42
20 4.1 109 74 58 60 2.7 57 78 4521 2.9 79 85 49 61 4 .5 52 76 5522 1.1 42 82 53 62 3*4 100 79 60
23 4 .5 104 84 51 63 2.1 55 86 40
24 3*7 91 81 47 64 4 .7 90 90 6l
2 .8 78 74 33 £5 4 .2 47 83 4726 2.6 40 87 44 66 4 .5 115 81 50
27 2 .2 58 82 49 67 4 .4 96 71 47
28 6 .1 168 66 39 68 3*5 32 89 23
29 1-3 30 89 53 69 5*o 104 101 50
30 3*4 96 83 51 70 4.6 91 91 ^3
31 5*0 94 78 , 52 71 2.0 74 95 60
32 2.0 73 60 29 72 3*8 72 92 46
33 8.2 123 55 32 73 4 .4 66 78 41
34 7*0 85 74 3? 74 2 .5 10 56 38
35 5*9 156 64 26 75 3*2 92 84 6q
36 5 .8 182 63 35 76 3*1 85 78 54
37 6 .4 183 64 40 77 2 .0 22 86 50
38 4.0 54 59 26 78 8 .0 97 71 49
39 6 .3 123 65 42 79 3*3 48 88 48









































B.L. U.L. F . I . U.O. Case No. B.L. U.L. F . I . u.o.
6 .2 137 • 7 1 45 121 2.0 49 75 49
3 .3 121 95 57 122 4 .9 52 100 49
3-9 no 90 52 123 3-9 86 86 65
5-3 198 96 59 124 6 .0 130 81 34
3-3 59 76 46 125 5.1 105 82 60
8 .0 169 53 38 126 2.5 69 , 68 48
1 .1 50 83 35 127 3.6 61 69 49
6 .3 129 38 29 128 5.0 64 76 50
5*7 63 76 38 129 4 .3 98 62 38
7 .4 232 88 53 130 5*7 189 95 44
7.1 155 74 41 131 1 .1 43 73 49
8 .5 71 40 25 132 6 .3 121 109 43
3 -2 56 93 52 133 4 .0 6l 98 592.6 50 88 42 134 2 .3 54 83 41
3 .8 £3 85 46 135 6 .6 54 52 24
I ' 9 69 78 38 136 6 .5 81 61 306 .3 113 87 50 137 4.8 84 70 24
0 .8 35 73 44 138 2.8 52 97 47
8 .8 50 35 139 6.1 166 56 Z#
I I . 9 209 63 20 140 7.1 201 45 33
3*1 97 61 30 141 5.1 132 76 32
6 .8 223 42 29 142 6 .5 203 78 35
5 .5 140 72 36 143 6 .4 158 71 43
4 .8 88 85 58 144 5-2 155 61 42
6 .3 77 71 5° 145 3.0 43 75 52
5*3 88 80 83 146 6 .5 143 76 32
2 .4 40 84 57 147 8.1 198 56 43
3 .8 97 68 42 148 6 .0 119 39 19
6 .5 132 94 38 149 6 .6 250 73 50
4 .8 116 95 41 150 4.6 144 74 52
5.8 114 83 56 151 6 .3 143 86 49
4 .9 82 93 46 152 3 .8 121 57 38
3 .8 142 84 60 153 4 .8 92 71 39
3 .4 77 77 50 154 2 .3 45 78 40
7 .0 179 79 48 155 2.6 77 83 36
2 .8 53 77 41 156 6 .0 171 56 37
4 .6 112 72 46 157 5-1 116 57 40
4 .2 78 56 158 5.8 129 61 36
6 .5 135 88 49 159 4 .2 154 59 41
2 .2 65 109 49 160 8 .4 181 43 35
161 3-1 92 59 30
APPENDIX XI?,
231-
Showing th e  r e s u l t s  o f  twenty F ra c tio n a l T est Meals;
(a) f r e e  HC1.
(b) to t a l  a c id i ty




F astin g  Ju ic e |  hour 1 hour l |  hours 2
.......... -------- --
hours 1 2j  hours 3 hours. 1!I
a 10 10 20 20 ! 36 ' 30 10 !
f 11 1 * 92 22 40 40
52 40 81
-.-j ; a  u u xyj \ u u u
S b ! 70 60 50 60 6 6 20
7 7 I  a  T5 1-----45----- — m — I---- 25------------ 18----------- 22------------ Iff
12 I b i 18 ' 8 0  53 ; 44 34 38 20
7 7 i  a  ! 14 ' 18 4 | 0 0 8 0
1-------
I 32 a 0 4 22 b I 16 16 40
36 10 16 10 1 
50 20 34 28
36
a j 0 0 6 
b 1 12 14 20
i A
12 8 4 0 
22 18 16 10
: a  : 16 12 92
3 • b , 80 32 122
60 70 40 30 
72 , 90 74 60
a l 0 0 0
46 ! b j 10 8 8
0 6 4 20 
10 , 20 12 26
cc 1 a
55 | b
12 8 8 
30 22 56
12 0 8 12 
i - 42 | 22 24 22 .;
6 0 ! b
10 24 36 
24 60 64
30 16 20 15 
48 I 46 40 30
75 i % 0 0 0 48 8 12
0
8
0 1 0 0 
6 ; 4 4

















24 20 1 
___5Q. _ , . J
100 [ ? 
1 0






10 0 | 
L„ 5P . .. - 3 6 _____I





8 : 8 ;
-34 i .  . 28 . i
137 ! b
0 0 20 
79 20 L 60
40
80
50 I 70 50 i
90 ! 120 i l l O
! b
0 g 30 
12 28 46
"""'IT i 14 ’ 0
18 30 j .  16 ... . 1
- | a 
146 j b 1§ 20 ^
24
..... 72
6 4 62 
24 ! 20 80
151 !  ! M 12 ^  1 i i t
16
24 i 36 !
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